var title_f10_31_10736="Straight leg raise PI";
var content_f10_31_10736=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F78695&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F78695&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Straight leg raises",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 231px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADnAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1f6cUd+acQDS9P/11xDExzRilxz7Uo6cYpDCjjApcUH8qAG/hRindaXrTAaKMU4dKMZpDsJ6UU7FBFAxoHtTh/kUAUoFAABQBSr1pQOOaBiY4FL096UDmlAHP50AJj0FL/SgD2pcZpgJ06UDpzTsUCgBO5oxS4/GlxSAYf/10Yp2P8mk6dKAG+mKO9OpKAExSY/KnUhHFAxvrSHrTj1pDQA2k7mnHrTT+lACEe1M/CpKYRigBppMU4+tIaBEbc+tNNPI5HpTSOKYxlRn9akIpppAMPpTGHGMVIaaaBEJ6Uhp7D3/SmGmMaab0FOIprdaAGMPb8qaw/LFSHOc9qY3akSRnpUbDP+FSHjpTCD/jQBGaYR71Kw9f1phpjOtppFO780UGYg5pcetHeloGAH40o60nvS0AJSgYpaKQxKWilWgYmOlGOPal9KMfjTAAPWlxQBTqQxoHFO+tJinAe1AAO9GKUAe1L+lMBAO2KXGT0pR0HpS9QetADQPzpQKU0D2zmkAn40tGOKXBzzmgBv4UUtAoAaR7cUmKdj0pCKAGkUmPrTz3xTaAExTT1px460h4oGMNIacetJQA09qQ9OKcaDQBGcZ702nn9Kaf1xTENbjNMI9uKkphA64NAxhphp5FNagBhzTWHtTjSGkIiYEZ96YQKkcZphGOe1MYw96Q8GlIppH5UANPQ4phHWpMD60098UCZEeM54NNPTt61IR14qMjPXrSERn8eDTT+lSkD2qMj26Uxo6yjFAFLSMxMUveilxQMMVh+KPFWj+GIFk1a5YSOMpbwqHlYeuMgAe5Iqz4l1q20DSZr69kEccY+8c9ScAfia+Q/Ffia91fxJPf3DuD5mVU9h2/SnCEqkrR+8pWWrPr3w5rdh4j0eHU9ImMttIShDDDxsOqsuTg9D7gg1pV5F+zXHM/h7X70qVtZ7uKONs8O6qxfAJ7b0H416/j0qqkOSTiAY/OlA7UAYpQKgEIB2pcUYpaBiClxRzS4x6UAGOlABzzzS49aUUAGKXtRzSgUwEx607rQBwKWkITFGKd+FFAxMUYpaKAG4/Ckx2p1GOtADcUhGKdSY6cUAN9KQ06m4/P6UAN/OkI5p2PSkxTGMIpKefxprUAMpMU4j86SgBD7Uw0/FJ+dIQw0xhxweaewGaae3tTAjPFNbrUh/yKY1AyMimkU8000hEbdDwaYR6VK3fPSmMOMZ5HFMCI/Wm/jTzTT7UxjTTWFPNNbHekIjIyaYR6CpW796jb6UCI25OM1GwP1qZsY4qM5OQaYHVUtMU8U7PFIgdilLBQS3AHJ9qQfSs/xBfJpmk3N3LgRwRtM+fRVJx+OMVMnZXGjxf43eIlvdWt9IjYlbdhLIA/y7j0BHfA/ma8M1Z92oTkkE5wceuK1dT1Z7u9u7+8cvcTMWAP8RJ5P0rniSzlick816FGHs4KPUmbuz63/Z8WNfhPp3lSFybu5MgOPkbcOP8AvkKefX6V6L9K8Q/Zd1fztK1zRnk5haO9iT2PySH/ANFV7gBn61zYhNVGWtgxRjj2pcUuKxGNopxooGNxTgMjAo60uMUAAFKO2KXHNKOtAABRilA9qUUxCYpaUDmjFACEUUoHFGOKBiYopcc0YoASkpwpKAENITS/SkpANIpMfnTsf5NNI9aAEPOaaRTu/HWhhn60wGEY7CmnOM0+m4oGNIPrTSKcQM9M00570AIabjP/ANanUlADT3ph98085NNPrQIjI9eaYakI5phpjGEdaaRzTzTTSBjDnmo3HGalNMb7poEQk8U2nGmnFMYlNYU6kboaAGHk4ph46/jUhphoJI2/zimsD+XWpCuck5pp70AdCDTweBUAbinlqGiCwpzXEfF+Vh4I1qJCmTZvlScEjK5xXYxudwrzr4236WvhXUQxAaYJbJzySx3H/wAdQ0rXkl5oafU+dZ/C15Kry6e6XaAjgHDcjI9j+dYEsZilZG4ZTgjBHP411OmaxNokaXllYxF1XmXcV2k5AbA4PPOfzrn7a1vNSuHZFaaaRizHOWYnknHWvXcb7GKOs+D/AImj8K+O9MvruUx2DOYLpuwikG1mOOwyG/4CK+x2GDjKsD0ZTkEdiD3FfC95ot7p9qs92qRCRtscbMC7nvhRnp74r6e+DfxA0TX9C0rQvPltdbs7ZLYQXcgJudgwDE4ADHGPkOGA6bsE1y4mm2k+qNYM9K7UtJ3wacM1wmglH6Uo+tHagBPrSjp2xQOnrSj8KYCjpTqBS0gEHWlxSilpgJ2opaVgEhlmkZY4YxukldgqIPVmPAH1oAbQOtQaff2OpMV0zULC9cclbW6jlIH0ViatMrIdrKVI6gjGKAuM7ZxS80cUUWAQ/rSdqXtSUAJSGlNIaQxMflTehBp59utNPJzQIbSH/IpxpDQAw0hpxpp4z60xjccdOf5U09acelIevSgBnSjvSnikoAYaT1p559eKYe9ADD1ziozxUjf/AFqYeOKYIafpTWp5phpAMNNbofWpD1pnagRWNIakIwSBSEUxkdFKeDTSaYCNwaYRTs+9BHFIkjYc+uKaeKe1Nb0zTEbCmnFuDiohT0OetMkkjOcV4B+0DqSPd6bajPmASSt17kAcfga+gU6187fG6y8rxbpVzLEfsk1kYtx7urNuGf72Cp/GnTt7SKYdGeQySSGHyvMbyyfu54z9K9f020ttPsBsMdvbwx7pGx2AySfU8fia8fu08pyByo5U+or3fRvCi/EDRr3SNL1+ys9Z8qG4t7KcYN3HglgWHIAwDxnpyACDXrRdotozep4zrupvq+py3TqVj+7FGTnYnYfXufc1lJMyuHUsoQ5DA4IPr9a1PFGi6n4a1KfTNcsprLUIvvRSDqP7ykcMp7MCQaxVBZVQev5Vi2M+rvgr8Tx4uNt4e1eGUa9Da5S6aTeL7YOcjGRJt577sMeD19Xxg49K+BoyyS71JVlIKkHBB9Qa9r8CfHXUbDyLLxdE2q2Sjb9sj4u0HGCSTtlx74Y/3q56uHv70C1PufR386Ky/DfiLRfFFu8/hzU7fUFjGZETKyxj1eNgGA98Y960+RXI01ozTcBTx1pmacKQDqdTRTwaAFAo70ooPHJ6UMDP1/V7LQNHudU1OTy7W3Xcx7n0AHck4AHqa+RPiD451XxnqbS6lO4s1b/R7FW/cwDthehbHVjyfpgV0fxq8enxTrhsrCb/AIktk5WLa2VnkGQZfcdQvtk/xV5PvJ75Ibmu3D0eVc8t2ZTlfRFoSKDuAAIPBHWvRvBXxi8TeHDHBc3H9s6apANtfOWZRx/q5fvLwMAHK/7NeXp91frUmTXRKCktSU2fa3gbxxoXja23aLcMl7Gu6awuMLPGPUDo6/7S59wOldL/ACr4Msryezuorm0mlt7iFg8c0TlHjYdCrDkGvf8A4dfHJJfLsPHXDchdWhTr6edGo/8AH1HpleprjqYdx1iaKfc9zPSm05GSSKOWGSOWCVQ8csbBkkU8hlYcEH1pDXOWIaQ0GikA3NHb+tLTaBh+NIfalpOpoAaQKYR1p5FNP6UANPGaaeT2p5ppHPvQA3tSYpSPekIoAaaYelPPXoKQ0wIj0/xph71Iaa1ADD+VNJpx5680hHPegGMJph9qeeuc0080CI29zTDT2Awfz6U00xkTmoialcVGaBMSlpMUooEIfemNz1p7D1prD1oEaIORxjNSL1qsh5FToenNUySwp4qhq+iabrFtJbalaxXFvIctHIoZScEbgD0PPUYPvVxScZPFSCpaTGmeX+Ivgx4Xu4mmgF1puwf8u0xZf++JN2T9GFU7Pwv4aJ03wL4sgvfDXieweQaN4mCiJL1dxeMk7sE/MMLuyCuAyk7a9B8baqujeGdQvmxm3geYZ6FgMIPxYrXhvhH4qpdaOfDHxPhm1/wzIAElPN1ZuM7XR+C2MkcnIBwCRlT14Nyk5K+i/rcUrHa+O9V1yPTl8LfGzQbe4tXYQWXim1jyIWJOGLYwCcDPCnC8q1eVePfhVrHg+zTVYLi11rw+/wBzU9PbfGoJwN4GdueBkErk4zmvZrTSfFNlonm+C9Vt/iN8PpU2Np15Iv2mFBj92Cw6hQoC+p/1YODWZ4ItfDcGq3K+APFEnh/U5i0d74U8Sxn7NPn5TCwb8RwXbB+ors5U/X+uhmz5z7ilHXmvaPHvwillluLrwdYXFvfwJ51/4ZmYPcWqn+O3ccTwk5AK89B1yq+MYwxBBDKcEEcg+hHakBZsby4sLuK6sp5ra7hO6OaFyjofUMORXvHw/wDjmjxxWPjlXL5CrqlvGM4z1mjHXH95Of8AZJ5r5/6UoNTOnGatIabR93WNzbajZre6ZdW97ZMcLcW0okjJ9Nw6H2PNTA4r4h8PeINW8O3wvND1C5sbju0L4Djrhl6MPYgivdvBHx0sr0R2vjK2FlNgD7faIWiY+skY5X6rkf7IFcc8NJfDqaKfc9qU09ar2s0N3aRXdlPDc2kwzHPBIHRx7MOKnGa57Fko5ry34/8AjH/hH/C39l2Um3UtUDRAqeY4sfvH/EHaP94n+GvTJ547a3eaZ1jjjBZmbhVAHJPsByfYV8XfETxPJ4t8XXuqEsLdj5VsjfwQr938Tyx92NaUKftJ67LUmTsjnZX5AHAHAqtFgSTAnjNSOeDVec7JGbsVB/GvRZiPVju6dGNTdqrk4cn3B/Spc/IaaAd705WKmmt92l9PehoD0b4W/E3UfBVyLaUPfaBK2ZrJm5jPd4Sfut6jo3fsR9S6DrGneIdIh1TRbpbqxl4DjhkbqUdf4XGeQfryMGvhYHGOfwrq/AHjXVfBerfbNLkDwyYW6tJCfKuFHZh2I5ww5H0yDzVqHNqty4ytofZdBrF8IeJtM8XaImqaNITHkJNC5HmW7/3HH8j0I6dwNmuFq2jNQNIR60tIetIYn1pvbv8AjT+O4ptMBpppFPpuO+KAGmm9KeevNNNIBpFJinUh9qYhh600jj2p5pp+lAyM00inN+NIaAGEdaYfQ1IRTeuKAI296Y3pUhphoEMbGT/nNMNPI4HSmn0pgRsM5qI9TU5FMI5oBkWKUAYp23mlagRGQaYetSEcelNNAiwvtUynAqBalStCUTg9AMVKvSoAfTrUyHkZ6E1LGeTftD6v9l8KpYK3z31ysRH+xGN7f+PGOvnCRsrjvXrX7Rl40muaNb7iVW3lnx7tKV/kgryFj39K6cJpTv3Inuamha3qeh3P2rRdRvNPusYMttM0bEehweR7HivStP8AinoWv20Vn8VPC8WstGNqanZ4huVX0IBXPXoGUf7JNeQqe/rTmXcOa61Jkn0xo8thHosOoeEPEOo6z4b0xxKjbd2q+G2IAMgUj99bnkSRY2lRxnBNTeLG8I+I3tl+KOnxaTqF4ubLxboh3WeoLnAJYA4bAAKuCRg/MoIr5u8O69qvhbWYdT0O9msr2I/LLEeo67WHRlPdTkGvoHwF440vxQtxbabYaVa6pflWvfC1+B/ZurSjnzLZmBFvOcYwcqx2ZyRuF/Ev6/r+te4HHeLvgh4l0i0Gp+Hng8U6I43R3WmHe5XgZMYJzzn7hfpzivLDwSDkEHBB4IPoa+lPD+lWsOuXEHwt16/8E+K0INz4V1vJglbA+5u3bhjcQw3EjkBRzSeLtU8N6verp/xv8Hz+Ftdl4j13TRujmIAyQ67t2AFXB8zGedtTZ30/r/P5AfNnNKD3r17xZ8CtcsrL+1fB15beK9EcF0lsWXzsDr8gJD+nyEkn+EV5FKjxSyRSo0csbFXR1KsrDqCDyD7UXuBv+FfF2u+Fpp5PD2pzWJnAWVUCskmORlWBUkeuM8n1rsLP42eOYHV5L6xvF7x3FhEM/igU/rXl/vSMWxjJAqZQT1aC7R6v4w+NOqeJPC1xo0umWlnNcALLdWkrgFM/MoRskZxjO7oSMc15UI2Y4XBPcVCT+8IxwBUjyMgAXgnqaUYKHwoG29xHV1J3KwGPSq0zbkXPTkVeV2CZ7gZpCiyJ84B78cVTAz1YtwepXj61IW3Rj0JFSNZtuBhYEA52txgVBh48LIpUg9xSTAt54xQPuD2pgNPU8dKuwDuozS9E/GmjoR6UrnhR71LA6TwR4s1LwjrcepaRKA4GyaF+Y5485KOPT36g8ivrXwb4p03xjoa6npDEAEJcWztmS2kx91vUHs3Qj3yB8TA4rofBninVPCmrpqOjXHlTAbJEcbo5kzko69x+o6gg1z1qPPqty4ysfamc+tFcz8PPF9t440KXULS2a1uLeTyrq1MgkMZwCGB67DngkDkEc4zXS849a4WrOzNbhSH60tJk0hiHtTT1p3emnOfegBDTTTvzppxkjuOo7igQhpD9KWmkdeKQCfWmnvTjTT0pgNPSmGpO9NIP90mgYw00j1qXy2P8LH8KBDIekb/98mgCuwppqw0Eg/5ZuPqKjaNlzkBfqQKBEBppHp2pzsifflhXHXMqj+tVpb6xj/1l/Yp9bmMf1pgSkU0/SqcmtaPFnfq+mjHX/SkP8jVZ/E2gL97XNO/CcH+VAzUIppHoKw5fGXhmM/Nrdp+G8/yWoJPHfhZSR/bEZ/3YJT/7LQJpnQ46+tMI4rmn+IXhdemoSv8A7ttJ/UCqknxK8MpnEt+/+7bf4sKLi5WdsD+FSLURIU/O0a/VwP60ongX71xbge8yj+taGZYFSIcEetUW1HT4/wDWajYL/vXUY/rTP7c0ZfvazpY+t5H/AI0rFI53xj8ONI8VvFLqJuPtEKGOOWGXy3VSScHIKkZJ6jv1ryXX/gdrVmJJNJvra8iAyEuB5Eh9s8p+JYV703ibQI879c0wf7twrfyzUX/CZ+Gk/wCY5af8BDnP5LSjzQ+Bjavuj5C1zQNV0CYRa1p9zZlidjSp8j/7rD5W/A1ng8V9g3fi/wAGTQyRXGowSxP99FtpGVvqu3B/EVwniLTPhVqwZhHLbzH/AJaWFs8B/IDZ/wCO1tHEtfEvuJ9nfY+eCM8HkVEVaM5Tkeld54k8JaTBmTw7qt7Ouf8AU3toEIHtIhIP4qtcjcWN1bg+bC+P7y/MP0rohXhPZ6kuEluj0rw58TrPWNMh0P4m6c2vaXEpW3v4zt1Cx44KSZG8A9mPpksAFr13SL/Wz4euI9EvdN+K/gwD95p93hdStlyxAYMCWwQMbhuOBtCivkwp826M4YelX9J1O80+9ju9NurixvovuzW8hjdfow5roUlLSX9f18iT6S8M6Jot/qc1x8GPFd54T8RqxFx4d1bcFZhkFSjbicAMT/rMZH3ad4s1fRtWni0348eD59A1Zh5cPiDTlJjfjPDruzgbRtPmAEnIWvO7T4r2/iGGOx+J2iw61Cq7Y9VtEWDUbf0ZXGA2OuDgE8nPSvVtH1nxFFoU0ujz2nxU8DMcTWdyobUrZckhXRgS5BweQSdvAUc1Uo6Xeq/rr0+egkeZeLPgfrdjZLqvg+6g8WaFICyT2BBmAHHMYJ385HyEng5AryV1aOR0dWWRCVdWGCpHUEdjX0x4W0bRtTu5r/4G+Lp/Dmt53XHh7UyfLYjggxtuPA3HI8wAnjbTfFmo6BrNyNP+OfhGfwzrj/LFr+nITFNgA8SLu3YG0YPmAZOdtTZp2X3df+D8hnzMq4dqVx7dK9j8UfAjXLWzOqeDL6y8VaMwLJJZyKJsDOflyVfHT5WJJ/hryW7tLiyvJbS/hmtbuI7ZIJ0MciH0KkAg0lbYCEfd+tOXpigKQPXNLjj3piEBwwIqcMCuCB+PSogP8igEdKVgHmGFhyCp/wBmo2tSo+Rw3oDwakHSlDEHinYLlZlZT86kfWkJyVFW1kOKR0jkOcFW9RSGVqfH39Kc8LAErhgPTrUBYqCo60nYDS0zVLvS72K9066uLS8Rv3csDlHX8R29q9h8N/HTVjrVnH4jgsJdNI2XDW1v5coO0gPndjO7BIxjrgCvD44JGO4jA6Y70piYkhYmJHX61nOEZLVDTsfWknxO09WIXSr4/WRBmoX+KNov3dHuD/vXAH/stfMdnqV/AuwXE8KgfKiuQKv22u3ttvPnmTd1Ep3DPrzXM6HY2U0fQr/FRf4NE/76uv8A7GpLfx/qt9aRXOneH7WWCSbyA5vDhT3J44A9a8L8L69Dcaqlv4juza2EoZTcxxbjEdpwSADlc4zxXrnhy1uIdNtrfwyNOutJlHlXF7bXCmXzFIPnbT69NhOQCMdK5aylT0OvDUoVbt/8E7W51m7ltBkW1usreWS4YNGcZweev+NZEmpXmnOJ7Z0WeVdjNPEWR++QNw9PXvUQ0+aZLldR8qcylSYgmEGO/Pf3+lVRpkMV5l57kMABGJJAyoM9Bkfoa4va66s9VYelFNJbksniXxI0zLHf+HVUdCYnBI/3Tn+dYmr+OfENncCKLULKc4yxis1G0+nOaoeJND0nQNN1fXJbd72QnzFied1SPPBCBSMZY59u1eIfa5duGuJG78uTXo0Ye1V0edilSopRUdX5nstz8StfiBMuqwRD08iIH+Waz5PinrDHA19lP+zCoH/oFeTGTd9fWk3Dua6Pq67nn+08j1tfHniG6U+Tr1xJ/uOoP5AVBL4r8Qufn1rUP+/7D+VeWBwrBlJDDoQcEVoW+tXUPDOsyej9fzrKeHkvhZaqrqjuZPEGsuPn1bUD35uH/wAarSanqEn+sv7xs+szH+tZFpqdvdbAr+XM3Hltn9D3q3tLHnvzXLLmWjNU01oOkuJnJ3zSt9XJ/rVeQ7hzzn1NSVFL/qnwcEA1O4zW8PeGb/XllkskiW3jO1ppThd3oMZJNbU/gmK20N71pJJ7mE5liChVIHXb349/0rb+GM5g0C0A5ibeGHvuP/1q7aS1RmJHKt27Gs4tv3j1KFGmkm1dnnWgwQ6LE7RKYobxGeVpDv8AMXYQiJxnliD1rKuvCNxf3saWIghuJBueJztC56kYz+VeoT2MbDlFAQBVCjAAHTFc14k0Vr21kNtcSQXBUruX/PrinFu9joq0ozhZLQ4PUfCmo2c7wwyW15Ig3NHC5EgHrsYAkfTNYU1vNE5SWN43HBVlwQa9bmtprnQrGecFb2OSNl5yV/vjPoRnNYniWyS+sysg/fJzHJ3U+mfSlztWutzinhFrys83amHnH9KejAs0bYMwJG0D+lG1tx+VyRwRtPH1rY4JaaMAF7qKcAnGVWmAjvSjINXqZk6hR2H5U8FccAfhUSnOO1PUg9OamwEoPH0p2Tn/AOtUQZemf1o8xAOfzLdaBlhWzz/SpVJPeq6uAMk49zTw+eB1HJHpSAsqcUjIj/fQE+vf86hLMoBKnBHUKelSL5m1CscjCQ4QhCd3096LAnYpXmi2d0STGN3rjn8xzWDfeGJEy1s545Gef1H+FdVGS8uwBiw6gjbj65qwhyu5QSPbk/lVxqThsxNRluebXFrcQczxFcfxDkfnVrQdb1LQdRjv9GvrixvY+BNA5Vseh9R6g8Gu5ubJbkhWA8xhnhlOfZhn9DzXM3fhuSZg9ou3J553KPcgZZR9RXZSxlvj0MZUl9lnoNt8QvC/jQwJ8TtIkg1ddoTxJowEVwMbcNIgGGxjqA2B91RXpen6r4103QjJavp/xZ8DzLscBQbtBwdsiEMWbLAkEO3HO2vlW5t7izbbcxlAejdQfxFanhvxHq/hq/W+0DUrmwuRjLwPgOAc4ZejD2YEV3xnGa8vw/4HysY2aPoXwxZ+Btcv/tXwu8W33gXxGzgSaZct+6lfccIYnbDknHCsQB/BW34m1HxJZaf9k+L/AMPrTxTpUKkf2xpCCVo025Z9hAZDxyw8sDFeYp8W9B8VRRwfFLwfaanKAFOq6d+4ugAOMjIzz2Dhf9muz8F31vGqR/C/4rNFtVBHoXilMqefuK5AwOvEYJ9+9U4N+f4/juguYb+APhf4zbzfAnjRNGu5MY0/UskbiOEXzCr5z1IZ/auZ8RfAvx/o7yeVpUOqQIu7zrC4Vs+wR9rk/RTXrfibS9Wu3ll8f/CDS9dBbdLqfh64AlceoTiVj/wKuY05fAK3r2fhrxr4u+Hmq+ZgafqLSJDGf9pWOMf70lZpX+H/AD/yYNngOqabqGk3n2TWLK70+7wG8i6haJ8HocMAcVAox3r611F/iPp2lhfEWiaB8S/DTZlEltGgnZP4W8vG1jjnCK5/2u9cIPBfww+IE7weD9WuvCniDJX+ydSU7S4JG0KxzuJxwjnAH3aFf19P8gPCB0oz613Pjb4VeMPBweXVNLe4sUyTe2OZ4QABktgbkHPVlA9M1w4wygggr7UJp7BYDg/SkHHtS4oxzTsAm/Ckin4Vzlhz0z3pjDCgUozU2AV0eJS0TlvVTTYpI5UYogEgPIzin54P0qC4G4CaLPmqMn/aFJjJHbYRyDkHpTpDlMDtVdzuwy/dcZFS7unoRUgAbH3q6b4d+LJPCfiBLsh5LGX5LqBTy69mH+0vUfiO9cocjOaTPNTOCmuVlwm4NSR9i+H76y1zSzqFiyzwGTYsgPDcAj6deh5BqPXIFaF9gAYDjtg15N+zXfH+0dd00udkkUdwEJ4ypKk/+PCvZdUiDwsB6YrwK8PZ1HE+iw9T2lNSPmz4k+MJ9WnfS490drbuRLngySDj8gRXCZ5rpvibYvp3jXUlZSFnYXCZ9GGT+uRXLA8V7lK3IuXY8Gu5Oo+fclVuPekZz9KjVsAk0hbNaWMRxY5NIJCD7UwmmZxSbAuRTskiujFXU5DCu68NPLrdtLsVHuYQWkRJMNt/vhMZI9cZx3A615yW5q1ZXc9rcRT2szwzxnckkbEMp9QRWNal7RabmlOfK9dj1GWxhT91v3M67klBOCf7oU9/zpIdN/tGdLWxtpJbllOIVbczHHfn5QPU1oeAPFuja262GvafZRag5I83YFjuG+nQMfToe3pXr2nWsFkpW0t7e2DkbjEm0t9a8mcpRbi1Znp0sIqiU1L3Sj4f8Lro3h22s3YNLGpZ2ByNxJJwe4GcVct3KKY5O3AzWmk6qu1uvYjpWTqioQWjYA+9a0UmlE77cvwkd7OijYOWJ4rJmcbjuIHfGaRZUM23duc8Adcms27NyxEkERKNnaxHBx1ArVwWxSmzUlkwgQcA/oPWvN9X8QpJeToufKUkIc9cVRv/ABRPIlyvnMAWZME9PasBf9Mlj8rJ2uAx7etKVH3bnHLFLmtEbCrNrKuv3sM2AM5bGa2lO6RwVOHUEkOo2cewPr6A1kLGft6FcN853AnAI/zmugdGa3iErNJMeeeQFz/e6EfSsmnF2ZwVmnK5mvZR7wNmwdcnOc+6ntnvSrBCjIJEQxnPfK7vZl5/DmryZWIHazB12YQYyPUk5A57Y/E1NDBhQrlpYgx2vEwIyO7KM478kGtTmuynDaxCRUKR71GfMAVkI/T/ABFOjgEqbZEAuNxkAZCRIvp6jpWjIv2gQAjfFL8jOvzehOM4/AZx7Gklwsrm7DW8UYPyuxUycH+Ig8Y7Z9KSTei3HfoVo4R+6K7ldv8AXKi54HsM49KdHDtjlkQFoJCY4WXqvHAGSNv5c0/T71byCcxb1lD/ACKVDAAjqo7Hjlqt/ZjJ5YhikjdCWUA/K3HUswGO3J7CnOEoNxktR6rRlPy/Lso0fG2BgcqrFWOeQGz+fT29afcoVAmfzAjkCKVGGBgY5wQSR6HirykeWqMhhhlJOMHezY67gAGB+vpSPG6F5B5ouIh8sqcr0/2eE/DnmpEVUi2zsHgEe0bs5RWYnp8w4Xr068j601o5DHKXj/fnH7pjuyCP4cZJPbNXUQ+YqKyO5PmfJIGVeQDtJJGTjuRg4xUkjhtvlRurr92Pfypz83UYI5IzRZhcqpCsnlgLK8MIztjJbLjsf7o7E4oSMok8atA0m8bJF/eBj7HGSR0z+tTTRqRL5brs3bnkCMYwPoVJVz3wQOlSoY7iePy0R0RVJCzHzAFAztyCePQGjlGRMplcGYosezMnm5BjYZ5Dc4OT0B9KrwwyAgSRv5iAv0y7Dv8AN/Dnnt0qzM6yRkxbWMTAmAqVK9TyDxkc5+v4Uspt/slzdGa3Fp9+ZncgxdAMYAyT0APPpQkFyu1pBdITNLGochlfZwRzwB/GenJxVU/Di11G3lmhZ7FuFiKp8rEdSy5IPOMFTUPhnUH8SeKY7aKeSDRbX94UZt7yKoOF56Bv0HevRJ9W8iZldQIuuMgbPp7dOK6oYWrFc8dDSjOm5WqbHhmu+EdX0ZnM0H2iBeTNb/MoHuOo/Guf4YDOCPzr3O91UfannXcSw2pGg5/H3PtXlfiiyiPiKCKEwWslw4EigcJk4BYDp1rui5xV5LYitTpx+Bj/AAz408SeGGU6Brl/ZIrbvKSYmIn3jOVP4ivTdO+PEuq2Sab8R/DemeJLDp5vlLHMuerAEFd2Om3Z9a8ZvrC8sHIvLd4wP4wMr+fb8arBsjjkexrX2imrvX+u+5zONj6d8HaZ4c1Oc3fwW8c3fhjVZcltC1FvMjkbbwPLcnPQksDJjPGK0fGt1FcW/wBm+OPgUoE/dx+JtFBkiUZKhmK/PGvOQrZyf4O1fKgbp7V6P4O+NHjXwxtiTUzqVkODa6lmdcYxgPneAB2DY9qbSlrf7/8APcD2Pw7p/jTR9OW++EXjKy8Y+HkI26ZqLqZYgeFTcSMYHON0fT7prG1vWfhv4o1F7T4k+FdR8E+JJBlrqONow5J+/kLhyTn5njIx/FWLZ+K/hj4ivV1Ax6v8PPEODm90dyYGOMAEIOh6nCLnuTXoqXviq50NnkTw18WPDKfM3lLHFeIdueY/mQkc8D5zmlKPWX9fNafeFzzTVfgNf3Vm2oeAvEGk+KLJeNscqxy5z90EMYyQOTll+leV6/oGseHbgQ6/pd7psjEhPtUJRXx12seGHuCa9vstJ+Hepa1IPCuua58NvFSfL9lvi0C54yCGbvnAUOP9012NxdfF7w3YPDr+jaN470ZlzN9mwJmTpt27Ru9eI3+tS7rr9/8AnsB8lsKXtXvOo3HwY1q8lt9d0bXPBOrA5mRYXjCt3URgOoH/AGzWqGofA1NYtZL34beK9L8QQoNzW0kipMgP3RuUldx9GCU3datf5feB4seVxjrVdpNgVVznNbfiTw9rnhe7Nv4h0m70+TcVBnjKo5H91/usPdSawXGWDAHipYA2RgAZAbj6Glz8mPQ0s3yxL6Dr703+E+4pDBjk0wnoaRjTSeBUjPRPgZf/AGL4kWCk4S5ilgb3+XcP1UV9MXIGOAK+PPCF9/Z/irRrvOBFdxknOON2D+hr7CRg8JPccV4uPj+8v3R7eXSvTt5ngXx/08pdadqIU9Gt3P47l/8AZq8hzX1F8TdD/tvQLq2UDzWXfGfRxyP8Pxr5ckDIWVwQykgg9jXXgKvPT5eqOTMaThU5ujBmycZ4FKTgc0xKQngnpiu484cajc5O0U7OBntUYPBPekwFLfMcfSlBPQHpyTTQD27U4YVeQcetIZKHwOcN9O9en/D34irYW66X4gupRCh/0a7bL+UP7j45I9Dzjp06eWb/AEI/Kl3K2A/HoaxrUo1VaRrRrSou8T6ml1cfZ45BMswddyyIwKsOoIx2rltX8UNEWBJYeo6ivLvC/iWax0qXTZWZkjbfCeu1T1X6Z5/E1Fd6yZpNsYYn3HFYwpOOjPYWKg4KVzvLXWEl1CC5guXEkThwCDz6j9a6zTZoHuhd208NtPJHt/4987m4AGMHnA56HivDIPEcttclVOQOPSnN4w1MTmSzvLi1bpvhkKHH4Vbp3uTHHwjuro6D4sWFvonjGVLR8LcRi5kTpsds547Z+9jtmuc0q9eGT5SeRk/hWHcXUt5dNLcSvLK53PJIxZmJ7knrVu1cjcwGc/KoA61Un2OByU5uS0R12kXQM3mBSzDO4g46jHBrZSaJ0CqoITlWZlVlPbHdqyNHtGtbQecP3r8sPT2qzl4y20kZGD9K6fqKq0+baRTp3RsjCsJyriR5CGK/KW3dgfX9frVkxjdKJDhhHkxsuHVSMZPYjAHU9xxUkqyLPbyec0ZmXI3Knl4A52n17YA59qzdU1G3sZ5Y4sysckRAYXcerNyTjHbP0rgpUZVZcsFqciTeiJ9RntrKOGR5TLA2SvyL5hb1zgZGDXOXN1NeyfPlIQflhX7qnpnHrTP3lzKZZm3yN1NaVlaZI9ete7h8JGgu8u51wp8oumwujq6Eq68gr1Fa8SlBkErgY46Ee46H8c0scQUAADA59KnUY6c1pOnCeskmaNJ7oTdgMqsyh+WCnAb6gcU44ldWkAcqNoDKMYPt0oxz/M04LgY6+4rL2FL+VfcJRj2JFmdUVWfzFXG0SAPtx0xnOPwojdwfkO71LfMf1zTAp5zinqMD3o9jT/lX3IfKuwzyQuwhcFeQfQ1Q1rWLXSmSW+eVp5gdoQlnYD3zwOfWtQgKCWbt6V5Z4jnu73WpFuvLjCsVTAwqr29z2qKijC1or7jKrLkWiN+58dCOGSLTrV1Vucyy4GfUqOv51yGo6pd6hIHvrmScrwoY/Ko9AOgH0qUWNv8AMJJpSR3VcZqjdW5iyYnLD0YYNYOV9bHJOUpbmh4b16bQdXivYV3qBtkjzjevcZ9a7fUPiJpUqh4bO7aQj7hKqPzry/y5COcD9f5U9LfP8TA/7uK0jOSWiIsb+p+KtS1SYxWg+ziQ4Cxcuf8AgX+FY11bG0YqzZnzl3znBHb6g9TT7MNbM0iMpkxhTnGPepJle5++URB1C5JPoP8APuamUnLVgl2PR9N1Br3TbW4YEmWMM2e56H9Qaq6hpNheqd9siOf44xsIP4Vl+HHe30yKHByCWO4dya2VlkYf5FdvJzL3kegnzLU5DUfD9za5aD9/H7cMPw71jNlWKsCrDqCORXpBZ+nPNZ1/psF7/roxu/vrwRWMqLXwmE6CfwnELV/RtV1DRdQS+0i9ubG8T7s1vIUYeoyOo9jxVm80KeLLQESr6Hg//XrJdWRirgqw6gisruL7HPKDjuj2ex+Nia1p6aZ8TvDlj4ms1Py3KqsNxFk8kYGM4x93YeOSa6TwxP4PedZPhr8StT8GzPukOl6sPMtw3YfvDsz/AMCc1850oP40016en+W34En15qmofEmx07yPGPgvQvHmjbQ/nWG1mfPRvLZTuP8Aux/jXBxxfCDV9RHlS678PfEMD42sZI9knrzuCgH3jrx3w14v8Q+GJA2gazfWKht5jilPlsf9qM5U/iK9Is/j1qN9bR2fjnw9onieyXP+vgWOTPqDhkB+iihJbx/yf+Qj1m1tfihp2nb9C1zw/wDETw/IBGEudiSSL/F84O1vTLO30rh/Eug+A77zP+Ez8Ja58OdQZyv2u3iMtg744UFVKepwqr/vVj2F98KdQumu9A1nxN8P9TKgboneSEknnlSzY/4Eo9q9D8PXXxEhV4fDnjjwf44sgm0W93KBOy++3nP+8xpSh1f5fqrr70F0ecXHwEk1KFZPCXjjw7rNuWA3MxjK59dhk/pXkOt6ZLoutahpVy0Tz2NxJbSPESUZkYqSpIBIJHHAr6W1rQobgCTxL8B2WU9X0W9jO4+6xFSB9c181eI1ji8Q6pHDYyadEt1KEs5Sd9sA5xG2ecr0P0qLK1/1T/IdzMP8qYT06UMeeDUbdBjpUMZK7lUDL94fMK+wvCWorqGj2dxkETxJJ1z95c/1r44Y9PpX0n8EdS+2+CrSIn97as0PPscj9CK87Hx0jI9PLZ+9KJ6FqEAeIjHbNfNfxg8NvpmrnUoI8Wt037zA+5J/9fr9c19Pn95GK8V+N/ifT7aGbw/apHdX0gAumPKwDqF/3/5fXpx4RTVX3Fp19D0cZ7OVBqo7dvU8IZsnHb0pGbsOnpSvGc/KM5p6Q45c5r2z5wjLFiABT0QfxHOO1SKVXgACkZs0CEY8nGRUe7IOfzoZjjI7U3POO1IYhNJmkzTSR1qbgTwSOsqNGu5sEbfWlmWcyblRk9s5rY0TTG8vz5uCw+Qe3rWodPU8tn8q6qOFVSPM3Y6YUZNHGSRylmbY2Op4qMbuwNdm2nx5wB3xTBpyj0/Kr+of3vwH7CRzNtayuQQuAfWuj0e3FqRIQGkHQnt9KtxWKjGcD6CrsVqgHU5xVrBQjq9TWFJxJYJiTxk/WrYG4A4psUKIOF7VZCDjGev51ryWNOWwuo6x9neVdPZVnJ/4+IMxhR6AHnPTmsIRs0hdyWdjkknJJ9Sangt88AY9/StWysTwWHHrWtKjCjHlgiIwUVZEFjakgcVswxhQMfnT4oQg2qAMVKqnt3qmMaM9MUoPYHJpxjzweR6Uqoc8ZqBidO2M0oJ7cfWl2d/5Uu30osgEBYdOlAYj8O1LtJPGaCOSKLANd2IIrNutPgnO6SNGz6gGtIoe9IUOOnFUtAOek0e1OSbaIn121XbS7ZOVtovrtrpHjJP3Sec1XljOPumqiop7ILGCLSIH/VIM/wCzTXt4xwI0/Ktl4iCeDUDxtn7tdCkVYyfssJ5aNPypyW0KnhF/AVomFieFpv2dyfuiqutw5SOAqoAUD0qysoHpTBA4zlc08QsB0qGkxWHebnIH0NML574pwhOKTyzn0qOVCsyBwCcE81UuraKZcTIrj6VoGNqjaAt0/Kh04vRkuNzmLvSFBJgcr/stzWVcQSW/+sHHqORXatbE9qqXNmWU5XIPtWbwUJfDoYyw6exyG4etG4VtzaKDkoGU+1VW0WcE7WB9iK5pYOrHpcxdCa6GbuNGRnOBn9a0P7Guf9mlGjXHcrj6GoWGrJ3SF7GfYtab4v8AEelxeVpniDWLOL+5BeyIv5BsVjXtzPeXc91dzST3MztJLLI25nYnJYk9SSc1pDRJv4nH4Cnf8I/KW+Z2x7LVSw1eW/5gsPPojDYioycnFdXFoAUf6sEju1TNoeVBdV46ZFUsA2tZI0WGmcgsUjMcI35V6v8AATUJLTXLrTJThbpRLGP9teCB9QQfwrlJNNaMZwPaoSLm2/fWcskFxHkrJGcMOMHBHtmniMqjUotJ3ZtRjKhNTPa/ih8S4/D1vLpWhTLJrbArLMvK2nr9ZPbt354r51lkZ3Z5GLMxLMzHJJ7kn1prMe5JzzmoicnrgDvXlU6caUeWJhXryrS5pAzZIJNLvzjPcVHuzk9KUHkewqrmArH5jimMc0hbqaaWxSAcxyc+tNzzUqwSyY8uJ2z6Cp00q9kwBA4z6g1caU5fCilFvZFEn3qS1hM8oQD5e59K2YfD05UGZZAT6DA/WtS10gQJggIvfJrqp4CcneeiNoUJPcl04NtGSdo6DNX9ntTra3RYmKkFV+8QchfrjpVq2QXBYWwaZlGT5SFsD3wK7nGx2pqKs2VFhzkilEPrmr9vA9w7pb291M6EBhHC7EfXj9KFjkKMywS5Q7ShAV8+mCQTWbnFbyX3oftI9yokXsc9qsRx9TzVmK0vGi81rKaOA9JZMKpz2yCaUQXIt/OECAE4UPMql8dcD/HrUSr0v5196JdWHcZGmPSplQ5wO/bFJdQXVvszHEXccJ84P6qAfzqS1sr+SN5J3tbSDjDyK7bh68Cs3iaPWa/H/Il1YdyOws14JA/GtRFAGAOOnHpVZLbUpUU2U+nzEgEgRuNv4sQD0PSltINWuLhoIr3TFnBICmNmLHGTjbmqljaH8/4P/Ij20C4oPf8AKn47Dr61Qit9acS+bNBGydcwKOfTDODn2696ht/7Sn2Kmp2QZu7wBUHrzuJyPTFL63Q/m/B/5C9vE1R1+lPA4znn3rMFtqzSMkeq2EgxlZFjVEJ9Mvjn2oihvpJjDJrFt0yZQECKMZ54P6VP1uj/ADfg/wDIft4mhnJGevSnrgdgaoxabqMkpVdd3womWljsyQDnpgA44wc0hs72SZ0XVwiJxlsAyH/ZG0HHbOM0vrlHv+DF7ePY0SQBx/Kozjmq9vYySqVl1TU/tO7atskCkkYzu3cDHqOCKbJpsqRkvf6sZlU5SJI3Rj0yGBPAP44FH12iuv4B7ePYuBT6CkcgLx371VfTGj04Svq6zu+VVY5xuHpwBj8D+dTWOhB7Fpbi81x5VYkmJE8sqO25uhHOaPrtBb3+7/gj+sR7Cfh7YxSMBg8EmjTtFW7V44tQvJ7xSWWFR8xXOADkgL2OeaV9KslRormXVbW4jUM8gn81c5HGFHp3yPQU/r9Baa/cv8w+sR7Ecig8sOKgK55FXk8PQRSZvZdXWORsQzSOI0OFJOQRz0PcHHY8ZT+ytNFwqXU000JXcr6fMc8jvuJ468YH9Kf9o0el/uX+YfWV2M8ICOg4FO8rKn5a0RoNrFdEaqb2BDzFEM7nGTycHj0wfTt2LzQbexkKX2l3RaTmELeMpIHDEqC3PI7nvR/aVHs/w/zD6z5Gb5Z6bTk/hzTwinIOc1qXOi2likANu8glYL5M4AVyeo80HIOeP4SMehq4/h/TFkGbWEpv2jy7wssYXIJkZsjGcEcA/Wk8zpdn+H+YfWfIwNqYwMfUGj5Bj5lA+o5rYfSLNoZRc6fDO8IaQTrOiqoJGONvzdvXr24pLrT7I+RJcw6RFHguVsYR5hyODjIHt1P060v7Th/KxfWvIxy0XPzRk+7CoHntkyDJDjkcsBXVz6dZW620Vva6UqzKW8242Oy89Sy9B06YOKtQW0dtHFHpkcTBQTLeKC6qP4iV24PJGMZOPxqf7Uivsfj/AMAPrL7HDyT2gJJng45PzioXlttv+uhx1PNdjavCsjxwzW0u9tzTNDFGqnoDllY9yMdB1qRTDDp08Fxc70QbYRbmNwBg5DMFyPrwKX9q2+x+P/AF9ZfY4lkj8sNtIQjIbY2D+OKkksXSD7RJbXCQcfvTA4XnpzjHP9a7mSeW5t1YarNPFhS9tIj7TjqpYZ98evqKZBbyXtrFLbyQoUyTFE85+UDJGcsCcKeB/wDqP7Wl/KH1iXZHEwWhnYLDbzu7AkBYHycdT0pz2kkMojlsrlJDghTCc898eldpfyQXkETi4+ztFI4KTzSSEdOQMHb178+9QxzQXEJivJ4bSOGTegtoBlhz8wbJz0PqelT/AGrU/lX4/wCYvrEvI5U2c0cux7SeNtob548ZH51KunXmT5lpcQovO+Zdij6k9PxrprQWxeRJ70z2avthEolKk9M/KcA/XJ4puoZ+3ncVS0XnDNNsJzkA7hkHPrn6ioea1drL7n/mH1ie5zaabeyyyJBaST+Xyzxuu0D1znpx1py6ZcMMbIVuN+wW7yYkJ7diP1rprm3jN1DaNaWccYJdzZ4UsR3DMQq5yOMk9TUmoE6bHHDBaLDgsG+0LHKGzzy/P+I4qXmlZ9F+P+Yvbz7nLnQ71lYywQQFeonnEZP03DmsqXRi9yI2Aj67iMuAPoBmuxuYU012V1s7ubdyHVzt44xyAQR06k1K73enZFld2qi4fzPKtQWK8EA/MCRwDyTn2701mldbNfcS6031/I8V1bw7cwXki2TpcwZyHGUx7ENj3/Ks7+w9TaQILVixIAAI6npX0BeQTWlvNMby5DTj96FiQAnJ4ZgTj8OvNUpIYLewjdRp93M4Bc/Z2EkeTxz0GPU1xyruWphyniP/AAjuprKsdxbNbscf675etX4fCk24G4mBTOGEADMte3+VFpcSNOWkZ1AbbNFKrDOfl3DKrk1BA0cYkle9SZnBUtayPGIlAxlgBz7k+nfNT7V22Hy+Z5lpngxN8hMUcyocD7TOsJ9jtJ9+lbEWgRW2n/vYvLlwSGFple38e7B/AGusa3dgjWBFzD1eY2mTGegDMQSeP4h+VOuxCLSNIHuhCPlcRSOybQc4UMAv16D0qliakfhdvQa0Ofj0e3trdmuSl2XICiC5aNou/Kkcj2FOisBaQ/K9vLbkgPu2ytGcg4YHvz0FdHcRLNa2/wBmtZViiGGm+yKXwBwwI5+pP51HK010ySOZPKQ/JLFaopVhyBwcjqOST1x6VDxNWS96T+9j33MqK1tBIU00wPLJuMv2u2REVgMjaCME9ttXotNgVY7axgNxfIN6NFIssaccghgBnqcDPXip9QuBPPCf7Ta7h835vNhOxGxnKjGD+H5VSuH8u7Sa2ltpRGcBoYCibc9AoHPTk5rOUpPdgTQRyvN8sWqXIiG2REURYfrg7T8x68H9KjuYdRMMYa2aC1DfujPEpaNs8ANjdnPenajtlVpHubaQqdpW2R0cjgbQduDx1/xpl+9rHZxoq2bshK+ZC0mF46YfHPv9eKmwXJfKisCYkjlurw9Aq7hg5+4ynPpknsKqBPI/0eTaZpehubdV5I52uWyCTjk1fv0keyjlme8dUVHMf2QKoGPuh8e3UHvVN2t40M9utoAvBRXeTA44G4cHgdMdTSWwMrtbNEyWyRQzO/DFYkk9yqEEn61JqLSWVsLVbi5yfkKuHiXjkDBByOnelXzTN58MJvNuFeJLMhBgcAAYGelOubaK4UzW0lu0kZ3PDbxzYA9MnIByOvrQA2SciaGaW6cuvBWIukpJHOCQePXp06c0QQMEIl0+cW0hyWuXcYOeGDL2z3xT7wXN7bxXEULLbxnJBnEpjwRx5ZGQfzpLuUXkLpZsJJ22Hy7W0KbBg8ZzkH6daErgTywJNemEWSteoQQZWXysBfvbQOMAg45yfWhY57q7htVW1nkaPzNsSeQCM5ySAD26UUVo9Fcga9u6alEslraKzAPmQtIrk8AnJzxkdseoqyfteo3ccVvJY3RTcSBCUjHI+8Dy3bt+FFFFtLj8isWiInN7aRny2MT3CyeXHHxwNirllGPTPtVqJ1W1kjRjqEKNgwlfKVQACOc5bt1//UUUPa40NezSK3S6ijhlBVR5flkogPplgcYPTFV7OOC4YyxH7LKqeahjfZwO67Uyp6/lRRTjqD0ZNOGurXfe20flYXN7kvJtzjdgsMk9Px6VHBeQ26zQm+vIrIjYwjRcjJHUfj1HPFFFOCvcTdghuLZLSS3lupfs2MARQJvIOG3MTjIB7daklWOF3Md6JYMkx28xcnB53YAC9yduSKKKfLuFy69qTpK3V2mD5eYxbsI1jBxhsAZzjtkjjvniKzhMtm6i41IQO2Zirr5e8cfcyNx7bj6g+1FFQ3ZFWLltp/22SSYW1xPCUy0M84yxwPmUjgcEHB+nrVeG6iWyeGG4eDzGLCEWyMFHQfNnOeoHUUUUk7tg9BIpYooZxqcIDIpKqI1Lk5yzmQZYE98H+KmQ2AODHLCQqmUxFcSFSDjLBcZIPUEe4ooq4e8rilo7EkaPcGS90jTkhgKsrHerhl45Af2B4xUtnbtcq8OkpcywA7p4Z5QiSbe2FII4x0oorPm0bKS1S7if6PBeD7VFaWU6MXjhjtzKH9WPzAHH1B+tPtH+06pPcQ3VirFCilIXCnP8SjAwcA5znHYmiitVG8bkt2diMzLIZZJLGzmijbEk6RkFVA52qWGDge9S2di95bqNLNwI0bewuJQVLjByqjjnvn25oorO+rKSu1cfcTXWos9jOq7ncgxwIq8jkjcxPYE9D061Cbq4sWmsL2NrgJGB9nMm1FA7kDr2I5ooovrbyF0uOFwYktJLG7UQudzWduZEUg5JALDvyOatvBeCCC6ghi05C29zDMSZBwOVxyRz1IB5zRRVTXLawo6ma13p8dy02ntM10o4FwgdJPfHrxnnA9qu6vY3phZ55rVjGACkKFCVIA+hHPQ0UUSVgTuMu76Cf7MrXt1PCygTMIlVsDJ4J5zkf/rqKW6jnuoEbUrhkhG5jLEG2MBnnGA3cdKKKFG7sLmZM0dzf3iPHGmp2qgsp2rBjjP1A74B7Cs+Z4ZrtZYwln5Z2ojMZPqQcHGT+PvRRShrJxKeiTLKhdWuxFG100qKAguZwytjHYLkDt1/IU26Ms8wjv41MUbFd9uiKykDHyk9skdRnmiipbsEddwuojbQDyLJTBJgl7hEaQHPUEHpjHX+tTNdtptnJbzlLyNDsxFPIgi64GCoB5BOaKKqmlNXYpaOxXsbedbaaWxtXWWLJZ3eN0zxtG0gE8epxTRdJCrSRTXaakq7n4Ty+Mnn1wM4xxzRRUrdofQW3CTQBo3vXvWGJJFcAOcEgtkj0JGOn4VHcPFJClzYyG2nJIkjMjszrjqTjGMjpmiiqh7zsJ6CyNKdNt0UTxGQ/KxuMhgQQflA4HPrUdw0EdntWG1RmGMRzTAsQSAAMbfrmiiqjG6uJlyW/aHQkEDzeWcRHEcYSQ9NuOo5z2/GnXcbabYARRXVvK8UbeZHKpUk/Lt2nPy8nvRRWWidvUsovBLbWplu7G1lVtpe4ZjxuzgYHOMcnA/wqCeYWto0VveGSJgX8iKSREjU8Dgjnr3ooqoK6uRJ20EksrtLZLqfMtsQSIhctlUUHJ6AZH+c1ZKXVrZJdWouYtOnBbyVnXeATgncVOcgf40UVHNqkxlKxtrq6TOkpMkRGXRrjlz3bgAfxY5z9OtV9QeJZTDBBPDcZMe43J+ZuNxPXv3z+FFFUne/kD6E/lSGyW6it7WMIyostuWDK3HODjPIPc96hhea9lPlCSUKwJZY443ZwSSSc9B6UUUp+6tAWrP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lie on a bed or the floor. Bend the \"good\" knee and keep the foot on the floor. Keep the injured leg straight. On the injured side, tighten the quadriceps (as above), keep the leg straight, and lift the leg about 18 inches off the floor. Slowly lower the leg back to the bed or floor. Rest as needed. Repeat 10 to 15 times (one set). Perform a total of 3 sets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10736=[""].join("\n");
var outline_f10_31_10736=null;
var title_f10_31_10737="Gram stain urethral discharge 5";
var content_f10_31_10737=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64347&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64347&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain urethral discharge 5",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10737=[""].join("\n");
var outline_f10_31_10737=null;
var title_f10_31_10738="Hip effusion MRI";
var content_f10_31_10738=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance image of left hip effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Axial and (B) coronal image of left hip effusion. The bright collection seen around the femoral neck (arrows) is a left hip effusion. The images were obtained using a fast spin echo-inversion recovery (FSE-IR) sequence, which is fluid sensitive.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Rosenthal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10738=[""].join("\n");
var outline_f10_31_10738=null;
var title_f10_31_10739="Pathophysiology PDA";
var content_f10_31_10739=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Patent ductus arteriosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 446px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10739=[""].join("\n");
var outline_f10_31_10739=null;
var title_f10_31_10740="Dimercaptosuccinic acid (succimer): Patient drug information";
var content_f10_31_10740=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dimercaptosuccinic acid (succimer): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12709?source=see_link\">",
"     see \"Dimercaptosuccinic acid (succimer): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/22/8548?source=see_link\">",
"     see \"Dimercaptosuccinic acid (succimer): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F223371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Chemet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F223372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Chemet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat lead poisoning.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702960",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to succimer or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may sprinkle contents of capsule on soft food or liquid. Do not chew.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10028293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696560",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it, after a meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12007 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-91.202.164.29-FFA7B79098-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10740=[""].join("\n");
var outline_f10_31_10740=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223371\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223372\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028290\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028289\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028294\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028295\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028297\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028292\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028293\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028298\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028299\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12709?source=related_link\">",
"      Dimercaptosuccinic acid (succimer): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/22/8548?source=related_link\">",
"      Dimercaptosuccinic acid (succimer): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_31_10741="Thiothixene: Patient drug information";
var content_f10_31_10741=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Thiothixene: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/35/41526?source=see_link\">",
"     see \"Thiothixene: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/38/27237?source=see_link\">",
"     see \"Thiothixene: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F227250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Navane&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10031367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692053",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat schizophrenia. It may take 6 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to thiothixene or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have low blood cell count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031373\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697320",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Parkinson's disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11090 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-4BCC47CC64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10741=[""].join("\n");
var outline_f10_31_10741=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227250\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031367\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031369\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031368\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031373\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031374\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031376\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031371\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031372\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031377\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031378\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/35/41526?source=related_link\">",
"      Thiothixene: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/38/27237?source=related_link\">",
"      Thiothixene: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_31_10742="Erythema annulare centrifugum - dark skin";
var content_f10_31_10742=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59741%7EDERM%2F80998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59741%7EDERM%2F80998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial erythema annulare centrifugum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous annular plaques with \"trailing scale\" are classic features of superficial erythema annulare centrifugum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial erythema annulare centrifugum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDsDMTHtblaSGYhhzkZpoztCgcZpBgP6MOwrmZ7aSsXGck4GT6EdjUqF8AuAyqcj/CmRDOATxj86eigHrn60mSTh8AHPWlDHdu3dO1QsTk8Y9h2NP6OWJIPpSGkPkAZsDnPTNTjiIhRgnrUSAsuGIyDzmns59frQMfCzxrh+hGKtJPiXgk7hjJqDLSIQcHAHPqKbtEQyWzjt6UE2uXI5FJYMQDkZPY0olLOSoBKjtVNW+UYJXsRUqPgMVznrwKVilEvxzqeSA3y/TpTZJd+NwxngADuaoxyN5u11HpyadkySKc/Lg9OtLY0UNS0u0xshY8Hke4p1vIFY4ByBjr0rP5KMSXLEggnkGpfNCDdhUONuB3NM0dO5dafBTbwQMnAqeGaMAE/d6ksKyY3WSPCgdck5qeAFvZOgHWkyXTRorIWIaPIzkgZpZJTsIQY74HJNQtINpyyAcDBHI4p4mRjtjdiB39RSsRyg8r8MeQBj6VIGBABOCehzVdwuSPvA9DjmpJcNGhVSuODmglosJIIjiRV254YU4gbT84CkcEDNViFUblGfXnnPtUjt0JOTnjPegjlHpIzAh/MUY7d6NsfAZWGVx071AskilgCq9yCKcWGAHbjsQKTuPlIJss+NqDnkY70wxMqfNsV05I7VZCKQVPDdnOeaVlRmxhR9R1pj5imkgJyS5PQDP8AWp92MZboMkZpvlIQU2jbzgc1EEb/AFfyjsN3TNJ2JaTHKSG3JjHoe9RMF35JU5GME9aVI3UMsgUjOVYkgZqIqXZXIxj0oBIY6FGVxjAGAetQYkQscbc9qtbVDOHXHGRUYUYwCcdlPahMCoUy7fKOvNMdQmQ3Ddzmr7KuwBMAjrxTHRGwNmD0yDwaq5LZQRUcdcE9j3prcMM8gDHNWZo/LO5uhJAx61SdiWK8n0xQBHIoY5RihI5yagyCx3YJ9amdlVlBP1FQyOhbOPrjtTBkMgAcHA9CKrupYlivJ7GnyyAEjFRPNjheR1poLFaZWGQvHt6VVlkwnTPIzjuKtvh84IyP1qq4woBYH6DmhEtETyBsEDn0pjEEL1GOtK64PykZ7VC7YXnhh+tNxuJOw/djgnIPeo2dgOcYqv5g3YbIPoKdLLwFyMd8mosO4nnHkbd2O/WoX2nnpntUVxPt3KCBjuKiMwwN3IHeiwhbg4U7eo7E1UkkYqUPBNTsd2cHP1qNgqjp7baLXHcqhxuUkY5xmpdxJLZHtmonjAz1NIWbawUe+PSiwr3PULOTjaT7detTMQr7l57E1XgiCP1/Op5x8hAPPXitDZbigSMwKHC55Aq4q5HLYOcVTtzlQSSD/OrKHufXkGpHvoWQN5BIBGOvv3qYJuPLDkZFVQwBKqcKffpUsb55U9vzpCsPRW+7jPofSngbiec1ESfLY5JwcEVCz5TKg59jQWo3NAMrRAZXHf3pGG5gI8nPvjNUfN2gION3BHtUqy7SpKg8YIPSk2NQsWBIjMAcnJ5zTklCb1HIxn6CqrfMu0YznHFSxIDGQCNxJGGHalcvlIXmZGJJIDcGpQwMedw+XHTufXFQtGI3LNlkPRh398VXuCwBII6ZGOCaVzeNnsXPOOwhWyp9OlQ+aShbhgp6ZwaihfdGsm3953BOQw9cVINr8hQrdgB+hpXNUki1E24KAwCuc+4NXUc7EzjauRz1H1FZRU4P8DgZG7gD/EUkdwyOBIoDE8jPH51SZLhzG6LiLjI524LN06daWOX7jKoGRg57k1ivJtY45Rh0649Rip47hol2kKT1+U5BGO1FyPYo0VcGVQ7EFT0J49ql84MSHydvbkVkzyoSrQsSrY+9/DVp5SIk3kM3Zs8fQ0CdM0DJvXYr5J4we3400EjBkY5B7NWckigkggrjGO2asRM3klg4A6gHnFUjNwsWzIVYHdjJwKbHKWY9FG7p0zUMjNIjB5BI2AQB3FMhhEuTsIGMHkHn+lHUnlVtS8zDcBlunBHf8KE2qSH3Fl9arhXjQbWOVycGpd3mRbmDbcjGV6/lSaIcSdJwx3P93JAFR3UiMNwiHIxkcH64piMYxhl4J6ZpZGXBDAqoOM9/yqWjNx1FD5jAYkYOABxUcwQDPQjp/wDXqHzWB2HAAG7kdfpT4pfvbsFjwoxQTy21I3KOBkbT3JGKhdxC4VvnJ5yO1S3GcKGBGM4qNuTsVSTjtSGM3Nzg9eDxzio5SOQ/HvmmyN83rj35pjFTjJyP5UxNCsfvbhkAcZ5qtKMrgcdwKeZBxgHH5VHI27HHX1FOwiiwz8wYdcVUkb5cLnJ4PtV6bGGBHPYVSdR15DHtVWHcrOSD84zVZn2nA6e1XvKV/vc81BPEASV5U0wuZ8khAyOxxxVZjK0hIJH9K0JIwASOvoKhZP4lHI6ii4WKR8zdk8+1NdgITvAznr3FTEEOVBPPIqPBCncMk0XJaKxQEZ96jkztJUfUVYfaAFHrwaY42jAOWxg49KQWKhAZuVHv6VAYiAWzg571dfoAR83rVSXcWwM9c47UdBERHGRkYHOO9Rb+uSQwHFS71ddo6HrTHhwd2SV9M00IhYlRkdf51CzlQeuSKkbcFJfr+dR57sAM96BHqccmH+bnNWSQV49OfaqAYI2eSMdqlRiqk8/MOapo3LETDG0Ee1L5nOOx6ms+VsSBVyCO1TIW2gOQBzn2pGsYl4yKgyPTqafHIxXKnAPPHaqgBdSODnnHtTomwMdOOmfSoZryouxvu2oD+tOdtvBVskcEVWTkBjng8cc1YMi7ScZX+tIVuxGWZnDkfL34qdiPLGF6e/vVds5UsCMnJHtTiSVBAzntSGx2QG+Xq3QE/wA6R2ZpAq8e54wfrTEBOdvB6kGlUtsYsCCvvQIu/KEAk3DjIPvSTW0WV3A8DIIP3frjvVRJ93U4xz65ojk3khQCcc4NBUb7jlQCXAXIH3WI7U5BsfK454OD/KpHkycoNrJ04wad8hCkbcsPr+FCRXOOC53AMAx4wRmmyLJMFiQISoAxkdKrSbxLzwCMjnimsz4CsA3qQaZSbHqAu4OuWHp2x6H+lSRFm352qRglW7++exqsgQIoAOBySDnAqQswQhiGxznrQzRSHiUKQBknOM/3h6VY7kqBhuAD3qi2fN37C68AEDGatCV2IG4Kp5IdaENu5bUmONQVLeo6cemfSnxMjqAwb2AP6VFG5BIVgp4xjo30qaSExhihQ5GSFOef6U7mbtsSyBWTcDzu2gr29jT45AvyiR1dhhs8fnVUFNuGkVs8E7sY9vrS+aY0CpjOCCQf0NMhxuXfNJQIrSDnhD/jTUkELsilirjOCcY+oqGOV3jLkoyrwN3DD6UqyvtVsI3pjt9fWgzcbFsBUX5cuSDkeh9RSeZ8qgjc3bFQhnXCONmRnB5x9KYZH+4qKQOCRRa5k0TszEA8kA/d9PpUW4AkkEinIZAuByM85pzRIx5Y7sUWM5MhLKVyBu449qc53DcR7Y6U1lIyrEBfUDNQzMwYgNu69OOKViLiSsAeuD39qrzMM9c561DPuOOTtqAtuyOnbI707IY/epzz36EdaadzDPTjsaYy7NuDyaY7L82MUBa5HNgAgnjrUbNlQWz+VOlUOucE+9VypHHP09KLhyoSTuQD70xyXUAHp+dDNtGM5HrimjBzjkk9qYWsQuuMjHeoXRWBXpmrcwyd3T+lV5AGHWkK5RdCSOmM4qG4bHAwPqKtSr6rx0xVSdQOAMH0NS2PcicAjnH4Gq7jlipwae/3CQec0KcgZGcnOae4tSMtghg3P0qvIrLIcdxxVqQY5OM1XmbHVTtqkSVpo8Auoxng1AGIyCTwOP8A69WUfKtnG33qtIpHPc9xTQmM8wY5qvk9D07U9unGcE459aa+8E5xikB6SzfOq/lVu2ZWRgepP5VmsxWQEjJ7fWpYJCGYggmrbNkie4Kudw4PQn3pFBfAByvc+9QykMpPXJzSWzkkHoRzj1rJs6ox0uakYwm0njtxUXBY4+9SeZhM8t7ehpwZXweRxgikxJkvmsFVGbg8r9alQZK7mweoqDIG5SencjpSIQQwYE5GNw5we1Ay2xBPBPljjj0qRXAQDcxj5CtiqUjbRknaSM47VatzmOXdgKm04zyCenH86BPQafl2s2OO2OppBEsxZCcZHXrUkh/cyYUK5Ycg9P8A9f8ASh1aQFgEQoAwAP3hjqPX/wCvTsK5BCptwSoVgp6Yz+ftSxxhj8qFd3P0q3GrpvlKBSwGfQZpyIIrtGnZQvRkzkhSOopWHcXAyXGGlAwcHr61X3jcVVjtI/FTVp4ySzIgwnDEdCPWoBtRQ7YJJweO1DVhRYzMhKyZA5wSwwKiKkk5BVjwdvercCF5ViZiY3PzcdB6n2qb7HJCdkuRGehz8pz3zTL9oloQRxBYdyKGl6EetOhGIySpVsdAP5+1Sqcj5nKsOhAzTxkjcsgXv6fjQHMN8ldikMFcHhcnNO2BWHzhA3ILL0PoajlVVYsjBh9enrUsZAYEkZIx1z/kUiuYq+biYqEDE/eC9/cVLFLIYQNzE5z1C5qOaEHDZDfMRlRSOsZwG554z0P40GiaY+Ubg7THkj5WH9RUc0ZIQ5yAu4HOcj0pJVjcNhSh6Y7VF5iopUggkY3KTigtFy3lVFG9PuqScqDyakhmzkRFTtHQ8ZFZRK/wEZPbBPP1q3bxTN8jqkfXBYdKNSZRRoPIGCtGzhgMYJzmpBIGVizOCBwf6GqMsUiLlvKIzncDUilg5GARjGR0NNGEoaaGipbyk2nPGcZGf/r0wNgkcg9x6e4qlDcBnIVS238CaT7QyyDCY7k5zVGEqbLJbDEAjae5ppjBwxJA+tMFwn3TjdnsKeu5m6j6etIxcbDJFQMTjrVKaEqcr68c1dl5BVFGM+tVJkIB2E8nvSBMp7W38nPHFMKgg7vzqXy8EknHPQUhADDA/CmUQOcD5eTTGYcHnjinvhW6YPeq0h3EYWgQyXacheKjUYOBQysWJ24IqMsQRx0ouDFkkKqcdT61CW3YOc47Urt2IqsQwY5H4UhWEmBBBOCSenpVZm2k7gMjvT53baRnjtnrVKV23HgAmk0NIjkwwznGexpAyqp6ZxRM4K8AVWMgBCn/APVQtAaJhJuODjHaoSSchiOe3pTGbAYA0wvlefSqIsNkb59u3rTJBgHcOMY+tRvJgAAnNMZjt3dSKaBkckfyAocDd0NQs5U5+8farEjgbjkHHr3qucleOvWgR6Ky/Ix5J6802GTdkjPuKkibdx3xxUEBCs4ZgcH0qmbRfcmEm1+c47UYKsOcLnio/wCLJ/8ArVLkeWMnI9RyazaOlS0Jo3DNw2Tj1qcnamVJJ/z1rPjYCQjng4zVqJlclW3EDqRQhEqykkZHzdcH1qxYIZZfLTp3XOMj0Hv6VAQqPujcuGxjPf8AwqdFVY2G05J69OKdhOXRDpVWOZ4nySOFYDqPQipYkke2ygHXAHQuf61H5ruykvngAZPtRHIVIydzdO449qNAdywrI8Y4KMVIbPc5pWuMSkKXCH7u4dj1GKjmbzkGNqkDHuc8/jSomRuYBiR0zuobuUordlyOR1G5MAsCuc5x7VFIwKjcQWXndjp+fWliVnL4Yk9wQePegw+amCQe/wAvc/Si7CyQLdPaMjJ86jPLcgjvkVahFlIu6RZASBlQeAc/yqoyb41UEAdCKRJNszrPt+VsBh/Fj3ppg4KWqNSCeKO3lESESNld+cALVEX00AaGSU+UT0UnGKmtpkB3A5z0IHH0qpMRuXOAQ33SOeDQ32IhDV3NIyo+nW7IQZQ5Td0OzHAIquXPmbXCpyFywxx+NMhdlklXcCCec9DV2aO2mshICizR/KwI4b3xQ1cm/K7MzZggcb8lwTyOhNCsqvsdMHsxPIqSTaDsXBQcbkOQD2600FnyGVSuM5Y4xipsaJjRtMqnJDAYOF4NMdyzjKsy9wOtOkYgjLj8O1NVhtO1iWJ6kFSPr60WLUh0ChjlcAN2Lcj8KtEKY/3Xl/L1xwT65BqOFmLFgiAgYPNPaKQIJC+Fzt+7zmgpT1IQNqjYSCxyueAwz09qUy5YvMoy3VmbPHqDTPKbzAFUvH2GRRIIvszOYm3B/l3E4cemRSuXdD4plWVhKFKDrgdffFAmZEaMFeeOT29aqjyFUK0bMSOCh7YogkKzxrhCOD85ByPf0oQ2tC5uDA7pGDDjKnvTJQETcXy4ORz94U1ZwLo7wqlW4VTwfpSySCRiH2bwT97tVHPK9xyy55YdfbpVqOQthdpyeQOlZrMMLgjPWp4izqd2SB0INMwnEtFickH9KhcAP90sP5UISCMkkd6ZK68gnJPalYyI3jKg7h15Bz0qItt4AGfShpPp7j2pokDEABcZIz6UAMb7xz2HOOaY+FB6ZpzkdMe3FQE8HGD9aBjZGHUE/WqsjAqCB9anbDAA4U+uaqO58zoDye9IViGVsZwvQ9qikcBRuyKmmYA52jJ71Sck5HPrmmURyMDkZ9qhb5uc5PSpnYnAwM9aruSuT1J5qQK8kat05I/SqdxGWU8Z5q8W4yF59KYxTacjBxQF7GcqHJHzdO9OMJCso69hmrLrtIA5HbmoicsDxkDpTIbuZ8quvUA1Cxbd04POKvyAFTkc+9Q+WoBIP500K5TLHjg4PFDtggIfzqd8EAMOKrFPvAcZpiPQLZ2IB7illJVyxxg96hVioyo/KrDDfH6f41bNU7MkjYMdvGCOaXasKspYkHpkVDBghgR8w7ipQ247epxyfSs2apkbDlgR0OfarULKUK5VTxx61XfDKFzyKsW+xW/eZ4GBiiKLk2TJIUU7Nuf4h1qUzZClmyfzxUII3EjGO2f60u0KpZflx1GeaZWhYjOHJbJz+IP5U9DhuAMrzuqvbFfM2sWAbgEHoasoSpJYHdz1pDZNbE7mwAGPB4/XNWI0G3ngYz16VTQgAHcQ+ePTParMMhaJgyDevXnp6mgGSeYFlMbknjAweh9fpUkinlg3Trg/yqkwxISQxfoBniraSbc7TuQ9V75oE0OTqZGB8we/X/PNMeDfIwVlfcOhwDgd6cux1PXOTjPXNNjuAzNAhBkRjnP8qBq9rocA6BAx+YcZPRh70kyb9rNhiB0I6fSpljwjDbsOcN/9emB48sG4wu3APXnrQCdyGKJycsdi4ztIyBQ65c5bgdecA+4p7YZsKACMnB4z+NIF3yEZZVA4LEflTQ2y1YXcYgeCZSYGyPu/MG+tSPYpNDvtpYn28EE7Wz+PWs8hUiLNg45yKfp85hdWimGHb7uOD+FVp1MpQe8RrxFTtdMSLztBI4/KmZbBZoMryCOwz71caaa5lKSsS4ztPI/Cqp+cMr7hz91WyfpUsIxfUYgYBlAjUNjAzkipFeXy8Mx5Oe+M0xWj3DdJ8vQk1LsjmBZGMkfpuwwpFsazE4kbapA7cVE21QWLRqp9ckD/AApZEwEMckZXPIb7341A7MMF4v3Zb5sdD9MUmOLJGfb8jiPaR94Lg49agEJ+0ZMe5SOoPb61LJJmMDeFPQ+4pu1mL4YFBx8ueRSSsaKVxJY4wEYeUg/2MkipCYtrBiWIzjHeoowjbdxVVAwAf88U+F2WcO5UH8gcU7ia0uSIMKAVQcZBqTzuu7HI4GKhnZVOEY4PY1HISTxJz6deaL2M5RTLLTbxuUbT3GaczkDcAB9KqLI2BlcgnG71p4cYI/hPQ+lUc81YlLhV/g59qibnnaCQO9POF43DJ4/Cq7njBfg9cUiAZ8NnaB+NQySHeRx702VmPOOhqu7ZOGODQwsOlkDPnb09KrSOQSVUk4qV3GTzx29ahkKjBJ4oBFVwSud3P0pp2gde2ORTmO1/b1qFpN4xj6c0DGkDn196hOGySOPen5bIzznjmq7MSxyTwc9aQhsq7QMNxUJwTtPfpmnnLE4zTHIWMnuOlITZGzgqeKqknOfU1KxLlj0xUbuMDYwzjAzVJE7EPCk5OfSo3YsOBz3pT945yMD8KiL4wM5yOtMVhTnHQ1HKwV+nUUb/AJuTx0NRMcseOnegDvARtCn65pwkAUDv061XYHqpyPSpYSHxkZYda0bNbXJEYNIwJxkdRVlAEA7+3rVdgA54oDZwefl9KgpErwguHDY9qavJI5HHQVMrZYNhSOtNZwgZhjpnGM/lUpFKT2JISFVA4IcDkVIJy2Nq7fQEZqGNxK+/bliMEnmpoxlj94dutM0bJBHvQsAu496uQ5CKZVAz361UibbFgngNzjvUqScFABjO7P1oYrt6FhYs7sFRzwOuac+4bfmyw9BjHNRxzbY23g4BBytSwzbl4PX2/nQPUmUt82/qVOCBkUhlEhC7S20Z3Dj6UwecrZ5VugI5xSplWyMhT1UdRUstbFgBBENgOG4YHqPeojFsLYdfMbk+metJuZSfL446HqKmMqlV3KuejBRjNAJ2DzyG2uN3y4BFR+Sd3BVuoOD1/wAKkmZkbaSNgxuJ5x9PWpEdZNpbbvGQOO1CKvZERVY1Vg4B6beooiYtEinLKecgc5pLgADIP5CpoNqRfOXKk8FRytBLehWkTfuWVWXjp3zT1t12ApG2VGRz1p0o3jzHywxgn2FTQEeVtZSwZehPb1BpgnZFccBXTJ289eVP1qWGGa8jkcRq0ifM3z4JHqKYG8q6JycE5AVs/WpLPc1y32XIzwBnABpFNaXRXkVtrRm3UMOCT1FMiimgO5tsYxwR3rQ1G1ubaeNp9vmOD8wGee4qtHDKWCgbmzgh04FGwlZojCEyfvrqJQwzx/WkmQphQwYg4yZPkI7EUjM8bFFJiYEjCx+vWmBY/Lwd+c/MrNjH4GjcdkRJKQw3BSBzng4poxMQUMwLdABkZqbeEZSkig9CNuQKasyIrJI+RnIPTigEiEQy2+Rgq2DuDADNKiozKwZdwI755980t2yuvMpZAMBsZqriRpNqREnGSBxSKRckkZ0RAuMHpj3oMjgHJ2k8HioFjcKm4Kdw4GR1pXDNuC+Xj1zyfoKLktCt82C+QOnPapEOxT0YE5x6VEVzucEhBximxFTJknjtVGMolnGAC524HaoXdN4VjyefagTAgjnA4GajmVWYO5+btzTMUtdRjLuxjkVBKgU9DwMDNWSRgYORiozjHIY0hNlfPy5JyT2NRzABQMnJqWRQMbQD354xVabpwBuH5imJETEHIY4PWoHABOPSplYMM5wfpUdwxLYGM9akLlYsKgnJLk4H4CnzHAAAUgn6c0hQlRnGfrQDZFLJwMDnGTiqokyDknpmpZlAJI59eapzMCCpHK0EkisRk9c1A4Vs5XBphbYFI6Y6CoGlyGPOO9AmPfDAc8Dj3qJgGOOnOORS7+B7+tRecWySMhaoRGzgKy5yaaCxxkZwOoPahxuYgZ5pM4XHAzSGd2O2afEB5uVHSo2ClO+6mPKYyoxjNXJnRFX0Lco3kkNz6U9HZUyPm7VUYh4/k606GQ7OSfSpKsXElDjaMAn8KXGQSxwKqJKpkGSM1blUGIkkq/dQeKEK2uhLbr8pAGPx60u90JIHOCCBg5/OoYV28qQAME81ICAyk8nr/wDqoZXUfb7tvCgehJ61ZSQ7Yyrt5gON2eBVaPczSjB2jkZ/pViJmjVWyCpI6DNCHIfJKASGKqGHXOeRU8bYCtnOAM7e9UmbdK7Bdx3YGRz/APWqwGMgAcRgnkMMDH5UnuUtizKHmUFCeuCD1pEfDMSuJANrY5JqBGym1gVwTkHsalkQl0LsQHUNkdxjp9aCl2LW5QuSw5Gcle/pUkWHXk5HTcoxiqcWUUM24hCMA/zxV6KTc3KYOM8Dge9K4NCT+WBEQxO0gnPI/wA9ack0cJEezJA5GPyJqNg2WKFQzDO4HikyC5MjAsBnjPJ9KAW1i0GUqAhynfcOlI+2KPbwpVuCc/rUdtKQ25YyygnccfpT32SNyjbQemORTI2ZOm6MjLfI+cED+fagIpiBCtuH3gOaYSwUIpbaeQBxkj2omkCRfNk4wQR/CKBWIZTsY7wFAOcKQfyNS2Mkcd9H5QL+Yw3L1xn/AD1qrNLEUOACDyCOv1pNPkEN3EwlIUH5T6UupotYs2dYjZHhw8apkgEkkrz3NZc0aPKvm3OShwDvzkexrWF9DcSrFMJ5QW2htwP04AqjKZVZ0NuDySMjBH4U2ZQbSsyIxorAjJGRwz53fSnyxA87FAbqC4OKkba7Bi0YYDIATHOKYwAiORCSwOH5yP6VJVyBHj3MhXnkEIeMVUlMqlSMYYYxgdKllnCOnyqwXhgg61MjL80vkDZjacjjNBadii0U7FVwN3UfPxUMolB3kdMBvmzVx90sYREG4HceBn9KiMchUsQq9gQfvduBQUpFdknGHcRjd938PYVEylDkyYJJPyjtVkoQ0KKFAJ3ZzkiosHawwp6/eNIq+g3KhVGSR9MmhDgMQAATkc54pkpAj2FQpAywHenv+7AwAGxjGQapMzkgYqBnk89qUICDtJOfbNV2wudwxzx/9elWTCkoScVRjOJK6uFBTBA4APeopZCB83U+1HmMe4qLIY4J4/nQ2YvQa77uD0NU5SVBdVGM46VPIygknBH144qvKQUO5hgnt1oFsV5WYZCBaidmD7QwJ9cVKcHGRgYx9agkUYyuRSHcimZWXJOSD60wyYfkjFBjAUr3J6VCzAKRnlTjGOaQm7ivzliD8x6VUlT5nyMD2NTlzhSSfTIqJwCpGAT1pkbFaXCqACCe1VmXB4bg/rVvb1xx71Uclj1G3+VOwXIJCQgOQckikQDYwyTT2BYFeB3xTOBuXGKQEgt5C0Xy4WbhCSBmorkbJ3Xy/K2fKUJzg1pW6JeQxvJFciRECZjj3BgPT0qlqbmS5k3RsmcAK3UADjPvQyU9Tt/+WeQKh2+aQWHOalBwBg8Ug9uauSOinIWFNpJGPpTUPlzHjjuKFZlYEfiKWcqZA3r+tQasbNEok3ADnkVYxsQO2Ac5z2IqsdwzwPr3qdlLxKME4yfmNCEgXKuSCTU8bqXQjr0YZ6fSmCM+WpJBHoP61C4UHG7vwKGaKzNCRQZD5T8q3G4U8yNgbRz0I7ZqGGTO4twSQSc81ct0DHEWPp3p2FfuKWdXxLIrbgMrjt68VIoVkOMhD8pUtk8HrT5Fzgng8jcOhpFMaZ3FuOQCO/uaTBO+xLMzLFtLHA+UHAqIq0ioFbLj5c4PA96SMMWIwD265xn0qdurcMGBOAe4pFxdiWJdqqhcBRyCxz9R9M1LG64bKk59CeKr7gY8SDIxgDPI9/zqZWLgFmYKACSOT9aegiXzCEXHKdQV6g007tw+6TnKsM4Oe1NDlyxQkOOTvXGR/jUhyq7WIKn9PpRcZGsnl/xMQeoxxn3qXzgzKiMXVuBgfoaawO05ZQx4zinRW4YkCQFhyDgfj9KQFhUcoc8kDcCeefp/Oq0jySOMYAA6AdPwqwGUZWRmOecZxg06U7jI+QrHA3cY/EUIEUWfLqQrb1HzITxiliVid3ljaOg6mhoA0uYy2F5w3Qn0qaAMrbTISR/Cev4Ux37DoWZDuyQEOQPfNXtYCNPHLHdZWVcgBfmA98VAoeSSKL5CxO0MTg/Q+9aG6KER2sqrgEuGXkYPpRuYy0aMpiz/ALxFlZ8Akt396jcygM8aKjHk5OePpV2e1XzG2XDbScDzGwX9OtVNqpKyuRt6K28Y/PvSGrdBiwyLlvMZ2fkYwBUJeMISFCnHG5skipZfKUAo2+Q8BADgVGkuVChNzt0KjGPakUQfathJjVRCTnZjH5GkWb90NijbzwM96dcp5aoWR3Gc4PQ+1R5dY/nGxOT1xj1oLRE/yL5Uy4wSQelRiVHYIvzY6EjGaSQbmSOPEjYLEqentn1qrHMI5RsifzMdT0AxS1RdiUqN4Un5uflbv6VIwTPIJx2FVQ+XDPtRsZBPXPvQrlWKu5DKpAx2pkskKRhizA9eOarCRCxCk7j3pxYNhtuR79qiVFyxC89z3600Q+7AuFfG7IzUscnyMwXI9KZJgYxglvUU4x/w5xn07VVjmm7jZDuUAYxVfr8x7cVZXO7PboBiop2ADY6Duf5Cixncpkc/7I6GopAQQd3y4GatEdSMcjvVe4CDCgHJpCbIWBZsgVRlDHoMY/Wr7sNpGMZ6VVl5j5PU4yKBJlN9w2jgE96a7fKTwDnA96lZBHJu5J6YqlIGEZLZJB4osG4sjgMwUnOMfjVYsShUkBf60mSynJ6nA9RTWQKGUZ4GfxpisR+aT1PI4pHkLuSe/HSmgkDJXrToZpIphLEdrDoSM0hM0XdJ4rfbfCJljCMmGwCPpWZKgSQ/vfNx/Hzz+dW21W7DH98M+mwf4VUuJmlZ5ZGy5PXGKBLQ7kY2DpQGKjimFdy47VKiqI8NyK0aNk7AWD8mhl3A4FNKqMZB4oaQA4XpWb0Oha7ApAI3frVqORANknTGVPpVUcODwQaXO1wTz7+lF7A0XOMdAB9ajCE/NwMcYxnNTOEkG+Ng+0DdxxTdoBBc4Hp2qmOL0JLd8sBsV9vOMckd6uRnqScbelUVjZCSWCKT0zyeO3rUyuyp85HzfLntSQWuaCziXcFjwiqGJJx3x/Wo5oyxUISUBzjrTotqb2IErFCpRT1445/KmRsUUgZGeMdaGrrUI6bE23ayAMpYYJX+lTLuGSVLD1z0/GqyEK6sVDPk/e659ak3sxJd1BJJwPWlYdyaZ14Kgn2Hf3qWIt5Y2jA68jINQDbIEO7B6HI4FSxS4wCwwnTJoKWq0HSlgd27/Z244xTpFKLll4x1z/MUx3ZowU2gsQSzA/iPalVsxtgBef4ue/rSGth6MhCsqAHByB0YVKAyp5g4U47dvT6VCSY2Zmj3BupAxn3x61J5kaod2NnPTv8A/qoBlyCJZUYgblwD82OP/rUiJGCU2rjGAR2qqJFEq8cHADA8H/Cpg2Y8o3JOTx+vtQTqguNqbQo2g8kAng1WWRxKo5AA+UntVjEqn5lySOSBuB9xVaZQ7BySBjABPahlQepYEQEhZXLk8k9h71bLxrH55iBTocEnaatqLaKxieKAvkcuzDDH6DniqjyzTuYhlYx82I1wCB3NFrGTlzBJemduIw0bNuIMROKW4kkAIy0ijjaYvmFJdnORvRWwFKoDlu/51EB5eHjZjJ0BkXPA/HrQr9RpLoQlpdqxN5u3Py8dPp3pkocOU2syHgM3H/6qsTLLLsZQHUfMfL7fnUcuxd6zmTBPHIyR2zSKM51kQtuLblbbtAz196fOzRRsjIobqSzZP0we9LsBJMaSZPI+n1pjw53bQQgPOWGSaGUZ8vmr8jrgDoRwc1WdlYHOQCRnHQAVblMbHHO7aSSX6c1WaFfmYbTHnrnOAaVrmnN3IJHXdhT0OeOf1pyyBwqnjv6mlYKVIjzg8KqjHFTwom0/Kc5wM00TJorsGBIz19qRFO0YU46EmrnlM6sobgEYG2nCNlA25xnHNWkc85lUIzqo4NLPtWQAHJHelmOQQBjAwMGom5Ko3GB/Cao55DmYE5XhVH+TUJTchBJBPX296VACSSxwOxpjvtBCqScc8UjO5XWMK4HNMkYGQZ4A4pZXIfzCCBiqskxd22jpz+NKwxJujc/d/WqsnERLdM447Usu54yM98g+1QlSIirAkk9/SgQk+Aijnpk/j0qgzI6sgznPTPWrMq7kAAOQeaiMQSXcQCBjFAFIDjjAbGB9aac4w2ferQhOWXuTUbLuWQjkD2oHcpuTuYY57UnXb2zmrBGZTxx1NRPGcKcnGeKBXCK1nlcFUADKXUscDA7/AEpt1J+8aNoEieM8he9aMjObFXNrJhwkMj7gAUBxwPfiszUZd15KpjMbAhNp6qAMCkLc7ZHwRnpUxYFcDGKppwMetS8EDDc1pc0RNtJ5LcUOqjnNNjOVIzmnuGUDjrUyRvBilFCZ/lTlV2XAHFSRBDH2z70QsC2Cc+tQzRktuv7iTBwM/SlkOwL8uQeMjnNNYLHIduDRK8jJuYYXpkdqaYo6sftONxQ5UjqelSrh42D5PPIHFV8bojgljnP1qeI+YmFwMcjtimNlmH5QFJJQ5U7eDTnTYr/eZR93AyfaoWZQq7d5YjDEjGPb/wCvUgkY7lUgKRngUWBMkRg/DFlOOW759alhbavy7d3TI4/zxUG3LKd6+WvXrUgJVQTgKeCwHWkUyzEy5ySgDYBwM5+lPSJA2Wide+T1FV0Y7+VHpgDt9amkk2vvLFiTjJz+lDErk+7r855Xg9Nw+lNZ8bgxOeOPUVGkiOyhGc8EDthv/wBVPVFXaGZgp/i44+tMpAHLEBUZVXnOc5qSNS6ZzxkEjPfP6VAUcEclV4yeoqeNXKsGEZdcsecHBPWlYLkjMSoDZKZP3exp2GiVgHbcMBkyP09ah3As+4ozFt3Xp71JIuUUn5X7EHpQFyczKqD5SXwe2R74xUDJH5u5uW6KM5x9aVlYpu+dQfun371GcFUZCxbABBHNJjjob1rprRaU8ssoZHG4Rx8kZ/8ArVnSzRgbHmdoQcYxjHrirCarcRmJQyGNV8or6jvmnXUcjSzSRRBoz84I6L9TTZjG6b5ilaxL5+Iw0luDy67uR74qx5KKz/uWR1UttcH16j2qOXMRUebG6OuTsfp9fTFRSM20CaR2Hbb82B9f6UjTfYtbPMj37SMfeOc/jj1onjKrhIiFBBDEDpUUcnmRGNZHUKdwwnH1z2p+WZWEs5ZFPJHOPpSsySnI+9gwDsy985AqFreN5STGxJ5IUdvxqwkipNPs3GM9MnHH4VFuz9xRgHBbofzosO7Kc0cXymOADZ1JFNmXOEQJjoAO341ak8vz5AwA3dERt2PxpJYotgUEMR83GfSiwcxRjhweRyOc5xUjEiEHbw4wcdcZpzxE8s46jvxj0NEskRY5bI6YBySfSmhN3ICvl5+YkHpntTHm+b7wCY/zmmXEygAjhgDgbsYzVDzsN+9VScYVad7D9nfcsuyg7t2fTmqsrkufXr7VG1yu7YpHAAIYVGZv3h5yo6HGOaFIl0yfcmWIB28cZo8w53E9Tyfeq+8kkMflHJOaeLhQMtggfdqkzCVMSRQxweB1x61A8SqzbTjAzSvJvTdjIPXFVp2ypHcCi6IcGRzBV+VSTjnPr/nmoX2yyDA/+vT5JPLYAjHqvtTVIG1gRjqaLkONiLKk5UHJ7HpUMnzHcM4xVgRjzWYZKjkCqzAopGcD09KBCSYI3Acr29RUYC724yMEGnxkkFDneOQaZLGTnaAMjPXpSGVhHhuegGDUZ5DLnjNWCjbvryPeoJBhDwDyKBblx3t57JxLI0LNGseNhYDaeox61lXu2e7kdFYKQAu7qcDGT+VbBnu2ggWzukSNEAYNIAVPfINR6pcrNBMxkWT94BEe/A+b8M0CWhrJnvT1HIqKNvlBp2ckYpmqLEXA9KnDliPaqwOR1qRGOcYquhSZKpHmqOc1YcCF1LDOfSoVwR7inpICArjgdOKz2N07oc5wDtOM9KUOFUCQlkPalYgj5emKhicByGGePSp6jS0LEQK57gjOTxUiHbkH+VVUlypGMEHoO1S72Py9M+9Xcdrl19uxeuSoyCO/cU/zg5wMqnHXk1XYYXhmOO2OlEQPy7skHJ+ooHYtgIVJBPoAO5qUyD7u0gDoD0xVZYyyOwI3LxgnGf8AE1PFjeg46Y555pC8yaWVpJhuUINoA2dOBUhb92rsxO4YIBwBVcgxD5mOAOB39+KerZIYNyDwCehoKRZDNIgOQW4GR2/z60hOD8ygZ5JNQZG9QeTjAA6kelSfeUZGCFweaLjSJlLNwo5I788UMCXYHapXJBAOB61CuVOFJyORkdjUibC+NrAZwF/Ci47EkbckIgbAB6fp70rOmMBWJ7elQxbVI2llkB49/pT0wTlpC4PbNFx2HzXK5AbeCTyHzg+9OhkwEdVDd+RwaZNG0m3ttGFbuKdJCVVkLMOMqcY3f/W4pXFZWH2zIZlyGck4xjOf/r1dSS8O0xWlwqKCFIiCjp+tU9PiX7TbrJKI8sNz56e9a2qWElvIktncBoyvysWySSeeT0q07Ixn8SRUkkWYJttbaJxwSBknHfFIUkZeLpSQxwuOQKgMJERYPEGZiM793Hue1Vm2IoGQqMBj5dx+ox1qTSK7F5Qy52rvLA8lxg/X3pLdg4yz8k5Af6etZvmnc58t2Vu4+UfUimLPsAR1XGPkUEksfSkiuW5ql8GR/lD7cewwelRM2EMi7m4z83AHvVY3w8jBZWwc5C8YHQZpjT7ncs+45wcfN26UyeVkiRPu4QEJ2U559TTJ1beAMeZ068fnR5oiiRQeSeR0wKb5sRO1QMhcgvzgetBNmIwXyBuG4r15yKo3RQJuBIHYZp91cyIB9nPAzk8Dkjrj6VTuWaRlT5QpwCByAKGyoxK8zLGCcF+ec8Y9KqOCyuwx69c1JdkBBh844/WoY5Dh3QDAHIJ4qG9TT0GiM5y4yo4yB+tR5G9ieTn9aSSRnUjBVc8A+vtVcbgoJYAk465ouS02WRKFR8kYOSPWonn3HlSMnsOOag3sZBuOOOwp0jq3QkZOM5pNhyokeX90CvAJIFQlm8wHqBzTIX/d/N13cfSpVGM7gcDt7U0yJJIgILs24854+lPhCrIQ3KdM04/KpXaATxUWCrBc468+lUmYuNyZMANnuQBUUqqVJbPzNUsZQoQAOOaJAGUNgfe5qjBqxWniMZDZ4IH4VEww79ORjntU8rZJV/TmqbOWOB1I5pkCSkBjnsMLVd1JJyMKfX1p4AdBk85yM05ir568cUCLe0RqscdtDIxhDoWQMXYY3Cs7VlC3j4CrnGVAA28Dj8K0ZYAsdu8Nk1x8oJl3N179KyNTDfaJcxiEjHyc/wBaTBam6h+UAVKo5yTUMPvUisAwBq2ak6kVOvQn8arkgkEVNE4P1oQ0WE5XceMU4lRjJIqEOAMHODTlUEhW6HvSkjSLtuW1AIqNwB/DjNQxuY52RiNvapiCy5HOPWs2jZaEC5jnBxnPrVpSrFVG4NngHmq1wvIJ5/HpSruJ4XAx1zSvYt6mqikfeHQZPrQmS2CMDtzVCGV0kQE5HQgk81YkKpOwjbdjuOPwq+lyFe9iyoC/u3OB1wDQC7OyxgbDyWyBx9ag4ADYHP51IrKxxnnGBnp9KkuxMkrMmNwUjODjk1KjksFC5zgdMVWClB8mODyP6VMCpB2gYJ5IPSmBYVWQq3IXr6E/jU67WLErgYwQT941WidAdu4OSMjJ6e9P+5kxoRjuTnPNIpInmRiAEOB3PaiJSQpK5Vjjrzmozlm28FSc8danGFUbc5HPNIPIeu0qFBAwSCcjI9qkAUDLxkknIHrVNZWlxgc9sDt61ciYbliA3O5HzdfyFNahLRCkbvuptU9KRywBbLKecbu30q/JYbLaRvOVyDyqAnv61RjEa3Sm6BMB68kfpTszNST2K7szx5BJwcE8/PXR6jLDDo9mI7MfaHTLHAOQBg8nqf5VT1aYW/kGKOKMqOUD/hyOfas6K6El0srW6ylhh93RT7A9qrRaEcvPaT6E0Yha1llIUEEAYUHP+yfek+0s8SxiNikfby8ge1R/vbW6KACJcgusbZU98+9MknIXiQrIQd2HPzD3zxmoNERXCZYFbZgCQMbs8epNQvC2GYmTg5DOAB9M00zNKm85CqQoYGoJTt3h2dkZeOOM+x96RoSPJgrG7pgLnr1Hv701tqx5KYEZBJHGff3qpKA2WJ+XcVDHnOOtR7gYwgJK7cgsMdulFylG5dS4icFuVjwfc/5zUMrFix3bsHGd1QMDJGgXKtGoVyTgDnpULTEwkAHBy3y85NK4cttid2V2LbmyTkA02aUsqrtwMc9sVWUuqtltoO0o1JEdxZQCeOpPfFJEtFe4LJIi7t2R1C5p8WxbUfMQzv0x6f8A66CFVA0iMXZeGLfrRCdw2gdB1PegT2I5cyAKOAoOB755qJ0TYzRjOMY759atySIGfdzt43d/WqzTDY2M7cjHaixNyKdD5as67RjvxzVOYfM7Afxdver7SiUjdyM/yqu7IYn4G7+tOwlJkMO0KrYU8nPHalWTbkjgEAH3qOMEpkkLjrjuaSZdp256YODxmiwnuOdxlAueevtzTFkyDnAJ6mkHzqpVtrdOaVBhgp4C5Jz3oFYfnK7V6EcYFKX2xqr8DvQ8hGNuKpTy+a7A5K1aMZRuOkcvgevT3pzYVwcf/Wp0SjbHx93Jz/KopJcvtweopmLRG6bSpHTOKJQAeBgN3pN+WIY8560sMzxsroAGGcZGaZLRemeCWGHdeSRMIgpVVOMj8axr5QZjsdpAR98jGa0n1S5L8FMAf881/wAKzb6SSWYyOeT6DFIhKzNdDkDtUxClfeo+oGKC54FVe5sh8YzkZNWIl25LdKrqpR8+tTZJoQ7kucMCOlTqwMeB1FVgDsOamgGV+tUNE0oQxox6mj7q4U5XvQE3oy557Gi2YKdr9f51lJG8JdxkuGTHTPerECAoeQD3zTZ13KSi1BC0g6txU2satXRPJg8IrNn1OBmpvMV2AyFJH3QO9VnLMQc8dqaA6Pu3EN7GmnqJxfQvFsABSCfapY8EDKHbnuelRWs6PL/pgwMcFePw9zVpJbba7ESMqkBVPU07C5+jQq4z8wB9qd8uSE6nsOfwqBnXzdiBgpOeucVasUJuMhZNwUtlQCenXnimN6ImkjhQBISwmIBDE8Z9MUjLsc5IJHf39qdAzS2sshZfMxk8ZwM+nrTI5OQOBnsR0oaFCTZYt2LlB/Fnn6VbjKoG3RKzZxkHGPwqrYFLq9VJG8uMgsxXqABzjNaUWnvKzC2IuAckbZACQPY9aLNilUUXZspIjLIZBkADIBHbuKl2hZoxKTG7YwT29M+1Nt3MmVtmjeQZVl35xjqPr7CpVjkaeMRKGlB+UOQBSsVzXJYpmjlkVXbaAVJXgg9qDOk+x5gS6jaWYYyR0J/lVWfPnEi3CpkHYr8Een/16aJWjlIwuAcbH5/Si4uQvX13JfRkeYpK84Yc8e4rP8t4XRtrK5GQxI/HmrBBC72Q56MOx/wNMMRIBilUP1Ktj+tDY4q2hVmLvcHzWBZeOW5FMuY2iOWZcsMrtO7FWby3BkAZWViMAAD5qha3fOMzAryQFwTUlop/vGGUk3d+QQPyphzsUfPjPGGBHrUs4AGTCyt6NwDz1FRyRhU+6HYgncSAB7UGliIs0igFYwHY4Oemf5U2dwik4wFGBj+//nNRzbsYJB+UAAZJ/KoZVVXUSSEYG44Pt/OgdhWZhECzkDkHjOcetMJy6srYPIBAzihzvb7o2jhe/X1pFwEOWXaOST1z6CgTdgmyvlMjsU6EYxTklRmVWXK5KjJ9aj8sOYiwAzyBin28EsskccCZfdgLxnOaduxk5JD4IwZZFcsI05cqAcD29TViCCF7aVmuCjhRhdueCemc4zT7lntZRZNIPLVmMgUcM3v6ioWAjbAPAyM+9UkYttkrw2bzBQhVVC55O9jnnHpnrVC+RfNRlQeUw+Ugnn149c1NOHN0jBdsoIyenb1/GoRPLCdylQVJwCN2CT2oaCz3RTaDzJjHiRgoJ44PH4VV7HJOCckYrULyliY5Xy2RkOR25+vWq7JHMiJLgTAY8zd0HP3h/WlyoLvqZsgICgYPPGfSlKbtm7JOcnHapbiAwShJOGU8Y7+9JuB2478HjpxSt0Y79UR7NhyOMcc/jUMjlVyp5x1AqVpCCy/3u3emMu4lSfkAoC5BISVX1JoVMYLAYzSTIWIxnbnr+FKrhzhuB9aBNXJQwOAO39ahkG0gnBOT1pFkEfPr+lMlbe6kYqkYyjZjWQcejDgmljdonjbajMM8MMj8qei5wO6jmo2GCufcUzJmtCsjQiST7BHlA5Vo+QD0JrJ1NSl06v5e4ddgwOnYVejlO2BZohiSPyyS+Ny54PtVHUpC94++PYQAu0nOABjr3oM+pcXJAyDU6DI5xUKMdo4pyv26GmjclJPSnK5zg00Akc9KCCCKBFlWDLipFIUZBquCADSp8wxmncaLULkNjPWpWUK4YcioF+5U6sTD8w6Ui9tUPRx6deagVGaUkDCdqljUOhKnmmMcDAPJrJo6YSuDxFct1PTFJGQ2WPBA6VJk+WQB09adGQRjGG/nStY0eqABCuCSKVASGRQvzfxelOjQll2rlc9DSN8rkMp3A9fWi7Ei9bSQrsS5i3BQcPnkjsPpmrZuZXSVAqorJtPPp6VSDfJ8w444HJpZN+NuOvTtV8zRm4pu5Zjk8kr90N1DYzzSnEqK0ahQx28f3h7e9Z+cDA3g5A6VYtpvKjKsN7E5Denv9aSY+W2qNSCFrZonR18zHIkGwKD2z1ovWuIpfKmnMkild8gk+RvTGO2D1rOkdnbLylm2/KxJOR6VKZlWNRKqnJ7jGad+guS7vIlgBhAWMKu3ldrdB2Oe9Xo7y6ERjDD5hl9wGWHp+Y7VnrIhVQW2MM4K8gj0p4bIXYSCOnHH4VNzTlT3LP8ArMyRvhByYyx79acyuBiNlkVs/wC8PrUCybH2mLa3XI7/AIVZgYyN5mU3Nk8+vbPtQGohjfzACWTuST0xT/OEjqsmSVHDAAY+vrTiQUILDK8Y9T9aS3XewaUbFJ4AO4/X6Ur6ifdj05427srypU8fQ0jKPNwoxx9w+v8AMVLOjCUZKEHt2HuKrum2crJgHsSDyPY9qqwolC7dpQ0ZRvMUgbWI6VVngaOPa6CPthjyxrTTZ88qFA/RVbnjp0qnOAEBkDk9MZ75pGyZRmj8ok7y5HH7vv8A4iq0SsjFiuefm3f4d6ux4DDBMaAc54yffvikPlP5zNwMFivT5eBxmhIcpaEE+8zFlUlSxkVDznPAzTPlKqJXPykYUEHnvU08kcrMvyhCMgochF/qelRpDggqoCnr9PWn1MmxGiGwSMd+DknP6VNpT7JtxUvG4ZGAO0cjj5u3Sq8jhQU8sgFcHJ5+pq1FiPTy1xcNHDKpSKEL98+v4Zq47mM72KpwoaVCWkwTgnOfz61HHK0qnzMAooAJ7juami2xxgNlmIzj/Z/vA1GHOAUA6DkjPemxdBJn2h+ctnH45pqcFSyjLtjOaWbCGQxhcqR2yD60SyKFI4yDkKPU0WJuQBhvUDoeuOmSe1VSUKZX/WDp6ZNLvdcFV2Jgk+vXFKoDqqg8kgjt3pFvRD5JDcWELTMD5bCNQDkjryR6Vn5IUZ+9/KrflskZ3ugYjoOcd+aryJ90HGelKXcyTsRSI25WJHp1pSSHJGOnODUUsjGYjGB1FR3DlVVcc9x7nvUFpMfJjaDzz2qpI/mZbAGOuPWlkmLjDEAqTUDOFIGMngk0my0rC7s4BJOO+amB2oAByKhIAPQY604Njkcd6qLM5q5MjbSxPcU1kaQfIpL+g9qVjlMqRyM4qAlwwGPbjirOdo0Eg+1QRPLbXW5UChowCHHbrWdqLu125eIxsAAFJ5AAwKvy/ZbeG3WSGdnZQzESYH4U3VraFUkeFXUxlQdzZ3BhkfjQZ3JlbAAPWlOPl9aiX5mHNSng807GyROpGzGaQtg8mo0PHWmtnPSgLFoMOtPUBuOAapKS2KtwHJpDs0ToOamhYtuXtULrh+O9Ot5hkoDtagfQsW4ZZcdu9LOuHyKWGQ7sH71Fyw+/29KCouzEPCZXlqYCQNx4b1qdFVgpHcdKZ5bbivbtmoaOiE11J42wpc/eI7UwOJBu644zTljIYDBI9KbgxltowPpUu6NI2ZNFMvy9cjpzViQkAKATzyPSqK/u8Enn61bgfLgnlTySetCbHKNhkpJ+6BTGIjYEjA9fSrMpRjvGAQeeKjQKWYrtORjLUN2EidJF27gA64wRnB+v1pE3bixcsGGOc9O1BUeWrBsdAAKQO5X+IZznHTFDY4xHBmLBPMPPY/40nngSbRkDnJJyBTXLsCyjJHJPcilT7oZ87T1H+etJstRJ33x4YsWVsDKcgelWoLhjBwGBHXBGKqJIPLwS2wjBB9KlZ1SMeWm0HBGaLj5VsXRiVAQTvI98H8asWokhBBUrxjjGGqtDKEQHB3K3Kt0zUwmaQb1wR0wOi5qkZTViy8iKwAO5+vOM4qvIgm39AM45b/PNISYj5jlWIOME5amPNJINwx8x5AOBVER0GiLZG7JCQMcnPH4nNUGDjuoB5PsMetXjIXjk5GB3PBqkSxBWT+PnoCfakzSEu5QdwJH+UgZ4GQKhK7llbGQSF3d81pvA8a7TjA6Keo9TiqtzG2S2XDkcAD+lJaFOSZVVAbeJgV2KSuSOtRwyIFlVpSGdDhSOOKseSke1gAzJ+XA6fWmwpH55EpMa7WJ29eenFMhjIiA5LMFXocL1HpmpLm6mV44ZRGyEBlC9AMAD+VV4kLPliTwOT061b1RGS4EgtysZQKC2cZA6iqWxlK17FV1AB+Y5xhsHIHNI8jsQWbgAcr15HNN2KUbzGy2fw4HT86buVGZW24X+L1x/+v8ASmgaK8lyzOygYODtPv8AjT45HIBYYfGTj0FTy7OGU7iWOfrVSWUomOxA6cZ7U2ydHsKSoZ8jaCpGOuBSWoxOu0ZcMNvPHHbnqafI6/MxHHIGT7d6pLkKoO4uCBnpjH+RSuS1oxZcGaUoeCTgnPNQXCnbndkgdBU9zuKwPu++u0k9yD69+CKhZgqsSoYng4qXuZohbgoRnB5x296rMcuxY4we9TgGTjJznI96glUsgwSB15HegpOxGF3Z5BIOaR1+Yk7R3GR1p6gbypPX0qG5kC9Dj39KmxopXGlvmb2pHdOPTOBVdpWYEjkds0zblRRsJq5aL/PlTxwKcJC575B7VHEMRkHmlVjGMcE9zWhzyRt28os4IknmmyV3gKqkID06/wBKztS8yN3gMrSJnzAT3yOpqaO6drdfNgil2jClwcgf1pupIyzt5pDyFQxIGOo6UGGzJ0ULRuy3tSRvnFKx74oubpkq44FMctuwDSK1SOAcECmWhYsrz1qyjFe3Wq0XqTVvAZetIT3JGO5eOtKI1YggfN3NQ5B4DYNTxdTz2oAfv2vkqSPXPNSl42BXpVeQZYY60rkNxnpQUi9alMKOnNTy7dwA6+tZ9uQZRzge9aEkqpGCVz7+lPoDdieNVwDz/hUFwAcjGKFn4wOal8wE5K5yKlrQcJNakMYVowHA9c0+PBY7cc9qmXDKcYCjtSxAAhCMUuU09qyExFQwBbn8KIzsUAg/zzVsKHIzglehqGSE8YXqfpScTSFS+jInkBYKnOex60M4hCszA5PGO9AiU43fKc49amSDOVOfl5z2FTY3U0iIvvP3WU+3T8qJSwxlyc8HaKk8pt2STgnFPWHa5YKcDqcnj3FKwc6GBlQFCG2k9eASP6U9Y95AjLNuYkYHIFL5aZyADkEYBqVYy8gLjJwMgdCKOUftEFumFG9kdQeB3/KtC2dQ2MAE9Tt2jH0qKHIHylfmP0P5VKrbZWEbbW+7nFWlYwnO42WfD7WAY46+1PDRhYiUMhz82OCB/SqssTtOQAV9jimSF0jCsF+UhRk4HPrRcnyLcsofzCVyCepNUnc4GxQE7dDTwzbMsMYB+71/GoZCpTczEY64GSD9MUyokp3gj+Jupxg8/hVeffhs4XqCc+tD3BS3I5BYgnHYdhVBpgN5cswYdc45yO1KTLjASUqVbyy2egB6AfzqDGWU8E4BPSpNwYBtucHGScZ/yKSYxj5FwfUqDyMUrXB6DY5PmbcFJPb0xV2CZbu2FqzjlhKrYJIxxgc96z1QsHKnAPy9OBmklQqx8qT5c4BPf6U07Gc4p7CSyNFP5Jj2lWJOB2PI/wD1VEziVn3AOAOR0xmrgj88B/30s4B4IGP8T9Paq6o+1pIlJTfggnn64/SrsRzEO4IUX7uIxnPqTUM5G0ZOV3EfX0qW625UjBUZBPfNQzEuuQNu1sDjgGpBCtKPKyvGWznH603aZ1yMjPC45POKQABPn5bPApY547e0aWPLTlSIyWICjocDuRTsRJ9iKeNogqSuN4AYKBng9RntUCuoBQjhueBkii9aNWgMMjuxjBkL8EEVA0pLMyjczDg4xSe4lFksTh05GBjgAe9QOxIJGCOgHekYMh5OcjBX0+tR78psXOc5560XDlGlyoLBOv6VWuCJFPHJ/SrJIKbW7mq9wG2goRgjrQxpEAAAUEnjil8xQmAeRSKjSIc9e1KsA9TzSKfmKpywPv0zV62MSuGlQSL3UkgH8RVMqqgEDqc1PY/6ROkLHAJLHHU4GcCqRzzNAX1pghbJMf8AXRqpX9y1zP5gUJnACjkAAYpDPbKQq2Rxnn96d1RX0P2ed4wSQACM9QCM4PvTMGtS/HgKKlHIxVdDj8KsR4xQbK4BO5qRTQvNKy4U4oKHoB17VKCDwKgQ4j5p0bfMAKAsOZccipVkAYYPOKjYhj7VMqrtBxzQBIkm5snjFPOHOeBUZOACBT0xkMetFh7Do0IPJ5q1uZlHOO1RnBIwetTIeBkcUwuQRF1lwzd+KuowB3fhVOWMh8gnntT0ZuPQdqRW5ekkwoA6nsKBId6+/vUKuGT5un05qRVDPlRkdDkUE7FuKZd23B3diBQZd2QATg9u9R8DjGAelC4IZen09aBJ9RyjILbcH09qkimGdrrgHoRRCqnIY02XKfdU4HUelKxqpXLG5SvBH1xmm7SE3kH2qFPlJbGVPU+lTW85DupIAz0PcUmUnYRSQflLbm7dse1SRqT8suVzzkjNSooODtGwg45xUvyBNrKCTxxnI/CgOa5CnCYAJOc54/nS5CqMAkMcFh/jSKoUjgkeg42/XNCsVZAo2rnuDz9aaGSrNKq4GzCdM9/yoZflHmKjKeqgk5Pv6UrOjE8A7icDPT/Gq7sWnJ2MyL0JwMUCRIhAjYFsAdFPOKHjR+H54/hYZ/Oqm1nBOcDPpwTU0cm0AF1HfANCGyldqqqzDoMgA8j3rKmm3OdrMzngtjgVrXajcVOfUD+vpVTbhdo+6epJxUSR0wloZ0YZJ/myxweSOg7/AP66lG1/MIX5DwTk/L75qWYrnLhio68dh2zVd5EAIJO0Zbb7n2pJWG9SSOSNIiQ24Z5GMf8A66ZLKo2lcYXpUO8/dJyFXAxzUWJDjaAcdjx60yHEeztlTkgjoM9Oaf55Zo3kkYlRhAOyj/69U2kUpypHJ9vpUccjGTy5GAA7AZp6mbinqXzJghnt4XBOdp3YzjqcVDJNExRTbhdpJbY5+b8+lRiZyoGflX5jgVUIALA7t55OOcU7mfJc1Wlhu12EQ2QBBVwGfAwQcn3JzWTdyq8im3QJEnyqfUdCeeeetLuBKKcnsajmbc6gKAOgOelDkxqNmQICWO4Z2EhfTBNJLIxOEA4wF9anIyAFU7OpPTJpnlkKTJxnsB1qfQZXxIHY4BUnkD9KcEYA8ksPSpRjk/dQHv1NJHIseSVAO7hfX3qhMryQncuD05I9aUJuUE7QM5xUkkvDEgf/AFqgGASAeeoosK9xsh28DGAahLkSc96c5IbJJxUDHncvrSBoedzBio6dKltI3aZFjIEuflJOMH61CxKxr9c4qxDE8zrEgOW6HpVGEzWA1Ibt88SsOCfMTNYt4jxyESPufOSQ27P41dliErfNe2zSHgnnn8cVRuYWjuDHIMFeODVPY5+paDH8KnhaquSAMVLDnOTmjc6UXQxHTirCHjBqsvOMVOpyvNIQ8qGXFIqbaajnJqUjeB1oY7DJBgdetSwTZTGDTXI2gdacqAJlaaQLYWQsSuOPepoBt4Peo1OVG7rTwCcMvP1pAWicDBAqaBvU4+oqoC+7HUEVIqyBs54xTHYt3I+VWTNMGdoY8t3zSh1ZdrUz7p6/Lj8aAWhNGqlieQanVlGB6GqYmVCfmHTrQj7vm3Z5zigfLcuyvvPGB9KI12gEEZ6elQJKDgADdVkMWXJ28cCglqw7LKpbAP41MrHGcnGPXtVYSMfu8npxUpY5ye3Gc4/SpaBDy2D8vfHFTrjyiSw9ge9V1U4yxPpmmSOpGQ7Bv5UbFLUuPJsiJQ8YxyKpTXbDA2g45yRwRSiRsFHZfUEHg5qKXKMJCwCnoMUmbQsnqSxz+dgxvsIHOen/ANarEcjiRgGLey8YrJAU5wwDAZOBxSNczRknJ2+melTc2UUzobbZKybflOMgBqe4RQ7fxAkc9SPp6VixXAC7j8hJ69KvpKHjGSSM9D3+tWtTKcbE5TDZTCkjIJ5FQv8A6krtAxxljtoaUvhd2TjI524prygDcxwcYyOv60zK5DI2VKsTx6DP61QkOM7sdMDHU1akLF8DknrioVhUsVOc55LAYqWrmsZWKRdivHyj1JqGRWPzHO0dGIxzWs8EQypJwORjkVXuYwP9Wqrjr6n6UNaFxqq5mbemNue5U4x61EGYqxKEDHb09fxq4cISBnJHA9KgdeTz7kLyRUml7ldwGwWO5ewI7+1NYnzfujLdTgHH/wBenq207DwwPJ+vP40sUQlTABXHU+p+lJEyGY3qqs+AvRR0P41EI8jkcHHtVgIA5LMDggKAcjFRF98ynnAOAfxpkMrzK/mHAHUsPU9uKeijPzAccKOv4mrJQAEHGcelQbg/IUnnkAcCkK9xsxDFdwO0cYA5qu2WBI+bb6ngH0qfczHGcY5yO9QI3lkZbA/PmnYmxAd4BPccVGzEz7jwFxgVcBBLA4wD6VBMFVd2ASRjFFhXZDKd+d2AQMVABgnB6/jirDISduOf5UgA8o/L6iqFexXkLbeE49ajWIOi8dDnirMh4wM/TH86YjEcZyaaRm5DCoZztzipbZ5I7hPKTe5O0KRnORgilCjDE5BzwKmsnWC7jkkBIwQcdRkYyKdjGTHXMMFu6+fZXC7ug80bfzxVXUTKbt/NQRsQPlHYY4qzDPFAZIZGM1s5weMHP94ehqPUZY7i8doWLKVABIweAKbXYyYsa5UU9flPFJF2x0qbHNNnREeh44zTo2w+G4pqDJp+3PekikTgIelTRjHGfzqrCSG5q2OD709xMTaWfipNuBz6U1CWYkDFSuGK0rjBFJAP6VI6jb7imxcYweakkTcvysfcU9xDIx/dzUrShSAfpUUUir68daJXWRsYOPekMniVRJuJ4pSNsmATjrTEIaEg4JHSnIO/86aRRHNiQlXGAaljGAMjjpQQySHoeOKdG3IyMYNJId9C3EE24xkkc1MWGAuMAVCNu07Dk0yF5A3KYz1INBm9SbHytnjvmniQN94de+KZ5m7PA+uKWOP5t3YelAJErE4IIwO/eoj98rn5SehHSnuGOCuNo65qpICHL7mwO3cVD1NKaJxlG7bSc5xio5JSmHU5IPYZpqfvF3Z6fmfwoMa5J3N744oNlGwx2fKmIEMeNoPNQyEocsT6Dcf84q+Apx1HGcnkiq1wiSBtmM9/U1LRpB6jIWVgNinjIJq+H3qAExx1zkms9GCYV4yD3xVwysAcBmQc/LyM+9NO45omWSSR+QfckYq5ledygk9MVThQgb15JFW40JOdvBB6fMfyqrHNO1xrKqkdFPqRmqjqEfBK7m9gCKtSRMuGbBU9MZH5VGsGA0hxx3xTJTsRgABQCu45x0Oaimhdnwz/AC46DoanDbTn19qY5O8FW3EgjBoBOxQZFXPmAKo+XgAE1H5aKrbcj0HU1Zkfy2+dVLA9xUUsYZCy59+/H9KmxpzlJ13yqijAOcsKY6AL8rgjvx1FSSqEcA/Ugc4pDGCu9jgn1HSkU5FaT7oGDtxgDFQROYsMDgqOParkqqzfLnaOme9RmINHyM4PI9KLCc0QeZvAJxgdahY7VIXqexNSOrAhUHTqMfrUUoUtjO4kdM8fnRYafYavDYVuMYyDn8KjcBTtB5PJI7e1TDOPlOSOeBUZTcxLECmkDdiEKxdQvTPWlEf73JY+9SlCrb1K+1MB2cqM7u5osQ5DSrKcsfWoWTDENyucgdKkKsxwOMk5qXyUI985ppGbZVwNo6+nvTMBH44JqVsAjA6fpUS7nOew4zVpGUmOyFOD0B6miNPMcbSNznjPQe/0qEkocEEjNWbd0S43SkqhUoSByARjNMzY5raDzGRTPuwHLlBtA9cdcVWMbRSuj43Lxxzn3FaPlkzicK28/wAZdfLHGM5649qo3jK0/wAh4ACg+oAxmoJZJEePpVj+770UVZsiRRjJpSScDNFFQMkTqKsjg0UUyxYmPmkdqnyQ2AeM0UVSEIv3s96kmY7Qe9FFAEbAbAQOTQvytxRRUFdC/CodfmANQiNQxxkfjRRTQkQXDtHNGASQeuasH+Fuh9qKKEWWYeE3DrVqNj9nB4zRRVLYzYxZWZgDjA5xirEYAfj+760UVLESPxtNRzgENkds0UUIcdzNncpJhcAVZikKY24GRz70UVCOroQuxkkKnjjORwaYFBh78HFFFSaIWJsBmwp+XPI9avwxodwxjtRRTQpbFqFR5T8D5RgVIzGN4gDuDdc0UVocshtwxWRMemfxpisxyrEkAnqaKKRPQhuUHkkjI5xxWdC37yTPOMmiikUthMbguaAoDHuBxg9KKKa3JkMfqxHBAP8AOqgYuw3euKKKl7FxERRkN3phJLEH0oooQMrzdVOTyMnFQSqqzDA6DP40UUi1sMkb9yG4yTTJB+7UdjRRTJYL99h2AAH501RubB6Bc8UUVQhrcKMetNk+XAHGTRRQQ9xgOUYkDOKhUktg9PSiirjsZSFYbpCD601vu/WiimzIYwCsQPSkPEq0UVmB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annular erythematous plaques with \"trailing scale\" are classic features of superficial erythema annulare centrifugum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10742=[""].join("\n");
var outline_f10_31_10742=null;
var title_f10_31_10743="Mediastinal mass compartment";
var content_f10_31_10743=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 547px\">",
"   <div class=\"ttl\">",
"    Common diagnostic possibilities of mediastinal masses",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 527px; height: 550px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The differential diagnosis of a mediastinal mass depends upon the anatomic compartment in which it arises.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Baue AE, et al. Glenn's Thoracic and Cardiovascular Surgery. 5th ed. Appleton &amp; Lange, Norwalk, CT, 1991.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10743=[""].join("\n");
var outline_f10_31_10743=null;
var title_f10_31_10744="Pregnancy in adolescents";
var content_f10_31_10744=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pregnancy in adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/31/10744/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/31/10744/contributors\">",
"     Mariam R Chacko, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/31/10744/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/31/10744/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/31/10744/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/31/10744/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/31/10744/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/31/10744/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The topic of adolescent pregnancy arises in pediatric practice during discussions of sexual",
"    <span class=\"nowrap\">",
"     activity/contraception",
"    </span>",
"    and during diagnostic evaluations for problems such as menstrual irregularities, gastrointestinal complaints, or pelvic mass. Adolescents may seek information regarding pregnancy directly from their healthcare provider, from whom they have a legal right to receive confidential pregnancy testing and counseling.",
"   </p>",
"   <p>",
"    The diagnosis and early clinical management of adolescent pregnancy relevant to the pediatric healthcare provider will be discussed here. The prevention of pregnancy, contraceptive issues, and an overview of the diagnosis and clinical manifestations of early pregnancy are discussed separately. Prenatal and postpartum care, pregnancy complications, and labor and delivery issues also are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/13/42201?source=see_link\">",
"     \"Contraception: Overview of issues specific to adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SCOPE OF THE PROBLEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The teenage birth rate in the United States declined continuously between 1991 and 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/1\">",
"     1",
"    </a>",
"    ]. Although it increased transiently between 2005 and 2007, it decreased to historic lows between 2007 and 2009 (",
"    <a class=\"graphic graphic_figure graphicRef72368 \" href=\"UTD.htm?34/29/35294\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. In 2009, the birth rates among teenagers aged 10 to 14 years and 15 to 19 years were 0.5 and 39.1 per 1000, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 10 percent of all women aged 15 to 19, and 19 percent of those who have sexual intercourse, become pregnant. Seventy-eight percent of these pregnancies are unplanned, accounting for about one-quarter of all accidental pregnancies annually. Among 15- to 19-year-old females with unintended pregnancies resulting in live births between 2004 and 2008, 50 percent were not using any method of contraception before the pregnancy (24 percent because their partner did not want to use contraception), 31 percent believed they could not get pregnant at the time, 13 percent had trouble getting contraception, and 22 percent did not mind if they got pregnant [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of the teenagers giving birth in 2009, for those who are younger than 15 years, approximately 99 percent were unmarried; for those aged 15 through 17 years, approximately 94 percent were unmarried; and for 18- to 19-year-olds, approximately 86 percent were unmarried [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    About one in five infants born to unmarried adolescents is fathered by men five or more years older than the mother, and at least four in five of these births occur outside of marriage. Moreover, one-quarter of adolescent mothers have a second child within two years of their first. Although 7 in 10 adolescent mothers complete high school, they are less likely than women who delay childbearing to go on to college.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis and clinical manifestations of early pregnancy are discussed in detail separately. Aspects of the history that pertain specifically to adolescents are discussed below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric healthcare providers should have a low threshold for suspecting pregnancy in adolescents. A pregnant adolescent may complain of missing her periods or of irregular periods. Some adolescents mistake implantation bleeding in early pregnancy for normal menstrual bleeding and, thus, do not seek pregnancy testing, whereas others are more likely than adults to report early first-trimester vaginal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediatric healthcare providers need to be aware that an adolescent may or may not have considered the possibility of pregnancy or may present with vague complaints with suspected pregnancy as her \"hidden agenda\". One study compared the presenting complaints and historical information of pregnant adolescents (&le;16 years) whose diagnosis of pregnancy was made or not made in the emergency department of a tertiary-care hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/7\">",
"     7",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adolescents whose pregnancy was diagnosed more frequently had complaints related to the abdomen or genitourinary system than those whose pregnancy was not diagnosed (91 versus 22 percent)",
"     </li>",
"     <li>",
"      Less than 10 percent of the patients who had pregnancy diagnosed mentioned the possibility of pregnancy at initial triage, and 10.5 percent denied having had sexual activity",
"     </li>",
"     <li>",
"      68 percent of patients whose pregnancies were not diagnosed (ie, who were pregnant at the time of the visit, but in whom the diagnosis was missed) had no documentation of their menstrual or sexual history",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, pediatric healthcare providers should elicit a detailed menstrual and sexual history routinely from their female adolescent patients, regardless of the nature of their complaints. Historical features, such as amenorrhea, morning sickness, urinary frequency, increased appetite, weight gain or bloating, and tender or tingling breasts are suggestive of pregnancy but are not reliable indicators for excluding pregnancy when absent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/8\">",
"     8",
"    </a>",
"    ]. Specific questions include [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      When was your last menstrual period, and was it similar to other menstrual periods?",
"     </li>",
"     <li>",
"      Do you engage in sexual activity?",
"     </li>",
"     <li>",
"      Do you use any birth control method, including withdrawal (pulling out)?",
"     </li>",
"     <li>",
"      Do you have any symptoms of pregnancy, such as morning sickness, urinary frequency, increased appetite, or weight gain?",
"     </li>",
"     <li>",
"      Is there any chance you may be pregnant?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Signs and symptoms of pregnancy are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Clinical manifestations of early pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pretest counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to these questions, it is important to ask the teenager what she would do if her pregnancy test were positive before the test is performed. Teenagers may have a variety of emotional responses to a newly diagnosed pregnancy.",
"   </p>",
"   <p>",
"    Some adolescents perceive positive consequences of pregnancy or childbearing and want to be pregnant [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. One study surveyed 200 pregnant 13- to 18-year-olds to see why they failed to use contraception before conception [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/12\">",
"     12",
"    </a>",
"    ]. Nearly one-fifth of the girls responded that they wanted to get pregnant, and another one-fifth that they didn't mind being pregnant. In a separate case-control study, adolescents who wanted a baby were more likely to be Hispanic, married, and out of school before becoming pregnant than teens who reported their pregnancy \"just happened\" [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other adolescents may feel stigmatized by pregnancy. In one report, 39 percent of 925 adolescents (&lt;18 years) who were interviewed on the postpartum ward reported feeling stigmatized by their pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/14\">",
"     14",
"    </a>",
"    ]. Feeling stigmatized was independently associated with multiple factors, including white",
"    <span class=\"nowrap\">",
"     race/ethnicity,",
"    </span>",
"    not being",
"    <span class=\"nowrap\">",
"     legally/common-law",
"    </span>",
"    married or engaged to the baby's father, feelings of social isolation, aspirations to complete college, experiencing verbal abuse or being fearful of being hurt by other teenagers, and experiencing family criticism.",
"   </p>",
"   <p>",
"    Several reports indicate a low risk of suicide deaths and attempts during pregnancy in adolescent and adult women [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Nonetheless, suicidal ideation occurs in 5 to 14 percent of women during pregnancy and the postpartum period [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/16\">",
"     16",
"    </a>",
"    ], and self-poisoning during the early first trimester of pregnancy in adolescent and adult women has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/18\">",
"     18",
"    </a>",
"    ]. A prior history of a suicidal attempt may place an adolescent diagnosed with a pregnancy at risk for a repeat suicidal attempt [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/19\">",
"     19",
"    </a>",
"    ]. Cultural attitudes regarding out-of-wedlock pregnancies must be considered when assessing response to a positive test in an adolescent from an immigrant family [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/20\">",
"     20",
"    </a>",
"    ]. Therefore, when possible, a social worker or psychologist should be involved before testing if an adolescent responds that she would kill or otherwise endanger herself if she were pregnant. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23834?source=see_link\">",
"     \"Suicidal behavior in children and adolescents: Epidemiology and risk factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The discussion regarding how a teen would respond to the reality of pregnancy or motherhood before the test is performed may force the teen who has not yet developed abstract thought to consider the potential consequences of her actions. Such a conversation may be a useful adjunctive strategy for pregnancy prevention in girls who are not pregnant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pertinent physical examination findings of the adolescent in whom pregnancy is suspected are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H8965674#H8965674\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Findings on physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory evaluation of the adolescent in whom pregnancy is suspected is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\", section on 'Detection of hCG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANAGEMENT OF EARLY PREGNANCY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Posttest counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step after confirming a pregnancy with a pregnancy test is informing the adolescent of the test result. Her thoughts and feelings about the test result should be elicited. Ambivalence, apathy, fear, tearfulness, or even shock should be anticipated. Providing emotional support to the adolescent is important at this time, and these feelings should be acknowledged as normal. Factual information regarding the duration of pregnancy and estimated date of confinement (EDC) should be provided despite her emotional response.",
"   </p>",
"   <p>",
"    After exploring the adolescent's feelings about the pregnancy, it is important to determine how she wants to go about informing her parent(s) and the father of the baby. The adolescent may not be comfortable with informing her parents at this visit, although the healthcare provider may feel parental involvement is the next best step to take. Scheduling another office visit in 24 to 48 hours for a follow-up in this situation is advisable. During this period, older adolescents may seek support from extended family and friends. In the author's clinical experience, most adolescents inform their parents within this time period and on their own terms. The provider may offer to help the adolescent disclose the information to her",
"    <span class=\"nowrap\">",
"     parents/guardians,",
"    </span>",
"    either by simply being present for support or by helping the adolescent initiate the discussion with her parents. Additional information on providing confidential services to adolescents is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link\">",
"     \"Confidentiality in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pregnancy counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adolescent may have considered her options already; the options should be discussed in a nonjudgmental manner [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/20\">",
"     20",
"    </a>",
"    ]. She should be referred as soon as possible to a clinician or clinic where comprehensive pregnancy counseling is provided, unless the health care provider has expertise in pregnancy counseling [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/20\">",
"     20",
"    </a>",
"    ]. The adolescent should be offered all options (eg, abortion, adoption, parenthood), especially when she has ambivalent feelings. Information regarding resources for pregnancy counseling is available through referrals from colleagues, women's clinics, and the phone directory. The healthcare provider should contact the adolescent about one week after the scheduled referral for follow-up information, to demonstrate concern for the adolescent, and to ensure appropriate care [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most adolescents in the United States carry their pregnancies to term, with approximately 20 to 30 percent obtaining a legal abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. The prevalence of abortion is higher among urban than rural-dwelling teens [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/23\">",
"     23",
"    </a>",
"    ]. Common reasons adolescents give for choosing to have an abortion include being concerned about how the baby would change their lives, feeling they are not mature enough to be a parent, and financial issues.",
"   </p>",
"   <p>",
"    Adolescents who decide to continue their pregnancies to term should be referred for specialized prenatal care as soon as possible [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/20\">",
"     20",
"    </a>",
"    ]. Adolescents younger than 15 years of age are less likely to receive prenatal care, and late entry into prenatal care has been positively correlated with preterm or low-birth-weight delivery and complications from preeclampsia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Early testing for sexually transmitted diseases, initiation of prenatal vitamins and good nutrition, and assessment of underlying familial and medical conditions are important for a healthy pregnancy. The healthcare provider also can assist with smoking cessation by educating an adolescent smoker on the negative effects of nicotine on the developing fetus and by encouraging her to stop smoking. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=see_link\">",
"     \"Initial prenatal assessment and patient education\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27482?source=see_link\">",
"     \"Smoking and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Assistance from a social worker may be necessary to facilitate enrollment into prenatal care and financial assistance programs because adolescents identify lack of finances, transportation, and waiting time for appointments as barriers to public prenatal care [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Social workers also can help to arrange tutoring or enrollment in special educational programs to allow the adolescent to remain in school or complete her academic requirements for graduation at home.",
"   </p>",
"   <p>",
"    Adolescents choosing to terminate the pregnancy should be aware that some states require parental notification for a legal abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/28\">",
"     28",
"    </a>",
"    ]. Information regarding abortion reporting requirements is available through the",
"    <a class=\"external\" href=\"file://www.guttmacher.org/sections/abortion.php\">",
"     Guttmacher Institute",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    If an adolescent chooses this course, parental notification of a termination in a minor is required only of healthcare personnel directly involved with providing legal abortions. This statute should not be interpreted as parental notification by the healthcare provider. A judicial bypass system also exists whereby a minor may ask a judge to consent to the procedure in lieu of a",
"    <span class=\"nowrap\">",
"     parent/guardian.",
"    </span>",
"    The judge must consent if he has determined the adolescent to be a mature minor or if termination of pregnancy is in the minor's best interest [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/29\">",
"     29",
"    </a>",
"    ]. There is no legal requirement to notify the father of the baby prior to a termination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=see_link\">",
"     \"Consent in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It might be helpful to prepare the adolescent for the potential presence of abortion protesters outside the clinic that performs pregnancy terminations and to let her know that such clinics frequently provide a volunteer escort service during an active protest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate nutrition during pregnancy is necessary to optimize maternal, fetal, and infant health. Pregnant adolescents are at particular risk for nutritional deficiencies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/30\">",
"     30",
"    </a>",
"    ]. Adolescents have increased nutritional needs related to normal pubertal changes (eg, increased height and changes in body composition). At baseline, they may have poor diet quality, with insufficient intake of micronutrients (eg, iron, folate, zinc, calcium) and excess intake of total fat, saturated fat, and sugar [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/31\">",
"     31",
"    </a>",
"    ]. Pregnancy compounds these risks. One prenatal vitamin tablet a day should be recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link\">",
"     \"Normal puberty\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/24/16778?source=see_link\">",
"     \"Adolescent eating habits\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A complete discussion of nutrition during adolescent pregnancy is beyond the scope of this review. Areas of particular importance include [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adequate energy intake - Recommendations for weight gain during pregnancy are the same for adolescents and adults. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link&amp;anchor=H8#H8\">",
"       \"Nutrition in pregnancy\", section on 'Prepregnancy weight and weight gain'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Iron - Iron is necessary for both",
"      <span class=\"nowrap\">",
"       fetal/placental",
"      </span>",
"      development and to expand the maternal red cell mass. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link&amp;anchor=H16#H16\">",
"       \"Nutrition in pregnancy\", section on 'Iron'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4329?source=see_link\">",
"       \"Iron requirements and iron deficiency in adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       Folic acid",
"      </a>",
"      intake - Folic acid (folate) requirements are increased during pregnancy. Adequate folate intake is important for prevention of some congenital anomalies and in red blood cell production. The preconceptional period is the optimal time for ensuring adequate folic acid consumption. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link&amp;anchor=H18#H18\">",
"       \"Nutrition in pregnancy\", section on 'Folic acid'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"       \"Folic acid for prevention of neural tube defects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Calcium intake &ndash; Calcium intake during adolescence is an important determinant of bone mineralization and bone density. Adequate calcium intake in pregnant and nonpregnant adolescents (14 to 18 years) is 1300 mg per day. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40040?source=see_link&amp;anchor=H9#H9\">",
"       \"Calcium requirements in adolescents\", section on 'Recommended intake'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Referral to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) may helpful for pregnant teenagers who meet eligibility requirements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pregnancy outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 26 percent of pregnancies in adolescents (&lt;20 years) in the United States are terminated electively, 14 percent result in miscarriages, and 59 percent result in a birth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/22\">",
"     22",
"    </a>",
"    ]. The pregnancy termination rate is lower than observed in 1990 (34 percent) and represents approximately one-fifth of all abortions performed in the United States. Data from 2009 indicate adolescents 18 to 19 years old account for 64 percent of abortions in adolescents and adolescents &lt;15 years old account for about 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are few data regarding the rate of adoptions from teen pregnancies. The rate of adoptions from pregnancies is not reported in the same manner as other reproductive health variables. The &ldquo;adoption at the time of birth&rdquo; rate has not been a standard pregnancy outcome measure in",
"    <span class=\"nowrap\">",
"     national/state",
"    </span>",
"    surveys. Estimating adoption rates is also difficult because infants may be relinquished at different times (eg, at birth or after being assigned to foster care). Data from the National Survey of Family Growth, which asked women about the status of each child ever born, indicate that the rate of premarital births relinquished for adoption declined from 9 percent in the 1970s to 3 percent in the 1980s [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adolescents appear to be at increased risk for adverse pregnancy outcomes, such as low-birth-weight babies and infant deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/33-38\">",
"     33-38",
"    </a>",
"    ]. Whether these outcomes are the result of biologic immaturity or sociodemographic factors related to adolescent pregnancy (eg, nonwhite race, less well educated, unmarried, lower economic status) remains unclear. These relationships were examined in a study of more than 130,000 primiparous white girls and women in Utah aged 13 to 24 years who delivered singleton infants [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/33\">",
"     33",
"    </a>",
"    ]. Teenaged (&le;17 years) married mothers with appropriate educational levels (for their age) and adequate prenatal care had higher risks of delivering an infant with low birth weight (relative risk (RR) 1.7), prematurity (RR 1.9), or small for gestational age (RR 1.3), compared with mothers aged 20 to 24. The authors suggested biologic immaturity might be responsible for the poorer pregnancy outcome among adolescents.",
"   </p>",
"   <p>",
"    Adverse outcomes in teenage pregnancies have been confirmed in some [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/34,38,39\">",
"     34,38,39",
"    </a>",
"    ], but not all, studies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Black adolescents do not have an inherent biologically increased risk for preterm birth compared with older black women [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The primary cesarean birth rate for teenagers was approximately 20 percent in 2005 and appears to be increasing in all age groups (",
"    <a class=\"graphic graphic_figure graphicRef77578 \" href=\"UTD.htm?11/54/12142\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/1,42\">",
"     1,42",
"    </a>",
"    ]. Teenage mothers require instrumental deliveries approximately twice as often as women aged 20 to 24 years [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/37,43\">",
"     37,43",
"    </a>",
"    ]. The reason for the higher rates of instrumental delivery is not clear. Proposed explanations include the physical immaturity of the younger mother and fright or lack of cooperation during the second stage of labor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Subsequent pregnancies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other reports have evaluated the outcomes of subsequent pregnancies after a first teenage pregnancy. In a population-based series limited to teenage pregnancies, adverse perinatal outcomes were more common among second, but not first, births to nonsmoking teenage mothers [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/45\">",
"     45",
"    </a>",
"    ]. In another study, the increased rate of preterm birth diminished in subsequent pregnancies after the teenage period [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Postpartum depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a prospective study of 623 adolescent mothers (&le;18 years) who were followed for four years postpartum, 57 percent reported moderate to severe depressive symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/47\">",
"     47",
"    </a>",
"    ]. The prevalence of depressive symptoms was highest during the first three months after delivery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=see_link\">",
"     \"Postpartum blues and depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Long-term effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data regarding long-term effects of adolescent pregnancy on physical development are too limited to draw any conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/48\">",
"     48",
"    </a>",
"    ]. A population-based cohort study from Sweden reported teenage mothers were at increased risk of premature death later in life compared with older mothers [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/49\">",
"     49",
"    </a>",
"    ]. The increased risk was attributable to both social and biologic factors and included lung and cervical cancer, ischemic heart disease, suicide, inflicted violence, and alcohol abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Social impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adolescent pregnancy is associated with several adverse socioeconomic outcomes for the mother, father, and child. They include [",
"    <a class=\"abstract\" href=\"UTD.htm?10/31/10744/abstract/31,37,50-55\">",
"     31,37,50-55",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    Mother",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Less likely to receive a high-school diploma",
"     </li>",
"     <li>",
"      More likely to live in poverty and receive public assistance for long periods",
"     </li>",
"     <li>",
"      At risk for intimate-partner violence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Father",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Finish fewer years of schooling than older fathers",
"     </li>",
"     <li>",
"      Earn less income",
"     </li>",
"     <li>",
"      Less likely to have a job",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Child",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      More likely to have health and cognitive disorders",
"     </li>",
"     <li>",
"      More likely to be neglected or abused",
"     </li>",
"     <li>",
"      Females are more likely to have an adolescent pregnancy, and males have a higher rate of incarceration",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/21/1363?source=see_link\">",
"       \"Patient information: Teen sexuality (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/8/35973?source=see_link\">",
"       \"Patient information: Adolescent sexuality (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 10 percent of all women aged 15 to 19, and 19 percent of those who have sexual intercourse, become pregnant. Approximately one-quarter of adolescent mothers have a second child within two years of their first. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Scope of the problem'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pediatric healthcare providers should have a low threshold for suspecting pregnancy in adolescents. A pregnant adolescent may complain of missing her periods or of irregular periods. Pediatric healthcare providers also must be aware that a pregnant adolescent may present with vague complaints and may or may not have considered the possibility of pregnancy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis and clinical manifestations of early pregnancy are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link\">",
"       \"Clinical manifestations and diagnosis of early pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It is important to ask the teenager what she would do if her pregnancy test were positive before the test is performed. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pretest counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When the results of a positive pregnancy test are disclosed to the adolescent, her thoughts and feelings about the test result should be elicited, and emotional support provided. In addition, factual information regarding the duration of pregnancy and estimated date of confinement (EDC) should be provided. It is also important to determine how the adolescent wants to go about informing her parent(s) and the father of the baby. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Posttest counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Options regarding the pregnancy should be discussed in a nonjudgmental manner and the adolescent referred as soon as possible to a clinician or clinic where comprehensive pregnancy counseling is provided, unless the healthcare provider has expertise in pregnancy counseling. The healthcare provider should contact the adolescent about one week after the scheduled referral for follow-up information, to demonstrate concern for the adolescent, and to ensure appropriate care. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Pregnancy counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescents appear to be at increased risk for adverse pregnancy outcomes, such as low-birth-weight babies and infant deaths. Whether these outcomes are the result of biologic immaturity or sociodemographic factors related to adolescent pregnancy remains unclear. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Pregnancy outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescent pregnancy is associated with several adverse socioeconomic outcomes for the mother, father, and child. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Social impact'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Martin JA, Hamilton BE, Sutton PD, et al. Births: Final data for 2006. Natl Vital Stat Rep 2009; 57:1. Available at: www.cdc.gov/nchs/births.htm (Accessed on March 25, 2009).",
"    </li>",
"    <li>",
"     Hamilton BE, Martin JA, Ventura SJ. Births: Preliminary data for 2007. Natl Vital Stat Rep 2009; 57:1. Available at: www.cdc.gov/nchs/births.htm (Accessed on March 25, 2009).",
"    </li>",
"    <li>",
"     Hamilton BE, Martin JA, Ventura SJ. Births: Preliminary data for 2008. Natl Vital Stat Rep 2010; 58:16. Available at: www.cdc.gov/nchs/births.htm (Accessed on April 21, 2010).",
"    </li>",
"    <li>",
"     Martin JA, Hamilton BE, Ventura SJ, et al. Births: Final data for 2009. Nat Vital Stat Rep 2011; 60:1. Available at: www.cdc.gov/nchs/births.htm (Accessed on January 09, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/5\">",
"      Centers for Disease Control and Prevention (CDC). Prepregnancy contraceptive use among teens with unintended pregnancies resulting in live births - Pregnancy Risk Assessment Monitoring System (PRAMS), 2004-2008. MMWR Morb Mortal Wkly Rep 2012; 61:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/6\">",
"      Stevens-Simon C, Roghmann KJ, McAnarney ER. Early vaginal bleeding, late prenatal care, and misdating in adolescent pregnancies. Pediatrics 1991; 87:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/7\">",
"      Causey AL, Seago K, Wahl NG, Voelker CL. Pregnant adolescents in the emergency department: diagnosed and not diagnosed. Am J Emerg Med 1997; 15:125.",
"     </a>",
"    </li>",
"    <li>",
"     Stewart F. Pregnancy testing and early management of early pregnancy. In: Contraceptive Technology, 17th ed, Hatcher RA, Trussell J, Stewart F, et al (Eds), Irwington Publishers Inc, New York 1998. p.635.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/9\">",
"      Bastian LA, Piscitelli JT. Is this patient pregnant? Can you reliably rule in or rule out early pregnancy by clinical examination? . JAMA 1997; 278:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/10\">",
"      Unger JB, Molina GB, Teran L. Perceived consequences of teenage childbearing among adolescent girls in an urban sample. J Adolesc Health 2000; 26:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/11\">",
"      Rosengard C, Pollock L, Weitzen S, et al. Concepts of the advantages and disadvantages of teenage childbearing among pregnant adolescents: a qualitative analysis. Pediatrics 2006; 118:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/12\">",
"      Stevens-Simon C, Kelly L, Singer D, Cox A. Why pregnant adolescents say they did not use contraceptives prior to conception. J Adolesc Health 1996; 19:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/13\">",
"      Rubin V, East PL. Adolescents' pregnancy intentions: relations to life situations and caretaking behaviors prenatally and 2 years postpartum. J Adolesc Health 1999; 24:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/14\">",
"      Wiemann CM, Rickert VI, Berenson AB, Volk RJ. Are pregnant adolescents stigmatized by pregnancy? J Adolesc Health 2005; 36:352.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/15\">",
"      Marzuk PM, Tardiff K, Leon AC, et al. Lower risk of suicide during pregnancy. Am J Psychiatry 1997; 154:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/16\">",
"      Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Womens Ment Health 2005; 8:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/17\">",
"      Appleby L. Suicide during pregnancy and in the first postnatal year. BMJ 1991; 302:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/18\">",
"      Czeizel AE, T&iacute;m&aacute;r L, Sus&aacute;nszky E. Timing of suicide attempts by self-poisoning during pregnancy and pregnancy outcomes. Int J Gynaecol Obstet 1999; 65:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/19\">",
"      Wagner BM, Cole RE, Schwartzman P. Psychosocial correlates of suicide attempts among junior and senior high school youth. Suicide Life Threat Behav 1995; 25:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/20\">",
"      Counseling the adolescent about pregnancy options. American Academy of Pediatrics. Committee on Adolescence. Pediatrics 1998; 101:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/21\">",
"      Pazol K, Creanga AA, Zane SB, et al. Abortion surveillance--United States, 2009. MMWR Surveill Summ 2012; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     Kost K, Henshaw, S. US Teenage pregnancies, births and abortions, 2008:",
"State trends by age, race and ethnicity. March 2013 www.guttmacher.org/pubs/USTPtrends08.pdf (Accessed on March 14, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/23\">",
"      Barbieri RL. Population density and teen pregnancy. Obstet Gynecol 2004; 104:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/24\">",
"      Teagle SE, Brindis CD. Perceptions of motivators and barriers to public prenatal care among first-time and follow-up adolescent patients and their providers. Matern Child Health J 1998; 2:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/25\">",
"      Debiec KE, Paul KJ, Mitchell CM, Hitti JE. Inadequate prenatal care and risk of preterm delivery among adolescents: a retrospective study over 10 years. Am J Obstet Gynecol 2010; 203:122.e1.",
"     </a>",
"    </li>",
"    <li>",
"     Cox JE. Teen pregnancy. In: Emans, Laufer, Goldstein's Pediatric &amp; Adolescent Gynecology, 6th, Emans SJ, Laufer MR.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. p.474.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/27\">",
"      Hampton HL, Powell RH. Obstetrical outcome in the very young adolescent. J Miss State Med Assoc 1999; 40:411.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. Parental involvement in minors' abortions. Available at: www.guttmacher.org/sections/adolescents.php (Accessed on May 13, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/29\">",
"      The adolescent's right to confidential care when considering abortion. American Academy of Pediatrics. Committee on Adolescence. Pediatrics 1996; 97:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/30\">",
"      Lenders CM, McElrath TF, Scholl TO. Nutrition in adolescent pregnancy. Curr Opin Pediatr 2000; 12:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/31\">",
"      Kingston D, Heaman M, Fell D, et al. Comparison of adolescent, young adult, and adult women's maternity experiences and practices. Pediatrics 2012; 129:e1228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/32\">",
"      Bachrach CA, Stolley KS, London KA. Relinquishment of premarital births: evidence from national survey data. Fam Plann Perspect 1992; 24:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/33\">",
"      Fraser AM, Brockert JE, Ward RH. Association of young maternal age with adverse reproductive outcomes. N Engl J Med 1995; 332:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/34\">",
"      Olausson PM, Cnattingius S, Goldenberg RL. Determinants of poor pregnancy outcomes among teenagers in Sweden. Obstet Gynecol 1997; 89:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/35\">",
"      Rees JM, Lederman SA, Kiely JL. Birth weight associated with lowest neonatal mortality: infants of adolescent and adult mothers. Pediatrics 1996; 98:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/36\">",
"      Phipps MG, Blume JD, DeMonner SM. Young maternal age associated with increased risk of postneonatal death. Obstet Gynecol 2002; 100:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/37\">",
"      Paranjothy S, Broughton H, Adappa R, Fone D. Teenage pregnancy: who suffers? Arch Dis Child 2009; 94:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/38\">",
"      Malabarey OT, Balayla J, Klam SL, et al. Pregnancies in young adolescent mothers: a population-based study on 37 million births. J Pediatr Adolesc Gynecol 2012; 25:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/39\">",
"      Salihu HM, Emusu D, Aliyu MH, et al. Low maternal age and neonatal survival of extremely preterm twins (20-28 weeks of gestation). Obstet Gynecol 2004; 103:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/40\">",
"      Ekwo EE, Moawad A. Maternal age and preterm births in a black population. Paediatr Perinat Epidemiol 2000; 14:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/41\">",
"      Reichman NE, Pagnini DL. Maternal age and birth outcomes: data from New Jersey. Fam Plann Perspect 1997; 29:268.",
"     </a>",
"    </li>",
"    <li>",
"     National Center for Health Statistics. Births: Preliminary Data for 2005. Available at: www.cdc.gov/nchs/births.htm (Accessed on March 24, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/43\">",
"      Konje JC, Palmer A, Watson A, et al. Early teenage pregnancies in Hull. Br J Obstet Gynaecol 1992; 99:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/44\">",
"      Moerman ML. Growth of the birth canal in adolescent girls. Am J Obstet Gynecol 1982; 143:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/45\">",
"      Smith GC, Pell JP. Teenage pregnancy and risk of adverse perinatal outcomes associated with first and second births: population based retrospective cohort study. BMJ 2001; 323:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/46\">",
"      Olausson PO, Cnattingius S, Haglund B. Does the increased risk of preterm delivery in teenagers persist in pregnancies after the teenage period? BJOG 2001; 108:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/47\">",
"      Schmidt RM, Wiemann CM, Rickert VI, Smith EO. Moderate to severe depressive symptoms among adolescent mothers followed four years postpartum. J Adolesc Health 2006; 38:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/48\">",
"      Lloyd T, Lin HM, Eggli DF, et al. Adolescent Caucasian mothers have reduced adult hip bone density. Fertil Steril 2002; 77:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/49\">",
"      Otterblad Olausson P, Haglund B, Ringb&auml;ck Weitoft G, Cnattingius S. Premature death among teenage mothers. BJOG 2004; 111:793.",
"     </a>",
"    </li>",
"    <li>",
"     Maynard RA. Kids having kids: economic costs and social consequences of teen pregnancy, Urban Institute Press, Washington, DC 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/51\">",
"      Klein JD, American Academy of Pediatrics Committee on Adolescence. Adolescent pregnancy: current trends and issues. Pediatrics 2005; 116:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/52\">",
"      Nord CW, Moore KA, Morrison DR, et al. Consequences of teen-age parenting. J Sch Health 1992; 62:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/53\">",
"      Wiemann CM, Agurcia CA, Berenson AB, et al. Pregnant adolescents: experiences and behaviors associated with physical assault by an intimate partner. Matern Child Health J 2000; 4:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/54\">",
"      Harrykissoon SD, Rickert VI, Wiemann CM. Prevalence and patterns of intimate partner violence among adolescent mothers during the postpartum period. Arch Pediatr Adolesc Med 2002; 156:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/31/10744/abstract/55\">",
"      Moffitt TE, E-Risk Study Team. Teen-aged mothers in contemporary Britain. J Child Psychol Psychiatry 2002; 43:727.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 110 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-4F5D24ED7D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10744=[""].join("\n");
var outline_f10_31_10744=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SCOPE OF THE PROBLEM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS OF PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pretest counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANAGEMENT OF EARLY PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Posttest counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pregnancy counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pregnancy outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Subsequent pregnancies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Postpartum depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Long-term effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Social impact",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/110\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/110|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/29/35294\" title=\"figure 1\">",
"      Teen births US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/54/12142\" title=\"figure 2\">",
"      Cesarean delivery by age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/24/16778?source=related_link\">",
"      Adolescent eating habits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40040?source=related_link\">",
"      Calcium requirements in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=related_link\">",
"      Clinical manifestations and diagnosis of early pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=related_link\">",
"      Confidentiality in adolescent health care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5512?source=related_link\">",
"      Consent in adolescent health care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/13/42201?source=related_link\">",
"      Contraception: Overview of issues specific to adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=related_link\">",
"      Initial prenatal assessment and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4329?source=related_link\">",
"      Iron requirements and iron deficiency in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=related_link\">",
"      Normal puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=related_link\">",
"      Nutrition in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/8/35973?source=related_link\">",
"      Patient information: Adolescent sexuality (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/21/1363?source=related_link\">",
"      Patient information: Teen sexuality (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=related_link\">",
"      Postpartum blues and depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27482?source=related_link\">",
"      Smoking and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23834?source=related_link\">",
"      Suicidal behavior in children and adolescents: Epidemiology and risk factors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_31_10745="ITGCN immunostaining";
var content_f10_31_10745=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64019&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64019&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    ITGCN immunostaining",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 355px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFjAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6Vu7uCzhM1zIsceQMn1rgvHV9LH4i05gbN2Vd6W9y20/h7msq61bW9Z0r7JY2kctxbQoouDICQ2OW475rqNP0Lf4f0q68SGGbVbRNzXEqhip64JPXHvXJCrDEXl9lf1c63TdC192Z3iPxNrcKWy2ug3szKd0scQ3bx6ZHSuz0V2m02CWSzezkIyYZANy1474n+NVppGtR2diy3QjY+cR0bjqCOOtYGoftGyWdrIsGlJcXmSAWfCCuWhiYqbd5Sv5aHTUwdSUFaKVvM+j5BuRlzjII3dcVgzPaWBKfbnZkHzJHgnPqfSvj7xJ8XfHGoL5lxqqxQTg7UtU2oMnpnrW18LvB+peMNVN14ne9fTJFAW3WRkFwxPDNzkqP8K2nUnUacI/1/XmTHCxpp+0kfSNxBeSKJbe80+1s2G9pnPnyt7ADCj8SaLe/BsZRagXUkXHmSEAE+pxxWB4h1DQvA1vDaXEjTSzJshs0AACjtgcKO3NY3hD4gya3f6ppwtrbRxZRhooVYF5wem0sMdwTx3q6dNPTqbLBVp03WS9zu9Pu6nZWGrztZTX+qTw29mhAEgUgH2Gev4VynjL4kJpetabp+nWcl89xEZtiqd7DOBgfUGq3ia8GoX9n5V1JdQqwJjmmDBDnBYEDGAfyrzm+1vXNP8eG80j7PJc3UbaXbSYEiod4O5SeCfTtk1dle3md+AwEZvnklLTvZf5+Z61pfj3wzq0Ulqkx0LWi210u7cMAwPIyDgn6kH2ro7bxB4bsibZtRNzeRj97LHEM89jtGK8y0n4W2UMSx+ILq5m1S7PnXDB8CJyScg/xEmuHsb9tK8S6xozSt9pju2H2uT5mZBwp9M8fnWi5k1FpamksswVVylSnLTp0+Tttv5n0bZ+ILDUdQuLLS7oyXNqI3uFnidcI/QqQOT+lMmivZpJILIjUrZuZEmmAZfYLjNear/aN14cttVstWtLm/ljXckM6rNFAGIVXGckE5OexJrzbxX408Rm5t7WV2juJGys1u5Q7AcBNwPO0g96VR+zWiuc1LKPrFVwpyslbV66/dqfUdte28Uos1dbe6QDMHmfMvH60/T/EkLX0llPcKtypwEkwpb0xnrXzf4W8feKvDDx3epG41DR1IE8Vwd7InZ0LcjH5GvUbr4maAbGO61O0jnXCyKoXJ2k/KQTxn8qIzjfW6McXkuIoT5I2lfZr8j2CK9RgN3ynuKljYN8wbIJrhPDPjHRfEqg6VehZe8E3yOPat68vRZYMreUuOT6VSnbc8qrhp0pck00+zOhqC7s4bqMpMgYEEHjPHoapWN8sirNvWSHHEiNkfiK0HVJl+V+exB6VWklZmFnFnlniX4IeDtYujPJoqwyOMNLYyGAj0+UfL+Qql4U8C+J/h/qUVl4Z1OK98JSs0k1pqIHnwuR1R1AyDgccfTvXsFuBEojJ5zxnvUjqrqVbBFZexVtHY2+sT2lqczYy3s8BjurZIrtRzn5kPp74p+mTPcB/tNn9nlRihKPuQn1FaGpWBmh2iWaPByskbYZT/UURr5HLDcx+8+3BPvVWSVmRc5zWNyebb2c8SamV3wJKfvDPP1qrpFkZLt7m7hltbibiSFWym7++K6e6tILwKZYldlO5GPVfcHtUN/FutJJolZpEUhdnDVk4WVomin3EgDQEtcy/aYSMSDHzL74HWlujBFcw3VtNm0kBEkcfIz2YD+dczpN9fXOhzXOoXCrPbhx5sUXXHcp1B9R+VQXt/qVzOtp4eso7m4Fj9pNwHCxszcKdp9cGp5ZXcEtitPibO3jv40nMTSrJIW43HGPoKn2OZnd7nBxwqjgVxOlavrMOl6Zb3trb3GqXUgiuFi4WPgknPbgfnXUzRxZKuN0oXJG7BArdJvcxkrMsFoN3zR74z1+v0p0kQjj8+BMr1ZfSs6O8iib7OjqjdAqHPPp0q2k0gKkrtL9m4DD+ho5RXINcmik0e9dmkjH2ZyzZK/Ltzxivivxd4/g1m8ihtIFks7Rj5O4kHBGCQ33hnFfYPxAurm30QxWgcLdq9pvUZaIuhAI7cH1r4d1Dwlq2jTR6XqFstv5k2Vl6uw9Qo5xj8K8/FU6UqqdXe2n6nqYCU1F8i/r+upv6YU13xBPpem2V41i8aSTQpIu+RiRhWPG4ZOMV9RxzReHNE0TSLEwRzYWBI1AVS/VsYGMKM/lXjvwC8F/YvFd/r1xcpJZQq0FpwC9yWwC+PRe3v9K2v2hItT07TNIubGO88u1maR7qJDtjY8DLdsk98VikoU/3fW1v1bNqt61dQn0vf9EbHxD8ULoelandXIDu4MVs/G6VsnaQOemcn6da8UvtN1TSvDry3lr9njvCJFvJztkywzyvXnOcnFX9CvbyH7H4m1t2v712IiSYeYuzp07HuK3te1iw8Qamqa3YXMtpypiFx5fLEfM2eOPcjFcNSt7yi1f+uh2UqXs4+6S6Jc3fhSzjt7BoprK7iRpsTb8uP4zjqDkVF4b0S5stUudQvMHWJHZI7RMERA8rIB/exnAxxSeHPDt5rWvT6XpCmfRYZ2AmhbcrR8YVX9tvrivpLwZ4S0nQ9PWWzsBBdTLl3lPmSZOOrNk9ulTh8NUxLcU7LqyMViKeHV92zz/wn8NIdV8MzQazD/xNdqq11MgLHj5WIHVvU133gjwxD4W09dPllF0UGfNdBwCf0FbdnHLZX8sasJbZ8bstl429/Y1cvWVVz8wkwQNnJ59u4r26GEp0kpW1R4tbFVKl430ZxPxJ0K71eaBoLWOa2ihIfPG7cQCOmeg/WvMF0nQdK162stejSx09tyxWbSFY3Q5ztPOcnnsO2a90juBZQIXvIpSW43KU5P8AKvPfid8Kn8WXFvqttftFPBGF+zOAwZQS2A+Rg8n2rkxWD9rP2sN97HRhcSoL2c9F3PMPDunxw6XqepaxmN7e6b7Ha2kWRCVJXaD1ZcBSG9BzU99pN/f+HludYmnuWtQzq3I+zDrgD1x3966288JWV9Da6g1xNEltnzYANgaQcYbjnoPrXO+MdUubzWrWWPVYrnTIoFgnt4X8pyuBuBTrk5HvXk1Y6c8tH2PTpTblyx1Mt20y30u3ktUuLuxuLhRJ564njYAZChei4J5561wmu6feWmtz+dZLp8Bcz2jMMnr8pJHQ8V6l4TGikMLOcPeR8IjqQqDnKDPVjx+Vcp8WdXJ0qGyjP2je4USupTjIx14I9/Y0Ubt6bs2UuWXLY9a+FPiuXxVoVvenBuVJgu1Q5AkUc/TPB/OuT+NNjBayXks7x2UckW63uOpaReWjP1HT3qb4CaNHoms38On6it3a31srzo6bSsik8pg9ME9a9B8Z+EdO8Z6RLpepNJH8/wAs0Z5jYd+a9mpTdekvL8jyIThQxDfQ+PNGFpqNhqGraxqb2oj3W9tBDFuZmIwWboOh9ecH8en1LTvDvhbwpoUOl6pDqV1evLcy6pGx2xNgBYfLP3SBydwzn2qzpvwx12Lw54uh1XTryO50u5hmtWdWWG5TLh9vZsrtOR046V2Xw38JWS+GtW07xHbwWYjdtXeGd1kFuqhdjugOVPynjgkHng1M+VNwb07fLQ6FO6VRatfruZfw9sNTb4f+L/EN9YiQW0cd5btOvErRks2D19DXh+g3a2erQX1yzOYG80ZY/eHTnr1r6K8KfE1/iF/angu5+z6Mt9bSw2E8ICK+VIEbp0GQc8EdMVx0v7P2tw2Nhby3VqdVlvdk/lTBo4rfaPn7HOd3Hf2q6HJBSU1ZsyrTnKae9tv60PR9S8TzeFvElxp3h2NhZ7g0kk75JPdc9cVlXXx0kvrrUNKvLaJ7QJtEqnKZ7/WvO/GsuoXGrbtQLQ3L7ZDtfblDye3XGK872uv2plUmEy/fHQD0rjw1KU4SUpNJ9F/X4Ho1404cslG77/I9F1a3tLzThexMq3rvmNUXA8s9D9a5rUvDmptMsHkpHPIxXy2kAJ6dq6PwVY3mr6Vc6l5DNFZhYowW5du2M+nFd38OfBd7qmqR3uqTkSxiRnc8kA9OD9f0rOnKdGXs47mtR05w5pPQxfh98KZr3UdMOpztJbqnnShQGEWGHyjPHzcjNeueK/F2m+CgdNs2A1OVdwcruEQ7D0zXSaVp9r4e8PJZ2kxAxsWVzhnc9zXi3jDWIrq9k0u3U30szgSXM3yrE3TPHU969ujT69zlwVNYiqnUjzQj8vm/8jH1zUGvLyy1TUb9buS5RoNpP3WPQ/nwenWshbrUWuoJbFJDP/x7kJgCRT1TA/Gun+F+v+E/Df8AbMPiixe+naTKFIVkjZB/yzGTxlsN74HpXM6P4hk0TW7a704zIgnJe2cgjyz68dQO9ac0dOXr+B9TFz5J0pR0jt0Ul2Vu39anoeu2MtxplpNZx3AXTogssJJjOCOU5Gcnv1rm5tL1q01rSrzSbJmksJxMIpiDGTwRxnt617Pp8b6xZyPdspV1GWAyD6DNcT8QhDpup2mlLrAs57tHfYYyXAVc/Kff3rir1nTk5vT+v6Z89hsfKypU4pLzuV/Gvj67ubeGddMuE1KIEuxR9gbptxjgDnmm2nheE6Fb6hrdjBqkt7Ibu4njYqY0Iyqpjlhj8zW1o1z9qsBDNdM915fyRum2XA7svcEdxWNd61qXgrSXGm+RLC8nlWscyEyW7N2j5wy5J4IBHFa08bCUm3tYqNaTgqNJKm793r8+iPPdZhg0zU72Wwt5IoTGpSGQct68H0Oa5jVtQmutQtpbwNLggbRkAAdsjpXodt4VudS8y+113WYsOY2y3PO0DoKyNS8KX1tcjzVDW8r43nqF965amLjdWei+4+l+tYZr2XP7yW/exk6feraWGoAzi4luovs8cb8sNx6A9yOa9ktvhnu+EX2l9SiWSKyacxeQDgglwpcnPHSvK7Pw9YQXb3kTLK1mSwRY+TzwT2q5qGq6hPY6ZaX+oTW+nSQs0qIx2bxuK5UdzwOeM81ssw9pU5Wt1b8zzHD6zKFOlK3LK7b1ehzEE63c8FoblbfLHzLnBJAA+7x9MfjXumh+PrbS7GNYklm0pSIpI5m3+Tv+66MeSOxU8emK+fJ/LivEuEgYQhgQN+SB3z/jW0t27WDxxwlv3glCHnaoHAJPbqa6aUuWLTep6OLw0MbK1bVH0j4H13SbwTiK9tY9S3lXtUkaNXweCqv3x1AJrs01EIk0kKtPJChYwoRvJAzge9fPdn4k0jTjZalPCsCHygU8gkTADLgEjHJxg16Z4ctrfWr+61XQJEgsXUNFvcjL91UjoPXORz0ronHmle+p8XjMvVJOUU4xX83f1/I7zQfFtnqcohkWS2uAgcw3C7XXNdEEBbcGPToDXnSaddyW11NpjweasmJLa4j3+VIOTtPbI/D0rbsr3UYdcjhZC1jLGGB3DdE/cY7qf0rR8r1ieLKDi7M60jjB5FNZA6FT+BpsUwc4Iww4qUAZ+tSQU5IjCvQFfUVUMgDEqcgc8npWixkdpImTCkfLJnI/EVzmmyXbX1xZ6pbGKSI7o5kB2Sr/AEPtWcovoVFrqWLlEmzJEQd4ycDrVG0tm0618qAiMMjKjIPmUHoPoCeKsRQXNjqJMCbrGc/OmcmJ/wC8P9k9xU97EyyqAm6J+Djqp7fhWU4dUzSMujK/hm0FjpUUBw7pnc+OpPPWs1pNup6ldRsiTSOIY2Ynoo5wPrXS2+37OU2kODVIWSfZzdiDz7iAbwuctkcjFb020rdzOet2ZMNzb2djJqNvHJJHKmRcgDIbJGAOxJ5x71HM9zLbzeZcrBEVDFQMyHcOM+mDjnNV2trqT7Ff6jdztIJjIsVoojKqeAGHPHH/ANetC90rSZZLoXWobfMYs/lsSTt6gjkcVs0Ypmrp8b3GlpBfMJpgMMxGcsOhr5J+JWmasmk6zqGsanDZXLXDwRW5bb5qB8NtP3iMYOPQ17p8T0u08DeIZ45iLPdA0ODghfNj2++RXzf4gddSjSfW55JhCrKks0hJQHrgmvEx9SKrx5lfr959nkeSVcZg6mIp1FGztZ6bJPf5/wDBPZP2YFEPw/kvrqWKUQ3MlnHs5AwQevpyDxU3xB8U+bLqrPeM2kRwlfKP+qkX092PbPtVH4Ypd+FPgvd3Is7Y6FMHu4LqWc+azSYQfIF6ZAHJU4r55vbzVdZvRJqdxdyp5oHlLkYA4G1emcVNe9f3Nlu7776HnRwzoVG5NSf91pr70ek6XBZSabHc2VpdW9vcMoFtIRK6t6ryMHI9uKlube9htrGER2dwLsiW4RzvEZz8u8Y+UNgEgHJx71m6Rrd/fXlw1iq6ZYIseZrpFuJSVz83s3c/SvaPg3p+jXqNZyql9JLKbqScjILLjGM8985968qNJutydWdtSryU+d7I9J+Gnhax8NeHoY7O4+2SyAPJcYwCcchF/hX0FdVIyIBuIHoM80sYRARGFA9B9MCoJbVJpEknCFkBxgdM9ea+qhTVOCjBHy06jqScpMzIdRtTf3bhzFOCqbJBt3f4/WpjI11JBNIWijQkOoUgk9ufSoLjwrp11cyT3HnvI+3OZSMYORj0rZmH7tlK71xjA71nCE9ecqUoacpDdxQrbSM0QPHPyBiR9O9Z4s7q2uX+zMfsbMMRqc4HcD0rSuITNbmOOR4t+PmHVfwNEask6qR8uDyB9K0lBNkRlZGDr9s8enme3WPyo3SQLtBGQeS3civIr/RNO17xQLqytwkkTSG5liITfkA7iP4uPXtXvDt9sF5avBLGoGze4wrgjqpB/DtXhfiSW6t/Ez+Hw09hIIhtks5CspHQOM5B+X27V42a0+W0ls9Genl8ua66rU8otIbUTXa6bcSXmmTXBZp2t9m2QEjAB7jj8KZ4xsZLnRFluXNvMg3bvvZx6eh9uldPb68/hpp9MtSh05SruJWLGR25Y+vrzWj4m0bRbnTrm6kaZWurZfs8Ykyu5xxhR1P+PavMjK8lUsetzOL5bnnvwh8aX+ieKNNu7obtJNykFxcDC7UY4yf9kEjNfXjSLDqDqcFJ8GNx0Jwf5gCvhHTtQtf+Ebn06Vore4g3Kxc4LDPbjk89K+3vBsEb+CfD2XlkK2Fu4ab7/wDqxyfSvfotqUo20PIxkU1Gd9Sbxvtg8D6/L5UksiWEwVY22tyh6Ht65rwP9nj4f6JqmleJLi61S4u57u1awktvK8swJJz5mcneTjj0wfWvaL7U21PR7y3sys00bNGseAwmHIZSO/0rQ8FeHNN8N2DPYaWunz3qrJcRBi/IHQE9APSrcJTaa26rqYRqKnTlHXm6M+Sp/hF438P+Lrazi0ya9Tzg1vqNrnymHZmb+DHcH0719VeB9Cv9G0RrPV5LS4uA5IlgQgkHrljyeSa6tWjlGQ6bRnOGqFnVI3dztRRuJ9B61XsU5qo+hMsTKVP2Z8Q+O47xdQs3a5WaW7j3NsbdsGBgflWfpg0u01KxXVYi2mRyeZLFk/veO5+tauhadc6nfvc3moW9iqjejXAIITgEdPTHWt7wl8PpfF/jD+zNbm+wwmIvbxFwssy9QyjHTHOT17V5lGb5lTvd/r+p9FV5YxlL+rHrnh290nVdN0rUNGktNgYRxxqmwRsQNw2/XNdbp13ax3LxQQJ580+2aQcbsZ54/KubbwHD4X+yafokLCBWVS0vzZJPUe9dhp2jW+n34w22ZmLEP1Y967aCUpyc1r+R41ZpRXI9DiPjZr1hp+lR6aZJRcllk2Rg8gEcZ7HrXluqaDc+I9IbXrGNo9OMvkrDuwcgAlm+vNd78c7GWHWf7Va3kkihtQ8fH7tnzjBPY9/euFvrzxHa+FcnUIobO6kIhtGXow67cdBz+NdKVr31Pq8vUaeDpuk1d9+76L7jlvGktosNnbaW6CZYwjFF2r7fQ9abZpY6RqUEukP5t0qlna5G/kdRg8EZrNkspphIWK4twBujQuCx7fWmaFZahquqxW8AjUPuXc4IUAc9e1Y+0bk+XqelTp+ycXXvK2n+fpufQ+g+Nr7UPD1jZ21gq3M0buGhwQduNxC9j9e9c4Wuby+a3kt5ryPY0xaUiYoy8gfN8yk+g61JpenP4e0a1uv7ThtLlQIoXUlkCNyV3AHJJG7IHGKpyarf2MU1xpsa2Ul/GfPvpcPI4GQTGoyc84BOOta1FCMbyWh4yp0rzlQStfz3/rsepQ2el6jplnqV0ZVcxI0Eocho9w6Bh/XiuS8WaQlrFFdbDdLBcA7t/KHOM5PWpfhnrGo6hpNnc2lyV0y3Q2y28sOfNxxk5PNb19qkVrLFbywxXNpIczRy/KsYB9Tx36e1eHiFCauvdPMhKdKpZO/+RlaKXu5YVuLWS6UHDKhIbd2Jx1FaPiWxM+jThYP30IO3apOPp6mlsL54dduDZWhs442BaeIq2BjuB2qx4oe5sI59cNylzayx4uJShK4zxtXoPrUQXPRcdxO/to8unY8estItn1/7H4cvTdyXVriZQRkkNnJzjnrxXQJ4csjezxgPeReS0N1HMPuYP3sdj71y13erbXs17ZWahfPW6jlQlXHPzqD3HXtTLXVdU1aK5ljvpLaGYA4UDzCBkjB6jtn1xTdOTumrP8vQ9dYSqpJp2XfudJ4c8L6RZS3d3Im6JY98AusMwUgjkHgg89fSqbeD5L+6ki8uG8W5O8MkhTy++SvQgZ4xx7Vfg8U2N1p8EN1eJDeTRmC4Dx8Bvug+wOc8+tW31VvDMVykUCJexL5Ue8ZLA/xEV0e2lT3106+v4mc6uLp1LyflZ9Uv+D2MbXdJur74f+Q1hIr2D+XHL5ikFt+GygHf1rf+GPi3SdI01bG7naGY8iPazKGA5HAwBxnNZmjTazZS3dlcXIu7WaFpyNuDvIrlF0y0TSbjU4bo+ayEAOcYkJ5H5ZFdFHGVJRlJ2ujrhCGNpOjW2bumvM9OsPiS9z4jeGyk2W8rEvMV+U9sL68Ada7/AEjxXpuqST20t2ltcR4CSuRGH9wT3r5/iRI/CdlqMjeVcYd+nDKDjn/Per3w01e01PxHINU0+1vZJv3dv5iiRU2jONp4Gf71a4Ks6t4rdbnHjMroTpSqwVlFW87o+jkl1CGQb5FmiY9QOR7g9xWzY6jHKzxSOBLGQG9s9M15RqOrT+AJtKt5pY203UZlt1tGypt2bpImeiDPI7cYrs7Cx1WLUZHvbmGW3ZMDau0n0r0Vu3c+WxGG9koy3jLZnaj68U11DqQwyK8b+I/xPm+HfijRori1uZtEnAa9kZCQisdoMbdyuMle4+ua9htriG6tYbi2kSaCZBJHIhyrqRkEHuCDRCamnY5Z05QtfqZU6yW12ByYm+439DUeqpdPbCSzVRcr0D9D9RW3PEs0TRv90/pWOoltrkrO+/P3Hxgn2NQ1yvyHF3KOhanHqMckbDyL2HiaE9V9x6qexqxql8uk2N1dzI8lsqZdU5IHrTXs7S41GO88oLdRArvU4bBHQ+oq0/leXy3yH5T36+tUpRvdbBZ9TB0G7W5ctpd3Hco0PyPIw+UjvjHP4cCmav5WledcXbwQwlQ4dE3FiQNxbPQZ6D9K0odIs7WdpLeNYHAIHlnaBnqcUmpQafJATdxRXSDGRIAwznjIqpVYr0EoX2K+lSWuoeGo5buIG1nbcVuVyDhuCQfcAiuZ+IPgGy8WafYI8n2eKzn86QKBtnhx80R9AcDB7V3Fpeb0KARhWHXHAH0rw+f4salo/iXVbW7tYdQso7qWJVLFG2BiAAeQOPauDE1aLd5bM9nK8sxmOco4VXcdbXtv66Gz8S72Wx8F6bomgxxQw3Dxw5wAkEYXoB04wBXzD4ldrPWPsEWx5UbBdRy3Pavddd8baV4h0eexWzuoJ5CogTaHCkMCACOfXtXj+r29uPiIymOQyRqiiNIzuL4zgL689K4HOPt5SjqrXPQeCxWEpKnXg4Nvr+h2HheOC91v+0bXTls7MwEfZpEDC4ZQAz7enHPTrXVeHPEs/hDVYNQ1C4ddAujtk8mHICMeQoxuU8cj0WufnfXrLQYru90OWJLJ2VGiKlkWTkBgOVOSePfHFV7u61j/AIRyxlvreK8sBkiAKXMYJJ+fH8X+fWvObaqKou/dD5VKLi9j7B0yezns4XsJo5bd41eMq2cqQMH8qsOqSoVcBkPUV5J+z7ex3Xh+6kt7CC3Xeu4wMS3OcKQeFA46HvXpVzHJHMqR3QiWQ7lR+SD1wB6da+noV/aUlOx8zWo+zqOF9i9BMkyq8DiSNhwynI/OmvFILlZFf5T8rD29abYrDDaiO1jVEQn5UXaM9TgfXNWuK6FqtTF6PQimWVhiNlQ5HJGeO9RqjMwEk28A5AxjkGrNMkZEUs7BQO5OKbXUm4ySeOKRUkbaSCwJ6YHXmvCfi/ZNqnjGKe1uvss32cRxSxoWLYyfz5Hp6V6/ql1aSTlGlEiqoMi7dygf49a8l+J2uXGm6wJrdY/tDNtSJWw4QAfNn1ywrxs2q/u+Vd0eplsH7S67M8y0sXuo6MbnxFpMlpEkjQxb4vKklxyFcdSBg8j1rZvI9X8QRWYt7p7NHbZJsjVo1UAFdpGDkelY2pa/fatDDcwakscFncPDGspA8xsDLE8844znvXF6x4sujo/2GKb7CkUxchXw+ccEEcAdeB1zXlU6UpyTireXY9Zu0dWvUu/8Ibea34iv9O0GxXUjaNiVlRUAA4yxz1+lfYMKyQeHILaTbFIlqiEJwFIUDAr5d+COoa3c2kMHhuJTeib95NIP3Yz3c19QmaSKKztbl4pryZcM0aFUYqPmIUkkDPQZNevhU05J9NDzcfPm5SfwxptvHpMR+zRh3O9vlwSexPvWxOrbRsBxnkjqBUVjiJUiTGVGCCelTtccYUEv6DpXqRty6nkyvcxZraC0DS2kCKgB3kDGepP6k1hX019q3g+8jszFHe3UckURc4XaRjqPY9a6J7R5LuWWaQMrRlfL/hFYurOLCytRaWfmWgYxkxtjygOjfTIrlqWjCTasb023JW1Z8ff8Jnd3WiXUF1bxy/an/dshwIAD0A7/AP1qg8P+J9Z8Hap9psXhfUJwC1w6+Y2CQwC54HGB9KqWOg3p0QXytEyGUo8MZ3SL6ewzWqiaKNes5rFrm61GWUCLT0jLCMY4Gf4jn0rzk4U5NU1f0/D0Po+Xnj7z+/8AE9+8Qaxfa14Bsry1jmF5qF1HvG45jfqFXpgZFbnhG21CW4t21K6kkuLUESCR95yfevPvhIbnx60Y1LQvsWlWRDQy+acTMGOcqehr1+C1t9LuSynCOQn09BXXRlKN3LT/AIbU86vUi6apQXd7fcT6hpVrrc1zBqFkl9A1v5bQSthSCeuex9xXzh4qi1nw1cX2lWMqyQRglA0u9rRSeinucHGcZr3fxzrV/othBf6REZbgOYsdiCOh/Lr615hYaTJBZXup6zY7tUnLNL50mV2t3+ldrV43R3ZXJU6cqlTWOi5et/09TldDjkj0600O109L5r6UPCQxbLMdu4AY6dTnpjmuwn0W1lMVghW21K238xxlAyLnIcDjPFcpp2s/2drVzf6RIIWgAWJsnyicDIA7dM+9dtqfiWy1Tw3casyR2Wq+SIprqBsoGPBwmOCf60pygo6/12PVxcMVHl9ls3r6vuv8upB8JtS0rXfGtzaeIUjBFqUsROVVcg4YAf3iMY9ga2/H/hWx8PaLBatqRnnuZwqWxQBiCfmIxyAACfwrxO8trSWYPDcODDHzv6jnoPzru/AfiCz0tLyRYGufEEoZUuJQWKxcEDLEk4/wrjnP2VHlqoWJwEqa+sUJPl0923Xvd7eZHaXWoaWZLTSbvzlB2oE3FfTeSR1z1PTipA19p88b6jIlzdSRH94gygOecnPOKpfam0c3WpOWv7+eQERTP88jMcHA59eldDLrep/YIQPCYS0yvnws6mbYepVB82cc8ivLpYaWJpycVa2xg6FRSUlqnvstTpIp/swsvs1sJo3t2l84L8ykjJBOPmB7VX1W+1C7+HmpWgLTy7Y2jiC7mkUuCxx68HiqmleJH/s7ztFAS2jZoUimj24XPKk9e1dHa3dokEbXE0a5AyD0Bx1BHaqhzUZp3OFPkkm46xf4o+bbi7vJ7uWWMzmZ5GQRINsag9tvatfTfC+s2OlR6hZ3kDo0e8xz4R0A/iHtxivWdY0TR7HWrC9s4TNcpcC4MUgJiKjDMC44BIPGfWsrVbH/AISPVL2GK3urCylKxtcyw5lILcKq5AAH6g8V6EFSnFtvU9ytmKq8jpRtFb36fLqU/AEzWWtWglksro6wi/aPMVWuI2xuBI6FRjt3xXofiHws+qPvik8gKVRDcICZMck/p36YrgNdjg/4SFLWC6Wzl0yaNrS6hVUY7cAbz1PcY6A16/pGt+dp9nca6PKnlj8084Xd03D6nt2zWP1S8P3rPJzB1YONePVfP+rHmMkNzp8rXM/+jxkmEDcrZ9TjrgZH51zOmeGota1qdSkaQZLOQx285HA/ve9dx4hvLXWNQuRb2120XllMRxYZ2B4IP8Pzd+/eneBtPtV0q5e6H72UKFVBwuOo+ueprgjH2lf3v6SEq9TD0rwdmzzbWPDbSa9Y+HLm5vZtOVWQnPzMiZcjgY5wBmqniHSLjw1JBqnhW6FgJZ/Ijh2bmiY8HDHt+td5dW6XNwv2qeSwuYW8yK4VM+WeeefvKRwQaytesTaXmi6jr2ow6jpUc+fKT5Sy4++w9a9bBygqene/3ndTxPtHGLdnZprrLd6dNfU5XxDrup3l1aw6nqUmsJpxeO2aVAHXcckk9+ncnpXpvwU8fajePe6f4l1aK6gDolu8yBGiY9sjqvQZNcF8TYdNvrmzi8M2E6zFJCzbQivGAGJxntyM981l+GPDepajcobCAxrAvmTiUkNtUjP+fauuPNz23R6NWjhcbg1GceSy0va6d/uPqTxj4btfFHhq90PV03QXAwGABaFuzoT3FedfA34h21hrEvw01MuLjSZ5rKyvZ2C/aVjY4Xb2bA4GTxXdfDrXm8SeDkunGLi2ke2l+bOdp4PPXjFeefFTwBZal4t0jxb4fgmbXUmjneASBI5vJYHfz0cADjuB69SadOXN06nwc6ThOVCpun+J9B96p39oLxFVm2bTkEDnNSWN1HeWyTwn5WGcHqD6GrBPHPSuhpTXkcOsWc3PBLb3JdzubpuA4J96sER3EL+bGrRFSJFB/OtF7cP5pdwYnHHtWTvXTpfKkVVRhuRx0Nc3L7N3extfnVupS0p7WbTiLa+a7ghLDzHO51H91u/A9eaintFki2xMDC2SZAMnFW7AKJ3kjgRElbc7qACfrTdPTUYryeC+jiksiMwzxHBxn7rL2PuKJRjWTaHGTpuxlWscejWE1xezy3EUK5IHzE+hGelc1onw58M6rqFxqN15989zM0zRvIUVWYltuFwe/c13V3alfMCKrKRyCMhhVWwSK1T91GqYbJ2t1rnahdKcdV9x24fGYjDKTw9Rx5t7Oz+8gi0rStBuitpplvbW0gB/dKF3ZGCPXt+tfOviXRbvw38TvEmq3USjbKHtpH+bZGerj3xxmvpvWDJ5tj5T4Vg6Dv8AN1H6Zrxv49eC5PE0g1QaitrttV2QspxNIucqT2OPY1z4yjaF72T0+T1f4o0weIcql6ju33fXoZ3hDxei38DpFObC9Py3UiiLzZD0ABJ+XORurnfGGrtH4g/ti1JW38xrd7eNiwYkne2QcHt19axvBlvbTWdvZ3ks+pwQbzFYtJthDgEnHILN6Htzwa27q8/t7TZbZre3sYS2Ht41VB8o4LOcd+Me49q8qfLH3Vqj0oxtLmOn+G3i/T/CarIl7v0y4vGWVYY8y4ICqz54ABIHHrXva2lvqNwbiWRGbIwVBxgDp+tfLVtpdjYeHZn1Ce5USghldiqMwIwoyPvAenpXsnwg8U2uoWZ0eS4ZJ0Xdb3O/BuFI6EY++vT6Yrsy/Eq/sZbdLnFj8Pp7aO/U9Nsnht9sSyuyk7F39cjtWhmudvrHUYGtWtrku5ch8KFBJHU1Oi6mkIJm+0Nv2uFwuB3/AM5Fe5Cq0+VxZ4soJ6pm2a53XxFrmny6bbyF0uMxyyRvtMQHUqcdat3k9o0SNcM+QexJCH8KiMNlqMDW80amFmIBRSu0jvntRVlzrlXUILlakZ0d3p9jpNsrZt1SPy44JeCWA6Z6H1JHavH/ABdfWGvatb3tksV3LCPs8aW7F3mzkll6E4wfQfzre8SHXI115bi2VrOC3ZLaS3bMkhIG0R9tzDIxjivOtGu7fUxfCWFrS2juEEUiH54T8u5ScABvf6187mFWclyW0R7eBpRV6l9TjfFNv5msNBNLG0U07qi7drxuQOcjjtXF+MbZbO5VEk3OR84xu2ntk4Fep+NdN05NdkQSi5MY3mZ8c/KSBkevXjn1rjLWDStVu7zzMwxqAxLAuWOMAZ9+TV4eq6VpS1SR2SgqsGo6Nnq/7PukLO2kPou1bGG2NxqsyOcy3G4+WjDphRk9O9e7W1tJdeIw6nalvH8rY6EivNv2b/Ctx4Y8I31/fxtHNqkweNG6rCgIU/iST9K9C1nVn04K6YHmDJA5b6flXr4amrXXXU8LFzfO120OiEbQy7wyuH4OeD70trMEEpcqQp7c8VxWp3E2pWOlSqzo8zFUUHDN16DueK3byZbG50uK4lhgkumCMzsAXOPuj8a6E2veicrj0ZY1S5ls7Xz0A+aRVyemCcEmuG8e6leaD4VtmiSOdmmEUsZ/j5JOK9NvYlntHikAxgZBrzrxPp2neKNP+x6nctZpb3bIsnBy+Dg8/X9KxxkJOk1A1wsoqonPY+T7mC4lsEt7HzJpnABSM5/AAc17V8KfCF3bal/a+uWywaxFbpHp1iqkSIrA/vWP8OcEZ+ua6XwB4D0vwKE1S00yTV9SC4kcOv7tsnmMH2OOa7m08T3d3diWfQLm3jjUgGSVC5z7A8Vz0aKiuaT/AAPUxWLc2401p6l3SrdrS6MV+VFw0eS+eCTzgH2pus2Fpqkc9pOqyRsAT/vDkH88VWn1Gw1K6Pmh7W6VcIJf5elauktFco6bNrkAkDpn29q6eVS/dtafmec5OPv9Tl7+21WxtImkZJcMVeOQAiQf/q/lXnfiLwlI9/Ff3d7d/wBkzygiKRiVib+6T/dx0zXud5B5sRinXLKMgdmFY8say2jwLsA6bHTcrD0INaqSTUTpwWNqYaTnD5/8A8U8S+IdI1JJdG0rQ1vLW0RnNzAgURsB68cep715bPdK1nLagMLgsrHknkdgO3WvoPXvDEmkeGtQXwxZI0V0rM9nu2sjEYJUnqO+D0ryLw74IuW8RX0V9cPBqOnyAm3DBvOPVWDdxnB4qXF1Hy/ifYYLH0IUJVKey6Xu35tdNWUrdIdGih/tSzZNRchjJKMqU6Eexqjost7aXGp39jEXsYkYK7rzlvlAB9eeK6bxHpt3p0FlHqTm6kuGIRmUGRApHyfTB6+1XNV8NasnhyDVr29ks0iZJUsmhKeWqseme+cEfWlWpOo+Toupo61KcI1HL43s/LsjDtotc0yPTdbukkWeykEqpMgLyc8gj6djXWaN8WtPsvGWp6peWE0trdKTHFENsmTj72T0AHBFYms6pJcp9qtdMkt5ppEQXcr5A75K55yR1xXNyRppGtrBc2S3LLEAqK20M5OdzHvjPQcdK0cfZfA9DOlRji4uOLglLWyXb7zoz4l+2vdRWQlie9vZbmKFukUbMWCt2q5bazcWdlFcEQxXBOJI5AWWVD39APasjV9Pi0zR4bg3m7Vrh1TyYyPKRGzwOM5GPU1V1CK6l0JhHq9vePbDzZIXHlSbFOMKx4Yd8da4KmEqSnKc9enoiVQw05Lka5W331f6nbaxq9/b6PpzWEc0c075l+XdE4XOFCc4PFdZ4b1jSteksNbheWERQbLq3AwrHP3iMcleQCK8k0vxLfTkWd288NrqAA82dyQF7qD16YBNeh6t4jjnXSba2hs3v0b7L5QHlqIyB97b/AAAcit5YaLh+73OTF4TlcaNtXfVdvP+tDC8WJpc2u67Ld2y3N28oSAyZ3mLYFGzsxxyO9eseFriPUfCzXN1bXsD6eqQmKSF0k8wAfMndtwI5+tcpY339q6tanTpraS5tZBN5aDcGA+UjBHAA43Dmt/xTD4m12/jXQplsLaONpC6sf3/ACRx3AGCM+9KhU5m4W1RxYqTq8lGT5bdW9rK34nm3jnxhqen63LpejWqTv8AZgtxLHFgxjJJ2t90HHXNb3w11mx1KG009i8ZgjLyeawaYuDjOB1GcY9qx38FeL9H8P6lrer2kd1AiPc+Us2+bnlmYEc8e+RiuS+HKTP49sdWWVbW3JSKckFlAOF6depX271FXDRb5l8TPSeGo18PP2TT5eqfWx9AaR4PtPED3N1eSuYmYD5Djd/hxXL/ABB8JyeHIp57COBtLMRRo/KIEXXn6c/nXaeHNXbRoZY5A81vuLCFPnlUZxu46k9cVn/FLxJpereDLmy0q7iu7m9QxRiM4aMnjLDquO+awaoxw107NfmfNQlW+sJNXi2eZeC/Dnm61p9vcS28z6jY7bNiSBE8ZEmDg5wy56elbGtaNqOjAXutJYAAmO3t7N2/0mQ8qB0OAeWJ7CuWfQINKiW3uZnja1AAmWUh4jjqp7d61r6G2sraTV7+e81F/LH2eee4aVohjouT3roweLagqbi129D14KM6ik53tpa3XpbWxb+FqyeFtJn1mNbqS263ySdAAcF1HYCvXY1tk1K0hEe7cDcQsT1OMEfka8A03xXeWGhzWsN5BNBqUYM8E3DWiZOVYn1r2PwdrieItGtbm4h8q4sJBEdrEjOOGB9CDXZ7vTYxzzCVOZ4hpav8On43Qur6nf8Ag7VhqUEbXOgXBzdRqNzQt03L7e1d5pGsWOs6fFe6ZcJcW8oGCvUZ7EdQfY1Q025zq11ps1u7xuhnSXYDHt4BQn174rDn8K2Wna091p0HkeZ8xEeQoPrj9awUpUYrlV0eA1Go/e0Z3O1duABj0Fc9NbzEyi2WUxxHa6SxkBgQD8ueo+nerul3sccn2OeVfOC7gzceYPx71rfWt3FVVcxTdNnGzJe3GkyR2k62d0CNrsm8DB6EdwR/Os/QfGNidQuNG1a9trbXLeMPNbjcF2E7Q6FsblJx7jPNdRqogtFZ5CqQghj228+vavnD9pLwy2kalpvjfTriaTy7gJNHL86q5GUKj+H7pyOma4ZqdOSs/L/L/I66XLV92Wh9Iqm9TuIZM8MKo3toI3Dx5xn5lr5s+GX7Qmq3Pipbbxl9jTR7xlhjlii8sWr8AEnPKnvnOOowOK+onRXGAcj6da3kuZWluY6wd1sZ9pewR+ZHK4zGQGBH3c9D9Pes3x3pA1HSFZJ0tjG3ErLlVDcE8dB05rUuLWJbpbloyzhfK9ip7e9T3N1DbadJJdYW1iXL/JuwvqQO1UoRnH2ctSeaUXzo+QvFPl+GfGt/o+nF754Qr7w3lYmCgkgYzjP0rd8K+EZL+9F5qGpW4u5YHmS0WTcXk6jIPGTg8D0FdD8ePBaXPjW21fRt0d1ewjzii5Q4GFbd6n+lcV4fv7S1vGGsTfY5dPXYY0fDNIB1BHPp3r5+vT5J8sem/wDX+R9HSqOpSUr6knjPXIoI4Ib2B7iCN18tFlwSe7Z/hz3AGffio/D+twWqWc9lZuIfNLRxtJjDjqCe45Bz3NZevs9zZRDUbWVWumJjllY4VVxt9PmOSTV/SrHT5vDXyAWkpTfGmGJyG5YEc8471hJQ9mrrr8jVRaZ6lpHxT186uPtNq0j3aiKFeFWIZHz7Opxz1Ir0Z737NpzpfXZuJpH8yXG5VByPpgYr5+tdMvIFGr2ojkEbOXkjlxIh4yoXtnkZ5yK6jxf4ygvvDTQwxJd6pcwLKxibBhUDhRx2J5A69/Wuili5bSZxVsJG65FoeuWusI1g2ozKIIJW8qOVZQQpzg9+eexqnqOtSXMgfTr9FLZghU5ZCxwCXOOg5Hfr7V554fsFh8B6cdrvmATi1hc7mIPzM2OnrXV2Wvq2h2d/LGj3DJkRwDCRbjwpz/Fx1Gc1r9Zm42lpY5nh4p3jqUp7FlnmRbi3nvmQy3LQy7RE4+6uTnt+VeS+OrG9tLCC6h06SOGfM3mFlIc9yMfdHpnmqnxI8S33/CQy2c0MUBeUSeYB8sse3jHp396u6l4km0rwSdFuJYPLuXaOWZSS8EbHdtxjr2zXKls7b7eZ6FOMo6723PM9auNU0lZ7KffGLkLJy2cblBB+uK9c+Cl89/PY6ObS3n0xGMtwHhGUAXlyccn6/SuN8B+HLTxF4hnild7yCFPlGcEk+lfSfw78K6X4VEgsrJoru9A3gsSCg7kHgV6NBKrNQUdt/u/yObF1PZwbb32OshlV7YTSskUJGY0kIXao6D8qw/EWj2upXDPIzG4C7lYNhcdR+AqzrdvDJrNrcyxoLdEJWYnd+8B4QKevrVnUdQt7e3inO0TSyLGqEcvnt+WeK9uVO0bwerXQ8BT1tLoed6nrVlaeHzdC7WTXdInZLK0V9plkODg5/hHJJ7AGuK8I+KvEPjLWtSl8b24l0zTQpa4tQiLbOzfJg+nB57Y5rgvi5fNY+O9UtoLggxzmWR0Xbudxn+WB+FbvwD0C9nuNW8SavdfZfDVvCxuPtSkw3nXIZf4lXk/XArxozrqktdVt33PclRpRTdtz6Vj8R2w06C8VpLzTT/rZw+7y155OMliO+KyvEmqf2VpVxe6ZYxagQftJVzgNng5+gGa+fvAXiTxN4lv7+z02+ubpIrpbhDD+7KQF9pAXoF+7x0r6E1qxaa4nt5lC2cytuHRgpUdPxrWnVqTU4T0aX6HJWoQoyg1rd/gcM/xH+watbWWl6HJc6fMhKeW5MgYZLcc8ACnN8QPD4uHunt7hQRl7fcUlGe+CcH8K4zVLHT/D2swmyiWTz7PzBGWO+NS3ByOnvWfpsUWvQTSzwpIEiaCOSQ/MpLcV6DcovTrc+jWX4RwjKcbJJXZ65pXiHTPGOlQXFjK+lyK5WIXWCJAOmcdD+NdZp7GCOP7TcILlBjfCPl+pFfNlhp+oapDqFvdTNbRwRmOJVjJ3kdAMcY4x+NevfCmyvk8H21veRNBe2xKYZcblzkA+vHFKcudKPbY83H5dTw6dWm9L2t5dz1KO4W6Aimwk4G5WHQ+9YVzHcTiaOHMUw6H0qf8AeSQbHfYy42HuDV2S6Elqkp2rcxkK6+tZSfM7voeQly6LqYNs88KLJqEbJgYDq26s+50OxOrw61awSfaQpUyR/Ou09ih/pWjr9hflWEblIJDww6CjRdPvYLdx9qV/9kp+tNOVN3v8jWnWcFeDavoYMHhttPnmmuUi1CyuJUkJ8nJiBYb855A78Vq/FCytNf8AB19b2VyJLto18iOI7ssrAgY9OMU+HULy0EkGrXFvayniOaDOCPVgelTQ/wBo2aoIlg1FX58xFCkr9a29opRszV4up7SNV7xPH9Q8Jamn9nre7ihnRGPmKRFuwOF7jr9K2JPAdne+INThu1uruG3QJa3EbBFJxk7jjHBr17zozHhkUN/EhA4+tVoLn7Y9xaW4e32MPnYYVvpQ6sZaM645tWhHTfX8Txn4k6VY6T/YN2+nyCzhZluJPMLKTt49h/XFeeX0MGrXkNtol0LpHUNvkUgAYyQ5PvgYHHvX1ZeaBaajolxpmt20d3ZTHLgZGcHg+x+leH+KfBN34YvYLC0VU0+5Jb+1CcskS87NvQED8+tPmduVPc9PKMdSrWhUVpRvbz6/h26mVeaWkmjrFeR2ieXIVC4KlRgZKE9TmsyxNna6JOklpcPrO4iC5UszY7cZwFrY1S0igkF6JLi7sIwGEt3cnMknbbgdP51He6rqEEq6jJawyRXaBjLCDGFHbjuPaor/AA8qWvkehNVOTmg73d7N2+X+aNPwVomow+JrG5GpEmVMyxRIcTg/dTnjHqPbrXt9pdz2V3LLqgggJj8tlL5YnOQABwOM15xpiw3tpaiWLzkeMHCtswnqK7XQo206RpIZGmXbuAlTdx67j0PavMoxnSkm3e/4fI+ZxlT2zfMtVoZPxe8X48N3FpZpcCGSQ2t1s+Vl3Lkc9k55PXoO9fO2lPeTfYLj7NcHTILiOK8mSJ/LJLBeXXpweO9fTWr6lbancvaw20c1s0sTXeQCnl7vmY5GCvABHfiuh1DU9H8L6B5MADQx/wDLK2i3lNx67VBxz0r0IVo1E23sb4bHRwlKNKFN8177/n+hw2u2Elp4hji0mCaC2MPlqdpkAJYtxzuGCByfWrFxp13camlnHa2sqSYmvZWOAoz1PGSTjp7GuwjGnXkVtNa+0isylJYwwHB4yM9wa53xZ4jtNHkm0q1hu7jXL5PJiRdoX5htUsTjgEk8CvNrYeEW5Sel/wCkccK852jGOv8AWrPPvGuo2erSP/ZOnr5AT95KEPIydp9gcHFWINFlfw1qGoSqq29oisbUOMHjgkeldjrGkmzgt9CTUpFs4bWJrqcr+9lkVgEXcMDBCnI9KbqumJdaNd6a8jFbtGjlcHbtBXGB+HrU4alKNR318joeIjyxWyXXX+rnznqhj13VJRFbrJKm3Dg5zxzXq/wL/wBBfULa2ctpzmFGLsWU3PzH5c9BtHP4Vya6To+iagbaO6aK6+ZgTlkA9ent6969R+D2kBLHUr43NvPHJJFJCsSbNnynkr2zxj8a9qK913PZzevSWDtBb2Sb6/0kek6XeI8kVwrjy3PlemfT9RT/ABNK9naT3sFrdXUsEDusNsu55SBkIo9TXH6rJe6JoNikSC4mjLSyIAfnwSSBXd6Fqtvq+nx3NtuXIG+NxhozjoRWMZwlKVJPzPjZQcYqpbQ5bSXPiTTNN1G+025s2ng837JdLtkiycYYevH6iuhtbg2UIURu9ogJL7ixTvjnmo/FOr6N4ftotR17UIrCB5Ut0lkbAZ3OFX/6/QAEnABNcl47+IOjeFLxdJ05LjXfE9wcQ6PZHfIWx1kIyI17knnHOCM040pQbaJdRS0Z3KXFpqUX7hg5YenI+tYfiPQ4NT0u8sNWtIZrGcbWjZsh8c846c9+1c38OvDPjA68PEvjXVvKuGjeKHRLF8WtsjYJ3f8APR+Bz29SMY9MuYlmhZGJGR1HUVU6XtI+9uKM+R3ifnt8UPh5qvgW/Uyr5ukXjlrWcdPXY/o4H59qo+D/ABn4k8Eas11pGpTQTqQskLnzY5QDkqynIP1HIycGvu3xH4dg1rSZ7HWtPivrKRcOjL19/Yj1HIr53vf2dZ4zNdeHNeiLJKZbKOa2OQnZXbPODxnH+FYe0cfdmjqjyy1v/ke6/Djx7pHxB0KO+0kjz1A+12jn95buR0I7r6MOPxyK3b24FrIPMTMbEoWIyFz6+1fCV+df8O+LZZdWkufD10+6CS409TACVPDYXGVLAHjr1Fe2fDT9oy3ube30zx5aNGyARNq9t8yMegaSPGRnHJXPPYVpBtq5nUp2dke122naXflNNvrYJcQKTHDvYKU9UPdfbt0rxHx/4B1ZvH1xqJ0rFusayAWw3REKoUeh4xkivoNLSJ7uC9t51mgdN6Yw6HI4dT2yPTgirrfPERyD6jqDWWKw0a6vF2ZeGxUsO9ro+PLvxYsHhvVdMnKlGuYmT7UAZH2Zyqg5xyc+2Md6j8LXEt9DqOoXV4fJU+RDaoMsQBnA5BC8449a9/8AE3hK3SW9vE06C8S4dWlDwiQjjnHGRk8nFeL+LvDWtaHJZ6mNL+z2wYrHGIwpROxYDnnPU14k6Xs4uLjqe3SrQqv3XYh1e/TTLe2tpbS63SL5ylCEjBIIBz3YDP51r+GLzS4bW9treYJEVDQ3NwqbpWIBEZznjI6A1keI5W1O5skmtBfzygzmKDhEODtGF59/zrI0+wuJrjTIogDbxNtu4VQb4JGJBBzyB/SuaKXJqbyV9T0vQbyyTRrZYtQnW9mkczyRyBY9y9lHTnGOf/rVRvdf0y3jvbK1u0uvNUbkDsTEM44bpxxVC203VdXsJNK8M28csVvcEtcM52vg4OwEfqcda5HUdHu9EvP7PnS4illBjkBQEshPQAdTmnZzSvL+vMiNOPM+/qX9U8iIl9DdL2IDfOWUN5Rzjgc4HJ/E1zdzc20s+pwXACYfdEgUr2yQB6Z7103g/wADatfXoFnBMBJ8qGVCqAZ5LHH869+03wfplnY6cl1YW+saxbbvLmkhBCE/yAwMV2UKLqzfs9fPYxrYmOHilPU8/wDgb8OJtNY63rDFb+VQ0Fun8Ab+Jh/e9u1e2z6RcDSbtbeTF5OhSMtwF9OfzrZ0q0W2gQyKn2lhmQr6+go1m+t9M06e8uy3lQqXwoJJI7D3r3aNH2MXKT9TwK9d15nN2tjLF9kgvLYeRbx7WJO7fIepHPTjPP4U2OyxA1zfxjbbs8yxoMiFRnHP97b/ADrT0x7PXprfUI3uFAQN9nb5QCf7wryHwRr2qaX4b8ZP8Stfm8598bwn5UtEwQViyAGY7uiZxgdzU1MRFRT5tHsFOhJt6arc+bdajmn1nULjVLhmnnnkkLFj8xLE11Hh/Xb5vDs2kJqly6zJ9naNwDGLfn93z2ySeK4uy1W0l1iVpBJPAJD5TXJGfLz/ABY7kV0Ru7WGWa90/wAlYRH8qtKgYH125zivMxMZ25Zb/qfRUHCSvHVHYfCKUaD4ourzRYNQnnto2ibZGxikh28h+2d23AzX0zB5l/FZXN3EYZlQB4j1BZeVrm/2f1EXw1tbx54XF1NJcfu2yq8hcdevH612MZ+22U92MhjMxXtjbx/Q11YeL9mrvVni4ualVdlotD5M0ZNS1GC4vpYFYwNty5wSnXjvx6Vu22lTHw/ewaTMqy+aHVXbDbjzhR16V0zaZaaZbrethXUDEW7IB7HFc7B4ik0K/k1BILaS8eYTIJyQFYd8DtXJSnarCDk/RH1NCvVrN8q9L/kze8H6hBYxwR3scVkImC3EzMSX/wBog9Oav+K9Y1hWSXQ7pIZog7smD+8TtweDx39653SNXtNW8SXk2uzRzvIDM7InlrgjspJ6fXNXvGo0648O6fHp0kltbGYJE28nencHPOO9ewo3u1uROjy4qHPe730utT1jw5fnxF4asb+NikhwW9cjrmtG5jeBDMpAAB8wHuK+fNE8Xan4D1W2tUZ7mC42qbeRwQ2OpHpx3r6LiuEurKOUJhJUDbWHOCOhqasFJXPExuG+rz54awk3b/Ihg1+0vdKvIXKxfZoTMZXcbNgGd2ewFSeD9QtNV095oLy3vIjja0EyyYyOhKk4PtXlXxi8KCH4ba/NoskscsgRpogxYNCHBKgdgOv4V5R+z9cQaT8UdLhsZXmtbq3lS5AJCodpKs2PcfrWEaz5rSe35ef9bnN9XUoOUf6Z9MeP4vsUEd1BpM18Y+JNhwAD07dc1e8O63oN5pkUtvPCJ4wIZbeOTLRP3DAfzrxn4p/FXUHdtJ0C6jNuC0cs8a7vMOcbR6/UVxT+Hbzw94ZT+zYbmTU7yUT3SxzbGiQdBkcgc5Oay+t3blFXj/X3G6wL5F7R2bPfNd8beDNJu9QtrvWrO2mgcLOpJO1vQH+I+uK4W9+O3h/S/C2lzPYG71e53rcRWswAiCsRvBI53dQPzr561WSI3MmobYXhExMaTMTuGeee/wBau65ZaDrsNvdeHCbL7OpS5hlziRuoKZPTNQqmqlNaPfTb+tjZ4RJcsdX013/rc+o/B/jx/FOkfbtASXbtyyOoZ0IPOR0HpXYzabDr3h1YNci3xSr8/OCv5dK+av2d9C1OHxfJZ3A1G2fyDcxRrKY4pFBAJfBw454HrX1dGPOtmQpjI6YxXVhpNpxvddH/AME48SvYzUo6P8j5r1rRDLr+ox6hN5GmWDNBawrIMyEcYHfJ6isnQ01TUreWzvwyaesuRJO2GjVSQF2/0r2n4k+GoL6CC4061t4NWcgG5ztdwvOOOp46npXilxEp8FJNca7G99FfFZrQczvn+LOcnHr0rSo52tB28z6/B4iOOoRv3S2vZ99O/d/M7XTJNAUXH9iXT3d3Gm15Fbnb/dGe36VvweJG1TQjaRQ3FnCgzuZwzBRnqPXPavMSkFtf213pFpNL5HEsVunOfc/0retmv/FK3yeHr0RwxQedd+emPKfJ2pn1bH4YrhjQmrSjLX8zjxOAvLmm/d7vdfd+Bu2mta9aaXJDpEFq0m5TDFPLukGSCGbtyQOK6vSvFN3qOkrHqkCW3ifT5F+1qkYVnyMqR7Ed+a8c1XxA2oT2ljpcEllq1vMDIqHMUbKRgrkbuozhs4Na+oaPqtneRa3caxc3F7CmS0pEhODk9fvLn3712zouUWoE1MBSUYqryxbem9369LM9s0+9jltzcsFjDhmYbgueMgHnr/hXGXtjZ6hrVrfzSyjUA6skxYkqBwT+FRReL7CLTDfagYIrQwea7IScyHOFx2JI6dqwrmSez1aPVb6+eykmQFJwzK0TYyAmfl24/PvXJSpRxDcZ9PzPMhh5wk7XTem1/l/maMvi2xtNQa31S8t7iWJ5QiwBmQ7T95uvXoD656V1s2pafrPhMahpEwlLKQFJKtxjO4dgM9RXyzLc3OqavcxW8wur6S5ZjKnyh9x+8OwBzXvU/hDSbfwrb6fYajPZ65bMJDelGMbtjmM9AEJyPrgkmunDYeMU7I9XH4HCUVTvN3b9V5/icNqk95ZauWji/do4R2CgM464C/3fp6V7F4Y019H8LXEdjKIri/kBiDNu8on/AAGTiuV8AyQ6+zG6jElzAdi28sQ/dAA/d9uvNd1qbvpnhy3htMC9kcLvHIXccs2fpn9K7pzajZHj5pXU5+zS23+RD4p1K30bw3e65qkrra2qZO04ZhnH6nFUNO+JGjah8Lf+E0WOWztYpvIuGBDMu1toLYxnOVwOvzAV53+0ZPf2/hmcNH/o9/NDagk5wud3T1ytc38JfCujaj4J8nxcb+fSLbUXmgsIZTHFdzsiqNwXDMwAIGGAHPqa82EY87V7t6aelzjlGTp81tjzr4leM/Efxf8AFi/Y7O9ubW3yllY28RkMaHq7BR95sAk/QdBX09+zF4ZuPDXg2X+3vD8Wl63LM2+7Zg8t3GTuBZsnbgkjbkDjOMk16J4NtdJttPNno+kWul2sYH+jxRLHg9+B1PvUtjdtDeS6bdxmCMbjFI4G1+p4OfrxXW6lrdmcXJe5tFCZg6vge3ORT5JUjGZGC/U1zdlLJZzvbwzeesYJWUkEHnocdK0riOzv0WHUIcZIbk/KT1HIohV5lpuEoWeuxq9eO1Z1zpke5pbVQkh5K5wpPr7GvEPj58dh4K1C30Hwn5Fzq0MiPeySDckKAg+V7sw4J/hB9Tw7Rbrxb8dYEupZh4a+HzsyNDaXAa9vtpIKsw+4uQcggcdmyCNZRUtzNNrY6O/l8GfEGXV/D18bfUpbADzpLdi4hLgjIkAxuHPQnB6jNfOPxK+EGveDNUkk8MWd3rWgXK7Ulji810Jz8rqoyCP72AP5V9p+GPDWj+FtIj0zw/p8FjZJz5cY+8fVieWPuSTU1xpcbPvt28l854+6fwrmdBx+D7johiGtzxT4PXvjXw54T0fw/q2iXt5fIGlCTHyxHbZG1RKflLrydhIIGB9PZpV/d7tpUH8/xqnc6Zby3lpcXkJFxZuWgfcQFyOfwPpRqFzdxvCbG2iuA7YmVpdpVfVT0J9qqnC273/D0JqTUrWQ1opIl805zH0eMkNj0x3qB0s9Ujngl2EyKQyuuSmehFaLKs0DKgkizlQWXBGO+KyNK+1FpY7qa1uZIzt863+U/RlJODRKmpRs1dCUrO+zOSt/BA0mA2sUSTtKpEcyx52nnk/3eDnPtXAeP/AGrJ4iSfQrOS5tp7ZRd+S2GaUDbvOex9ua93me9iwbcxPGOCrZB/Oo7i9vUtSLaONJScHeuR/9euCeBpWUVodlPG1Yy59zhfhfpE3hPQhZavdwwXJZmMhVQMNz0PIOc10114U0LVb2G/uYWvbpAQkpY5Iz3PT9K2dEIvoJH1JLUXQO1SqjI4961B5ltAPNkLRq3Dx8kD3HpXRDC01BReqMJ4io5uezMi00YpcpM0xt4IuIbVUwvPdietbNvNFGWjZCj9SQpIP41zl54vmt9en07+yZyI2URzSyoiTgrnchGeh4+bFa+oaulrost9qaHTbdQPMknlRRGCcZY5xit4Tpq6g9jGcJuzktyxJqtuu8ruYR8NgYApdSgj1HTWR0BRwGGeR9aTRrnTdS09L3S5bW6tbkZE0DB1kxx1HXHSrTDy08vYfKI2/KfuitLOS97VMi/K9N0eA+LPiWugXV7Fo6KtlZRHzpmHzTuBjavoM8V8xand6r4i1s3mp3k03mEkksSqk/wqDwK9q+NHgbWNL06RtNtp7+xF2XYwAu0MZ5O8D3P6V5xBbvo8Z/tOzZLK4h32/msE/e5zgZ68V4lKbpJt/Fsl29D6GFOnUS5dtPn6lfT/Cdm0N4JLr7NdLE5iMxwrNxhR6k81leGfCWtanLILfSrqaDOGlSJmXPpkDGfar13qH2yELdNtYH5FxjBz0r13wz8QLbwRaTeGNNh8+NbX7RJdq5WRrl0B2g9AAcDPX5femq9WCak7t/hb+kaVKMLqVOO369yH9mOXxPo/jq90ObTLn+w7jcZzJCVSGRQdrgkcZxjH+FfUdtEVMluVUKASMdDnrXzD8PvGuvaL410yXWtVlv7XUMx3aXJ/1YIyGDe3X86+kdP1izvbOz1DT5xNbXX+reMFlYc859ODXZhK8Kl3fX+l+h5OPozhLbQ8b8V2F09hNd6bbXE1vZL9om2LuBAGcD3x2rmNe0ay1uKw1iIzx2F1EM+XH/AKvjKnn8ifevV7W1u7fRtSi8PSK4v4MKlw5Hlvt28MAccVyj31ja+DnS6crPpNqVazVthJToBjqDkfXNefJOE/aX97/L+kethq7hpDZP8+/zPOvDvh2W81+4gmu1jubcMm6GIkMOxJHB/DNdFqvhiO60mIT6jbrPavt2RjLAk8YHSqUmsR2muJqlmscVqLVZPLc43E9Q3uOlZzeJZ/FWuXRgt5NPhuEVFBTOCvI+XuD69ea1+sSny26s9Z4irWqpxdkrHUXPg7SLjU5BJPHql7HHsiMaGHy+MMDzjIruvhTrVte6C+km4+0X2kn7PMxOSwydpz36Yz7V45qviLTdaure402C5025QN/alukhCSDPUHg4YZ/OvS/h3bQR+ILFtPt/KtZ7V5QEAAVCBgN6nNexZuJwY2nenJVJNytdLTS2nTTU2PGtwsmgPazRuWu3a0ZV7N0H58V4NdaPq3w1WG4g+TxDqk3lB1IMcCA/dPGNxyDmvqHU7WGaNlkVXLFThuxHQ1wPxA8LnWNLla+BKWoa6OTjGwEnn8K8nE0uW8/PbyPOwuISSptd9T5fsfFuq6ZqCXETsbyK8WeO0mjDRYUkkkNyMk9B/hXTeLPiomuaVqVlaWM9hcXuBNIkgIAByVBxnBPWuCvnuvEs95q6RhLpTvuChADZ43BQPpnH171p+D/DyX8U08iq6QjM26UJhSeMZ/wrr9ylTd1Z6XSM1z1pp9Ojfb/MybeyjutLlne73XEJCx2+CSRV2w8O6yQAujajLKE83akDE7RxnGOleu/DTw1oH/CLQX8sqjWb+VorJ7QNK8TBiqsx/hAHOeOlW/haviS2PiZDfPfzLL5UGoSOZEcqSG2k9Tjoaxr16tJXa0e1936WNaVOnJ+69Vo+3zuT/BCLWNA8e6Fa661zFI9tMJLWckGKI5IUqemDz+NfQ+n6xBNfXFsf3cls2Q2crIh6GvJ7TQJbXS7DUpzBJrNpuZRbs7swZiW3b+eR1H1rr9H1m41Kfdc6X9kmMOxpUXdG3px1HripwlZxT9ora6fPUyxkFUacOi/IPiTJHqk8eiGKUTTQNdWdzGSNkyA/KSOMEV5pp+h6Xd6Bov8AZdl/aV9dxtJNv2iUSEtvAbjGPT2r1uystU1GOJNYt4o4IzlJoHGAR6A8kEflXK+P/CV5p2lXFx4HcWjySCSW3jOHJ7+We2e4HWvVlKMf6/r+kb5biXyfVXNxu7p7L5/mePeHtavPCC3kclnNIBcFovMXChjgfNn0/wAa27STXPDaXepRXNmJ9VQzXFgUwCATgL3yMn/69YOuT3Eeny2F7cs0zuUaPJLKAcnPftj8a3rvTn1zSE1XVrm4ETW2+GVwoZtgx268jGamMUr6n1WIpRhKNRpWbSfXm7f5mJfXt/a3P9uSSNe3DQCG4jdcYwMYBPUjHXj2p0fiO41r7PYW6JZwAeV9quSWMKkfNgD6Guv+DHhOz8SR3d7rkyDTtOlUiBX5fI3At6duevBFet6enhwWmr2J0bSIrTD3k0CRBS4A5dlxweOPbmrV0tHuebmWNoUqvIoc0o9drdvU8UfT4ZdLe1k1FItNEot4whIDsAAHfHPJOOcdKq+GdA0y78cXOn2QuJrAxH5WYMpZSM8jqvPXPtVDVX1NbPULuJp9K0e8uVkjtsAsVJ42tjOa7rUdY0fUruytvBemyQPZQhBdRxeSUYDJRwfxzk8nJ5qIxS1e/wCZ0+9TT5JNppq62i9NX53MLVb5bGxh0pNMtrRzcAOQqkREHgBsdTwT7Vm3+raza3Jl1oTS53RwvEwCEDjIHc5HU0zWNU1N/EgOt28MrQvgRLh+SO4Jxnk+1XfBkukXGr38WtwqqMQ2+46RtyDg9OmPSr5nq4vVmlLDqjTUqkOeKV77tt9j0n4cW0994Pub1lt1u52DfaDhWdOMl8cA9fTPFdMbQahaadHDcRmwhOXKnO8qMAfTPP4Vl+E/DyaN4RbS47xbjzX+0eYuSGjJyn4YrqtDtYoLee4dCiBfLQSemeTj3NZTkm7X21Pj8dOM8ROcNU3oeI/G/Q9S1zwpYR31wsVzBdNK0hl/domSASegADVpfAvUNLvtIv7OK1MaaXepHbSOPvt5WDJjtkq3X19a4v4zeKNRstY1G1nis7u0kMb2tqIDIRGCrNJIScDJGAB615v4b+Jmr6X43m1+MWiLOBDNbeXth8nP3QB90jqCO/1NedRjW55TW17r8DWp7N0lB7n1F4l1++0tba802WKSwiy00jP+8abcAqfTAbP4Vf1/xV4V1iOzvfE1pm2siZWWYb41IAIcAZJYEAAHsx614L4r+LGiXWmTR6ZHPHK0pYQluGwcBs9sj/CvNr7xYbizKwxGfUJid803KRDoBGp7/wC0ea6ZXk26a0ff/L9TJRilH2js1ppuz6u1z45+BbOURwW93K3llmkjttgQ44U9Dk+nasub4nXfjDw7Mvwo0y5l1q4BtpJbx444rFBg+YdzYZ+cKoz0JI4wfmzwzoPibUrMw6Xol9eeY5zN5BZcn1c8V6p4X+Efi3TWhvPDv23QdVC7ZZpLuNo3BHzZVc+vQ9Kj23JP3nd+X/A1/Mc8NFxXLp6/1Ys+Fv2Zp7xze+L9eaaSVvMdLAFt2TklpXGST3+X8a+ivh94U8P+CNJbSvDdvJawyP5siyzM5d8AFvmOAcAdMDiuE+Htp4y8LWr2Wp6h/a9mg2xwmH5os8na46j26V6Mt/C1rGbiylVmAzgZKmuinXco80tDjq0VCXLF39Dfz8xGDx3p3asnTLgxkxTzB9xymeCB6YrUVlb7rA/SumMlJXOaUWmKwBGGGR6GsHXdLuxCk2iTCCdXDOrDcHTuPat7tRTlFSEpNGDBd+ZhZEZHPc9Px9KnVEQMyogY9WQdfrV+5jVYyUjUtnj5eprl0l8u9lTzl81hlbdjhsDrjPUfyrmnJ0t9TaKU9jUuZUis5JssyRgsxjUscDrgDkn2rOsNUstT05LuzmS7tn+46gg57gg8g+xqxbPIhYKw85W+ZeOPrirrIjoojRSueQOxo0kvMPhfkcZb+JNIj1lbG3adpn3M26M4ibPRs8rnPB712FvdrAcOREpJ3Kf4feszUtKtLmcXHkwx3KgDziOTyCAfxxXmeu/GnTvC/jHWND8Y6Zd2Jt2j+zXMY837Qh4L4HQdxyTjIPPFS+WDSpplpOabZ65NZ6Zqd0ftEEUuxgFLfTqPXtXjeofEHUfEHiXVfCniLRbaXwrPI+nXEkRImjGSqyDrk5CkADjr2r0Ww1bTNYEUukapp1ykqbomjnXD9M4HX65AqPVtC0p7mW9m0+OTU4tsgliYq0jLyqnt+J9q5atSpbmpWT6+ZvRUIu1RN9vI8V174jn4MhvBHhCwW6FsRO9zqLE8yDdjC4ycY5BA9q9V+D/xh0v4iK9k8D2GtxRiSS0dwySLwC0bd+T0PPPfrXzt48+0+NtauL7U2ax1N7g28dg682sY+6G78k5z71k/CjxDH4d1yS81KIQjTE2oycM7+YvHPXgH+dFPE8kLrVrfXuzpqYRVN93+Z9bfEfwvPqWi317o08lpfLbSB415Ey7Tx1644zXwVcWZRJBNMXkGflycgj/9VfpB4d1D+1dGtL75CJ0EilM4KnkHn2xXmXjb4IaBqV7c614fsbW11p8sqSlhbM56sVGQO/AGM9q6JU+VOtSV79O5yUKyX7qt069j4+8IzC+uvsksUbgRyP5z8mIBSdwz3rs/h9oNlqviG0s5r/YZ1K+ccfLgd896qXXwb+IkGozWv/CM3ErByFkgKCF+cZBzgD616FqHhlfCq6N4f8VaU0z6rEQ0mm8tbhiFZd5BDNkduxrjxsGruOz3/r/hj08LiE4qD1fT+vI7TVvhz4d03w/di/1DUL69CjMtqqho4+vyA8cjuc8Vs+LNeufC/wAONGHhC4kjtLaSO3mkaPzZFhKNg9OTnGeK8v8AHHiOfw5aWUGmM8kRgESwzxkGExnYFIP3jgDqO9cnD8S78a1ZSa3Cs0BQo9vGmxXXuWUda4qMqmsqUbL11KnR50nVlfXqfU2jx3sIdGls1iWKPMMhC7WbP8Xrx0qDXfD+ky6DcLHbmS5ZdwWMhmHzDIB6HntXLtY3ehNBJeJbXlrqOoFY2mBLW8jkkuwB+YDJxjpXYbLK2vvslhJLJOsW6aVAA2CcZ5GOx4Ne5UpU50rPt8zmqR9nJShK/p5dzxXUPDF1e6y0Gt2ht8ZkLhQvyA8HA9aoa8x0i7hvyxmRQBFtPRMYBx616brrtqc9yI3dY5V8oefncpxgcg8j2rnr/wAPWdjNEJ5mvEEeHR2yi5HWvnoUmm4wu+x6UcTrGc7LyOTgsNM8XGC00WwnudbkiVIAD5aW8Sk5MhHbnrTvA19deHtfMer6gbK5gkVY4lPyzICVK+/IHWtb4XeNNC8LeIfEM+ob7W2uIlW1MUJY4jz8oA6E5yM8Vy0N/B4t8dWt3rANmBc74LIwkM6k5G9ux6V72FjyQTk7t/h/wT0m6t505wfsrXu9Xr2PffEt67XFnbRqGMjguu4A7a8k/aX8UXlv4ai0zS1lSO8kC3Dox3KijODj+8SPwXHevQPEWrmykk1G/ZbawgjLtIw+YNyQPbgVh+F/Dsuq3Fzq+rGW4e/Y/ZI8YCxMBgY7465rlrcyrRjFXvqfM04xdNylpbQ8I8BfDTW9ZTTdQnWW10v7Skc5hZY5UjbB3DcR2/Hpwa9ph+DHhySKCzt5dUMETM9xJlFa6J7SPtzjHGFx1Nem2mlaJJaWMEHkTrBKWi6unmrwenUg+tV7ybUp9au7B7uOzt4YBIHhwrS7h0B/h/nXTOk5Nc1yaUpN8sdLd7+hHpvhzSHaG2tNMe1FogRTDCI1KgYx05+tat1YJpdqsVnY3CQ5yfs8Y+SvHvhdqV94p1HVLfW9VvYNMTmBJLslt4bhWc+2citbVNVi02x1O90rWfMs4p2tnUtkDjgJj7wzkfStuSNlJ7HZPLKiqOip3lp0dtdj0l7S5+zGaxkeWfqPNUZx+NNjnlugsEtrLBOF53x4APsRkGvL9P8AiFr5u7WLTNN8mBzjZJC0ivjqRk/L+Fdf4d+KujapIkFzBNFfMxQiFSyEj0zUyjF7f8Ezq5Vi6Ku4372d7epqwS6r4fs5Y5XW6sd5YBh8ygnP44qzhNSnWO5hJEkeGDKTHKnp7H0q+ZI7+B5YJN6fxAjkfUdqZY3C2a/ZphwTlHByCPf0pRcrtM86aS12Zn33h6DVZUgvWtZ7VQNgnhBlQ9MeYOWH15968p8d+E9asbm20fSof+JaqMwaRgyn5iSE4yMZ5+te6Xkf+j77cAvwQCM1lXttbXl1btdMnmFSPLc4DY9qvm1947sDmFTCvTWPb9UeaeCLCTwemu2WvRw+VdiEEiVGw+fk2oOoGTk9a3fFkujaZc3GlWtldjUrqIvcSTEgmIkZJJ45xjI96NRuLS911vD194Zlt7eSBhHfQplFH8QJ/h+tTHR4rrSo3tbqa+LIsL3TzmbzFXO1dzZ4H8zV+15ktPmdX1mnWre1qbvptfRWZ5rc6mn9rx3N3HAhsbTFnbyfPHvHOcAc4BwOuCa6vRZbJPDkniqfVraH+0JQv2dMMLcA/ddf7x/rXEeLNT07XdRtYbC3ZVsgyzBBgyHphTwSOKwBovk67YWcN2XaT95LuiwIF5xux0NEql1y2PdeCpShGVR8l1qulv0vvctalqr6jr093pmnie/nY4gt0Zlyq43A9Se5zXYfDeyluL6ztbrTZYHAN1KtxG2WB7kkYPXtyKv+APBGof8ACVA6nDPBpcUGVl2naxzyFboOueeTXrt3qWmWbpYiRFZFLGJBukIH8hSc1CN76s4s1zKMWsNRV0ktUyKzSRbuWeQ7I2wRn+LAwPoBXM+J/F0emw6tqN7IDBY27OzRkGNT0VFB6sTgfU8Vb8UeILfStMurm4jTake8mZyqqvULnux9BXyd8TvGF14r1n+zbWZI9OEgIUHakj9AT7DP864I4h1ZSppb7vt/wT550OWKqvpsu5geKPE9z4puL7UdTuJ1u5nASCPiFIx0X1OP/r1jSaZeppkd6bO5WxkbalwYjsY+m7pWvJ4auv7b/sWD7PcXEX+tmgkEkYO3J+Yegr6R+G/w51G88M22jeJ9YF34ZAScaZGgTcwJIDOPmwDzjNdPtFTilSWn6f13IdJybdV9P6/pHg/g74fa/wCJplsvD0EV3BKoa5u3TbDb+xc9++Bye1e7+GvhZ4G8BSWs/ia4fVNXIGxZEJiDE4BWNQSeehJ969esbZdJggt7KzS0sN4htrOFVUvx95vRR7c1k/FSzvYtASK2vJPPlcMYIiE8xVOSgPBGem7NaQoylb2j08i6bjOooR91PRN/1/Xc2brU9I0S0U3uoWVhABuCtKoIHrisLXPF/g+ex8261uNljBGyIMzNj2r5y1Rn8VeIr+5ntmtRJ92NRhEGOFPfoPz5rU8S+Tptzphu7ZP7D80YXIfzBtAbGcHimocsVKnoj3FklCNRUq1RuTV7afPv8j3PTvFWm2EUEa2l+kE8nlxKXjZsnplByucgjParOoeLdJeCW6h1O9Fsi4kdLXzo4+3JHQ+2a898Sat4X0LwlCvhgG51SVU+d1MrW4B/1pPPzAlQAPT2rjvCd7r17qGn6Ppt+jaXJveRXmRFDZO53JPDZ6Z68Vs1FS06iWTUqlKVZJxUejdm1+J9AaZb6X4g0mObS79LvYx/ewOQwbuCrcqfat3R7SWFWgNzLLHjCrIfnX8e9fP+k6Fq8mtatY6N4gt7S5uFin8yJt6LIrNuXjjdgAkV6Zo+u6pbN/Y/i2W1v8wFpZ7RXTCjjcG/vdCR2znpUXc5NX0R5OJy1Q1pO+l7Pex6HDczxSgKfNizhgxwV+nrWnFMkudhzg4I7iuR0w/2fArC/mvrFyPLeQBmiHozdx6E1qx38G6Y27pJNF8zJGcseOh9/Smny7O6PKlG/qbvesy+0uK51GO+lPzwxFEB7Z6mrOnXsd9brNEHXIyUddrKfQg9KsOFYYYZHpVSUakddUQm4M5BbFn1YXdpANgLI37zDHPU4A5+hq8heOcMWO0nHbDVntBqOjeLJGt90ul3yszLj5Yn+vY+1QX3iCVtWNhpVmk7QMq3Ukr7FjB6cn+dQqLm7LoXz2NZWkS0umb/AEq6UF0ThS+Oi+npivEPG3hHSPjRZWmt2VzPYarp8MlrPYyIDJwSQMnrht2PXOOMV67Y6q15qt7p/wBge3NqoO9mDBgT1GKjGkwLqrajbRQw3AXy5G2AF+c8n1/nxWVZSjo9zooyp2d1/XY+AIRf6DrEiJ5tpfwStCVIw6sDgj65r6e+H/x40tNN07TPGIu4NZhkFoZYYTKHAwPMccEc9huPtXo3i7wXpniDW7KTWNDtLqNCJUuMYkSUdA5X7ynjrnpXk/xw+E5utMj1bR9KisdUgJQw2KfurhOuTzlWHOMZB9qXI5yTaBThy8qPeNW0izaWW6uY4ndgUz5CueeO457HFcF4f+E+n/adQm8W3D+KUvJkliiuYfIFu655wrdwRkYA46Vo/CD+37T4caRa+MGEOoRM0SNJJumMWcpv5PIBx7ADNdsLL/SCUndYeNsqj7re69x9K55U1KSmkNVJQi4XLIu5dO025un8kQQ5YonJCjtjjFL4M8RJ4o0X+0YbSe1iMjRqspBLbTjII6j3qjf22LWaKZtiupVyOd/uP8DWh4Q0660nRI7S5kRiHZl29FUngf59a66MnflOaola5p3smxfM3kKhywzgH2NV7W9tLzmNcuvZkwQfxq+VDDDAEHsRVe6hjdMHcvPVB0raUXe6Mk11PC/2ivAHiLXZbTXfD3lSCwgaOa23bWIyWDqOhPOCPavk+S7nm1KR5A/2krsbeOgHUYr9DNej1eTQdRt9HlgW8eB0tnueF3EYGSP8K+GvGMMUurXcWrqul65bSRwzNuJjdlGCWHJBPByM1w1LU6nw7/19x62GlKpTtzfCfR/h7xDLPqd2NTsd6QYktmknCgbsg446ggZ471XbxhBBqt5JZTTyRSDyWR1BGQOqEdOc9aW+gs42KXk0j7VIUKAAoweSa454El1J00WM+TaRh3leLOxQvU4PUnIGfWvNr42SShB+rPYVGlO8rdPkej/2xbzRWJmEEMjDMKMvzMue+f50kmnMVkLYKzMQsJOQPxNcZ4buodJsftmoASXUrEBZfnk254AB6c07xd4kF3o2oQabDdRM0TDzpht28fwj86vDxbane7Mfqs6kuSC0vv0OJmu9G0/xbeyyeaLW3VhEwj3gzdCAcYIHPP0ruvgpbQ6/4h1HxFcQLstQsUIK55PPJ7npWZ4X0GG40+xubkLewXMCRRWjn5Y8gbnH+1kE4HrXrWn2EGg6Fa6dYMI4LNDPJgbQWPQH/PavYjF0KbT2/E6czxkGvZxbc9I+Xn/kY3inTLPxR4jTSpIpZ4FizdIcCIBjxz13Y/lW54k1Cw8MwWsZKRQKiwgE/KiDovtnvWVp8suiW0t6/m3F3MGuZnYclBnAA9ScD6A1gR6no+oTR6jdXB1bTTIZpbXUIwHCnqVHXGeQPSssNCTjzy3f5Hlxoe0enwrT1f8AW1zb06+0jTb+SVJoIRM0kzWpmwAznh0Xrzjke+ayvFGuWjpYXOgXf9q/aiFu1t2wFwOMZ5HX9K57X5/COvaxPMdUubW1sk8mwW0iZJZ5XzuAZh0GcDIAHJq5Lpfh3TPBtnNp8a2erW+oRy7fM3zeS8gR0LYy42txnuK0qxajzdvyPT9hGnKMmnzvo1pt16/dsYnhdLfw5r11JemRbW53yK0eXEZHVWA6nB6+tT+JbJNVGmnTofsnh17oNI5wu92/jI7KPf1rtfBPgXSfEOnajf8AiEzzAOdqeYUWNeSM7eTj9ayrax+06jHpwuHk0m3Dsp248zGRtI/z0rkqVKqgmlp0XW3mV9ciqzq399fF226eZj6Lf6npN/caZoRhn1TUC1pBKHEpzg7nYdtoGR2rX8DeHdI07xdbCbTmdWk8lZJZS5Y4++B25/Wue0fRJv7VfVdLJ0iWxn3W6KuMr6n2PesXx74xl1jV7X+wluNPmiUrcLFKFDyf3kOcgHrnjGa1o4yNSKnONm9v8xxw9TET9lhqjV/if+fl2+Z3Hjpte0vWb7WdF1S4t9NtZdqOoSTzAThs8cLkYwa3NC8awX+hTarr9lJaXNtL9ncQDckmcZZfTGQSPyrjfCPjbSLDwHdaS2nT2728ZRbfcsvnyMT82WBPUkn04rpdO8CSjTbO11aW/cTQidvLbaokznauPm6Hr7fhW8aaTvDYWLoU40OTEx5ZJ2Ttq1b8f+CejQ3RghiktZRNbyAFT2IqPWbePUEMc1uXDDG4dBn9QfesDwBNM0OtaFfzyTSaRcCJJJVIcwuoZCc8njvjmrV/cXNvfJJArseE2qcg4rnqc0JWTPCq0PZzcHrb8VujUa0DWa2UivOPL2MHbdvA9fWiKMWOli2t4YYo0UhIiML9K2dGu49RhWKaGPdj5xjlTXF/EXxIugeKNM0aTyYba7haZbm6l+UMCcqv4D17ilPnhBzTuYw9+ahYqweHdCvGY3fhyzgm+8Z1kYNnOeobP9MVt2mm6dZXVxdWGlWi3VywaaXBIbAwM9enp+Ncj4Wa1u4Gl0jTn1UMxy3nA4YZJXDHr9fasnWfibpiXjaZPYXkko3LHFG4Vdw7PjGB1z9KyeLSl2fpb13Oxxr1FyuTa9bnpGo67ZzWc3mX7RG3OJHiTcAf7q/WvGNb+KemeGfELWGlaFFLdbz597dXJaV8jsoHGD2J5xWVJ46v9Va503Q4Nk1zEbe2FvErxpJxjPXGeeT06147DD9j1pl1CWGS5R3WTa/mKrdCSy9SPYnNZ+3dbmj0X4+ZpSwiptOfU7fxF481Txfax6RrF5DJbRXLXaSCARSNiPiPA4xu6dz3rjL1LPRZoJtQs01GW4jDJGzFShHQHHr3xzxjivV/Dvw4Gs6P/b1pOtu7r5ltBOuGkVR8z8cdjgV4/pdpNr/jyzgCSXAluF4RipCZ5OcHHrnFKjrJ9IpXfn8zSvKKhywSu3b0Pevg54Kih0WO9vtP/wBOEkkm+M4LlsYjA9AR1+te66bENNtYhMBLdzME2J0Lf3F9gP5VT8LWi6dp8MYVt0MeGIGTgD26mq1n4w0/TYLXUtZY2MMvmbEnG1wc9MeuMcda7MMrpy6M8+pGdafJFXt2K3j1de0m70TxNBZzTW2lTvLfQQyrkW5Uq5xkbiByB7c1TvNYu/GvjDRX0iEP4VuLN5JL5lwYmXO9ev3h8owfWu2ufHHh2GATXWpWsNo8e8SzNtVgfY8nPpXkkF7pV/Dqa6Dau8F5OSotk8pYQTjpx8p68DNdVRulG6Vzsw8XKH72nZpWTtpr+q6fcbvgtNI8O+IvEH/CQta6da6qUNlbzRkRtDGWAbzCcbjnJU46jHFcX8QIbXUtTn1LRbC3bTY0e0tvNj+Ulv8AlqBjhcjj867uwhm+yI0kkpMcYCPMx7Ejbzx361xt89099DAUljLK4lMjbkXkd/4vY1wVMdZOM42eh0UKzVf28NXs+1krfkjkNDsp7nTbXQ9G0q4ju1kzJeRhlIIAJ3N0I68HtjFYGl+H7xb6K5TSpLi1urlo428ppFZQ21jkd+DzXsvh3SbeSE2t1PLLCHyEDcNkHlsc8elcRLJr+iT3WhJqTQabK7yRxoQQI+49gR2qpY6EOWUonsLMo1eaFNWtZ7vz/wCBoa+mtY6Lqt9/ZsskltaPN9kaY8SDoAT26kZPYVRN1d+LPFGnaRa3N5b6dJMSsaYwhxtI35+bAJz61QbxFp+nyQWWmQNcmQCN2U4z0GRkY49K6u0tY9KkGq6LbQx3dvGZI2P3WbGDkemPTFYYfEOF1prrb1OP60ouUpRd3s33tuz0vxPBp3gLwiL22uHgS1ZEy/z+Zk4wVPXNX9Dk0/V9LtdW0mFBNPCJNu7hgedue4B/KvMfHV7d+NdH0uLUpYbd5ZcRJGGeNHZeGYHGSBkAH1rYsPsHh/StE0nw9NJBOziGG6llJCkcsSv3TnJyoAr01JPSOx5FTDQlRjzSvVbd+1jutH1BdYtpXEMlndQyGKaF/vKw5/FSMEGultZGmhRllRscNx37/SuTtdRfWNPuri3EdpqdnObe8jxlfMUA4z3RgQQe2RVvStQih8m6eZYBdfI0Mvyt5g7emff6VVkpNrRHk1Iyj7st0dLcRCaFkYZz/OuB1p7K2uLiOfzluDmTbF0lzjhiP4hjj2rt5rmVoVlsY1nwcMhbaR9Pesm78PWupanHqivPb3ONssWRtfjGGHrVR5XK5lrazOW8O6pBquvtPpqF1iBtbiRwQSVPTnqR61sX29J1aR/IEg2Kd3BI56dzxV5NIl01LltNsInkf59vm7N7enTj61xmty64+iQar4m0j7MbC5LCCKUOrcjaWwM7e1Y1/e97axrT00OwGoBrOV51VHjGHIBIIx94f4VDo2pS3OmAarGj/NhJ4gSkq9mx1U+vvWTp15Pd2y3k1jcQw3CBgCvygnscVrW8qWkIVGjSLGSuRgev4VhCve91Y0lStsVfENraNEHvIvMiwQki9U45+vSrunraXduLfz2EsaAxru+Vlxxj1FSwSxXOYisbQv8ALhTmqVzpXlhUhUmNBiMd1HsaG7JOKuJK7tJloXVrcrPalon2fK6Bssoqa21P7BbG3nVnZM7Xzwy9sepqjbxW7mSZk23qjG/aNwPvU6oxiWNogTnke9Ck7prcGlszftbiO4iWSN8g8/Sps965iaJrOCeWIM3ljcsSDBJHWotJ8TRXSoyl0YgAxyKQQa64Tk1do55QSeh1ZAOQQCPpXg/x6+Ch8V+ZrnhZVXXNwaaCR9qzqBj5T2bpXs0OoeZOYg0fmgZ27hmrSTMw/eRlT2oko1BwnKm7o+U7i6V5rqWS4+zzRphlDZYkj+XNXvCdw8+nMtjKrTOdjYPDY7Nj+vrXIaRLc3c9nb3DQO2oXEUTqWAMQLAA/SvZtN8O+HvD/wAQrWw0yWW2tnUSrAZvM3y9PmPOMjnFePTy+U5Xfu9F37n22JjSpKUU23q/u6HK3+hXl/r+nW2o+dY/aI2lklxt3KONiNz83zZ4xwKzpbW30PVItNMLTxb2MCXcLF5D/vBhuGeeRxXuXxKNra+G01C4QZsbiOWNgDlcnawGPVSRWXBDpdxf2uqyx+dLDu+zluRlhg/XHr0Br1YUY09fvPOoZg44e7Xu2a+f9NGf4R8LnTYp9Z1siTULh/NijBwkK4H8I4z749Kiv9UOp+JrfTYG3o3zTmPkfiaq/GHxPFpHhrN5cC189sErksVAztUDueleefAzxEPE/ieS6nt3itdKt/lkLYLyyNtGQP8AZB/KuKsvbPljst/8jj9tKbdWs9Xt/wABHsXirzbW3SHT0t5LwoCIZidsvbBI6ALk/WvEtXa8mu4tA02wX7Xcq1s2wYIG7LHJ7/lxXY/EDxa8WsXumiyu/tjXAFuwTh0AA4Pp9Kw7u313Stc8OX5MH9qlmihtEz0ILMr9fQDPau1LmXKj2MDQlh4KVVKzV1fvuvkQfDXTNI0fx3daf4/gFgbOAJbfatwid1OS2TkHIIx27Vv+JtU03XPEM+tabp0sttYfu7UwxsTduvRhGBnqDz6DtXT6j9r1rTGv9SslbVpFMKhAD5DYI+TPBHua53TZNT8Oat9ve1dtIaza2+0lePMycFhnrk9sZ6dRXHWqObVBO3dkqrKtVlV+1a1r6eaXqcf41vfFWk2gv1stZ07S5SsssVzIQkjk8lwv3eTwp59a7bwbaTeIdNN7YXtzOPLXfJnHOM4GewOR2rKvdZi1zQL+28QajFdP5YZnZzu+9wdnQYIrtvBenT6b4Isoigs5gNrbjyyk8bh2baBms61CUUpJuy8xYmq3QSlFJp2238+7MS80yeSeWS4WVLeXBGxhhiBg8da8z8Z2VuL9I9POy6jTC5Qe+c9/SvXfEeqRWtw6CdvO3BcnjZ6nP4fnXm/ivR4Esbq808StPLKGSQkkbdp3kt2ByMe9ebTmvaqMVd669TfLJTVRO9r6LsU9N0qK2g0TUI9Vt21CdxK8BUFYiMnJA5x/hXtd78R9K0zRNPvNRmi1LWY0KC3tSR5pYdRu6ds56V4B8P8A7ZeeLdN0+xjjNrdv5Unz4OSp4z+v4V73pvhiy0sXdl9gExiCyK1wchW/iOeTX0VPRX7l5v7GUoxxDcmvRXT/AENDwaXm0+81O7QLqV6d07BicgfdUE84VcAVSS5lnju7qCKRFVTt9Q3PNbUMsOnWAllU7WOVUHoOgNY+ra3BYaaohRg1wflUDnHrWGITqO8EfMufvtyL/gK7murMPdtGt0BmVV6jk81e1W80q9vHGpR2+oxwYURzxqyoDwWG7vg1xnghroXdy8jBLdT5QZOp+tcx8Xry1ngvLMRo9qIdkrOWVZWYjAGOTjrn2xXNWclorW3/AOGHTpqU7L0OO+L/AIm1vwb8SpNK8Lpd6NY2qrLAYcpHNuG4v82Qy5JX0+UjFeW654r1bUdcfW7ySCe7kbe5dFKuTwTtXA7elO8SX1xeTwQXt3c3jbQqSXFw0p64A5J+UDtXqHgPwHoupeBdXF/ZA3NwWWxuizAhiDghR2Bx1prlcb8t938uv/DHU70lZvsr+fT5HjsHiALo95Zo08dxNhYypwgB+9wO5HHp1qrpRSJI1KyEeZiUhcYHYZqKzvJbPzYzHCpUGNwyZJOR+R4rU8HRajq+pXkWnW8l1drGbmKFVLLlcE8Dvjp9AO9bzgoRk0rLcwp1XOcXN3e39fkdpceLvENz4bs9P0rT2jsngezMwZ3eUdDgDhflGMD1J71v/Afwykviy5nhgkMNsyQySFs+WQCW5HYkYHrmuP8AD9rd2+kQXBe88+7uGiSEAnfJzlBjpzjII/Ovoj4X+Gbnw74e0C3khktppoy11uH+tY5OSfyH0FclJ80pRTVl66/8MdFe1OmnbV/gdpHq5TSr2W12pcRsIt7LwhPAY+tefeLv7HubLy9buWvHsch1hyWEjZPmD8uR0xXa+OWfTvBOorZ4S5uHVYmH8JA5b8Bk14do/im5v7O4t74x6oqBokhjiIluGz8vmsvQenHNdsZKK5YroduUYec4uvHo+mjOR1k/blhawjlMFsCgQhiEBPJ56ZNex/BVG3XVxdxPGIogoaQ5AJYnaB24x9K870S1zpmoPK8tnqCSAmIsQQpwwQr/ABLyDyPpXqPhDU9INwummR/LbBMqNhWcjofXnn9K4njLRs9GehmeKVWEqai/+G6nYpMn2S4sooovtLOZAsYJXnksTjAJrkvFeq2trqlpZSXVtBdRfvLhGBPlgjgZHrXcNYRfZY5rJVTyyFLs5HnuRgsw5HJrhtU8Fz33iuGZraIYmUNCOPMUc89cr0rgxMKkrRSu2eHhpU+ZuTsjb06xXXtHmvdOdbSW2+aX94MA4+UYxxkc89M1i3PhOwa5SS6vH2R7Y5/ObDsW6kHvjpiui1HVdP8ACUiaZepNbx3JJbdNkvITuCj+8uT37cVqX/hyyea31a8vPKtoozNJnCopxy2Dz3x+FdVbBSdOLkrtGUMTySfK7J7HG2nhKwWe4iiVI7eFl2v9/B7AEZH5961b3TlhcQz3EZVFBKqApf6j0qGK9ivtWtTamS0sriAvBaTBUmcZO1zyeo5GcYxyM1oa7YN9iMVtve8lBO58llzx97sPauehFUbuK9ddzSrKVRrnZ5/4x8QRxaroNnYxJNCJjJdFRzEgAAKdMkAn/JrrtK1bwrpGhrNZh74xFljt9rIFlb++zcKOeuTXIarbahfy2ttaJ/Z4sHDXV7NEG3nbyiZ+9nuemRVHxPp8NvZrFE8szSo0vJ3Hd/eYDoOe1ehSxM4LXWOmv9bm1KlRrThTl7v9dT1Ow0/U20i6vtOvlvNZdzO8cDqLVxwNu5vvDaAM5B4rTFvaa54Zt7h1kNrdIs8fkoS8Zx0A9R0/CvHvBl7qXh3R5v7Y1SO1t7kOvkeVhVD92xzk9h6V6J8J/GVtrlqdGWHyJbWP5dvCnaccfXg16KnG65PUyx+XVYwlUtdRe67f8Dy2Ow0SfUrK+v4b0I9iHX7NIDh2Qr/EPUHitq1vxIpkdQsqnbIvqOxFchHe3uo2FzZzNF50cxVZkQ4bacgMOxI/+tVuw1eDUI7qJImee0cKcjDA8dRTqKcdVsjw4pS0Z2qSLIoZCCPUVgeKI9Vn0q/itbO3vd6lFt3baJFIwQT1B+lZktzd2ciPZssWOWhJ+ViTzkdq3bHV0uLqK3lUxyvGWX+6+Dzg1lGvGp7r0Y3SlD3lqeRQyXDw6fo95NfaHeQz/afs5kxG+0FQpf8AiUnB5rV0r7Zalk1IRuAxIZclcHjBJ69a9L1m304hLnUbWOdoztRjHuYZ9K5fXdC1KMxXWkXEMtjImbiG5BwVwMMPcCuTG0pt88Xe33o6cPWi1Zq1yu5jj8uTTGeJYyRIcGQIOpAXIz6DJ4zT/DPiGDxJbSTabcNcfZnKNgFCHABIwfYisfSNTtpblxaXKukY2vHt2kHHp1x+Fa+i2Vlp08s2n2xiuJczIUPyMSOeO/QVlSqScrvR3LnCKVjYnRri2kDDzZGQho+hOR09q858A+N7e/1OXwteW9zpd9DvjiZpvMOQfugkdQOxHSvSdNuob23NzFuDk4dSm0hqkn0ixlnW5lsbV7lclbgwqZFz/tYyK9OMXFNPcwp1aSUlUje+3kcTbJr3hzU7tIdMW5sFdS19NcbQ6HqcDOGyQOldZBDFL/pQt1guWA8xAQxHocjqD61ZmhWeKSCRmMTqVLA4YU21McZfy0YmECPLHlgK0qzVVXa1OdJxehjXFnocuqPcTvDFfA/OySbCW9Tg810MMcqQqYZzMBztY9foa4260rR9I06+1a+s0S4uZBJtnbcE+g6Z61f00XEPh2K6gn+zLP8APE9wc5B6cA8D0punopXv0FzdD5o/sW01GQweGZr271BQXxKixxxqD1J65rW8LHW9Y1+1WxT/AEiG4GHKkKu0/MC34V6d4e8L23g1C9nfNK0zMTuVW3A+/PQVqadq0OmvPHZ6YYTKS5YfNJKzHk+oHNcjxMYauWq/rQ+yxeOpT92jC66P87nWXjz3dvi9aFIYyrsi5PIriPHfiJ9Isw2lWQm1KUeVbpKAkcQ/vEent3ryv4u/EzXdNvjpOiyNBcBCZ5ojuZQf4R6H170621RX+G0F7c2V8s1qo826uG3hn6n5j+grjr42ooKcVv8A1seTRwilLlkzhfjDrV3eeIjpur6gkrBFaeWABwrbc4ABwPpXtH7P3ghdD8KNereRXn9qFLmN4h8pQD5Qc9xzkdjxXynrN3Fe373ESmMOSTnuT3r6O/Zh1prTwy9nKZJ449SMZGcrGjKMY9t2T+NdeHw8owilvu/U5cRXU5y200T8iL4h6zfz6zDbWhmlmtldpfKUlo2L8t9OAPStH4WNf3Gu6t4rvStzb6TYyfuZpP3zuQMZHYYBPqau+LPCWt3em+I59Hu5pbexneM2KHB253Fhz83Bzg9e1cr8IYLiKz1ZEub2yWTZul8sNG6ZPB3A81tzcjTkz6idWnPBzhTsrJJv13X/AAx3cmuX1zdy38otpJbeECSO0QomWI+Xbk/Nj8a63wNqNpc6ZfaWwSSFJCWQkiSNmJypzz8p/KuTuPDsV3pjHR7eW5nt3UyLb3GxpSSC2/HQkDg9R2Fb3g+zvNGM0s14lxeXDH7ZC5JnDZJG7sw7Z9q8r2s1iXO1keLW9nOlaPTbuO13wrotrqWh3dnHc73vBvjMzOkr8tvfqf4Tx0rovEtmbuOO4W7MRRuIguQ6nOcnseaw7uO6Grzvc6uLOwitjLHyGMhfAB6fKByOKzLvxBPptvbQXIeeO4UsrwnJ47gen60513U9yS3IftanK3K/L/w/UqeKdN8yCFBGWiNwDtMZKsvPJY89fX0ritRmktNT1TRvNhtzcupzO21WQL0B+pPTvXZr4wOoxSRCa5+zQDcBMuH9gK53U9Kt9ce1ur6OVL0v5cdxGciM9VyO469K0wuHipqpCzR6GDU5OUal46b+e6Y74bW2oeGLU63Y6bbXloZXj/0twEQoc7kcjKHnGa9d0zVLy8h+2axHFapMciNG3CQEfKMkDjB545PtXI2PhDW10q2TUtYS5tYAHt7KKAIrtn/WSf3j/MjNdZqEcWxLvVLmOG3hAaTecc8Y57V31aqgrLY4cfWjWlupS/mV/ktevyJNREU9uGkyURs56Z9vpXKX+uaW1xvuDA5tl/dHIOwc5/kfyrzH4t/FqXUr1vDXhOUwR7yk11sILeqp6D3ryuXxa4uFgkU/aIFaNpNgVduAMN6kYPNefVlOpFRh/XmZUaEY+9Udunz7Hs/g7xpptvoXiDWsXEtxdXHlpChBREUHY/sSSw98CvMvG3jfU9dtxY3Dobeyd5AFgAzxxkj8a5y08QK8f2RUjzIN0mxAA2B2/wA9q2/COjXGvarDp1sm25m+cbxjA9/pXO4Om71Ftsd1OMJXlF7/AIaHD2wuZWEsSEzHJQY610+k+O9Y0rS1tLXLTwbitwzlFgyOgHQ+te8aP8H9PWEjVDc3MxwrMD5SgdwuBmuu0z4deFtCt1uNO0Gxe+QbfNnBlYe6hiQD74zXV7Tm95xOKc4RXLGTZ8V2UEt5DcBIJXKL5kkygn5c8k/ia9N+DPjKPwrqKCIeXbXZNvcQpje7fwOO/U8gV9caPdzPp7272cMcfK4CL+8H0A/mKzNX0bw5qmmf2Zf6ZDbRrMtxFNbxiB4Zh0kVlHDD1rSpLntfQwp1FH3Wr9DmrpbLWryWK1v2R/I3SJbwMrjtuVjgBvqMg137uTo9nbBiwgj2h25Z8LgHPrVPU/s73UE6PCH6iUYbcR1zj17/AEq1IEiYiJzJakiQ4/gP+HNSlyrddtNDKT5rb/M5XxtaPL4Bdkjkne1lEoiDcleePevOPA3i3QPDNmqi4nW/Mvmy4QgOSeQwHQAcYOfavcYLnytVaxaIC2mQhZP9v0Pp2Ir5P1zTJP8AhNr1byeW1tpLuRpZp0GCC5HbJyceldkJyVna57eVcmIoTw1S6imnodV468Q6f478WSXiW721jbQpEkfCtMBnGSOwz0qHwfavbpdshMdm7hlBHLAdBk1q3+neGdE0W0toDdTahLcBZrkRBY5d2OAD0AUgg1Yl8N69rNqsuj3FobZUEUMdxMFa5OBjbnjJA7V5VelJ1eWceZb6dTtqQgoctOXLDZN+X+Z3PgjVBqkU0Y+1QiOUMGmbKrzn5eemB3rubFvtH2u/uciGViI5FB3KF9PY/wBa8O0bWJ4dJuHuXYXkEgi+zKgUhsYzg9fSt/UfEepR6NPEZkWdGREV2yEVs7nzjjaPxrKOIjh7X/r1PFq4Sc5tba2PQdTt9A16wsNRurGC4lz5lrNcsI5Cw/2Tg5B7dq5668Q2lx9qt9WxGzEzOXdRHjAGNp4wMZwa5rw7qEiXB1S/+zNplhB5UEDoQic9VB/ixznrVG7v9J1O0k1S01i0e2nf7PNbTKzkKS3ycc4zjk/icVcsyVWnqhLByhLlv8/0H+FPE9vpemSzpp91qTlpJrto5TMkeADgGTbgcj5VHQZ7V1EPiJ7rTYZxuSW+iG61hUvsDD5VDew6nv8ASr/h6CSz0mztr638ywgt0hilOMyccnaDwPT8ayNFtDZQahLcRob43Hl2yK5jT5m2oe+ByOAOgrCnGrK0IvcuThJtta3EgVXmc3TpNEq8oCQikdRzyenQ1mW+iR6lqRjt5TIltbfbJYcfNIC21VP+x3I71j/EDw7qK6tp9vY66p8SOWYadbA+UehAHHXk8t6VleDLvV4vFKeJU33Wq2CLa3ttPmMFj8rBc9DjIycjPNelCgqDUp7dTthhJOk6sZq9tOnpv37mz4l0yV5DqN8tu1soV3tPJ2B4x94jnAxtPPB9M1W8EaNrtlLd+JtL0L7PYzDdC81wIERd2cqGBYrjHJHPbNaWr+Jl8ReJrHTNS0iLRtDsrr7bqk7ym489EBkCkKBgHbg9e3pg9b8UfH+jX3gjVNN8O6xDPq95FHHBHCpbKu6g44xwhPfiu+LhVtOL0TB18T7GOF5HLm0fWyv5afN9DqdJktp2mvLWWKDU5Il+0Ro2VUno204z9agsdMla7lu9UmVr9XbDxcHy8dGx94ex5FeTav4nvtOttGuzdXN9eTfujDKmwzI3BUEAbQO1d14T8WWVzqMVm9pfG7iiVJCxEhXtliOo/wBoD61cajnzRR4mJy+dGPtLXj/S/pnY32qWs7QQy2zuhQOs6jGCOxpECTyoHuPLAH7vYMeWx6ZouIoITtcSKXbJ3DcPwqe3M6o8cYiUCMlSw53DoR6iuSad7tHMttBbnVtMWGaw1i6Crt2NJJlVfI5wfxrVtYYrTT4oLSNpLaNAqDcWLDHHJ618zRfES81G+u9E8Z2tvPaiVoWMSFJY3B4II6jjvXq3gHxVbWenxaa909zaxEiOUfM0cfYEckgcDjpWdDGQm2paP9DTEYKdJJ9P1Lmr+F7DVbiTVdDxDeQ/623KGNnxzjP/AOsGs3w/KJLiWLzTNZ3C7hCwIeJhw23PQdOPUV6bJsljSdXO0DzFde4/wrznxxaPpl//AG3GiRw3A2tPHyq8ZUup4x1596nGQlSXtY6rr6dww01Ufs38i3p8l3pp1u+uj5+nmTz4xCoeUYABXA64xnHWup0fUbPVtPju9MuEngccMmR+BB5B9jXkXg3xV4Yt/EOoSLqUkM2pOokgl+aLzQT86kZHPHOegrvUtrVLa4FqGtvtMgke4sm8tw39/wBD9O9dFDGU6lvl/VjKthp090dNKkcu9NquQMMoPIz6+lZn9nJAokiaTzVDKrsx5z6+oq7b2dt9pivFd5btYfIaYtjzB1yyjgnPQ44ycUR2kkd7dzm6lkhnVAsD42REZztPX5sjP0rsst4s5btbnM+LYpXt9KujOFjtJ1a4VhuVgRjkdDz60lteTahZxHUbWS5cMwTy8BAuR8pA9M9R0Fb9xDE0hMoDDbtxjP6Vz/iO0lV4J7bEMMQy7xsVxznJHenCfNaD6BOOl0bNl4ZsYNOgtriKOedIwjz7dpcjvisq5ubPQtV+xwCCLULhcxMx3HH0HI6VkeD4/EWieHrjVPFvih9UhMReO1hjXjng+ZjPPTHatjwdptpcWseq6hZouoNl1aZt7xIeg3GvNfLOcY0lZ7/L/M9KzgpOcrrbTucNqPwxurv4hPdbmbTNQQyXUwAzESOQCe5Nc9+0/bHw38O9D0TRoZINHuLsrcTZyoYLlFb3PzHP+zXuEninRI7gwtqUAZThm3fKD6Zp2u6To3jHw9c6ZqccV/pd0BvCt0IOQysOhB5zVww9FJ+ys3/l0IniK117S9j8+fDps7HVrO51a2N1pImAnRT8zpnmvpf4SReELa91/SvBuoveW9ykVwizLzC4ByAxxu5wenFedeM/2ePFugXbtobDWtKJyHg4lT/ejJ/UZ/Ctr4KfC/xLoevRazqcE+nxkMiRSnYXGDklTz9M4qas+R8ybv2/zRvTSlG1lb1X4Hb/ABWhtD4ah1a4t50nmxDctbysjSFfl5AOCMZ5IqXw34r03VIJrK3tvLENqsEcUkoKSL6ADn8T6V2HiTR11/wrfaduQzsnm2xJ/wCWi8jj36fjXgWsXbReIFs9Bhjsbl7XbdvKDhHHLAEZ6kDt1q1K93bR/wBaHv5bThisP7KTfNF/5WPSIb5vD81vcW8qpIJNjxp92ZfQ/THB61jeCtdvL3xzrzna1ty0KljuiBOSqn3x3zXkn2++e8Sa5kubiRWOzfkKB3xniu48JGe90q+1qPU7XTjZsIpbeQB3uAeQ23ghe2Rz1rgnCc6idrr/AIYdTK5Uqb95Xen4npmtX9vJpyNc24ki3iOMBsEe3PT864bVNTu7bxBDCjR38TxhLVScbAecbiOR71pXGo6HLou3U7oWw2C4SO3l8wSAnjA68Y5BANcrqn/CRXumQWunWJt9MuMIkjKqyvgcDj7pPJA9/pXOqNWNZtLUmlhJNck1bprovl/wDqPEXiCxtrGCHZarqUUimSKJgxcHoAx7jg1rfDQX+p62EkhaOwtcvLJJ90A8oMDgnk8V5H/Z15apbST6dPt8zG9c/vcH7ucdf1r6D8DaZqX/AAjEcV4Et71m3PFnlY88BsDk161GPs27aXN8algMHybyel/8vQ3bfUTa3T3euuYftcm23thz5USjgt6epr5y+LHxWuvEOsS2GnSvZ6LbHb5ZA3TsDgsxB/IZrpv2h/FJ0O8g0Kznl+03sQFxKg/eRQ9Ai+m75s14lZ6bYpfNP5eLdVwInJY5/vGs68qc/eex89hKU7+7v+RQe+ljmeeInz5iQJG6qnt3/GsEsVJTqAfzrsb9o1jknMUXlqNqO46n0A71neD9Ak8Ra/b2QnihkuplhUMcZLd/w/wrShUiouTVgxdGTnGCdz034L+Dk8Y30WpXtusdhp0ZjcImPPc5whb15568fWvc/DHhLTfDfmXMUapcDKvcNzIec7QfyGBxxXWeGdCttF0q20yys4rHT7ZQkMKPuLY6sx7sTkk+9Jrmt2ulzCCOzlvL4fcREJSMnpubsf1qaEYxk5yWnQzqVKlf93D+vNli2uFurBpSklrEOA03y/jzWBN4i0DT/MgfWBdXSkb1gieVlz04QHivLPiJreo3mr3Z8R28siWKxSx2SsY4WQsASBnLZG4ZrP8Aht4xi8NaXeSwaeftl628TSDKuyj5YyD90c9fetYqM37nU9ankjVD2snzS7K35+XoexWHxC8KAiH/AISS2jlkOxfMR42U9PmyOPxrTk0nVLuFH0/X42tnw29ohLvHs2ehr5InmstV1DUEvUSG5ubqSVppELiIt821ef72Rn0r3jwnepZ6Fb6R4fknufEEUeY4xeFQq4yWwAVx6Aj2pxvPpcjGZRCik6ctX/Tu9LWPVbawj/s6OG8EMl0uGaSJdm4+uKGtlW7Dxb4zj7o+6RXnmn/EIrqv9keNrU6PrEaqBKp+WRsA5GOOhHFd3FqjzgvYSwXSKdhkjcMu7AyCR0bBHB9aTo82qR5VfD1sM/3i0fXdfeM1NSZoZw22MkCQ45XHII+hrz74peA5te1WLU7C/SGOZg0iOv7sPjDSe/ygcV3puYzlX3ybzyD79QakuI4vsi6eY/OtplOFbocHOz6+hop3l7uzHh8TLCz9pA8YufB+maRY7kWXVLxk8qS4LcCQ/wAMadyew5rLu7zxDoPh+xh8Q6TcRQQ7GguFjYKigDaMjgMAD6V23jvTZNA17QNc015riyinLyxM4yF2neOejbcirHjj4h6f4x0tvDnhK0bUXvI1aWaSMrFbYIJznByvXPQe9aQjvJ7n0cK08RGnePPCWre3LbfyRgwvFdzXOt30fkDVZDOi4/gAwM/XgkfWuXspz4iiuZJrv7NbRyfMr8Bh0Hvjj8c16F4k8A2dr4Ae/vLyTUdThjxbT5CjJx90fwgYz/OvIdOuLPT7YQeIIJGe7Ilb5SHVccKp9D69a8PG4ecZJz1uRThGrCVWi72dvu7X8iHVZ7i90/y7K6Ny5m8sQRruyMEtt9CMVo+EbvWIpnitJktIgQGjmh+XHOFyeeMnn3Fb/gaysNOslvnV1l+eQK7fOqZ6Y47VGkGm6jJ9u1EyRWU8zSwWat5RuVABD7hzz1rGGBqTShG3f0QlVjKTb2Wnq+xuWus3FvdtZ2a+Xaxp5xTezhZM4bafQmu51cNqvg6ZdMhE+pGNWgiL7MtwQS/GMHvXhmm3d1dRX85eeURbmLYw5XJ4Ld+MHPXrXrPgK7mOnIzqgg8pSh3ZGcdCK1wsJUqrptar+kc2PpPDyUrrSxR1HWkR1kgVNO8VqUW4iu7Vi+w/xRsuQ2SMA5474rba0+0W+oXdxesl1Id4dsKwRQAqsPYD61Y1aS7KJcJGDA4AQkElQTzz6f8A1q57xTZX1xok8WnoQsoKvKvHljH+RXoYrESdOXOrK34nMq0avLCGmv4dvTyM+wSzt9I1m7uFuryF2FrI1rCZs7fmYjHPA7/WuU1bwy2i+ItIurS83adduzQ/ZpDIANoMchwPlYlgMZ/hr1/4Z2MuieEktId0iysZHA+UISBkcdelS+KUkFpFZWatCLgCLzI0BEKdSfbisKM/Z0LJa7nRQzCpQrtRfudvla54xHrDfZV1LxBdG5aHfFauUwWODgADufU+1dV4K8XXi+ErfU7mws/tmnqyQzLG26RWOPLY5wM4Hr0rCHhK+kvbLRvMheFpS0ZaPJAORuJHTHvWt4osdJ8L+FtU0XRbrULueIg3hETOiTAA4YhcAEMMfrW+EqynTcZLVPt+J6U54fEyjC12+2yV9Sx4Y+KnizW9Q1C2sNFN3LGcpF5DSpGA2G5BHA6D39a9W8MeKbDxJHcx2TGO7syvnwMOUB7+654rwbwh4wvPC3hO3l0a504iRXFxC65kcZHI7qfmPtx+FZ+k+MtTXXm1i0mls4JbtY7iSN9gVTnaMEEMBgk59e1d0VFRUXuzGvlMMTGbpRUbbPu/NflY9q+Jvhm0l0+TV7WxWS9i4kEa8sp6njriua0eC78PeZCumSLbT2ibLiI7X3HqoPY9/XpXb6Hr19f2nnQPbS3VszW95CikLuPMcoGchWGMr25x05d4tjl1Twmsime3dCHaN1y0TA5JXjPqOOCDXmYzL7XrQdjwqeInTf1eqrjfCX9rW99EP7eF3Y3OnoI9Ou3Xz1eNijyAn5juA5OfvZNd/brDNZCB4y0YUKUlGeMdD618ua/410TSfDofVdbkbxJYXRudLGnxqXijk+YI+cDHcgnIz74rY+F/7RcupTWem+KrFXuZH2fa7cY3Anglegx3row9VKmpSva2vb/hjlr0JSm1G1/xJPij8M77R9f1TXdI0e31Hw/LbFDZxZMkBKEFlT1B5B5+lef+BviFrWgWBMLwX+n2gO+0uZ1WUAAcpk9vTFfVvh7xXpmpXMtgupWsmpxAPJCjYZUblSfqMcVgeOvhF4T8XQ3ck2nxWOpzoFW/tV2upByGK52t75Gfes3g4VPfpPQ2jjpRXs66Mj4bePNK8T27yaXqfmTMSy2lwwWaPpuGP4lyeD74rodV8WLptybe4spRKyjyXZSInb0LAHbj1Ir5y8Xfs+eMPCt0NQ8KX8mrIuXElmvkXMRHcLuyf+Akn2qvY6n8XLCw+0654f1rVbCPDxyXcUkUsOOM5GG57hgc11Uk6bs3dfic1SEZrmj/AF+p9Oabqg1KQJLZy28rAsJeCn0B6n8q0mTbIRn5emccN+FeB+FfiLqd7IkWsaZquixuGVXmVpIJB/dXcAQR2GeefpXquleK9Juo7YQ6pblmAXbLmN2P+63Ipe0Teu/5EypOO2xx02ma3o+kyPJpcwt3dQYgfMI/4D6ZqteeIdTtLSbT54JraKQb2MiHft9B7V7hIyGEyN93GeeK4zxpqQsLcy7Ule8QQPG7rhMcjr0z615tbArDwk1PS1v6sehSxbrTScNbnKWN7b6vp0FlaQQvEAC7IpDKR7Edamgd1vlXRNUkspeVmVGXCe5U8H8KyZLQeI9fkmuNZ07TQuEREco+CMkDOMj3rS8DQ6bIJJvDsZvb1ZXt5ZLlCuMHGWB6A9R61x0ozlJPp36/K2p11OSMX37dPm3odBZ+MNR0uW2TXYGewCsrXyIWLt24A4ro9F8QaX4mhlFvMsoTko3DAdjg80+10y9itkFzqWCBlo44wI/yrJu/CGj6xfy3IEsE7D/XW7+Xn8BXrx+swsn7y7Oyf4XPLboSu/hfdbfcV77So9O1WAJI7REl4SzfdPdfpzXl3xi8Hapd6rH4h8Nxlz5flT28YAb3YD39q6/xN4U1jR7c3FvdXWpWtuDIibyXTHf6VU0DxHHrkRSRWguY871Y4wR1BFc0KzjJxlFxt/X3HpYatLDyValJS7nkerQEwqsvl2UdqqxyRFdo34z0J3ZPcmsGLUr3RZrmDdNZyXEK+YirjcOoz6jBr37XNA0vxEjNfvvlldV2XBycjupHI/OrcvgnQZ4YVvkuJZYU8teAQmOMKcZxXpe1imm2eqs5puD91qT36r5HhPh7Rm16W41G8abYZBD5keFP3eoB7DjP1q5dS27XdzbRXW+GOQKYNhKykD5W3Djn65r3Gy8PWem6etlFbwTQAkrFcAhVJ6tkck1iaRo3h6x1B7C00ozhn3uEzHCGHOWYnc306U1OMY+60ZxziDqOU02ui0Nfw54K07TG064g0xVutglkkkkZ1icr/AhJG7Pftiq3xM+JGi/DzTkilkNzq1yjeVBFhmX/AG354GePfnHSnfEPxbF4Y0O/uJzI1xDFuVEO3cSPlUe2SBXy94c8M6n48vr3XNWvYoIBKPNlmJLOT0VF7gAVzykkry0X4+R4c51K8+abu/PZL/IZeTan4z8SalqU2oJbGFTIHkbDbccY7nitXSPAepX/AIAbxMPOZXlaM26dXVesg46ZPT2Nc/8AEbwvJ4S8RyWk10LlXRZYXClS0bDK5B6fSq1v4u8SJpy6RY6peQ2RUqLeJyAR1PSp9m5wTpuy/wAv+DuWqypy97V/fe/5abDZmito7hLi2aWXBQbif3Z6fnXqX7OWgSpqb6vPYrLaRfIsrtgRyHpgY+ZsfTAOfSvLjc3GpQ30SwohiBmmMhw4GRnr7npX2b8LPDtvofgbRrEwIkiwiaTC8vIwBLH35x9APSiO6hL5lV5q3PH0X6m94uuLhLAQ6bn7ZIpEJXGRgZJ5rxvw/q15Pp95Lf6hdWF4rRmKZnC+UoY7lcnOckfrXT/EzWdestTjvNH01HtbeOSETyyYV2GNwx25wB64rkvDD28moS3HimCeZXHm7bVgXiJ/hkU4zn6+ldikoO8nY9LC0JUcFKaSbdn3e+3/AADufitoS3HhjT/F2nSwSXWnqsoSaMSfaULAlGGRnn5vbBrC+Jmv6F4l0GwsPDsEV3q8zRyGWGIhISACVLEDP09BUmv31zrhs9MsdOvINJtgZo4klR5pX3DmT+FVHpk9q4zW9L8WeGfFGlyR2VtDBqMsgs1nufN3bRyr7BwTkHjjiuPF4iVnCmvXyMcLOyhzy96N+XXv0+W5h2/hHUvEvj+y8N6kbS3KJJKsseIwIyAVIHfJ4A5712mheA10j4lXvh+PWL231SKyF9prpj962PmQnGCBg9vWtTRdB8UaD4kl8Y6jp2mX0UqI0lm+/wC0WiITzFtBH3cnB65Fcv4/8ReINe1mLW/7JudGt4mb7FKMRuIjwSzA53MO3TnHPWpo1YYejGc3qdaxFatNxhL3WrX0ev5/ec98QbrXZPFcEOviaXUrfPJ4YbxhcAdDXReBtbtfA/hlpEvnW9W5EktvOpK3SsAGVeOvynB4xVHRNDF1aSTpcK07nzZGfJbdkkAnr3rK8VW5vdWaU6eIEjdYpEMh37gvUknHI6Y9K3o4n2yc0rX+49PDww+IpLCt3cd9vL8z6d0rVdG1e2+02MsUkBbZIcYKMRxn2PY960jbKpUeWGCnI9vpXy78JtcvofiBHphhnuoLtDZvC8hyiDLcE8fLjj619V2/ltbAxkkYAG485HrWqUZq63PkcywbwVbkTvF7GVLYWeoNL9stRIkvyurDr6HHqK8/Qv4J17W4NT0mWXStSO+LU7aEsEhxkxELwp3D075r1BvKMUzBwkgOHVjwPT6Vk3NyxAjeaaC62lWi271kX1APBPuOaqCk35mFDF+xTi1eL3V7fM8e8ReIdMudKm1DUZmlEKO2m6WWKxbifkGzqzZI69fTFcp8QdMttGhWZJr+a6jVWM12/IbOSu3oB14Feoal4PtbCew8QaPa20ws5Ha7tpXAKqVI8xVcgb1PIGfp2rM8fSW03gGS6g0KaW8ulKtc3EX+oBySRzjnpuHHNE1zwftUfRUMXGc6aw0vdb1Wn3f1uYg0aC9+FN3qsMka3l5ZrcebIVXZIv3iG9SMge+Kl17wFPret2Wn28kyWNpZj7IZkEbpJsGFbgbTjAP0/GuR8OSXni/WvD3hWHUZntg0YbzE2RwpGN7KAPvH5cAn1r2n4pXkukahcjR43vdQmUPJbRtnZkcMQASDwcDvQuRq60LrzrYXERoxalJ3euy6LftY8n8P2NxbWV3p80gFwp+yySxYdd57Kc4Y89j2NTnU7rTrvTtB8OT28QhQy3JuF+ZSvUYHv/Ovb/hzp50/QUvtWjtYUW3XLMMGMfecuW4H/wBjXh+l6PZeJ9X1LX4m221xfTiDa5XbDvxu3cVwYuhy2mtWctXE069SpfS3XdNnpFp4sttZ0eymVvKil274dvMX976gGtTT7nyLg2cnljexBwu4H8q8Wu7BE8XX08dyYrGx8o2sCEFZCoBPzDqc5HB7mvR9J1L7RrUvkwPJHIpeKVeDA+eVIHUc1xc7crzX3HJOgoq0PXU7ixjjsJHS0RC2NsiAgbSc8/SpILWOae4FzgsYydj9MY/SnadbL5LB0Es86hmbdtyT0xjpXPa/rZ07XLfSp9PmZrgM8siJkIgBHX0JHHpxXQ5eyim9jjUXUk0ty/Y6R5HiH7VBIgSWLy9sj7igxnAHfkdTXjuleJNe0fXPEaWmix6pc2d3KTc3JNuE3HBON2WB449MV6/cxSy6FuhQ280pzAJ3/eMMAgNg8E+leNeKf7Qh8Wazb6haXjHV7eMK1ooO3bj5mGeOnrzW2HrKM+V7s9bLFGTlCbVnp9zPOLqG+0PVzc6xp0cltJOGdUztJzu2j+8K9JTURdQ2k0VpDMJIeYZ4gotYwMKQThS2COMcdar6Rp2s+I9IGg3EZttMtnF0JrhB5olC7TsPoR60fEHTpNCstNltF82Bh5chml+6x6EKOT0rqp1OWT5du+m57E8RQdRYecrt7W1/Hz7dO9i58IPEtxo3iyeCa4aWy1B9ryXUgyuM4OTj9a+jVeC7tA0TpPBInyOpDKR6V8m/D1INa8SyT3kCbbdAiwjChz/ExHPQdq9o0gX+kX8uq2dwk9gzEXlgGCgxhc+bGB/y0XHTA3DjrWsabcXfqePnVKjWr/ufdkl9/wDwfwPI/wBoj4dT25m8Q6ZZBraKMJcsnGz5vlOO/pn6V4pp/wBqS4tFtZZEn4WAR8OGJ9Rz1r7x8V2Njr/hS+hZvNtrm3YgxnJZWXIZffuK+H105bHVZYZXMlxbuVEiZIIHRh9a43PkvTl02/I8qjTdR8y32f8AX9bHRX1xr11aWl1rjj7Nbu9vFfKoMm8ZJWQjDNzxk9M17v8AAP4hazezJoOpLFc6fY2rSyXu/wCaNAPlUcZJzxg/0r570TRta8T3z6P4fFzLFIgnuCWPlxKOdz9h9epr6u8JaTpfhzQLXSPD2lr9nYpDd6jKmTO4BO5iPfoOgzXNFqk1ytJ9v67/APBOjENSg4SV/M7TRvEWhz3M6Wup77iRy2yaTLL7AdhW+JFuEYRSK3bKnOK8m16Gx8Mie5kutJ09pQX8y5Ii2gcnHOSfYfhXn3iv4i6gmhiXw5fWVwSQ3npFJIzkkY2Lgc+xFdX1zlfLy6fr+J5qwnPqmfTUkfmwGK4VZY2GGVxlSPcGq0thYyrtksbV127SGhU8enSvlLQ/E3xX1DVxeW93q0TblUQGykW2cdMkMu0V6La+Nvi1pl266l4V03XLXaGL2UoidR6D5vmPtito4ulJ2e4p4OpCN00dv4pu4/EXhho4L37HFM2FYYbzSPugEHgE81ytp4GuvDej288EratqFxOFuZ7qXISNuCVyeo7VhfFzwvf6TqccuhyeXp124ZbcPsVJAOg+taHws0DVnln1HxLeGRraJ/J0zzSTv/56Nk49cAetebf21VxmveXntbqeio+ypKUJe69fv6Ho3iLSoNV0u3sbi0jumXaisVGY+OWB7fhU/hLTLLRtOmt9NQmJHO6Vm3PI/ck/pS+HLyJ7SGGYn7YSd6N1U9ao+KdXtvDWmx2lt5cVzcufLTBxyfmP613uVOnfEPt/SPPtOb9gu/8ATGard3lwzCzkMZY7WL/dUetUXvFRUgOqW5lXAcxNyD/ntWlBG93YeUeXkXG8cYz3rCTw8ljappmmwtFGBukuXAdpCeuSec+9FOmqi99v1G5crtE6zTL+UBvMlW7h2/LIDyfbFUb/AML6Rr2nX0MaeSbhss8XyvG47g+vFZXhZbmzNxaTzQzmM53oeQPQitY6jJpOpoCqyQzuqvjjbnowqq0aaajU1j39RQc1rDR/5HLL4QvfD+qobCQ3aSkIBKd7KD/FzxxXU2elpOjwLqLQ3IJBRlAIP07/AIU74m3c9n4SuXsw6yvhBPGMmEH+LA5P4VhfDDxKPENmNK1uOYa1bqJQ8sRQuhJAdSfpXJGlThXdG7b31b+650OdSdH22nb/AIJCPBPim71pru41uOG3UFUhjYjI7cAda81+NN94m0bxDY6T4OvLi9maJ5JvLhLvnoVwcjgc5r3U628F9ZLbOt9p0srQzzE/Pbv2Bx2yMc10i7d+9QocjG8AZI+tdbowrJJPbv8A1qYKvOlK8lufDtnL4u1vQNSsNZubp47lwiPdfOUdTk4c9AeARnvWNY6pqHgSd7S6sxBqAPmJLLyWXkDAzg855r7s1aysriwMN5bwPbtINyMgIJJ/rXkHxf8Ahro1t4fuL+O1eW3Los4PzPCgPDK3UAH+dcc8NUhJ8yTg3rbSzO6njac1ZK0vPW58sal4jkvtZj1XUmk1KZo9jGU4CjnAGOmOeKh0dL6CV9f022E8Fq2ZiynZFuOArGu5h8Gwaz44J0/TYYfD4jWSR5JgsSqqgOSxPLE9hyc13HgzwpNLNN4evEaPRNRzM7wkBcqMLt6jBHr7VM8TCCUYLV269O3qaqlJvmm9N9F17nlXhVZNZ8Ux3OqLGlrq1zHatwdrjcpYcfQD8a+4EOGjKIFXHyqvTHpXndr8OtA0zRtGsoY5GaxvRPb3DkeYG3ZIJx0NegLIg1WOIyLjYNig88da1otyk9Lbf19xy4iUXFWd9zznxrqNrcRDRL/U100R3UgYu4/eEklR82AAQevPI9a47RIbZtZuiZJZrYBYvNZ9xlcdXB4AB7Zqn8dJZbnxLdRfZy6WjAuNuSQSDuDAcfj61t6WGtdFVooI40uYgyl8M4Yjk8dR71jicQ6sOR6J/p/me9Gk6GGjOGvN07GvY6muj6ldTWNtJMrIqAu+T14K4I469c1LrGq7/E2i6jfwBktYzGLjBeOEnI2kY2hm4yeO1VfC6RI9vdtJ5wRCisrhlGe3FaGo6qtlaXlvNDGscuQ7MAI/y557VwN1IL32cVoSlaMddjqI/Gk1t9is4LO7vLmaBhG2zZk7gAR6qB3/ACrz+M22tX8OkXzw2v2RQJIWk80vycsCPQ4OB6mrPg/Uozda5bwtcyskCW1ufMaTyvlZmVC3IG4j2rkfBNpBqXimOPXbu2hWGB35kwysG4Qehx+VetKnHE0U5as2oYaNJTsrNK9+v3FrWLmLw0xaFZNtxGJolU7kxnByTyCPQjvWIzXHiHXzaJPFatfmJWhbLKCD87A+y7j7V0Hi7TmvdRlmEDNpiFdof5ZSSOAV64wOvrXnniFtIFvDHo7RyXauXmcMcxc9M/nmvLwkqsZWi2kjswzSqRcfjlpft6/cd+kK6Vry2Gi2itqMVwGtHgi3NycBgSehz1PbOa9m0PVLi6vNRtXcNJp915NyduFDFAzYPcZP61836LbeLbDWYbDw/q9wt6bf7YPJQKxVFLKpJ6rjPyng5Ga9V+DOpX50XVn1WaW8nuL1PMkkwWMjkhgcfSvpVNNJRicea4GcaU6s5Xtbrrq/+HPWYXtbkXCnayzYO49GFYslm1vdJauWntAdyGV8lMnseuBRr1vJZaLDDYAJ5ZCjPJK56V5rr3izxmNQ1ux0Xw7HGmnyJFA97J81wCDvZckccqwI6DrXDWrygmlsjwaNFTfqeu6lBa3dnPbXMUM29droVDZHuD1qhZ2cuj6MLMWVpcaXGCPL3chT1HzcD6ZrxfRfinFo+o2q6xPF9okKxThlOIm6MMg/dyOvr2r12/1JZLGO7Md0IJfkM0REkPPGG7YJOOcUUMbGove0XmOthJ0n3KcnhrSNXsZn0O2+wT+aJGMC+VJvHYMMHn9a5Gaax0rRBfwxzwR2tzvu0uhtlfZkYyepzjHriu9tHisNBmuNNHlPu+bedywv0zj0BxkZ75rk/F2o2Tap4X1jxJpsU+lsZ7ecoN6Q3RA8t2U4z0Yc9OT1xXT7GHxR2udmAxM5zVKd5fnotvn0MDVNZ8QeMPDE3mPBpWj3UoSSy3n7VNADk734wCOcKOnGa4tr3T38fWOiOyPo0MywrEHVI5Rjt268YPUV3OvaBr/jO8Z/C88CaakRlabYMbiPuxt3Yj0G33rmPEvg+a38N+fJJBaOZ4U8uf55blh8pYY5GMc+9RVpWqe1k72Wx7eDq0aclTekpaWXS/frf+tjUvdJ0/TfHstrZ2clraBBdJBvEiRyNwWB7EqBkVPqPiANF9m0JEivGlWKORlwqEnHX6Ck0bSIdMtZLy980MG25kySyDoenA68dKi8TC3WFX0myV5VJnZT8g4ORn8eleJXm/aOpSWktLdTlq8tSfJN3t16X7s7vRL+bUGjlnv1ilswC0aqF8w46fkDiui1yC01yze+SURTxROodQNwJUgAjGeOorxL4fa5cazDc38DLFbQld53bXEm7gHqCMnv2zXWa/JYNpmpW1tAt/rBVvOhFyypCxIAfIOUAznjk+1ONeylCS08zhq4VxmrPXyHat4mt/Dfhi4gtoJ3urGSC3LSKx3SPyAXOSTg9eetUrfxB4e8R6lCt7rBsdZA8sQlGj2juuT1Pbj0q3D4S03WvC9gl1rmszNHGtveSXE5jAkxkOQc5x29iK1vDeheHtFjj0+2Eod5Y4jdyoWkmlVS2Y9wySMHJA/GoUZu3b1Kc6cU+5yeu6tZaGZbbw7qrS3dz96cKG2KDyFz3PT9a8+uovtH2251d7oPG/nQIo3ZfoSzc45XpXr3i/T7W61aztrqRZHnk3GaWJUYgZxuKgcZGPqeetee6dZarqXic+GNMaKJ5rsyblUPGijlmPqoHb8KzhGc6zp/cddKaVPmjv1fkcb4bhvbjxBaabBGIr2WRy8jqUjjBGQWIHTivYtH8OXVp4gv/CukT6ksP2ZZLrWZyjxn5ctsRhgLknockd6xviT4J1DStU+2aBfNq0wg26mgKxFF6gquSMhcnGeBimweKdR1K4tdB0nUVfS7xViuGAXzWTafkJ/u8HLDrnFfSUv3NNc71/rY65YqtjEnSs1bXyfd6a23Vz1rQxFHoGlWEshcPbmFXVcB1UEBvxFfMi+FNVv/AB9e6JpghS+WeaJZJFwCFy2ScZAK85r6juD9njsr6fasNrb7Cir1YgBcD6Zrzz4h3Fn4VuR4ohgDXlwRH5jJwMjjOe+AevWuTFRjpJLc8bBYpxlUi+u3r0MS1vNL+D2hQ2Ut3FcajdyCaVYYt81xJu7A/djA4GRzyQKu2Nn8QPEVjNa295pPhuz1B3yFO6aNCcbUBySxBOTx+Fc98EPCl/q2qX3jbW7iOGxZpJEnlYOZmzznPRV/ngdK2fFHjsTabKmiWTWoKyJHqEkWJvTerY4z1BFcalCjeVST3+9ilGdSXLTSb6t9De0j4TeCPDQabxLcTa7qCqGd9RkL4x6Rg9P97NXovF3gqzMcOmWFtbqjhVxCI0HvgDtXzl4au72DVNWutTvb9iqCOQGYh5yxyFJOeyk856Cukg0pvE+mPc2U728CgyLHcN6H7u4DGcdutZ4jEzhOytbvvuaU8JCUf3kn6bI6TWfjt4jbxBfWmjWenjS4ZHijknRiWVT94/NgZ9K0oPiJc26m6fTtLsVCGYMkRk34bB27TjqfWvPpvDmsafBFcxWUDxNyhiOVJHUkng9SCKsanu8PwjSdXhEzEC538IFEirnHqO3pkZrOpiqkmlSdvRmkcNRS96KZ9F/EWdZ9T0m0iAeeOZWVXXKZPr+FQeIfDmsBZNSgmtVWBN8kMaNulUckZ5/ICqer3F5pGoyXV5cwo6N5paYjac8HH9K6TR9fub7ToZIxCcj/AFvIDfSuyMYV5Tc7p37eVjhcp0YwULNHGaLfa9Lr8eoy2ktpbXoR42KZCIMDZz3I9a1vGBTV9ZhiEZaWN18oDGUHcn8a2Nav9QGny4jjkwOR3X1Io0zw/ZW1pcusstxPcR4M0rfOh7BcdOaToSlF0U21u7h7aKaqtWe2he09c2mY1KtuwfTio7OaO8u76JpYlNsqgnOXJIz09KzWurxNENtARHeEHyy/94dc1Vs9S0e9giuJLiNJjKQzwvtxKnBDH8elephkpwUlr+hxVU4toh0fS5re88+fUIrnU2fzCVUoWhPHzr/WtjUmcWdySo3KpKN64rE1i+sPD8llL/rL+4wjuGyxQnOcZ9TgU7xTrN5bzwQpYj7F5Yd5t4DEkEhQPXpTxUZzjot9v+AFJpNXO6s5rTUra0vGZeV4UtwD3GPWuX8UyeFNa1ybS9Wjzq1lEHi2zrA7oeyOWHT0rn/B1uL7ULx2ivZIrvY0kaMV2MO/X5ffHWvRJvDGiXDF59LtWkI2mQpliPTPWuWlUliYcyivO/8AwxrUjDDzs2/Kx8+eBviVfeG4L/TLvw2YLZ752je2nEywJx+7LFjvI46V6F4a8fzLp94bbRbsW9k7XFwAAfkY5BQAn0JI7Vtan8KfD99ZXNoomtoZvu/Z8I0f+6QOKnh8AxaV4Y/sfwzLFprHBa4O93k/3mJ3Y/GudU8XHW1rbJHRKthZ6bt7tnHfEP4hwanpGnXOh3d1bhHYyRY2vu4KZXqRnNa+s/Ea5urC0sNIgtru6ubdDcys4KoSvzDZ371D4q+F73fhq1eK/to/EVsVDXzxHZIu7ncBk9O9cLq3hHxn4b8Qz3+kaYL2WKFJXurbJjkZgd23PORtzjHp61E6mKhf2i0f+X9fd2NIU8LUSUHqu57XpN5bS6ZHb6hplvHCqgbI4wU/Adq4nxV4Xh0fxNY6npCMtrd/JKqudq46FeePwqD4afEKPWbS4i1q2kt7yIgPlCVPbOccZPauw1KOO4iijFwVtmbcir82D7VNVRrUlf4l10v8/ImCnQqtbJ/cM1/TC1nZm1v3CCSOUyKeQynO0+x6Ut9YyHXrS6MrROj71A5DqVxitGK5iSzW2vxGbUqAJF6j3qlqdm97oV7ZWM4OqWY8y3k3btyjlea66SUZ3g7X/Dv+ByybatLoed/FaC2gu9bkv5xbw3MSFTtJLfT8cVQ+GmvaDdG8lvDJa+XGI7ISKShCou5c9Mk8gYrtNb8Y6dp0Omahq1i9xFcRGJrZEVt0nod3HHNeM3d5Z6rpeqRfYFtri6mabTo7bLM0hP3emFVQBkjA4PSu1Qtq9bH0+Bi8RhOScWl0a+7b5amvqWvWWm+IYp1nZcgNsiUgEdDuX6ciqVzrK67eMftUyabCoJ3qFAPPJz0z71wJtJrK8tptd1EAzAq+xGdvbqOfzrXC20FjG084kSeVZpoLfDn7OvOC3TOQOO+DXn4nCxlvpqdlPB05QU4t81t9P0udnYtDdCRLC6jWBk+zrcI207T1cnocc1u+HfFvhzQL+00O10y3v45wIXdFVpdxOM7h36kn6Vw/iDxjpuu6rbrHZS6dZRwnGzDNKBg9BgDocVH4I1hfD8st1q2iyX+ma1A9sjx4EybTy8ffA7jjNGBXsnKnJaX+RnPAzq0ffvp0utfn5bnpc+r3NxZ3N5b+Hr+zsbAKDLNIWyzcLM+QMjjBKlsd/WsPxD4Qj1Dw/FBo9tax6pcSCWQ4w0pKljnpgE/hSaxrt/rfhe50qaWLTdJaJTEjlnuXjAONzdBuOOpqWHUxYabpbX9zcSj+z/NMkbKZIti5AZhgkZAwhP8AFzXZ7OEHto+pxU6MoSVWi0mnsm3sur+8wfhXNq2n+KtU1O40++eG1tpEnKQmQiQDasW7GB1HBxxXrnga2TQfCdj9vt44tQkL30kK5Hztng/QcVmfDLWtb12wvpdWVf7LLb0unyjuegQL0Ydz6Vv6tbyXLyLaYSa4TyhI4yIkA52juaurNR925wZjiXUlKny21V9b7bfmZ2r6pqI06ye0YyyzynfsAbaGIwo/Oug8V6YbdL2/0xIn1EW+EWXlZmOPlYdwafpHhuaA2nmWzR20eHB83LEjoT/h71Z8TeH31S0nltLh9k9u0OyTgxns6n+ErXnSjOdKUuXU8+M4RnFX0Phe8TUrbxpc6VFHHNqLXDRuGAjHmnOcc4UAk4r6Q+AOuDW9CTw5Jqwa2kgK+RNF+8E2Sz4YfeHHU9uK88+IHhGzj01rfRrcHUbGAS3t9MN32tlX5s/3eOR61ynw5uf7HujqceofZp7a5hMQSQjLNnJx0K8YOfWs3VXKqnVWvbqd6puopQvo728ux9Z2OiatommajYbo5dytLb7juVmweOfUYHNUEtZfGHg/U9O1CxksJJgrRNtzlhyG/MEevNap1jUPEngO9kVVt75FUpMo++AQS6jsDz36GpvCuoz3GnWpvI5UnRADv+8xHc+9elTqxnG8db6nlx9pRnzrSUfzR5Nf63BpXgfU9F1uO6k15iY4FjkCqUX7jbVPAXGcHk/SuI0e8j8RWEmp6prry6xaILWztmBAQAhjLu6ZAz+pr0j4jacIfiPO05htrV7RrxpmcIvlkBec4ydwIwMnmvINVu7YxrFocV1LqNxLtCeV5UaQ4IJHHfI5Naa25pH2WDqKaUkrc1pN76vouy023PctMuZtV0a2u7iSOUyxDcwfrgf/AK+a8w1PVp5dTuLfSIpJ5gWj82PJUAnGGPcDn+dbFpqJTTodK1KaK00uFPLlnjlALlcDaf7gzkH3FcJZeJrm3i1GLQwLiyM58typ3hemT/TNeTiveaaVrdf0PLpYWVOrONt9l0tff/gHQ+C7fTPCNt9u1u6MF00rQrZ2/wA4fjhm9cngKK9Bu9XsXvLRZ1t9OtbqKWad5gFdVVcFWQ9W46HniuB1DR/+Eh8OxSQ3Mkt8+ZYVjj3NE6qcLnt0xWp4Ps7fxN8N7Z7rF3rUFu7MzSYlcs5Y9ep4HJrz6lOaXNPcKk41J3b8vQ9LhuhFZNYxWwW6t0RrfaMCTONuBk/Kc4IrnbybUDf6DLPd4jiLLJJbv5bRuSRtUZ6Y79u9bNpqEWs6Xai1uYFuTafeByYmPAU56dM4Ncpb3iXa7JZbW38pmFxIqkMrg4LLnK89emc1MnKUoxT/AEMIR5U20dLrWgXU9/Df2N/bfawgjlS5DYkG4lidv8+ee1cY51Xwx4ntddult4EhcxyeRuJmibhjnHvuxjqBXdWmqWUOl2U7XKQmQEfviMuAeWwe5/KqGpa1p7xr9pRIbFxhJmIZXOc4UHueorvWG5YqtT3FQqVXPk5br06GRDYaRqltd6bo95qt/ZyAXeqXt3GY0dSflhQHDDOOvTFcq+k3Wr+I7bRPD8EdtfxLvMsSFBbRgghiR14r0mCGPUsyaVA9obmMxiSMh/MjI43DGM+ncV1Wg+HLbw9ZzyFhJfTxhJrnYA7AdF4r2Izm6alNalPHfV5uzfN27t9+mn/AM63vLoarFBdElmk8oKSBwo+8QPTHT3rzX41pc+KPHuh+ErRgVuF3fIc+WxPMjAdQFB6133jXUrTwnpr69cx+ZcYEEJJyFLd8dzxWX4S8OR+G/wC1/F2rStJrWqgiEyJhoYccIB6nj8Me9cFeXNbp/X9epwUJezbn93zMP4nSr4Q8LeH/AAfoq/Z9EYmKS4d8vKQct06ZJyfXPpXE+CrDUNcTVdI1JriDTpAskCKhfEiMCShP+znPNdD4tnuNT1TRpPLa7htXcr5iYDFscE+oxWjoOj3NtFLNDfRWtrzIVb58oRzGAOfXpXkVqylPTX9D0KceSkk9/wBTgdYsLW91RYdMgVba/wBsUyzTktGynIkDHnjBz25q14b8Q+ELNJfD0UWpvYzSBm1F5B984G5YwPu5x3ziukbTtOu9UR2ggjiDlI3XcFXJGQRycYJ9+evFUdZ8J2fgiNdbtZoUv4XZ0iWIrgcYBUnbhfXqc81MX7tpJvsU5Rk1FM0PiBqGq+HfD1vBpELXWku758iPIjbdgAjkjcefqcVymr2d9deIdJh122uv7QvFjgljkCnZAxHIB4Urz0/Su10S4vLS+06WG4VpZmE7mVsKec7AB6CsW4udSuPiCt5q+rRPJazZUkF403c5CnPQEYUcZAqo2nbl3/MiMnC99j0qW3j8QalPfajCJZnA+zRScxge49q1b97W3sIrc2yyXESBoIlPlpI/oCOPzrO8N6hb/wBl+Z5ivdIudh4O7H3RVq0vnvoLa4ni1Kxmjl3SW6YO8j+EH+7XvZe043k/x6s8vFRalZIytbsNSt7mwvtOS+iupXTz4Fk8yMEkblJ9AM810lvqWyZyQWuIgQsC/wAbDoK0MT3gj8tTFvPzbzyo71x0Vg2meObm8mvkuUl2eUqZGwDrn/GqxeK5nFSVraXJoUr31+Rp6PdaxeXt9deINOa0gYh7fan3OMEH3461g3Q+3XjQW1lpt5IrGSSJnMTt6PgdT716tcXto1oHnlQwt+7PzcMT2Feb6x8PNMaeaaK7eCAZkCn76f7IIOcGoqSnQlzU9uv9XHS5aitPR9C68Gk6ZYjUL+KOW+IG2Eyb2dwOEB9B6Cm+E7DV9VtpbjXZUglnYu0IAKxJ2H1p2laTY3a20TW8ebT94m45Kn15/nWybWe4lEf3IOcBTy9YSq1K/wAauuhpyQp/C7PqT3GpRaFYNBo1k0pXks3G73yarWmv67dqSIrWAYyN75P41j+I7Ke0kRx9lUbljT7ZdbY19W2jqRUg8R2FrGbHT5LW9v40/eNGOCfXvgVtzuMOVyt5LoRGjzu8Y38zS1LxLq2gaZ9qvljvF3bcQxndz7f1qXSfGlzfsNmnOCyk7ZPkwB61yja+W8Q2FldalNETA0s6smFZ+MKCOg64qrrF3qGlPJNZmTy53+QhiwAJ6t7D9Kr2kmlaWh0fUUtJLV6+R6O/ikwzJFeaZdFXH34sOo+veqUHio6XqU1lNp1wNPQBoZUO5+TyCK8+1n4iw+F/C6veOmpa20oEShV2iM8liOpwOPckdKfF42S7njmu4ornTJEDG4hUpJEPXGcFfWrlKbXPFrQUcuk1fl0e3nbsezQX1pdRlLRoZy3zPCpXcue7L2NcwPDcn9vz3lpHNFAeGtrh/lPqY8dBXHWGo+GLS9a9i1i306Zzz9pmCE89Bk11y+MhDKBHi+ttoYTRkFcf7w4rNOGJSlJbdjCVGrh78vXudLY/Y/3mn+bFMVzmJiCyj0I/GsnUbBNFniubWF1swf3ogTLIPp6VMG0nX5ILqCUR3qgMjfdf8fUVPeave6bPHHf6ZNNbO237Tb/OB/vL1FXNRlG8tLbPcwjzKWnzWxz/AIn8O6brOkSW9wqrbXO2aKZBgxt2ZfT3HevLJ/CHiay1ENc2GmCwsIZnt5LEYF27rt2licr2OCPpXssMy6haTf2URLA5BW3nBUxn/ZH+RVdZbsaZcSQRxkpkBJW+TI6hsZwKIVOV2Wx6WFx9XDRcVquzPDd2oA/2P4g0aGOaWP8AdGRgdm4jLDvnHftisTxC+mx6uLDT7e2lggTAWLhZJdhwc9yueBXvVrZWN05vZNLW01EjY6I4mCfQjsevavO7/wCGk6+I3vdP1HTYo5WdwLiNo3j3D7oHQitrqUu57mCzTDN/vPcVttbX697GLrHw/wBUi8GNrmrxi1S1ljYo5zIUdlX5RzgDPqO/FbWh+GLz/hK7C3ma3jn0KXN3GMs/lyKQgXaAoBz17V2+oHUdRbQrDXLWOCOymEzIgkuYrvapC7tq4Az82G7itbUI7aW+kvdRIgnmQIxt02tIg6Kfb3PIrVxiveiefUzapy8lSV3rt0v/AMC/3o88v9C/tawvLO1S4ud00kSSSSsI12tjOAOW+9jOR3qW38ARafqNkL3Sk1JtxaJJpyI4unMg+82AOmMV6TYXtla2sUGmWyxRnIjihXJHcnio4NJFq+o6jqJuookD3EpZi21AMkKB7D61zc8XeLV/66nFUx9Xk5Ie7F/exZLW81TzEtI0RIf9WOiA1r+HtK/se2mfU7yO5uJmyxYDavso7CsHwl410/xZosl5oEdxBpsLGMtNHsYkDoB3pIdSvoLi2nvtNiaxnbDyqx82AH7rMOm319M1dKk1fS78/wBDzKk29Hojvo5FkUGNgyjuKy5rhdOvb24mk22SRiVwf73TA/Lp7159OdT0G/nnsr4yRu5kmilYhTnuAOmF/pVvwoNP8TPf6ib2R0mk2CKXnaRj5lB61zLFzq6Rg+Zfd95r9WjD3pS0NPwp4Z8P6pFqmuNYrJcazMWulkbch2fKEC5wBjr6nr2rP8Z+APCdvZQ3UGi2MEiTIBFGFiRwWGcjp0rY0ueHwnHc2z2V79iknaZZQu5V3Dpjt0/WtWK0tdekt9UlUSwlAbZXjwQD1JBpezhWp8llz9fLzG6s6dTn5ny9P8izoml29jahY4kUOOgGABjGAPTFed6XrV/b6ybPVrJoVlunt45BgCMLz+terdBjjiuJ8f6QjCDUPImmSKVfMWH76gnBYfTiu104QiklojmjUcm7vc5b4waTo+p6Tp2oa7FI1vYTeTPLCfnWJiDkeo/xNY/xLi0bUrbQ10RIU0qI7d1tEoEgYLtAHHGAK7C/utNunk0XUA3kXUQUsV+Ug9CD68V41e/DvWIvEf8AYlzdPZaVPdCOzuJJS0PlkEggjHzYH3TjkgVlCV9Gtz6LLnzxSVXlcLvXaz3su6/U53WrbSNY8ZazELyZraACC3gRgWlkBAGcZyAePwqxo3hbxDNLd6L4Y06Mz28Mc2pwSERtEzjIQFiPmxzg+9etaJ8GbTQpbhraaAL5XF1KPnPctj+E/pXmmh/EafQvFepajpawSfbwVlhdsRvKgwsgJ57k+hzTqYenUspnq0sc8TSl9XSbjbfrsabLrfgR0sL2Cxkv77Etu8Uh8sD+INwPmHTHc1jeCNRnbVdXR0Ntq6B2YQLlJFckjGOOD2qv4r8c6l4m1fT/ABHcJaxW2kyQxeVEPnlOdzMM+pBr1/4eeBILwalrnjCwltb3VJ98OnrMyLBFwVJ2EZc9eenoOa5qmFTXLTX3nHjVClSVStpJ721u189rHkXh9zFr9pZpcLNcXJJYoo+Ug9T7cGvV7vUdOttGFzCYvs8KuJWkQBgB97d71ynj7wcPCPxBsNR8PLL9h1BJCgZ/MMcoPzKGPJBHPPOc1QjgvNf03xLYXjS20Ua5G2PHmSHoD6jpXn08LClU5amrIlCWJjGpB+73+dtjuvDOjaDfeDptZ1ZIb3WNXhDSeeocRRs/yRRg/cABA3eoya5jTfDtlpFzqOm6w5+x/Z2udOtpF8qOWYY3BWJzuGRjHGCe9d58DNzeHbuHVGtxeWMothEp6QhFKHB7cnn2pvi6zt/Gvjrw+lnNBc6Vojyy3rwy5CuRhY+OCcr09M17/Lyw0XQxp4qdCvUpSbsuva21vyJ/hfYXWheDbeXWnUyEF1AOSqD7qk9/aqqap4hv7pd9l/oszs6yDjyYlOOB1LHnrxWz4h1CV0gNqhaJJgGERzuwDiNR6kjGegGa5/xxe6jBpclnpUJOq3kHlz+QxItw4wCT35OBisZ1OSK0TuePUm8RWlUk7N6+SODig1D4p+LrNpIWj8GaJc7pJZM5upFOfLUHrn+I9lyfQV0fjDxNpmu+IbdbbUEnCEKIjxHgnt6k/pil8Y3UXgD4eadoFi6wTTRstzKBuaNGBDkDPLsRj868g00qlgyWqK0SDfHKy7XQDnH6V4uMqWXInr1PRw1JTvU6dPTubF34xv7rxSmnaZbRQwCbyZfMQ5kQEgkkcqMc8Y6V096k76lIlhGwtD/q3QDepHrz6ZyK5jQfENtc6y0lzaJb207eXNdyRhXKj5scdc4AyfWu70SzPirxdH/YrW62dsgkkZFYImD8qBRgEjk9e5zXJK83orS/M2klBeSMJNC1Np0i8N6lHcFGdCrH94hPTtgDPfNdlqHh64mgs47iwiF1CjeZJcsWSZynIPX5ST6Dp2r0LSLHTre6ZoxGY2IkWUR7NzDjGO3SrGt21jFtu58GBch4xj5iT3z1+ld6wN4X2sefLGvmseNaV4Pl03UruHUbyWG7iASD7O2Uj5zlQegwffrWiPBGoX17ZmezglnQNmaQ7fMbJ5YDqAMZ+tehWHh62uxNJdzzzyxzMQocgqvZfpj0rTmsfJvHNtKQcb1A5K+n4cfjVU8E+ZVGtCZ4zTlT1OM0O70/7Paw31qYQy+SHxtYn1NW5dNU3zW2mXcvChzgbgc9sipdL8PW2pF7uQxvG7nNu/OPT8ag1DPh0JaIFiEwcl164PQCo5XGClVjZd1ubOSlNxg9ew6Bby6u7i3UlLaHO59+cnHSmX39nGzaWWRIZ4lCjC43L3zWFpmuM1g8f2eQmJzskAOSScH6mo9SVJ7qKKaNzuByjjr+HpXPLER5FbVvv/XQ2VFqWuljmtY8P+JPG3i21tdPaa28NwKJRc7sLGM5ZwOpc4wB/IV6bYhZ2c7OmF3N/HjuabYeIbDTnTQ4I3+1umWIHC+1JfSRNbrb25aFBJh5BwQo5b869CNK3JBvW1znqV3NPSyW36soy+Hjdo3n6pNa2yOZ7sw/IZQOxb+FR6CuB8YeP72UqNHM1nppykfk8SSY/iYn7o9h+Neg6rqGl6tp93YxyqIkkMcxJKAEAHr1OK8Z8A28F/rEml3Gj3F4u2T5o93mcnAbPQ/TgcV2xl73LfU7cuoUZ051avS39epqfDeS38S+NrLTp901pJHLLMZiGVGVSR17nnjnsa66X+x/D/jSSz0K4ia1lQAEgsI3PJUeo9+x4rmtV8IN4OttM1RLlpnup/IitreJmlDkE7WHTpkHFUdXv4pkku7S0kdLWXG2dNre4wOa48UqdJ8yXvHVOXtZqcW/ZtW+a6noer3UV/c2sYhJQASSuBuXHp+NcIP7QsfFVzc6dNcafATtSYjkqeGwDxjrxW/o18uoaMzWNwqx8vIQACn+zzTpTaTyQQLqAmuoRlMEPg++K82viPa2cVZrfzMoJ024vbY4O08Ox6lrF5eyX8lxabzC8YZVkeMHqGPT8BVrU9QstAsdRtNA+1yyXK+S0syKqxRA4CL6nnrUuoaVfwanLcGNBtOWdV4Y+3Fat94bt4dGuZNUnBuPLJAJ+VOP1ohmEo01BL1PQhVtNKo7x0sZ48P2hiSAX0DyRIJbl5FGcYxzjkCq9nrWqWmu281hMFsfIS1ltwAgwoxyPcc569KwvDmmatevIxvJltSm1SDgsM8Ln0qxaaBNcatBbT2ryWCSI15JExZ9pOTnueQATXoOvColCDtfqbQhSlKbnPmutn0+X5HrXhLxFbaheLpthA93amMMWDKJLZs8gE43L9OfrXoumapdWlxHaT+ZMuQqMeuPevDvDem339qP4m0N7ODTkJt1W73ASAcEqo9DxzjpXovhXV4PEX2qaC5XdGRuWM7l9iG+oPpXY4OFpRev5ngY/AqneUdY9f7rPRbmFbST7ZAgCqP3saL1HqPcUy5hiuYBfae/zsnDxEEOPcdKwLDUr862tpNdBU42kjhvqKm1C3k8N3v2vSoi1nP8r20aYRG/vD0zih1oOLkl7v5PueT7KSkot6/mVnFqtwwvlvYo3GGmSMrsbsBgc/lWPrOtyW80lpoRe/d4yEbcmVPqQa6rw/4tsNakFup8u4Yn5OvbrXOax8OjZXl5rHhW+W11ydwyC6OY2Ockevpx7VKpOEeeGqavp/w5SmnLkno/PY1NA0TxFGkUuqanDdvsGUjXacnsegGKq3y3PiBXgg0W8Ty5XjeS6Jt4spx9WUnuODWR4j13XoNItorvSZbPV0Ktd3No5MZUfeZSAMZ9xxT4L+y1U2lsJrrM6k3G+6kDp68HAz71z1MXBzcU3f7tfu/Q2jQny8z/AK/E7Pwjo6eH9Hhhu7mGS8IzNJH8ibvRR6VV1nxE8yTW2l2d5JcK20SCL5Gx1wf8au20ek+H7GCIKy2xJ2yyAuAfdqeniTSmumsreVpJ1GfJjjJyPUetdk/g5OZR/FnJH43PlcvwRwcepareNfWK2K20CKPLiZfLLnPzc/nRBoMEmhC0D3NrEpUTIZS7sindtJ9CepHUV0epgaiBc2ulu0Sth3Rwjt/n615p4mj1Kz8buttfb4Htsw2zMyBW6FW6j/IrjhXrUVyKXo9dex1unCrrax0kc9pbw6lfWbS6nPHC0ptw2d+1T8i9cZ6d6g+E3jXRdeec6XYTWa2G0TwNHtRd+cYPc5B/nWz4H8OabH4TS9Ev2WRwzzXTzAiJQT8vJ24H5V5L8RPiZaTaTc6L4dne9YOYkuoVMSSrjBwB9foetZydWm1OWvY0pwhWvCK/4B9Dahr2gzagdAutUtft1xA0n2YSfMUHU8cD+dVPDmovb3smhurXQthmOeLkBOyN/tAGvnn4C6N/Znmav4gNpDa+asKR3T4YlgcbfRs4+ua9iu2Um5h0Oc2t04IeUZwQfUevvWksbeamltp3ujOWEUL073/RnpCuSpLIyAdd2M0F1LiMkbm/hPU15RaeFTzJqWvXc96mJElhcg5I75PSqFzb6np2g2n9p63d6kxlkIup5wr4LE/Lg9FFb1swjTTfK3/WphTwXO7cx6Tf6fZhgzLbNCS2RIRx64J/EVjxpaLC+nb0ubfnCzOrjB7Z68VxXwv8YaT4j1K40eBY7hLcsvnTOCjOfqcncc846/Wui8R+BrOdxc2apY6pApcEtsR1/iJYc5/DiojWnOPNCNl2/pGrpqlPlm9e5b1PSomtDBPquq2WmqfntopMq4PG3d94L1yAcc1wfjf4P6ZrmnBtFuraC7U/us/IrJj/AFZPPTsawB46vvCYjn1bXZLiz3vALaaDeGIBIYsefTp1rqvh/wDENfFVnej+yI/LhAeDd+6WUnPyruxzwOnrW8pczcZfZNqWIr0UpQlo+nf1PM1+H2v6atvb6ppF0umG5RbydJEdBDnoAuWPrmvX73R9X1dbGHwzraW0Vthrh55ckpwAPrgGoLzx0+manbpqKXOmQSHYFuYQYx7+YrH+VbTa94U1WZ457/Q7mTaesse5lHPPOce1VCtGKs3e51VswrV5qco2tfZXWvk/8znfHM9z4m8UaV4c0Ap/Z2l/6XfalbsDtlIIEQ7Bj1PJ6+1UE8Ba6niNp9L1COHT2iCyRzDcWfJJP05Pet/xH4g8Lro8+l2HiTSNJLgNutpYwR07A55HFcnr/wATPCGi6HaJP4iu9WuEQ5SxBLSkcHczcL/OsakIVpczl5WM44yrShyU42iu/wCbOutPh/4dN0xvwb5o0yY35BHce4z26VctryNYylrDBaWUDmJLK2GDnrhgvTrnHvXI+H5tU8b+E7bUbKWXw3a3TNtW3PmzvCCRy5+5nHGB+PNdrbGDQ7CHzwHnmbarY+eQ7QMse546mpjVbkqcU7f16nPWqVKkeapO77DZdWuIoLaGztl3yyKAmMeUh6n61a1KT+xtOM0MUDynMlxcnaFt1Ubixz1IBOB60lmqpf8AlwpuldSFdhk8DqfQAmvGPixr9rf63DoqXxjsIcNIWyvnS5IJJ6bf8KdSpGklVmtei3+ZlRouvL2cHp1OM1XxcnifVGluLaScSzcSeYV2ouQoK8ggAk565Jqw0qqGj0i3Z2AMYkB+VRjB465zyOelVNN0oWeqNHGy28YmZTMWASQA9B14PGCK6HRPBmp+J4YrbTrxLSCJgJWuHwgPf5hw2eo714VVxqVNOvzPdjalDXSxb8NaLfeJ/ETabYWcPn26j7TcXBxDn2AGSecjn86+g/AnhO28LeH4rSFIWuxuMlwqYaRj1JzXMfDnU9LbV18OaCTJDpMflXczQ4EsigjcD9eOfSvR3nihmRJZD5khwowcH2r18vwsILnlujw8fiZzfItEczBpeoQQs8ys6Qu0saSMN4BB53LgZGTgGltrPW7u9triG6ji0o4cxzIDLICuMNwMV0N9KJYvs0JRpZvlwwyAvcmlULYWqJHFJIoOMRjJye/0rs+rRva+hye3dr21J0jSMYjRU9lGKzp7qNb6WKW3kLR7CkiDj5sgDP1B/StDcArM5+Xr+FY8StLqkrXCrb28eFCFuZWPQ5+g6etb1HZJRMYattnhmmfFnw7p+pBje3Edwg8y4kijaW3cjgr65I6HGM138vijwx41s7eXTNdsDdBxstXkAdyDkjb97NfEcM1zFHMkbSqHPzqvcd80/T7yazvI5oHKMGDIQeh7GuJ4dezdPdfqep7ROSk9GfcZ1HRZbPSrnSbxDLFMyG1I2yvnIZCpGQev9Km1wrfatYKVCwNGB5o4KH3r5x8GfE2LQfEdtf6tB9qidoxOwJGw55YepAzx+FfVbG01jSpZbOVZrO5TzoJkHBBHWo9l7Sle1vLzS6BN+yqb38/U4iKwj0vXzeTwGXUmzGpB3Ar2NbdzYpeSpbMxByGcD8+ap3ztLfQuvymNVViDxnrTo7x7rxDfw2+VlMJw4OMnBrnoScJWWtnp9xpNc67aHi/jfxjqur+I9T0zRbWAWVvL5Yk2A4xxn3JrU8FeJ/FejXmneF4bSO1m1Il1u12MVQnAbD8ZB7H06VnahrlhZ2L6bJYTRziVGhvUI+dlOXB46dcVseJfEGlav4W0ycM8l0QRbqX5x0YsV+uRV0I+xkq82rdf6/Q990FGEYOPuv0fpp+Z3jyP4c1O7vrZ7vVtRjHlsb66VdjnqY4wFUE46jt0rz74iLFceM7OeA+QdVtUeeK35Uyliq9O5GMjr3rd13xb4P1vQ7b7fp9y+owyJM3mZUyMOMbxyfckVy+pSz63eNc2tkRcSOXHkn5mYHAx/dA45pZhiIShyRd35HLQp2tOaaezv+HXb5IqjRbnwzpk3mR3Uhu5lCRRuQrHuBiltLPxJDqdlDpOjwWk8rlkuJpQrADrhTyO3JGTmu70DwfqEFushvyBCVaM+aSm7BJwjDgg8Zz+FZUfhHxHqmqXESajKiSOHLq+SnQ7wf4a8iMJKa54t3B1oyTSkjWjPiC2vyPF09pJpYcecYRkhccEkAH72PzrlvFOlDVLaaf7Uyxb3liTcdijPAIPfGK9Z0jwPGIwb29u7uH5Gf7ROWDgcg4HHXnP0rjPEXhe3Hjm5dLt5LWzRXeFBuaTdyELdABjg/ga6q+HlD3mtHs+pzUcRBytGWq8tDLi8LXem6HaXM0o8twI0QHczuRnbt+g/SmXOn39pHJdSXBtGRP9XuBDjHO4Cus1G71HWdYsYzCltZxqipHEcMhb5QSe3Bbn0zWL8TdYOk6SptY4jOowVKbjtBIzWaUYaq7S29S1UqTklom/yOWsfEWkW1i1j5dwpk2gGUg7GPBCcd+vc816B8NfDfiCLxLeapdW62GkGNoRbyL5bzEYCybMccDvXi159t8U2VqFvIhCgKQIEBd8nnJHPbr2Fa7+O9bNsNA8SaxfHS7OPA+zYhluDtG2N5PvFOuT3r1sLilJONTf+tDrqqriP3dN6y3vrp3R7vYara6kupw79nksU3A/Mv8AdIP1rb/tpr7SpbSAtJflNokQDBOPvV4t8FPEGm3Vlc6HPexJdOGEBZsOR6DPUjt9K7Gz0rWLW53abeLHMk6ogcZ3huxz2ODUzqzhG6Wj0PIxGEVOs6cumz6HYWMcY0e1/smwha/GTNIwKBWU/OCfX0HSuCk8Pjxf46u/7Q1S9sZLSTdHAJGcE4GfLPRe3TmuknY2WvKmrG6htL0LJdLC+Uil6YJ6hDxnHFdVqOiaXNPa6vFbF7nTlLQG2YZbj7vocj1qVT9uk1oo7rb56feYKr7BvvLZ7m8i4iWM/MAAp3clvrVDWdJh1O3KEiGQcrIiDIbOQf0/Wqul+KNL1GFJI5/KJ4KzfIVPpz71s7lCbs5HXI5zXqtU60ejR5vv0pdmcLH4mvbU3OizQr/aNuuWkH3VUk4Iz6joKp+GNC1e7vjdXqGyh3MpZHzJIOOo6AGr+pXWk6ffanaajLJ9r1IrcrGFLOVUYzjsOK2W1y1HhxbrTpBcSyr5dvFAN7SS44UD+eenevLjS9pO9Wd+Xp8+p3uo4R/dxtzdS6s1vc3k+npz9i2NKnuRlc+vSvOfHd+0F3qM9jYvLqYBXdI4iQKRgDOOfWqvhs3/AIe129uNYkCXXMlwqMzqvcH3OM/Su81/TbXxHpHnR7ZYZ4wQyYII6ilKq8VRk4K0l0KUFhqq5neL6nzNqN3q/iCB9G1CwvLaXHmRQm5EVv67yvG47cc545qxodkZvEC+E7TTYVkW7VRO5CtEpI6t/FkZ4qHxnoOqWesy6rrunvfR2UiSQxgEidBwYyB0GOp9Mms/wL41dviXHruq2tjBFLKEaF49yxqNu0JnowwMN1rgpx9rq3p18v6X3HrOTivdWvQ9utPDGm2evhJrQm7jfDMDiMFekn1/Ouss4LaGJvPuTcFMlpCVO764ql4l1HQtVdjYl7md18qaSAlSqsOmfX8K4Dw/o2o6Jql8mnBl0e9ceRazHdMxH3nDenTqOav3MNJwir+hxWlXjzSdn5ndQ6Vd6zJczRT+RZxA7XzjccdfTAry7xp4L1fxdLp6XuuWun2kPyy26xZMPOc7gfm4J9K9X17U9TOjra2NssUSIPNKDc8g/uqB0P8Anivn3xvZ67rU7JPbahH5TOGtyfKiQg/L5h/jbGM9ueKdT2dKS5Xr1fT7mXh41Jp7LyLcfwy8LeGvEsLxeL7e4AnjmhgmZY3JVtyqdrZOSByMV2Piv4uCyjmbUtRgguUd43ht7UygHHT5umeteM3Pwg8by71k0LM+d7XL3MfI9Rls8ela/hf4c6+mk6nDq1hYXS3MWyPzJt0ls+PllBXqOxGTn8K6nTlUu1Nvul/TM+aEWlJLyb/XY6W78OaP4yjtbr7dPd+dCWhuLSXCxOfm+ZDnDDOCCB/KuhvtK8V6H4ds7ezvYZXtsbJ7mwjERTj5GKngA9wCea88T4PfETREt7nQLm1eOdBIwtbraA2M4IIAP617d8NRq9j4QNt473TPKHjaFFBeGPaADx1Gc/Sps6Ulyzt/XW+3y0FKSqRfMk1/W1jyDxbca3qGhzN4pdXZDvkjRQtumDww5xnB47npzXkFzGl4qoLmxhk5+bdtBHuMcH8a9m+Ivgy8sLeGG1nF7oV1HJM8ryqxt3B+7tJ3enzYxycV4r4h07+xLyGKKWGffGGEkbbgQe3StsPJVJuzs/63KqtwpK6vH7je0nw9ObFF0u402W8l6sZwOvQDPU1oWHgG+EJu9XilUDkRsMGTnkhjwB9a9D+BnjC0WSHRrmwsrLKE2/2SDdLIwGWZyQT0yc5HTAr0DX9C0LxZdpNHqpnuoQ5HzZWInC8L0PX61x1a1aLkk/8AP8/yNoqmmk46L7v69TznQ/F+l+CI7pl1AahqTIpitIAxihA4VS3AyOpx+Fe72UEutW+m3N9sE5gjnZI+VWQgZA9s+9fKvw98GN4p1+4sfNWEwguXkBwQHAO0V9a6HJCmrm0sHY29vGIWxwqlRjbXRSpKTUE9Fuc+Llye91f5GP8AFLVLDwvoD6i8wh1GRfskEjHP3uWAH4Z/Kvmq2juNR1KS7Gn3F5aRL5H2jyiy7nJxu/p710/7Qmptr3xLXS4pc2WloI2w2QZW5Y+gIyF/Cq2n6cxjbSNOkuQ5nENxIsihGODjA64BxzWWPqpOy7fcjfA0uWnd9Sv4XVtPvo4ruSH7ADmUO3OR2APfI6V3tjcahpGoWcWktFdaNqKre3c86BY0IyAuTxlcj6k1ztz4XmtILy68Q+XdRwxZRlZmJ4+8cYAGcnvSXH9o3GmWDR2MOlWLxAJvkLgqTjcF7ZODXmKTbcl950zUZWVz1fwdM8/iCOXTIYLOxyWnlt4toKj7rN2zk4/GvTZDDqDskUhzbSAnGVw+O/rjNeUfAWTZ9tNpIs+nPEpaYDcWlBwee/Ofyr2N3Cgs5AA7mvfyuN6N31Z4WYO1ay6FUXgF2beSJ43KhvMK4Rj7Hv0qP7fKjt59sVjU4MiuGH5df/11DffZjPGWmkSRgSjnlF/A1R0a9Mkl1DLP50e/dHvUIVTA5A6lfr6V2SqNS5bnKoJq9joc5HHeuf1KC4bxNYSStA1koLrGThw4GN3XpzitX7QGuMIXZdueOQfb61lapLNFOtwXtlCsoKygqwBPGGPBPt3qq0k4k0k1I+CdUim0nWo2hXKlxNFKVyrKeR9eK6DWdN0zXdJS80WEw6gzBZYRgIOuT146VBc2upT6Z9pvrea60xRhZg2RCQBjOPu8fnmtD4e+Hb+a5v7hSbeBocxRyof34zyRn0x1968x1Fyc17Sj+Pl/wD6F07SaavGX4f13OYOmT2r3FndSpHNuwVYE54z+Br6A/Zh8VXKS3XhrVL6PyCols45ckk5wyKeg4wcexrxrXLO3OuvNLeTyrncingsOmefWtPw5aWreHLzWpVuZZIpZBmFvmtNoBjf3yc9PSqpYiVlPfv0/MVbDws4PTt1PqzX/AAzatLJcxyiO6WTfuzjjuCKwbS1m07XI753YEOI3zyCD0P4ivLPhz4/TXbmz0fU9Rl+2XbJEHnfOGPfjnPH617HPB9gvhp13IJYnAKSNwzYrGFqdVTUHFXsYST5ORy5jxjxRp7WevXlldxiaFGJij3YwGOSR+dQWmjxxwnfZ7YI8FVDZ+U9xXrnxF8OQajp6atEu2+06N23hio8sjkt/ewOcV4lYalLrU1vb2wFjZgYuFVuJ+Ox6jPcDpVypJu9R7bLue9hakK+HutLb+vkWtR1SyEkcFuiARgHIP3vx7GrPh3Xns9PiVJQh3EBWGc4bgjH1xzTrnSodPb7TPFGYByE4JYVxl8y6fapKJUTzJN3lddqnsK8yMHpKGjuRUjH4HrHzPcvCHikX2+zkiK3BleQM4yjHA+UkH2Nd6utxR/ZwfJzdAW5G75WBPYj1r5aOqARQNHCGBIJTJwxBr2LwY8t5odvdXjTW80Um6G3XhUQc8k9ckn8q2pV6kfiPPxOEgtVsekmZllWzlaWJw22KWI8KqjkEdxj1qWezsordrfUYIvsLLkW6oZC4GSWPGQSfyrkoNTb7TbG7MzqvmTSRk4IB4AB7+tJrGsLfm5hluhAxiaSOSMBmTHQYPp+pro+tR5bvVnF9XlzaaIuxx2dxNDbWt0ZBEU3b2UmR/u7tvXKqCfTkelcn49skvvtMC288pKeWpIOGxx16d6t6DpKnxGvkTG5DKbi4nEv72QDvIcYB56LgV0N6LWytHn1QLOzvmQjKlQeAy9sAHFcs4OtDtZnVCXsZqzueDapCfDMWnxafashgGJJw+VRmGGXHtnr7VyvjIQS6tcvprPKA6ruc7t7qoyevPOTXvMs+mtod5HLZPdWQjdAo43PzsOfWvM4fDFlo3hgTa2YnmublWWRCf3Kk4bk9/wAKvCT5dHq7/methZwc7TVr6f1/WhzsU6zeIrO71WN0DCNj5ACcgjnj165FfTupIZrpbiznIUoJYwj/AHscgj1rxXw94eg0Rr258RW/2YRr/oiSP80gOcEDqR05FesJFMui6PqLsiR/ZEWRz8oTg5GPxFevUg3T5no1qYZ1OMpx5NVe1+mtnodPFqsWtnSJYkP252aK5gPJSPHO4fXGKS+8P3Wk3H2rw7qU1vcvkLbSNmN2POSCDis/T99nrtjr8ECyWl7AbSVt3+rk3cEj04/Su7W1McpmLtLMeNxPAHsKypUvbpylpK+60t5/Pc+dqz9i0o/D/WnyPLdVsb6w0577XPDMVzZBGa7Nvc/OCT94KR+PFdT8MtT069sJU0ue9miUgr9p+bYvQAHtXZyqkiujqHRhgq3IINebzzL4U8VXLaTBELR9oazRtob1Kj1rN0lgakan2Xo+/wCBSqvFQlC2u67fiegyadaSX8d7JbRNdRqY1lK8hT1GfSuT8KWMGl+MtWtAhG1A1qGHCKxJYL/nNdVpeow6pZJc25wG6qTyh9D71y/j+11m3mtNa8MQxSahbKyvE44lTH3a68RGMeWvFXs76dn/AFf5HPRcm3Rk7XVtfI2vEGmR3SfbEjVrqGNlGcDII6VyvwvubTTrNtOhS7fzT5u923KrqArKB/CM5IxUmnf23beBWub3cbqVWuZYCCdofnbntjpjtU3wy1G2j0CGC6VbTUJJZCInwGZScjHtg1yxkpYqMorlbV3c3cXGhKL1SdtDodf0aPWIPJLvAHUgyR8MM14No3w/0/T/AB7Lp+rqbloGMqTRDc2D935ehNe9a14gs9KsLq8n81ooEDHYudxPAA/Gud0fSpY76/13WFtYZL2AMmX5gQdAPfoSanG4eFWonT36+nmXhK86VOXNs9vXyOS0GeKLVbnU7CzmtgrvFHBcId4XuV7g9BnpXT6FLfahE9xc2mydwAo/uKOij0HJ496fo3kXU326OIBWJQuQOQO9a8975NvKY9sUagkn0FRhKHLCzelx16vNLRanO+LHlFn9htmuIp7jhRbplz9D2+tQ3A020Sw/tB0hu7YYQF98v1b39zVT+3NU1LSr06YhsJGhLwy3bKsrH+7gk7M8e+DVnw14d0nVfhjBIMf2pcQebc3TZaU3HRt3qAwIH0r0FTUkqbWi1YpUXRvUnvtZefcnj8U6Lny7u+EZcEKcFmP4DmsiXWPC1jehJLu7DBjtXayqT6EV5brljBaeJoXsYnnkt0K3MyLujWbtluh+nasm4bz5xE433c7suI2zuPrnt71M6tKleMT2IZOqihO+j38j3vT/ABl4flQGDVVgi3bQbgGJd3pluK35pmiha4kijdOBhGB3f0rw3Utfiu9OiS4s4I0tIyrMISUkYDGCR0B6Cl8M6v4is7Kwtft32C2s4i0q3H70zf3Fxjjrj2GKiMU1qTVyiTjzQdvX/gHqurWI1/TQlnDEksL7ngkIIOQQRx6jvXnnjf4baldaZYz6THa211aswa1CfI4buvB5BHTHTFdVovjAazP9h0sQrq8W4vBjaJVU4LLn06479q66Ce8v0tbmBmikJzLGflzg4PXoairQjJXS66HmOVbCz5ZaM8q8DaHrmn+K5JdR082FrJasktxdRqHncjH7v0I6n2FdHpHh/SbbVtJuNOllMltIAQrDBbnJ9+tel61Kl1o80c4y23AOfUda8Oj8RWOg6hJdaxDciwiLeSu3aw2AnIGf4sAYPrXn4mhTotRe726GtCrVrptdNzy/xx4judL+MEZhuXS2tLoRsEwMKz/OOMZ/Gvp7R7eKwtLiC0bM892cMwyZMfMx/LNfPx0LSvH/AI4tvEmnkva3OoostjMCsiALuJfHbjGRxyK9r8C3Nxq5mubiN4n0+9mj2Mu0uCmAMfl+VdmFtdcuijv662/G/wB5li07e899vwPB9W0GL+3dR1DWpmaO4ldjOilgkhY/K3vnitjwpa3Nw8dwhjt4ZEkHnS87AOOR13Hj3xS+PryFn1K00GZp5mnD3Fzu2rb87tgPXdnHTpiqPh7UZodPliW8ZrqbKZc4ySOGORycjrnvXk1r9Xc9WCcoXasWG0q/s4r032YNNu5gsk7fddAckKp7Ee3enadY22tQSJYXEtlDpwMkVzcbnAQH7u0cL2xioYbq9NlcLrKu0fmAJE7ZY4zu47DoCat63p8lx4bspIXextY59y2gPO0jO892BxisLtOzZT21Om+HFxqGo6vDHpNk8AWUl2hcgBACSXHqSQoAHGSe1euzX92bR7q4l3MjcWq7R5jbeFz1HINeHeGr2JNUjsLqeWGOcCPfBIYRz3Zu35YNe36J4TttG0+S1tYY5YdxuElVyXaRvvdepPXrjk16eXuTi1G/6HlY9RjNOXU3bhZb2COMlovMj3OFbBQ+lc7HpN0by7a+vGWQsXh8slXAHTvg9+M96i8I3upvdXdvqCok8THyYi7KfLzgFgw5I4zgkc108CRXkPmsclsj5HwV9RkH1r1OSNdKXVHnc0qN10Mu0v49LjSKa0njRwo80yb1ZiemT06/Tmtdmiv7TKBJYnHDYDD8DUM2nQOUAXYkYIRRyvIx0qa1hNvbRxblPlrtG1dox24renGa92WxjOUX7y3PmGxs7y0hgtJXWYZCyNDgox9GA4xU94IZdbSASR/aVUjZg4246cdK1NV0fVNCtLqHULRohMhKuh+RmJ7Hsar+HxFbR266jYhZZM4uOCXUn7vNeHSo068pOK5Wlp6n0NSrOmld3TZW/sbSdZtLez1PTEF9A+fMV9v7vn5eOTzz+Fc74+8M3mmWbW9paW7WzjEkdqCrkdmYV6VqejxWWq2l1bRfewCg5OP6mr2qaUjXiahbSi2v9m0FwWXb6MtSqLVvL7h+3s31TPkmxja0u5ZY5nt763fdEehyDxj3r0nwn8Stf0jV4E8dm+u7C6G+KWcYeIno6Ej7oPYcVqeP/AtzJI2owIJpyp89I0wpPqPY1wOvXeraguny+JFnu7a0g8iCFm8sogPODjr7muyGIhXVpfNdfkZzwzhZ09v63PqTRdYvJrdIbpzdRXCh45wMqwPTnoQRXLeIvh9c6hoKX1q8UWqWTOHNtHsE6gkg7RwGx1rG+AvieK50H/hHr6RlG8rp91ID8oJJ8lj0z3H4169pUklncuEZJEGFljXqP9oHv9KcoKq3Ce/R+n9aozjVnhmp0/u7pngWq6X4j1vRo76a1jtbCGPCtIwjMuOCTmvMJLPUH1OFp5oVtmbCGUkrtHoOv5V9geNfDNjqfhi5jtw8dum+YrGpcqxHJC55HsK8RbwfoOq+F1u11mQ6tArk2q25woBwqt/dz1ya1oYd023uepRqxxtNt3VmrWv+O5nWMGn2PiLyYXkubNV82MMvIyAQPfFdg3iJrSFktJ5JJ5dpkUZ2gc8YNcVpLTRTm/lRTHAojxGfTpn9TWhDdxvqs073EymVVBbZlVIGce3Fclaiqd5rZ/genicDopbuPTzOpj164Roy+GbAAHLHnnqKs67ei0txDPDGjTqSY8kYyf0/GsDTZY5bxZCf3RkVhIeASO3pUfiu7uhqMU06RlJAVTd87ADHI/xrzJULwck7nmrSooyVjuvBWsw2NxqESwtJLHAeWbIyMEKv6Z+lR6349k8mFYLaa/uLaTDiCHciKeWyx4yB+ea4fQL5lE7rceQ7ZVmYffb/ADxVW0vrbw/aoLy8urW6hkLPEiMy3KexJ2g816GDpuSUJuyt9+ppSwlKpUnKW6PSL/V9MbTFj0O6+08s80EcPlNEcZLHPbHf1rl7C68L+I72Sx129mgnh2w2gaMiKHozTS7iFx0UDOevtWReW+uGK91OJYbC1ngGxWmV5HixnBAPUkj6CtPwB9nk8OalHJYC7vZirXsk0RkCgZ2rGOB06k9z7V6NOjGnUbS0safV6dGi6yb0e6s2u/l/mUX0P7R4nuzrl6bu4gkMEUqPvWVQOGUdlAxx6mvUfEAS/wDAsemx3JEs+1lDDaQgI7f8BNcN4S8PTDXLe1vhPZ295E1xYGVSxOwjegHVVGeCR2rudYih0Vbi+uiHjREit4weS3PJPQdT+VXUb+zuzgzTEqtKMU/dSv8A5ktv4i0/TUmsNWaQWGzJuHGFjYnv/KsC8+LP9h2jxaLef2gWfFrFfJtYgH5gMckDtmvCfiprGoalqkNrHcyypLIZigPAY8KPwFZEVjqttJbWto95qGo3bfLBbqZW4/A9z29K5I83JHllZ/5d/I8/2cOeXOrr8Pl5n07B+0H4fti8esW15HOi5McMQPz/AN3r1+tU7zx34M8YaxZQ3KXVre3siG2jmiIcsp4wy5AJP514BFq+q6Z4lQeKdIsg64iltrm1VGK4xkgDr79a+kPAmheEbbT4dU0HTLEu5DfaB87xOB8yHcTsxntUVZzqRUKmq3vfQapU6X7yndHaaM7W9y72srLGTnYzcMPf3rqbq6EenNdRkbFXeeM/L3rlLA2dzAfscyGOcZDI3HPoayNR8bDw74IvpzZXGpXNvcG0WEKUBzkAk4PHH4mt6FZUocjdtHY46lJ1ZXiru6Op8NeIbfxJ4dW9sgYxJI0QjkHzDDY5H05qt4v0G4vtQ07UoZVSDTlkkeGOHdJMSOmc9OPrXN/Ci5Mlw8UkJtmkH2s27kFkLL04r07cpkEW/DsMj1+taUUsZQTnv+qJrf7NWaht+jPJPE3h6PxD4i8LajqmsXkNtaET3GjocRvnlSxz9ARg8cDGa6LW/sesJctfTo9hGNpY/KIoxyxPsAOtcL4r8Q3Wn7RcQfa5jJLZmdAFDMpOCAfSskarJ4h+F/jK2tNU0ydoLYhZ4WKsMjLI49wGUHoa4efnXI09fy8/n/wDr9m4++nt/WhX+F/jXWfHnxD1Gymhjg8N2ULy29vHFtwpcCMs3UsRz+deueI9XtdNsJ1Kma4KgmBMbm9AM15p8E9Gk8O+FZ9d1Yv9ouY1uLpBlfkVT5cf4A5Pu3tWdpvja4j12bUPEKI9rcv5iKqZFsOMIcjkdOfrXbdxinFGlDCSrOU46qP4vsQPbtJNd3Mh+yMjBvLuCFbZ2ZVOCRx2rjbHxd4j0+9v4NHu54rW+k+zoQMsSTzjJ+Xrmvab6K08TXUU6JHPFGwCqyhih6nn8q5DX/Dka+OIYYLKWVAVuvQ5PQjt1x1rnxGKmoWR3QrwqScmtWl6aG/baY9rpcOlpHMIbcYIzukJ6kn1PJ5rlrDQnvtZ1aRpzHBaSgWxPDhsfNjHOa9ETVc6xc2b3tpFdRqCFDZUkHDfN65qHwlpQtdMc6pDBFdRyyRecsm9ZcnO8kgEtziuKUHdKK1XUwhXlFSk3ueeXunYVbYTXU8u8nymPyDHIyO5+tUpra9iljuIFaaaPPlAsQoA4wR/npXoPiTT2kgd4SzLbEfOg27lPQn1/wDrVkiWG50x4ikgnjAWJox046n8a1jKTftNdNGb08ZUh7t737nCrqdzplt5y3U8F3Cc7Yx828/eA9B6V6L8KfF99qtrqiaxf+ZqEDiWGMx/vDHjnp1IwOOtYDeFYte1WO13m3WC18ySUtt3OScKe/Y81Z8LzaPBeaVpkF/DZ6jDOhc28ZdZACcdT1bOD39q7sNGVWPM1ZHo4udDEYflkvf722/4B22lTXF8LyaxvZJg3z9eS2f7pHy8cfhXk3xX1yO/8RGwawa4EUJeUxnA3Z6gf3sZr3O3tY9MZ2sokjaVmZh75zXz/wDH5xY+I7K302FLZr6AyTShtu/kjk9sDNcmIg6lVNfj5dTwMK1FNP8AAj8FarN/wkmnT6XdW9u7skccIX5pUHzHdgY6DH1r6D0LdFNcuqhHmchkBPytnIP5GvlD4dw3knjfw1ZxQJA8dwSM55XaSSfU45r6l1LUNOtLzSzC8pu7jCKnuv8AEfY8j64qYU/Yu8X8vIrFSdR2aPn34nac+meM9Vs8hnMhulgU8lX5zn8K0tCsLbVrYXE9zHZ/ZvkufNbjgZArs/iZ4Wl1XxsdTt9kkE1r5EiKMMsgHUnGBwRiue1eTTtC0ZLGS3YwbsiFMebK57lj1x71yVoe84LodMKvNGL6syNSBttTOs6fq32me3ZSB5QUtx6HIIxg1Jfa5f6t4qsp5C11IyhHRDtTCjAAGODn8DXO63dtPHKmmWf2K2tgrmBmEkjHuznofTHSqVhfrHHLeotyrsUjgmRyoRydzHjuMH86UYNrU1tt3Oz065u/N1IOXj84LGY5wN0o5+ViB6nORxXufgjxlpMljptnJqavcsgg8t2G5XX+HA5x718xR+Iru41Wf7FNLFezsqgu+4lv724449K2r7w9etqFtqF2fsst4cNeKP3f1z1DZ7960oTnhp870uc2IowrR5T6pvI45dUguIbdZbiIHGe+cZP6CmW0y28ksSqoeE/vIIDubLcj+prwiLx3qXhW9ubKC8tngtn5d4zIj8DcVORjnOa6Dwt8SzaPcf2rCHnu41m8xBkHg4I74PpmvQhjqcnzPS5588DUirLU9K1LxLcWdnfSrphkmtozMIhOvzJnqT2OM8U7wt4pg8TW0kunQSxpGxjcykAq4HTHfr1zXjuufFK51UT2OgWc5kugbfygAZH4+Yn0Az3rqvg34r0iW0uNDhvQ97F84iCHLcfNhujY9fSrp4ucqyhfQipg1Gi5W1OF1Lxxq1xP5Os2TjUbEPExZm8ry3I+8nTdwME81asWbWtBsbe1NvsRlcF3PyEHkcDuM10/jTStZ8NWLXsSxa/powZ0uQftD47u38Qxx0rz3wh4r046xNPY28dnb3B8v7NknYwPOCa45ubm+bRo9Omo8nNBXR6Frmt2ugWaXMrskCsFRcbnck+/Sue1nxVctrtlaW8cj2rKJJJ3tymQ33VVjgGtPUbOPVIms9dtDc2DOHhkUnch/Csr4hSTWgtrZCtrYuw3Sb9zIFHGAeBmvRpR0TirjwnJUqezmtzoTaPd4jt5hKo4ZeMj2NQXXh1D5sDWcJSZNv71B+h7V57b69qFrdSrpV9GYIcBmk2kk9eMc46812Gi+MdW8RWd/D9ijjEDxolzA+8FjzgqRx9axq4KnWeisaVcPXwqbTukee3nhTVPDmoyvZW8Z8tt5QSbCCWBUg57EcfU16/4S8SQX9qttrDrZamvCyscKx/uk9zUMot1u1s9ZgSUzoEd2AABx0rn77w0qx3CaVcfbYncPHbynPA6ru7Y7GvPgqkJLm1X9f1cmpOFSFno/L+vwO+stWu1uJYg8YuEb+H7rgdxWnBHFcw3LjTbeOadSsqOceZn/aFeO3+t3XhDVbbUbxLuTT5kO8N8zxjb905x3xzXoPw88Y2XjXTRPpHDoSklvKyrLGR3x3B9a9DD1+ZPS6RxVaTptST3OG0/wD4thlvIkFlYwXBAkKYYFR0VevGOOa47+zLxdf0/RSoSP7QIpnIyqkNk/QY5r6Rlnmgyjo4YcjdwD7Zrn9Y0+z8VQm3kSWxvlO7zlAyD06j71a6y96LvbpoetRzuqptVUrPqunn5nlPj7Xp21h9J0LTrQxoSMtwGAOD36DBqCXQp47Bbm61C2ku7lC0dkhJKryeGPQnrjrVyPwVcWPxKik1nUJoodm9ZIlw0o6degFdH8Up7F4IIPDzyyXEpC3DeXmOJDxuz2b0zn1p1cPGrTva34HS60ZThToK/n/welzgRFMzW1ppY/eSyBg2eEz6k9TXR+I7GeTw/PMZkjjt0QzRtDnzJN3yoMnIJIP05r03TNCXSdM0+5tkj3RQogRk3N52Rg5755Ga8+1eWXT7/AOyXti1tZ3t4k8PnSCVkjJIfzADgY5xSo4OMEubcVPEvEVYyp6KPpr3/AAG+J7HT77wjb3VhrtqkcVuD9nRy8rSH+Hb1HQjJ46Yr0j4Y6ppGk/DrS5Jb8SSvGXmWV1ebzB1QBeTjGAMZxiuY0zwfpCatdapYokWmzOn2SDymMsg6lgOoBJ4zxxXcrp2k6O8ssUFpYS3JOZgFDOx6nP611RlKU2+XR7f1Y8vG4mi6SoJtpO/bfoyG4nm1nVYNRmhNnHbwkQxyIPOw3LFj/CDgfKPTmsPxZi60OTCxywvII95cApnOCK19TaMW0MEF0Et52+eSRmLyD2wM1nt4I0l7SR5pmJxv3XEmEBHQ7TjGK5q0JymrxujgVWLjva2x4r4y8FeJ4llutO0u6vYAilWSLcy44x/+qsPwRcax4d195b+1m0u4aNcM5MZ2EjI+hHWvpjw+JE0+Tyb2Sd2f5TEwKYAAPTjtU2oWsdxDNLd2UF7fFS0SXUYKFvTNZyoVKU7Kzd+v/D/oarExnG0k7Wtp/X6nmXibU9B1zTHgtBp11e3JyiCVWbbjqXH8utcr4HvpfDuo3emS2SzWxmFu1xagqcDqWHfOR74rsrr4d6N4gtG/tbRYvDmslm8i6s18uFz23IDgjP0NYejeBfGXhbVIdU1bToL6ws5GdnsyGMkZGCWXgnGcjuMVxYnCuk5aWv8Ad8rHRh68ZxUb39dzvHa91PTIW8JX8Nq1k7LPbSx7UKdSRgZyOo/Guy8G3c0c5S6uIbgSKIjNFja0o5PHb6e1fPfivxlI0keoaWVgkWTmJG/1inueh7frXP8AgHxvH4d8Z29xdOWsWvN5ijkPlxseNxB69adBTp1F1t22/qwqtFVKV9r91qe86vrQsfjTp6yKtvMLZknj2lfOiGSJB2OOnFeuowYB16EZH0rhfFHw88NeMNUtfEs9uZNXhgCwXEUzKjFeVLKODjkfQ85wKyrPxf4ilDJo2kyX4tJCl87oQu7skZzzxyTzivTpS9jUcJO6eq/r7jyqkfawUorVaP8Ar7zn/jX4aWbTNcuFjKJa2kt1AUJ5cAFhj6D+dee/svaNFcx61e3GHs2mt1COmRKU3Mw+gJXP1r6C1CeG71W3knDxrKgRoZlyBnqMU6ztbPT0MFpZwwQxowXyECqgBzgKOBkk1hQgoTnybXOipVlKnGMjG8f7rbwZqNpp9t5k10oiCqPu7j1rx7+wDqN8umF/LuCvKOD8qAcmvVdS1DWIviFpVja2gvNIvHVbgFcmMYySD2x1564rY+IqW1itlLBaxm4aTBKAKQo6mt6t403OJ24PF/V4qjy3b1v/AF6HOaRd6f4b0D7VfNssoQARgGWZlGFRfbnJJrEh8d+fai90mxX7RcXKwMJW3GNCDyO+Tik1zw7earJGwkj+zySAknqnb5frms3xDp1joev2FpZNDa6fsyZJnP8ArgNrs57fh61wvFxhTUpRu0ylQjNtJ7jvFCtYardXGmxrbrCpkkk+8V57DGOWq3B8StP0nyZL6RLy2dkjcxpuNuWHLjsQOhHWvPNR1S7v3kuLQpdKz+VuCkJgH36+nPpWLF5bNI08fmI0u3y2O3DdQCOuK4nW/eOcdtNDaOG5oKMtz6wurTT7DTprhYo55Zxv35yGyvHTtjFec6lJbEQpt+yyythlQYy3Tj/Cu28PwS2fgzQYHkUtHZxqxkOAGAzjPXjpXmPjfTtTuLuGV0AuOJIwnIPJxz2+tb4yo6aThoceEpqcnGTuVNZka61TZHqEGnXUED+bdbPneIfwsB1ySPpXKXdnoukWNx9jme41iRALW6hZk8ls53Hn5m/lXX293DpOvWmqXcgu7aImC7tZCGOxhhmCjlhwKreOJfAiWxfQ57i4uJQAxClfs655c7u/avQwU4qnZu561OpUk4U4JvX/AIc674Y399c+FtPt7+VrmaASJLcOxZpPmyMk9xkj8qwvjJ4Ql8TWVte2Dol3ZI8a7yFDAjBGT+daPwnv47zSr54ZPM+zzAKv8WGXA3DpzjrWv4w1W00DQn/tOGaaK7t7pgsXBysY4z2zuPPtXPW5ppcuj/U8+tT5MTJKPXbytc+fvh9qLaJ440FLi5t3Ys3nTMPMCAgrhcc7j0z7ive/HlvaTvpmq2BMUwAdcN0cHI/UdK8w+BehWUl//aTiO9tRG212U/uX4G3B/iH5civdhaw30s0MsKtbLFt8oqME+o96inJpuS9P8/8AIxxVnJLyv/l/mUNb0m71PRbprKRUubiCNmAOBvXnr9K+bfFOp+Zrgla7aR4MwKyncvT5j744r6WttXXQLhNPvlcxsS6S4+4ueAfWvCfi34eg8O+KHkEYk0PUg13byhipik/jUED1xxz1FVXg2o1GtP6QsHJKUodTOsdR07w9ZQyyWX9oTX0HmzS3EhjKqSRtXb9Oc8VHrujwzyQ3FlIUsZ4I5woHMORynAGSCMc9e9QzXGl6vBBp0UAiNmjGKcNy6bc7ckcknOPTNVbGWfUbq3tvtcixkbYiwOyNRk9ug/P3rz7Ne8tH1PSS77G54N0kRG6mS2juNTCA2zNHvO0cNhDxnoc46Zr17T3l1/wC0PiKOG2ubciOLzUCDK42t7d647SJbGJra/03V3eOKJmZAq+ZCgXhm9iSOw64rldanur23klv7qSW2gO9pI5d+GYfIN2cHPXHaojUld83UxqU1NpxdrGbNYTebd7j5gZyp8liQ67jzk8YwprvtF03QvEQs9P8PzGO6+zM+bhfLZGzhlO373cjFcf4a1gypBb6NDGjxxsZ0nIkjk54K7hjPPI/Kuz0aefQfFVnMNJiuPtKrjY2FQuOGB6fKeoou+blmOotG4knhPw3qekeLJ7TUrECCEOVvQhPygcfMeDnvVXQbfTvDOua1qGmBzcQwn7GX6M5+8p7jAPAHUd67nUp7+68O4u7mGWN5yJZLVhIY1CnrjoCRgmvA9f0/U77xC0MTSlI4zIrEEbSPU9ieP0rRpRnZO3W5lTbqRbl6H1T8NL+51fwBod7qUpuLme2VpXYD5zjuBxXgHxk0PTdC8bSyaRaR2pdBMQmdu8tgnaePwoor1s00rQt3Zx5dvNeR13w0vJ5tDt2lkLlgc5A967CfTbPW9JvF1S2juR9nLjcMYI7jHSiiiDtCpYJNqpBruv0PD9V0mxtY52toBGwDcqxHY+9b/gZBYtEbXMZmjBfkncdoOeaKKWGk21qfYVNaMrnfeK4kktI5XUGQlfm/Co9IjUSRNjkMQMnt6UUVjD4pr+tz5aa9yLF+JdrBN4YdZI1YFHBB78V8w6Td3Oh+JbSbSZ5bSUSL80bEcbhx7j2oorLBNqtNen5GlRJ0It9z7dtLiS98OO90wlfys5IGayreJPPgO0ZK5P5UUV24le+mefR2kjTiRX2B1Vhkj5hnimpaW6WtzEkESxlCSoQcnGaKK6IbEOTTsjze91O9bxRpu65kIhtLidATwHVcK2OhIBOM1veBtLsrsXupXdtHPfL5arNKN7KME8Z6UUVrV6Hq418kY8umn6s6HUJ5LXTbu4gYJMsRIfAzXL+GVGsanaz6pm5lCtgyHPQjHHSiitaGlCTW/8AwDxpa1LeR3/2eHzJJPLQuBwSM4rM0VE1e2u5NSjjuWhuGWPzEBCgAdsY70UVi3pc1ppOEn6HFavZwNZazCIxHFHeoqJF+7CgsM424rrvBs0l3pMy3LmUQyCNN/JC7RxnqfxoorO7cmn/AFsb4mKjsuxoSRRzTNBKoeFgco3I6VV064mg1O1tI5GFuVYlCcjggd6KKybfLYwsrngPjDT7W3vfEEUMCqkVw4Qddo5714tdAFpGP3iDk0UVwYDb+vM9XE6rX+tj7p+C88s/ww8NvM5djaqCW6nHFXfBBKX2vwp8sSXrlVHAGetFFei/jpfP8jxp/wDL3+upd8TY2ocDO5ecc96rwRp/ZluccvCxY+vNFFZ1F+9foOn/AA0c1rVzNpfiHTZ7BzDLcqyTEAHeAeODx369aq67PLe/vbp2kkSRkUnsu7piiiqq/wAJep1RS0fWxasuBap/CI8gHnmuW8QWVte2eoSXUEcj+QxyR3BBFFFeNjP4bOnDu0keN2H7nV7VI/lRwQy9jzVvwhbRXni24W5XeqvuAyRzuUZ49iaKKwfwN+X6npy+I+h9UJtIYxb/ACrHIkaL1AXA4waoWlvETdzbAJQNwYcYOKKK7KvT+uh5NPb+u54xqk0nka7dFybiOd40kPJVcngVy+pqFtSwHzGzjYk8kk5JooqMIv3iPo8F8UvT9D0j4CXMpuNRBfiSCLeMDnBOP5mu88Z20N7os5ukEpjjnVd3YMmD+lFFehW+Kx5GP0xLa7L8jzn4EqIPAdy0Xyk6oRkHttFem+L9VvdMTRFsZzELhgJflB3DJ9RRRW+XJTrtS1XvHj4/3YaeRvz20OoaQkl5EkrgAhiOhzVTxfpFhqPgvUrW9tYpoIYJJI1YfcYA4IPUGiis8R8E16k0H70X5o+TfCTnyNTT+FRvAI6EdK6q0s7ceH57sRILiSxDM4HfPXHQUUV5WL0np3R7lLZmRoxKi4CswUxtkAnB+U9R36Cuk8KIja/HpskcclhLZy74ZEDKSqEqeehGTgjmiiol8ZUvgZn6Dp9tY39ybWMoVRAPnJ4JXPU10WrXEr6NrkZc7IpYI0A42qW5HFFFYXcql2VJJJJFb4PX1za6jrYhmYKLBjtb5h1A6HI6E/nXD6jqF08dsWmY7gc++Bx/OiivQSTtfv8AoYLSUrdkf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The large neoplastic cells of ITGCN within the tubules are highlighted by c-kit immunoreactivity which is predominantly membranous (pink). The Leydig cells (arrows) and Sertoli cells (arrow heads) are labeled with inhibin (brown). Note the mast cells are also labeled with c-kit (small pink cells of the right side of photo) as an internal control.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ximing J Yang, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10745=[""].join("\n");
var outline_f10_31_10745=null;
var title_f10_31_10746="Rifampin (rifampicin): Drug information";
var content_f10_31_10746=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Rifampin (rifampicin): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?36/42/37541?source=see_link\">",
"    see \"Rifampin (rifampicin): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"    see \"Rifampin (rifampicin): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F218187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Rifadin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F218188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Rifadin&reg;;",
"     </li>",
"     <li>",
"      Rofact&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F218238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Miscellaneous;",
"     </li>",
"     <li>",
"      Antitubercular Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F218192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tuberculosis, active:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     A four-drug regimen (isoniazid, rifampin, pyrazinamide, and ethambutol) is preferred for the initial, empiric treatment of TB. When the drug susceptibility results are available, the regimen should be altered as appropriate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Daily therapy:",
"     </i>",
"     10 mg/kg/day (maximum: 600 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Directly observed therapy (DOT):",
"     </i>",
"     10 mg/kg (maximum: 600 mg) administered 2 or 3 times/week (",
"     <i>",
"      MMWR",
"     </i>",
"     , 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tuberculosis, latent infection (LTBI):",
"     </b>",
"     As an alternative to isoniazid: Oral, I.V.: 10 mg/kg/day (maximum: 600 mg/day) for 4 months.",
"     <b>",
"      Note:",
"     </b>",
"     Combination with pyrazinamide should not generally be offered (",
"     <i>",
"      MMWR",
"     </i>",
"     , Aug 8, 2003).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Endocarditis, prosthetic valve due to MRSA (unlabeled use):",
"     </b>",
"     Oral, I.V.: 300 mg every 8 hours for at least 6 weeks (combine with vancomycin for the entire duration of therapy and gentamicin for the first 2 weeks) (Liu, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       H. influenzae",
"      </i>",
"     </b>",
"     <b>",
"      prophylaxis (unlabeled use):",
"     </b>",
"     Oral, I.V.: 600 mg every 24 hours for 4 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Leprosy (unlabeled use):",
"     </b>",
"     Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Multibacillary:",
"     </i>",
"     600 mg once monthly for 24 months in combination with ofloxacin and minocycline",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Paucibacillary:",
"     </i>",
"     600 mg once monthly for 6 months in combination with dapsone",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Single lesion:",
"     </i>",
"     600 mg as a single dose in combination with ofloxacin 400 mg and minocycline 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Meningococcal meningitis prophylaxis (unlabeled use):",
"     </b>",
"     Oral, I.V.: 600 mg every 12 hours for 2 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Meningitis",
"     </b>",
"     <b>",
"      <i>",
"       (Pneumococcus",
"      </i>",
"     </b>",
"     <b>",
"      or",
"     </b>",
"     <b>",
"      <i>",
"       Staphylococcus)",
"      </i>",
"     </b>",
"     <b>",
"      (unlabeled use):",
"     </b>",
"     Oral, I.V.: 600 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nasal carriers of",
"     </b>",
"     <b>",
"      <i>",
"       Staphylococcus aureus",
"      </i>",
"     </b>",
"     <b>",
"      (unlabeled use):",
"     </b>",
"     Oral, I.V.: 600 mg/day for 5-10 days;",
"     <b>",
"      Note: Must use in combination with at least one other systemic antistaphylococcal antibiotic.",
"     </b>",
"     Not recommended as first-line drug for decolonization; evidence is weak for use in patients with recurrent infections (Liu, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nontuberculous mycobacterium",
"     </b>",
"     <b>",
"      <i>",
"       (M. kansasii)",
"      </i>",
"     </b>",
"     <b>",
"      (unlabeled use):",
"     </b>",
"     Oral, I.V.: 10 mg/kg/day (maximum: 600 mg/day) for duration to include 12 months of culture-negative sputum; typically used in combination with ethambutol and isoniazid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Pharyngeal chronic carriers of group A streptococci, treatment (unlabeled use; IDSA guidelines):",
"     </b>",
"     Oral: 20 mg/kg/day once daily (maximum: 600 mg daily) for the last 4 days of treatment when combined with oral penicillin V",
"     <b>",
"      or",
"     </b>",
"     20 mg/kg/day in 2 divided doses (maximum: 600 mg daily) for 4 days when combined with intramuscular benzathine penicillin G (Shulman, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prosthetic joint infection (unlabeled use):",
"     </b>",
"     <i>",
"      Staphylococci (oxacillin-susceptible or &ndash;resistant):",
"     </i>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Debridement and prosthesis retention or following 1-stage exchange, acute treatment: 300-450 mg every 12 hours in combination with an I.V. antistaphylococcal antibiotic for 2-6 weeks (Osmon, 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Debridement and prosthesis retention or following 1-stage exchange, chronic treatment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Total ankle, elbow, hip, or shoulder arthroplasty: 300-450 mg every 12 hours in combination with an oral antistaphylococcal antibiotic for 3 months (Osmon, 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Total knee arthroplasty: 300-450 mg every 12 hours in combination with an  oral antistaphylococcal antibiotic for 6 months (Osmon, 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Following resection arthroplasty with or without planned staged reimplantation: 300-450 mg every 12 hours in combination with an I.V. antistaphylococcal antibiotics for 4-6 weeks (Osmon, 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Staphylococcus aureus",
"      </i>",
"     </b>",
"     <b>",
"      infections, adjunctive therapy (unlabeled use):",
"     </b>",
"     Oral, I.V.: 600 mg once daily or 300-450 mg every 12 hours with other antibiotics.",
"     <b>",
"      Note:",
"     </b>",
"     Must be used in combination with another antistaphylococcal antibiotic to avoid rapid development of resistance (Liu, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F218215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"      see \"Rifampin (rifampicin): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tuberculosis, active:",
"     </b>",
"     Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children &lt;12 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Daily therapy:",
"     </i>",
"     10-20 mg/kg/day usually as a single dose (maximum: 600 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Twice weekly directly observed therapy (DOT):",
"     </i>",
"     10-20 mg/kg (maximum: 600 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     See &ldquo;Note&rdquo; in adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tuberculosis, latent infection (LTBI):",
"     </b>",
"     As an alternative to isoniazid: Children: 10-20 mg/kg/day (maximum: 600 mg/day) for 6 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       H. influenzae",
"      </i>",
"     </b>",
"     <b>",
"      prophylaxis (unlabeled use):",
"     </b>",
"     Oral, I.V.: Infants and Children: 20 mg/kg/day every 24 hours for 4 days, not to exceed 600 mg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Meningococcal prophylaxis (unlabeled use):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;1 month: 10 mg/kg/day in divided doses every 12 hours for 2 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children: 20 mg/kg/day in divided doses every 12 hours for 2 days (maximum: 600 mg/dose)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nasal carriers of",
"     </b>",
"     <b>",
"      <i>",
"       Staphylococcus aureus",
"      </i>",
"     </b>",
"     <b>",
"      (unlabeled use):",
"     </b>",
"     Oral, I.V.: 15 mg/kg/day divided every 12 hours for 5-10 days;",
"     <b>",
"      Note: Must use in combination with at least one other systemic antistaphylococcal antibiotic.",
"     </b>",
"     Not recommended as first-line drug for decolonization; evidence is weak for use in patients with recurrent infections (Liu, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pharyngeal chronic carriers of group A streptococci, treatment (unlabeled use; IDSA guidelines):",
"     </b>",
"     Children and Adolescents: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F218193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F218194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment required in renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Poorly dialyzed; no supplemental dose or dosage adjustment necessary, including patients on intermittent hemodialysis, peritoneal dialysis, or continuous renal replacement therapy (eg, CVVHD).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F218195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dose reductions are necessary to reduce hepatotoxicity.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F218158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 150 mg, 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rifadin&reg;: 150 mg, 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rifadin&reg;: 600 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F218142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F218162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Administer I.V. preparation by slow I.V. infusion over 30 minutes to 3 hours at a final concentration not to exceed 6 mg/mL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer on an empty stomach (ie, 1 hour prior to, or 2 hours after meals or antacids) to increase total absorption. The compounded oral suspension must be shaken well before using. May mix contents of capsule with applesauce or jelly.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F218245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Variable stability (consult detailed reference)",
"     </b>",
"     in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Incompatible:",
"     </b>",
"     Diltiazem.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F218161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of active tuberculosis in combination with other agents; elimination of meningococci from the nasopharynx in asymptomatic carriers",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F218235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis of",
"     <i>",
"      Haemophilus influenzae",
"     </i>",
"     type b infection;",
"     <i>",
"      Legionella",
"     </i>",
"     pneumonia; used in combination with other anti-infectives in the treatment of staphylococcal infections; treatment of",
"     <i>",
"      M. leprae",
"     </i>",
"     infections; used in combination with penicillin for the treatment of chronic carriers of pharyngeal group A streptococci",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F218247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Rifadin&reg; may be confused with Rifater&reg;, Ritalin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Rifampin may be confused with ribavirin, rifabutin, Rifamate&reg;, rifapentine, rifaximin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F218236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal (1% to 2%): Anorexia, cramps, diarrhea, epigastric distress, flatulence, heartburn, nausea, pseudomembranous colitis, pancreatitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: LFTs increased (up to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Edema, flushing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Ataxia, behavioral changes, concentration impaired, confusion, dizziness, drowsiness, fatigue, fever, headache, numbness, psychosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pemphigoid reaction, pruritus, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Adrenal insufficiency, menstrual disorders",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Agranulocytosis (rare), DIC, eosinophilia, hemoglobin decreased, hemolysis, hemolytic anemia, leukopenia, thrombocytopenia (especially with high-dose therapy)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Hepatitis (rare), jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia, osteomalacia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Exudative conjunctivitis, visual changes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Acute renal failure, BUN increased, hemoglobinuria, hematuria, interstitial nephritis, uric acid increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F218166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to rifampin, any rifamycins, or any component of the formulation; concurrent use of amprenavir, saquinavir/ritonavir (possibly other protease inhibitors)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F218146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Flu-like syndrome: Regimens of &gt;600 mg once or twice weekly have been associated with a high incidence of adverse reactions including a flu-like syndrome.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic effects: May cause thrombocytopenia, leukopenia, or anemia with regimens &gt;600 mg once or twice weekly.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperbilirubinemia: Discontinue therapy if this occurs in conjunction with clinical symptoms or any signs of significant hepatocellular damage develop.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity: Hypersensitivity reactions have occurred in patients taking &gt;600 mg once or twice weekly.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Alcoholism: Use with caution in patients with a history of alcoholism (even if ethanol consumption is discontinued during therapy).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with liver impairment; dosage modification recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Meningococcal disease: Do not use for meningococcal disease, only for short-term treatment of asymptomatic carrier states.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Porphyria: Use with caution in patients with porphyria; exacerbations have been reported due to enzyme-inducing properties.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Medications associated with hepatotoxicity: Use with caution in patients receiving concurrent medications associated with hepatotoxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate administration: Do not administer I.V. form via I.M. or SubQ routes; restart infusion at another site if extravasation occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Compliance: Monitor for compliance in patients on intermittent therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Contact lenses: Remove soft contact lenses during therapy since permanent staining may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Red/orange discoloration: Urine, feces, saliva, sweat, tears, and CSF may be discolored to red/orange.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F218233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of P-glycoprotein, SLCO1B1;",
"     <b>",
"      Induces",
"     </b>",
"     CYP1A2 (strong), CYP2A6 (strong), CYP2B6 (strong), CYP2C19 (strong), CYP2C8 (strong), CYP2C9 (strong), CYP3A4 (strong), P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F218151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfentanil: Rifamycin Derivatives may decrease the serum concentration of Alfentanil.  Management: Monitor closely for decreased alfentanil effectiveness.  Increased alfentanil doses will likely be needed.  Alternatively, changing from alfentanil to a different opioid anesthetic (e.g., sufentanil) may also be considered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: Rifamycin Derivatives may increase the metabolism of Amiodarone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: Rifamycin Derivatives may increase the metabolism of Angiotensin II Receptor Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Candesartan; Eprosartan; Olmesartan; Telmisartan; Valsartan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents (Thiazolidinedione): Rifampin may increase the metabolism of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antiemetics (5HT3 Antagonists): Rifamycin Derivatives may increase the metabolism of Antiemetics (5HT3 Antagonists).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dolasetron; Granisetron; Palonosetron.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): Rifamycin Derivatives may decrease the serum concentration of Antifungal Agents (Azole Derivatives, Systemic). Antifungal Agents (Azole Derivatives, Systemic) may increase the serum concentration of Rifamycin Derivatives. Only rifabutin appears to be affected.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Apixaban: CYP3A4 Inducers (Strong) may decrease the serum concentration of Apixaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: Rifamycin Derivatives may increase the metabolism of Aprepitant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: Rifampin may decrease the serum concentration of Atazanavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atovaquone: Rifamycin Derivatives may decrease the serum concentration of Atovaquone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: Rifamycin Derivatives may increase the metabolism of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bedaquiline: CYP3A4 Inducers (Strong) may decrease the serum concentration of Bedaquiline.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bendamustine: CYP1A2 Inducers (Strong) may decrease the serum concentration of Bendamustine. Concentrations of active metabolites may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Rifamycin Derivatives may increase the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Rifamycin Derivatives may decrease the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Atenolol; Carteolol (Ophthalmic); Levobunolol; Metipranolol; Nadolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: Rifampin may decrease the serum concentration of Boceprevir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bortezomib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Bortezomib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosentan: Rifampin may decrease the serum concentration of Bosentan. Following the initial several weeks of concurrent rifampin, this effect is most likely. Rifampin may increase the serum concentration of Bosentan. This effect is most likely to be observed within the initial few weeks of concurrent therapy (and may be greatest immediately following initiation of the combination).  Management: Weekly monitoring of liver function tests during the first 4 weeks of concurrent therapy is recommended, with a return to normal recommended monitoring thereafter as appropriate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Brentuximab Vedotin: CYP3A4 Inducers (Strong) may decrease the serum concentration of Brentuximab Vedotin. Specifically, concentrations of the active monomethyl auristatin E (MMAE) component may be decreased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BusPIRone: Rifamycin Derivatives may decrease the serum concentration of BusPIRone.  Management: The degree to which rifampin alters buspirone concentrations warrants the consideration of an alternative to buspirone that is not metabolized by CYP3A4.  If these agents are used together, buspirone dose adjustments may be needed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cabozantinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Cabozantinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Rifamycin Derivatives may increase the metabolism of Calcium Channel Blockers. This primarily affects oral forms of calcium channel blockers.  Management: The labeling for some U.S. and Canadian calcium channel blockers contraindicate use with rifampin however recommendations vary. Consult appropriate labeling.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Canagliflozin: Rifampin may decrease the serum concentration of Canagliflozin.  Management: Consider increasing canagliflozin dose to 300 mg/day in patients with estimated GFR &gt;60 mL/min/1.73 m2 who tolerate canagliflozin 100 mg/day and require greater glycemic control. Consider alternatives in patients with estimated GFR 45-60 mL/min/1.73 m2.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Caspofungin: Rifampin may decrease the serum concentration of Caspofungin.  Management: Caspofungin prescribing information recommends using a dose of 70 mg daily in adults (or 70 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     , up to a maximum of 70 mg, daily in pediatric patients) who are also receiving rifampin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloramphenicol: Rifampin may increase the metabolism of Chloramphenicol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: Rifamycin Derivatives may enhance the therapeutic effect of Clopidogrel.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: Rifampin may decrease the serum concentration of Cobicistat.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): Rifamycin Derivatives may decrease the serum concentration of Contraceptives (Estrogens). Contraceptive failure is possible.  Management: Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): Rifamycin Derivatives may decrease the serum concentration of Contraceptives (Progestins). Contraceptive failure is possible.  Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Rifamycin Derivatives may increase the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Crizotinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Crizotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Rifamycin Derivatives may increase the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Substrates: CYP1A2 Inducers (Strong) may increase the metabolism of CYP1A2 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2B6 Substrates: CYP2B6 Inducers (Strong) may increase the metabolism of CYP2B6 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Substrates: CYP2C19 Inducers (Strong) may increase the metabolism of CYP2C19 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Substrates: CYP2C8 Inducers (Strong) may increase the metabolism of CYP2C8 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Substrates: CYP2C9 Inducers (Strong) may increase the metabolism of CYP2C9 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: CYP3A4 Inducers (Strong) may increase the metabolism of CYP3A4 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: P-glycoprotein/ABCB1 Inducers may decrease the serum concentration of Dabigatran Etexilate.  Management: Avoid concurrent use of dabigatran with p-glycoprotein inducers when possible.  Closely monitor for decreased levels/effects of dabigatran if concomitantly administering  p-glycoprotein inducers, particularly strong inducers.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dapsone (Systemic): Rifamycin Derivatives may increase the metabolism of Dapsone (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: Rifampin may decrease the serum concentration of Darunavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Dasatinib.  Management: Avoid when possible. If such a combination cannot be avoided, consider increasing dasatinib dose and monitor clinical response and toxicity closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Rifampin may decrease the serum concentration of Deferasirox.  Management: Avoid combination when possible; if the combination must be used, consider a 50% increase in initial deferasirox dose, with monitoring of serum ferritin concentrations and clinical responses to guide further dosing.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delavirdine: May decrease the metabolism of Rifamycin Derivatives. Rifamycin Derivatives may increase the metabolism of Delavirdine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diclofenac (Systemic): CYP2C9 Inducers (Strong) may decrease the serum concentration of Diclofenac (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Rifamycin Derivatives may decrease the serum concentration of Disopyramide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: Rifampin may decrease the serum concentration of Divalproex.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: CYP3A4 Inducers (Strong) may decrease the serum concentration of Dronedarone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Efavirenz: Rifampin may decrease the serum concentration of Efavirenz.  Management: Increase efavirenz adult dose to 800 mg daily in patients weighing over 50 kg (per U.S. manufacturer; CDC sets this at 60 kg, and Canadian manufacturer recommends the dose increase regardless of weight).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: May increase the serum concentration of OATP1B1/SLCO1B1 Substrates. Management: According to eltrombopag prescribing information, consideration of a preventative dose reduction may be warranted.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elvitegravir: Rifampin may decrease the serum concentration of Elvitegravir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Enzalutamide: CYP2C8 Inducers (Strong) may decrease the serum concentration of Enzalutamide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Enzalutamide: CYP3A4 Inducers (Strong) may decrease the serum concentration of Enzalutamide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Rifampin may increase the metabolism of Erlotinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Esomeprazole: Rifampin may decrease the serum concentration of Esomeprazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etravirine: Rifamycin Derivatives may decrease the serum concentration of Etravirine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: CYP3A4 Inducers (Strong) may decrease the serum concentration of Everolimus.  Management: Avoid concurrent use of strong CYP3A4 inducers, but if strong CYP3A4 inducers cannot be avoided, consider gradually (in 5 mg increments) increasing the everolimus dose from 10 mg/day to 20 mg/day (adult doses).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Exemestane: CYP3A4 Inducers (Strong) may decrease the serum concentration of Exemestane.  Management: Exemestane U.S. product labeling recommends using an increased dose (50 mg/day) in patients receiving concurrent strong CYP3A4 inducers. The Canadian product labeling does not recommend a dose adjustment  with concurrent use of strong CYP3A4 inducers.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Rifamycin Derivatives may decrease the serum concentration of FentaNYL.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fexofenadine: Rifampin may decrease the serum concentration of Fexofenadine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May decrease the metabolism of Rifamycin Derivatives. This appears only affect rifabutin. Rifamycin Derivatives may increase the metabolism of Fluconazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosamprenavir: Rifampin may decrease the serum concentration of Fosamprenavir. Specifically, concentrations of amprenavir (active metabolite) may be decreased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: Rifampin may decrease the serum concentration of Fosaprepitant. More specifically, rifampin may decrease concentrations of the active metabolite aprepitant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Rifamycin Derivatives may decrease the serum concentration of Fosphenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gefitinib: Rifamycin Derivatives may increase the metabolism of Gefitinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     GuanFACINE: CYP3A4 Inducers (Strong) may decrease the serum concentration of GuanFACINE.  Management: Consider increasing the guanfacine dose by 2-fold when adding a strong CYP3A4 inducer.  Titrate the guanfacine dose up to a max of 8 mg/day when starting guanfacine in a patient who is taking a strong CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Rifamycin Derivatives may decrease the serum concentration of HMG-CoA Reductase Inhibitors.  Management: Consider use of noninteracting antilipemic agents (note: pitavastatin concentrations may increase with rifamycin treatment).  Monitor for altered HMG-CoA reductase inhibitor effects. Rifabutin and fluvastatin, or possibly pravastatin, may pose lower risk.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pitavastatin; Rosuvastatin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ifosfamide: CYP3A4 Inducers (Strong) may increase serum concentrations of the active metabolite(s) of Ifosfamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Imatinib: Rifamycin Derivatives may decrease the serum concentration of Imatinib.  Management: Avoid concurrent use of imatinib with the rifamycin derivatives when possible.  If such a combination must be used, increase imatinib dose by at least 50% and monitor the patient's clinical response closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indinavir: Rifampin may decrease the serum concentration of Indinavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: Rifamycin Derivatives may enhance the hepatotoxic effect of Isoniazid. Even so, this is a frequently employed combination regimen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: CYP3A4 Inducers (Strong) may decrease the serum concentration of Ivacaftor.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ixabepilone: CYP3A4 Inducers (Strong) may decrease the serum concentration of Ixabepilone.  Management: Avoid this combination whenever possible.  If this combination must be used, a gradual increase in ixabepilone dose from 40 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     to 60 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     (given as a 4-hour infusion), as tolerated, should be considered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: Rifampin may increase the metabolism of LamoTRIgine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lapatinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Lapatinib.  Management: If therapy overlap cannot be avoided, consider titrating lapatinib gradually from 1,250 mg/day up to 4,500 mg/day (HER2 positive metastatic breast cancer) or 1,500 mg/day up to 5,500 mg/day (hormone receptor/HER2 positive breast cancer) as tolerated.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Rifampin may increase serum concentrations of the active metabolite(s) of Leflunomide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linagliptin: CYP3A4 Inducers (Strong) may decrease the serum concentration of Linagliptin.  Management: Strongly consider using an alternative to any strong CYP3A4 inducer in patients who are being treated with linagliptin. If this combination is used, monitor patients closely for evidence of reduced linagliptin effectiveness.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linagliptin: P-glycoprotein/ABCB1 Inducers may decrease the serum concentration of Linagliptin.  Management: Strongly consider using an alternative to any strong P-glycoprotein inducer in patients who are being treated with linagliptin. If this combination is used, monitor patients closely for evidence of reduced linagliptin effectiveness.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lopinavir: Rifampin may enhance the adverse/toxic effect of Lopinavir. Specifically, the risk of hepatocellular toxicity may be increased. Rifampin may decrease the serum concentration of Lopinavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lurasidone: CYP3A4 Inducers (Strong) may decrease the serum concentration of Lurasidone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Rifamycin Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Maraviroc: CYP3A4 Inducers (Strong) may decrease the serum concentration of Maraviroc.  Management: Increase maraviroc adult dose to 600 mg twice daily when used with strong CYP3A4 inducers. This does not apply to patients also receiving strong CYP3A4 inhibitors. Do not use maraviroc with strong CYP3A4 inducers in patients with Clcr less than 30 mL/min.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Rifamycin Derivatives may decrease the serum concentration of Methadone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: CYP3A4 Inducers (Strong) may decrease the serum concentration of Mifepristone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Rifampin may decrease the serum concentration of Mirabegron.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Morphine (Systemic): Rifamycin Derivatives may decrease the serum concentration of Morphine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Rifamycin Derivatives may decrease the serum concentration of Mycophenolate. Specifically, rifamycin derivatives may decrease the concentration of the active metabolite mycophenolic acid.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nelfinavir: Rifampin may decrease the serum concentration of Nelfinavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nevirapine: Rifampin may decrease the serum concentration of Nevirapine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nilotinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Nilotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omeprazole: Rifampin may decrease the serum concentration of Omeprazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OxyCODONE: Rifampin may decrease the serum concentration of OxyCODONE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pazopanib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Pazopanib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: CYP3A4 Inducers (Strong) may decrease the serum concentration of Perampanel.  Management: Avoid use of perampanel with strong CYP3A inducers other than enzyme-inducing antiepileptic drugs (EIAEDs).  Increase perampanel starting dose to 4 mg/day when used with EIAEDs such as phenytoin, carbamazepine, or oxcarbazepine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inducers may decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Rifamycin Derivatives may decrease the serum concentration of Phenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pirfenidone: CYP1A2 Inducers (Strong) may decrease the serum concentration of Pirfenidone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pitavastatin: Rifamycin Derivatives may increase the serum concentration of Pitavastatin.  Management: Limit pitavastatin dose to a maximum of 2 mg/day with concurrent rifampin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: CYP1A2 Inducers (Strong) may decrease the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: CYP3A4 Inducers (Strong) may decrease the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inducers may decrease the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ponatinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Ponatinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prasugrel: Rifampin may diminish the antiplatelet effect of Prasugrel.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Praziquantel: CYP3A4 Inducers (Strong) may decrease the serum concentration of Praziquantel.  Management: Avoid concomitant use of praziquantel with strong CYP3A4 inducers. Discontinue rifampin 4 weeks prior to initiation of praziquantel therapy. Rifampin may be resumed the day following praziquantel completion.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: Rifamycin Derivatives may decrease the serum concentration of Propafenone.  Management: Monitor propafenone serum concentrations closely with rifamycin initiation/dose adjustments/discontinuation. Propafenone serum concentrations/therapeutic effects  may decrease with rifamycins. Propafenone dose adjustments may be necessary.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pyrazinamide: May enhance the hepatotoxic effect of Rifampin. Severe (even fatal) liver injury has been reported in patients receiving these 2 drugs as a 2-month treatment regimen for latent TB infection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Rifamycin Derivatives may decrease the serum concentration of QuiNIDine.  Management: Consider alternatives to combination treatment with quinidine and rifampin due to large potential decreases in quinidine concentrations. Monitor for decreased quinidine concentrations/effects with initiation/dose increase of any rifamycin derivative.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: Rifampin may decrease the serum concentration of QuiNINE.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Raltegravir: Rifampin may decrease the serum concentration of Raltegravir.  Management: Increase raltegravir dose to 800 mg twice daily (adult dose) when used concomitantly with rifampin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ramelteon: Rifamycin Derivatives may increase the metabolism of Ramelteon.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ranolazine: Rifampin may decrease the serum concentration of Ranolazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Regorafenib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Regorafenib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Repaglinide: Rifamycin Derivatives may increase the metabolism of Repaglinide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilpivirine: Rifamycin Derivatives may decrease the serum concentration of Rilpivirine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ritonavir: Rifampin may decrease the serum concentration of Ritonavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: CYP3A4 Inducers (Strong) may decrease the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: Rifampin may decrease the serum concentration of Roflumilast.  Management: Roflumilast U.S. prescribing information recommends against combining rifampin with roflumilast.  The Canadian product monograph makes no such recommendation but notes that rifampin may reduce roflumilast therapeutic effects.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RomiDEPsin: CYP3A4 Inducers (Strong) may decrease the serum concentration of RomiDEPsin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saquinavir: Rifampin may enhance the adverse/toxic effect of Saquinavir. Specifically, the risk of hepatocellular toxicity may be increased. Rifampin may decrease the serum concentration of Saquinavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sirolimus: Rifampin may increase the metabolism of Sirolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SORAfenib: CYP3A4 Inducers (Strong) may decrease the serum concentration of SORAfenib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: Rifampin may increase the metabolism of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SUNItinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of SUNItinib.  Management: Avoid when possible. If such a combination cannot be avoided, consider increasing sunitinib dose and monitor clinical response and toxicity closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Rifamycin Derivatives may increase the metabolism of Tacrolimus (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tadalafil: CYP3A4 Inducers (Strong) may decrease the serum concentration of Tadalafil.  Management: Erectile dysfunction: monitor for decreased effectiveness - no standard dose adjustments recommended.  Avoid use of tadalafil for pulmonary arterial hypertension in patients receiving a strong CYP3A4 inducer.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: Rifamycin Derivatives may increase the metabolism of Tamoxifen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Rifampin may decrease the serum concentration of Telaprevir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Temsirolimus: Rifamycin Derivatives may decrease the serum concentration of Temsirolimus. Rifamycins will likely cause an even greater decrease in the concentration of the active metabolite sirolimus.  Management: Temsirolimus prescribing information recommends against coadministration with strong CYP3A4 inducers such as rifampin; however, if concurrent therapy is necessary, an increase in temsirolimus adult dose to 50 mg/week should be considered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Terbinafine (Systemic): Rifampin may decrease the serum concentration of Terbinafine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Rifampin may decrease the serum concentration of Thyroid Products.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ticagrelor: CYP3A4 Inducers (Strong) may decrease serum concentrations of the active metabolite(s) of Ticagrelor. CYP3A4 Inducers (Strong) may decrease the serum concentration of Ticagrelor.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: Rifampin may decrease the serum concentration of Tipranavir.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Tofacitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: CYP3A4 Inducers (Strong) may decrease the serum concentration of Tolvaptan.  Management: If concurrent use is necessary, increased doses of tolvaptan (with close monitoring for toxicity and clinical response) may be needed.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Toremifene: CYP3A4 Inducers (Strong) may decrease the serum concentration of Toremifene.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: CYP2C8 Inducers (Strong) may decrease the serum concentration of Treprostinil.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ulipristal: CYP3A4 Inducers (Strong) may decrease the serum concentration of Ulipristal.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: Rifampin may decrease the serum concentration of Valproic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vandetanib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Vandetanib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vemurafenib: CYP3A4 Inducers (Strong) may decrease the serum concentration of Vemurafenib.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): CYP3A4 Inducers (Strong) may decrease the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inducers may decrease the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Rifamycin Derivatives may increase the metabolism of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: May increase the serum concentration of Rifamycin Derivatives. Rifamycin Derivatives may decrease the serum concentration of Voriconazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zaleplon: Rifamycin Derivatives may increase the metabolism of Zaleplon.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zidovudine: Rifamycin Derivatives may decrease the serum concentration of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: Rifamycin Derivatives may decrease the serum concentration of Zolpidem.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zuclopenthixol: CYP3A4 Inducers (Strong) may decrease the serum concentration of Zuclopenthixol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F218183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may increase risk of hepatotoxicity).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Food decreases the extent of absorption; rifampin concentrations may be decreased if taken with food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease rifampin levels.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F218154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F218169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have been reported in animal studies. Rifampin crosses the human placenta. Due to the risk of tuberculosis to the fetus, treatment is recommended when the probability of maternal disease is moderate to high. Postnatal hemorrhages have been reported in the infant and mother with isoniazid administration during the last few weeks of pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F218200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10924208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The manufacturer does not recommend breast-feeding due to tumorigenicity observed in animal studies; however, the CDC does not consider rifampin a contraindication to breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F218170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rifampin should be taken on an empty stomach.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F218168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Rifadin Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (30): $103.74",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     300 mg (60): $293.87",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Rifampin Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (30): $47.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     300 mg (100): $201.16",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Rifadin Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (1): $189.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Rifampin Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (1): $136.25",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F218156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Periodic (baseline and every 2-4 weeks during therapy) monitoring of liver function (AST, ALT, bilirubin), CBC, mental status, sputum culture, chest x-ray 2-3 months into treatment",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F218171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Arficin (HR);",
"     </li>",
"     <li>",
"      Bactromax (CO);",
"     </li>",
"     <li>",
"      Benemicin (RU);",
"     </li>",
"     <li>",
"      Diabacil (ES);",
"     </li>",
"     <li>",
"      Dinoldin (ES);",
"     </li>",
"     <li>",
"      Eremfat (DE);",
"     </li>",
"     <li>",
"      Fenampicin (ES);",
"     </li>",
"     <li>",
"      Fimizina (ES);",
"     </li>",
"     <li>",
"      Fuhe (CL);",
"     </li>",
"     <li>",
"      Manorifcin (TH);",
"     </li>",
"     <li>",
"      Oxitrin (PY);",
"     </li>",
"     <li>",
"      Ramicin (ID);",
"     </li>",
"     <li>",
"      Rifacilin (IN);",
"     </li>",
"     <li>",
"      Rifacin (PH);",
"     </li>",
"     <li>",
"      Rifadex (EC);",
"     </li>",
"     <li>",
"      Rifadin (AE, AR, AU, BF, BH, BJ, CI, CY, CZ, EG, ET, GB, GH, GM, GN, GR, HK, IE, IQ, IR, IT, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, MX, NE, NG, NL, NZ, OM, PK, PT, QA, SA, SC, SD, SE, SL, SN, SY, TN, TR, TW, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Rifadine (BE, FR, LU);",
"     </li>",
"     <li>",
"      Rifagen (ES);",
"     </li>",
"     <li>",
"      Rifaldin (BR, CN, ES);",
"     </li>",
"     <li>",
"      Rifaldin[inj.] (ES);",
"     </li>",
"     <li>",
"      Rifamcin (TH);",
"     </li>",
"     <li>",
"      Rifamed (HN, HU);",
"     </li>",
"     <li>",
"      Rifampicin (PL);",
"     </li>",
"     <li>",
"      Rifampicin Labatec (CH);",
"     </li>",
"     <li>",
"      Rifampin (KP);",
"     </li>",
"     <li>",
"      Rifapin (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Rifaprodin (ES);",
"     </li>",
"     <li>",
"      Rifarad (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Rifaren (SG);",
"     </li>",
"     <li>",
"      Rifarm (FI);",
"     </li>",
"     <li>",
"      Rifasynt (MY);",
"     </li>",
"     <li>",
"      Rifocina (PE);",
"     </li>",
"     <li>",
"      Rifocina Spray (CO);",
"     </li>",
"     <li>",
"      Rifodex (KP);",
"     </li>",
"     <li>",
"      Rifoldin (AT);",
"     </li>",
"     <li>",
"      Rifoldine (CH);",
"     </li>",
"     <li>",
"      Rifonilo (ES);",
"     </li>",
"     <li>",
"      Riforal (ES);",
"     </li>",
"     <li>",
"      Rimactan (AT, BG, CH, DK, ES, FR, HR, LU, MX, NL, NO, PE, SE, UY, VE);",
"     </li>",
"     <li>",
"      Rimactane (BB, BF, BJ, BM, BS, BZ, CI, ET, GB, GH, GM, GN, GY, ID, IL, IN, JM, KE, LR, MA, ML, MR, MU, MW, MY, NE, NG, SC, SD, SL, SN, SR, TN, TT, TZ, UG, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Rimactan[inj.] (CH);",
"     </li>",
"     <li>",
"      Rimafed (PH);",
"     </li>",
"     <li>",
"      Rimapen (FI);",
"     </li>",
"     <li>",
"      Rimecin (TH);",
"     </li>",
"     <li>",
"      Rimpacin (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Rimpin (IN);",
"     </li>",
"     <li>",
"      Rimycin (AU);",
"     </li>",
"     <li>",
"      Ripin (TW);",
"     </li>",
"     <li>",
"      Shu Lan Xin (CL);",
"     </li>",
"     <li>",
"      Tubocin (HU);",
"     </li>",
"     <li>",
"      Tugaldin (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F218145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial RNA synthesis by binding to the beta subunit of DNA-dependent RNA polymerase, blocking RNA transcription",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F218165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: &le;24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed; food may delay or slightly reduce peak",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Highly lipophilic; crosses blood-brain barrier well",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Relative diffusion from blood into CSF: Adequate with or without inflammation (exceeds usual MICs)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CSF:blood level ratio: Inflamed meninges: 25%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; undergoes enterohepatic recirculation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 3-4 hours; prolonged with hepatic impairment; End-stage renal disease: 1.8-11 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: Oral: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (60% to 65%) and urine (~30%) as unchanged drug",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Acocella G, &ldquo;Clinical Pharmacokinetics of Rifampicin,&ldquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1978, 3(2):108-27.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/346286/pubmed\" id=\"346286\" target=\"_blank\">",
"        346286",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Advenier C, Gobert C, Houin G, et al, &ldquo;Pharmacokinetic Studies of Rifampicin in the Elderly,&rdquo;",
"      <i>",
"       Ther Drug Monit",
"      </i>",
"      , 1983, 5(1):61-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/6845400/pubmed\" id=\"6845400\" target=\"_blank\">",
"        6845400",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Infectious Diseases, &ldquo;Chemotherapy for Tuberculosis in Infants and Children,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1992, 89(1):161-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/1728006/pubmed\" id=\"1728006\" target=\"_blank\">",
"        1728006",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics, &ldquo;Pediatric Infections,&ldquo;",
"      <i>",
"       Red Book&reg;: 2006 Report of the Committee on Infectious Diseases",
"      </i>",
"      , 27th ed, Pickering LK, ed, Elk Grove Village, IL: American Academy of Pediatrics, 2006, 530.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Thoracic Society, &ldquo;Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2000, 49(RR-6):1-51.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Askgaard DS, Wilcke T, and Dossing M, &ldquo;Hepatotoxicity Caused by the Combined Action of Isoniazid and Rifampin,&rdquo;",
"      <i>",
"       Thorax",
"      </i>",
"      , 1995, 50(2):213-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/7701468/pubmed\" id=\"7701468\" target=\"_blank\">",
"        7701468",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baddour LM, Wilson WR, Bayer AS, et al, &ldquo;Infective Endocarditis. Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - Executive Summary:",
"      <i>",
"       Endorsed by the Infectious Diseases Society of America",
"      </i>",
"      ,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2005, 111(23):3167-184.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/15956145/pubmed\" id=\"15956145\" target=\"_blank\">",
"        15956145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bass JB Jr, Farer LS, Hopewell PC, et al, &ldquo;Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children,&rdquo;",
"      <i>",
"       Am J Respir Crit Care Med",
"      </i>",
"      , 1994, 149(5):1359-74.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/8173779/pubmed\" id=\"8173779\" target=\"_blank\">",
"        8173779",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Blumberg HM, Burman WJ, Chaisson RE, et al, &ldquo;American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis,&rdquo;",
"      <i>",
"       Am J Respir Crit Care Med",
"      </i>",
"      , 2003, 167(4):603-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/12588714/pubmed\" id=\"12588714\" target=\"_blank\">",
"        12588714",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Borcherding SM, Baciewicz AM, and Self TH, &ldquo;Update on Rifampin Drug Interactions. II,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1992, 152(4):711-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/1558427/pubmed\" id=\"1558427\" target=\"_blank\">",
"        1558427",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, &ldquo;Treatment of Tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2003, 52(RR11);26, 64. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/12836625/pubmed\" id=\"12836625\" target=\"_blank\">",
"        12836625",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control, &ldquo;Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection - United States, 2003,&rdquo;",
"      <i>",
"       MMWR",
"      </i>",
"      , 52(31);735-9. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/mm5231a4.htm\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/mm5231a4.htm",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Daher R, Haidar JH, and Al-Amin H, &ldquo;Rifampin Interference With Opiate Immunoassays,&rdquo;",
"      <i>",
"       Clin Chem",
"      </i>",
"      , 2002, 48(1):203-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/11751562/pubmed\" id=\"11751562\" target=\"_blank\">",
"        11751562",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davidson PT and Le HQ, &ldquo;Drug Treatment of Tuberculosis - 1992,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1992, 43(5):651-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/1379145/pubmed\" id=\"1379145\" target=\"_blank\">",
"        1379145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      De Vriese AS, Robbrecht DL, Vanholder RC, et al, &ldquo;Rifampicin-Associated Acute Renal Failure: Pathophysiologic, Immunologic, and Clinical Features,&rdquo;",
"      <i>",
"       Am J Kidney Dis",
"      </i>",
"      , 1998, 31(1):108-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/9428460/pubmed\" id=\"9428460\" target=\"_blank\">",
"        9428460",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Tuberculosis,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 1993, 35(908):99-101.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/8412982/pubmed\" id=\"8412982\" target=\"_blank\">",
"        8412982",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Furlan V, Perello L, Jacquemin E, et al, &ldquo;Interactions Between FK506 and Rifampicin or Erythromycin in Pediatric Liver Recipients,&rdquo;",
"      <i>",
"       Transplantation",
"      </i>",
"      , 1995, 59(8):1217-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/7537398/pubmed\" id=\"7537398\" target=\"_blank\">",
"        7537398",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gould FK, Denning DW, Elliott TS, et al, &ldquo;Guidelines for the Diagnosis and Antibiotic Treatment of Endocarditis in Adults:  A Report of the Working Party of the British Society for Antimicrobial Chemotherapy,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2012, 67(2):269-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/22086858/pubmed\" id=\"22086858\" target=\"_blank\">",
"        22086858",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Griffith DE, Aksamit T, Brown-Elliott BA, et al, &ldquo;An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases,&rdquo;",
"      <i>",
"       Am J Respir Crit Care Med",
"      </i>",
"      , 2007, 175(4):367-416.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/17277290/pubmed\" id=\"17277290\" target=\"_blank\">",
"        17277290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Havlir DV and Barnes PF, &ldquo;Tuberculosis in Patients With Human Immunodeficiency Virus Infection,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1999, 340(5):367-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/9929528/pubmed\" id=\"9929528\" target=\"_blank\">",
"        9929528",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Herrera Trevilla P, Ortiz Jimenez E, Tena T, et al, &ldquo;Presence of Rifampicin in Urine Causes Cross-Reactivity With Opiates Using the KIMS Method,&rdquo;",
"      <i>",
"       J Anal Toxicol",
"      </i>",
"      , 1995, 19(3):200.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/7564301/pubmed\" id=\"7564301\" target=\"_blank\">",
"        7564301",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Holdiness MR, &ldquo;A Review of the Redman Syndrome and Rifampicin Overdose,&rdquo;",
"      <i>",
"       Med Toxicol Adverse Drug Exp",
"      </i>",
"      , 1989, 4(6):444-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/2689837/pubmed\" id=\"2689837\" target=\"_blank\">",
"        2689837",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Iseman MD, &ldquo;Treatment of Multidrug-Resistant Tuberculosis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 329(11):784-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/8350889/pubmed\" id=\"8350889\" target=\"_blank\">",
"        8350889",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kindelan JM, Serrano I, Jurado R, et al, &ldquo;Rifampin-Induced Severe Thrombocytopenia in a Patient With Pulmonary Tuberculosis,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1994, 28(11):1304-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/7849351/pubmed\" id=\"7849351\" target=\"_blank\">",
"        7849351",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liu C, Bayer A, Cosgrove SE, et al, &ldquo;Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant",
"      <i>",
"       Staphylococcus Aureus",
"      </i>",
"      Infections in Adults and Children: Executive Summary,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 52(3):285-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/21217178/pubmed\" id=\"21217178\" target=\"_blank\">",
"        21217178",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lundstrom TS and Sobel JD, &ldquo;Vancomycin, Trimethoprim-Sulfamethoxazole, and Rifampin,&rdquo;",
"      <i>",
"       Infect Dis Clin North Am",
"      </i>",
"      , 1995, 9(3):747-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/7490442/pubmed\" id=\"7490442\" target=\"_blank\">",
"        7490442",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nahata MC, Morosco RS, and Hipple TF, &ldquo;Effect of Preparation Method and Storage on Rifampin Concentration in Suspensions,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1994, 28(2):182-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/8173129/pubmed\" id=\"8173129\" target=\"_blank\">",
"        8173129",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Noble A, &ldquo;Antituberculous Therapy and Acute Liver Failure,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1995, 345(8953):867.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Orisakwe OE, Dioka CE, Orish CN, et al, &ldquo;Charcoal and Rifampicin Pharmacokinetics,&rdquo;",
"      <i>",
"       Am J Therapeut",
"      </i>",
"      , 1995, 68-70.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Osmon DR, Berbari EF, Berendt AR, et al, &ldquo;Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guideline by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2013, 56(1):e1-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/23223583/pubmed\" id=\"23223583\" target=\"_blank\">",
"        23223583",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Plomp TA, Battista HJ, Unterdorfer H, et al, &ldquo;A Case of Fatal Poisoning by Rifampicin,&rdquo;",
"      <i>",
"       Arch Toxicol",
"      </i>",
"      , 1981, 48(4):245-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/7316759/pubmed\" id=\"7316759\" target=\"_blank\">",
"        7316759",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Prevention and Treatment of Tuberculosis Among Patients Infected With Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations. Centers for Disease Control and Prevention,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 1998, 47(RR-20):1-58.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shulman ST, Bisno AL, Clegg HW, et al, &ldquo;Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 55(10):e86-102.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/22965026/pubmed\" id=\"22965026\" target=\"_blank\">",
"        22965026",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Starke JR, &ldquo;Modern Approach to the Diagnosis and Treatment of Tuberculosis in Children,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1988, 35(3):441-64.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Starke JR, &ldquo;Multidrug Therapy for Tuberculosis in Children,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1990, 9(11):785-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/2124671/pubmed\" id=\"2124671\" target=\"_blank\">",
"        2124671",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Treatment of Latent Tuberculosis Infection (LTBI), Last Updated: April 8, 2004.&rdquo; Available at",
"      <a href=\"file://www.cdc.gov/nchstp/tb/pubs/tbfactsheets/250110.htm\" target=\"_blank\">",
"       file://www.cdc.gov/nchstp/tb/pubs/tbfactsheets/250110.htm",
"      </a>",
"      . Last accessed February 16, 2005.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al, &ldquo;Practice Guidelines for the Management of Bacterial Meningitis,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2004, 39(9):1267-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/15494903/pubmed\" id=\"15494903\" target=\"_blank\">",
"        15494903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Van Scoy RE and Wilkowske CJ, &ldquo;Antituberculosis Agents,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1992, 67(2):179-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/1347579/pubmed\" id=\"1347579\" target=\"_blank\">",
"        1347579",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vesely JJ, Pien FD, and Pien BC, &ldquo;Rifampin, a Useful Drug for Nonmycobacterial Infections,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1998, 18(2):345-57.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/9545154/pubmed\" id=\"9545154\" target=\"_blank\">",
"        9545154",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Walker-Renard P, &ldquo;Pruritus Associated With Intravenous Rifampin,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1995, 29(3):267-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/7606073/pubmed\" id=\"7606073\" target=\"_blank\">",
"        7606073",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wong P, Bottoroff MB, Heritage RW, et al, &ldquo;Acute Rifampin Overdose: A Pharmacokinetic Study and Review of the Literature,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1984, 104(5):781-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/6371210/pubmed\" id=\"6371210\" target=\"_blank\">",
"        6371210",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yoshikawa TT, &ldquo;Tuberculosis in Aging Adults,&rdquo;",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 1992, 40(2):178-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/31/10746/abstract-text/1740604/pubmed\" id=\"1740604\" target=\"_blank\">",
"        1740604",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9864 Version 50.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-5CB361C86E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10746=[""].join("\n");
var outline_f10_31_10746=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218187\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218188\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218238\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218192\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218215\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218193\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218194\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218195\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218158\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218142\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218162\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218245\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218161\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218235\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218247\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218236\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218166\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218146\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218233\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218151\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218183\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218154\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218169\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218200\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10924208\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218170\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218168\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218156\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218171\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218145\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F218165\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9864\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9864|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/42/37541?source=related_link\">",
"      Rifampin (rifampicin): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=related_link\">",
"      Rifampin (rifampicin): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_31_10747="Granulomatous liver dz meds";
var content_f10_31_10747=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medications associated with granulomatous liver disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Allopurinol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        BCG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chlorpropramide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diltiazem",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gold",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Halothane",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydralazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interferon alfa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mebendazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methyldopa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nitrofurantoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenylbutazone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Procainamide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfa drugs",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10747=[""].join("\n");
var outline_f10_31_10747=null;
var title_f10_31_10748="Chang staging medulloblastoma";
var content_f10_31_10748=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified Chang system for staging of medulloblastoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"2\" rowspan=\"1\">",
"        Extent",
"of tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1",
"       </td>",
"       <td>",
"        Tumor less than 3 cm in diameter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2",
"       </td>",
"       <td>",
"        Tumor greater than 3",
"cm in diameter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T3a",
"       </td>",
"       <td>",
"        Tumor greater than 3 cm in diameter with extension into",
"the aqueduct of Sylvius and/or the foramen of Luschka",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T3b",
"       </td>",
"       <td>",
"        Tumor greater than 3 cm in diameter with unequivocal",
"extension into the brain stem",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        Tumor greater than 3 cm in diameter with extension up",
"past the aqueduct of Sylvius and/or down past the foramen magnum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        No consideration",
"is given to the number of structures invaded or the presence of",
"hydrocephalus.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        T3b can be",
"defined by intraoperative demonstration of tumor extension into the",
"brain stem in the absence of radiographic evidence.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"2\" rowspan=\"1\">",
"        Degree",
"of metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        No evidence of gross subarachnoid or hematogenous",
"metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M1",
"       </td>",
"       <td>",
"        Microscopic tumor cells found in the cerebrospinal fluid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M2",
"       </td>",
"       <td>",
"        Gross nodular seeding demonstrated in the",
"cerebellar/cerebral subarachnoid space or in the third or lateral",
"ventricles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M3",
"       </td>",
"       <td>",
"        Gross nodular seeding in the spinal subarachnoid space",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M4",
"       </td>",
"       <td>",
"        Metastasis outside the cerebrospinal axis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Chang, CH, Housepain, EM, Herbert, C, Radiology 1969; 93:1351, and Cohen, ME, Duffner, PK (Eds). Brain Tumors in Children, 2d ed, McGraw-Hill, New York, 1994, p. 187.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10748=[""].join("\n");
var outline_f10_31_10748=null;
var title_f10_31_10749="Knee examination part I";
var content_f10_31_10749=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F53905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F53905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Detailed examination of the knee part I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Examination",
"signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Confirmation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pressure of the patella against the femur causing",
"retropatellar pain and crepitation**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        #1 - Patellofemoral syndrome",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Bilateral sunrise views taken",
"on one cassette to evaluate for patellar subluxation and arthritic",
"changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patellar clicking with passive flexion",
"and extension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive",
"Install's maneuver (retropatellar pain with quadriceps contraction)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medial joint line tenderness or spurring or both**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        #2 - Medial compartment",
"osteoarthritis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Standing",
"AP of the knees on one cassette, showing narrowing of the articular",
"cartilage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stiffness or",
"incomplete flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crepitation",
"with passive flexion and extension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heel",
"to buttock measurement differs side to side**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Knee effusion",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Aspiration and laboratory",
"analysis for cell count, differential, crystals, gram stain, and culture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loss",
"of the peripatellar dimples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Synovial",
"milking sign",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ballotement sign",
"for large effusions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Distension",
"of suprapatellar pouch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cystic",
"swelling over the antero- inferior portion of the patella**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Prepatellar bursitis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Aspiration and laboratory",
"analysis for cell count, differential, crystals, gram stain, and culture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No",
"loss of range of motion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thickening of the prepatellar bursa**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Chronic prepatellar bursitis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Local anesthetic block in the",
"bursa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No loss of range of",
"motion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lateral joint line",
"tenderness or spurring or both**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Lateral compartment osteoarthritis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Standing AP of the knees on",
"one cassette showing narrowing of the articular cartilage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stiffness",
"or incomplete flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crepitation",
"with passive flexion and extension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness",
"over the medial tibial plateau, 1 and 1/2\" below the joint**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Anserine bursitis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Local anesthetic block in the",
"bursa 2 to 3 mm above the periosteum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No",
"pain with valgus stress testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal",
"knee range of motion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A line of",
"tenderness over the medial tibial plateau extending up to or above the",
"medial joint line**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Medial",
"collateral ligament injury",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Empiric treatment with 3 to 4 weeks of straight",
"leg immobilization;",
"local anesthetic block placed just over the ligament (optional)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain aggravated by valgus stress testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"aggravated by external rotation of the tibia on the femur",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ** is used to identify the hallmark sign; that is, the sign that has the greatest specificity for the diagnosis listed.",
"     <br>",
"      #1 and #2 refer to the two most common conditions affecting the knee.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10749=[""].join("\n");
var outline_f10_31_10749=null;
var title_f10_31_10750="Screening ECG features SCD A";
var content_f10_31_10750=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59279%7ECARD%2F67009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59279%7ECARD%2F67009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ECG features of the cardiac diseases detectable at pre-participation screening in young competitive athletes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        QTc interval",
"       </td>",
"       <td class=\"subtitle1\">",
"        P wave",
"       </td>",
"       <td class=\"subtitle1\">",
"        PR interval",
"       </td>",
"       <td class=\"subtitle1\">",
"        QRS complex",
"       </td>",
"       <td class=\"subtitle1\">",
"        ST interval",
"       </td>",
"       <td class=\"subtitle1\">",
"        T wave",
"       </td>",
"       <td class=\"subtitle1\">",
"        Arrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        HCM",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Normal",
"       </td>",
"       <td>",
"        (Left atrial enlargement)",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Increased voltages in mid-left precordial leads; abnormal Q waves in inferior and/or lateral leads;&nbsp;(LAD, LBBB); (delta wave)",
"       </td>",
"       <td>",
"        Down-sloping (up-sloping)",
"       </td>",
"       <td>",
"        Inverted in mid-left precordialleads; (giant&nbsp;and negative in the apical variant)",
"       </td>",
"       <td>",
"        (Atrial fibrillation); (PVB); (VT)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Arrhythmogenic right ventricular cardiomyopathy/dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Prolonged &gt;110 ms in right precordial leads; epsilon wave in right precordial leads; reduced voltages &le;0.5 mV in frontal leads; (RBBB)",
"       </td>",
"       <td>",
"        (Up-sloping in right precordial leads)",
"       </td>",
"       <td>",
"        Inverted right in&nbsp;precordial&nbsp;leads",
"       </td>",
"       <td>",
"        PVB with aLBBB pattern; (VT with a&nbsp;LBBB pattern)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Dilated cardiomyopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Normal",
"       </td>",
"       <td>",
"        (Left atrial enlargement)",
"       </td>",
"       <td>",
"        (Prolonged &ge;0.21 s)",
"       </td>",
"       <td>",
"        LBBB",
"       </td>",
"       <td>",
"        Down-sloping (up-sloping)",
"       </td>",
"       <td>",
"        Inverted in inferior and/or lateral leads",
"       </td>",
"       <td>",
"        PVB; (VT)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Long QT syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prolonged",
"       </td>",
"       <td rowspan=\"3\">",
"        Normal",
"       </td>",
"       <td rowspan=\"3\">",
"        Normal",
"       </td>",
"       <td rowspan=\"3\">",
"        Normal",
"       </td>",
"       <td rowspan=\"3\">",
"        Normal",
"       </td>",
"       <td rowspan=\"3\">",
"        Bifid or biphasic in all leads",
"       </td>",
"       <td rowspan=\"3\">",
"        (PVB); (torsade de pointes)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &gt;440 ms in males",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &gt;460 ms in females",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26:516. Copyright &copy; 2005 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ECG features of the cardiac diseases detectable at pre-participation screening in young competitive athletes (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        QTc interval",
"       </td>",
"       <td class=\"subtitle1\">",
"        P wave",
"       </td>",
"       <td class=\"subtitle1\">",
"        PR interval",
"       </td>",
"       <td class=\"subtitle1\">",
"        QRS complex",
"       </td>",
"       <td class=\"subtitle1\">",
"        ST interval",
"       </td>",
"       <td class=\"subtitle1\">",
"        T wave",
"       </td>",
"       <td class=\"subtitle1\">",
"        Arrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\" rowspan=\"1\">",
"        Brugada",
"syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Prolonged &ge;0.21",
"s",
"       </td>",
"       <td>",
"        S1S2S3 pattern; (RBBB/LAD)",
"       </td>",
"       <td>",
"        Up-sloping in coved-type right pre-cordial leads",
"       </td>",
"       <td>",
"        Inverted in right precordial leads",
"       </td>",
"       <td>",
"        (Polymorphic VT); (atrial fibrillation) (sinus",
"bradycardia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\" rowspan=\"1\">",
"        Lenegre",
"disease&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal&nbsp;",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Prolonged &ge;0.21",
"s",
"       </td>",
"       <td>",
"        RBBB; RBBB/LAD",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Secondary changes",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        (2nd or 3rd degree AV&nbsp;block)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LBBB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\" rowspan=\"1\">",
"        Short",
"QT syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Shortened",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal&nbsp;",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Normal",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Atrial fibrillation (polymorphic VT)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &lt;300 ms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\" rowspan=\"1\">",
"        Pre-excitation",
"syndrome (WPW)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Normal",
"       </td>",
"       <td colspan=\"1\">",
"        Normal",
"       </td>",
"       <td>",
"        Shortened &lt;0.12 s",
"       </td>",
"       <td>",
"        Delta wave",
"       </td>",
"       <td>",
"        Secondary changes",
"       </td>",
"       <td>",
"        Secondary changes",
"       </td>",
"       <td>",
"        Supraventricular tachycardia; (atrial fibrillation)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\" rowspan=\"1\">",
"        Coronary",
"artery*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (Prolonged)",
"       </td>",
"       <td colspan=\"1\">",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        (Abnormal Q waves)&bull;",
"       </td>",
"       <td>",
"        (Down- or up-sloping)",
"       </td>",
"       <td>",
"        Inverted in &ge;2",
"leads",
"       </td>",
"       <td>",
"        PVB; (VT);",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Less common or uncommon ECG findings are reported in brackets.",
"     <br>",
"      QTc: QT interval corrected for heart rate by Bazett's formula; LBBB: left bundle branch block; RBBB: right bundle branch block; LAD: left axis deviation of -30&ordm; or more; PVB: either single or coupled premature ventricular beats; VT: either non-sustained or sustained ventricular tachycardia.",
"      <br>",
"       * Coronary artery diseases: either premature coronary atherosclerosis or congenital coronary anomalies.",
"       <br>",
"        &bull; Abnormal Q waves.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26:516. Copyright&copy; 2005 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10750=[""].join("\n");
var outline_f10_31_10750=null;
var title_f10_31_10751="Map - Mansonella";
var content_f10_31_10751=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F85853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F85853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    Geographic distribution of Mansonella",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 313px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data of the southern hemisphere from the US Government. Map of Africa reproduced from: Simonsen PE, Onapa AW, Asio SM. Mansonella perstans filariasis in Africa. Acta Trop 2011; 120 Suppl 1:S109. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_31_10751=[""].join("\n");
var outline_f10_31_10751=null;
